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Summary 
 
The highly active antiretroviral therapy (HAART) drug agent, indinavir, and the 
endocrine disruptor compound, 2,4-dichlorophenol (2,4-DCP), are directly related 
to two of South Africa’s, and in fact, two of the globe’s most fundamentally 
important and comprehensively researched subjects areas, which includes, 
HIV/AIDS and water pollution. In fact these two compounds share multiple 
significant commonality factors. Firstly, they have a profound effect on the health 
aspects of humans, albeit from opposite sides of the ‘equation’. Secondly, in the 
context of metabolism, they both share the same rout of biotransformation, and as 
such, both have a profound effect on the main first pass metabolising hepatic 
enzyme, CYP450 3A4, as well as xenobiotics sharing the same metabolic 
pathway. Thirdly and perhaps more importantly, in direct relation to the human 
mortality, their levels preferentially require constant or regular monitoring, a 
process, at this stage, is still only officially possible with complex specialized 
analytically-based techniques. Moreover, these techniques are only based on 
centralized detection and quantification, which essentially means expensive 
procedures, and long waiting periods for results. This thesis firstly reports on the 
development and characterization of reagent-less and cobalt(III) sepulchrate 
[Co(Sep)
3+
] mediated biosensor platforms (biosensor platform 1 and biosensor 
platform 2), with human recombinant heme thiolate, cytochrome P450 3A4 
isoenzyme (CYP3A4), as biorecognition component. Secondly, each biosensor 
platform was evaluated by using an entirely different category of compound as 
model substrate, with the overall objective being the development of alternative 
analytical method for the detection and quantification of each of these  substrates, 
by amperometric transduction method. In this regard biosensor platform 1 was 
evaluated for the detection of 2,4-dichlorophenol, whereas biosensor platform 2  
was evaluated for the detection of protease inhibitor (PI) HAART drug, indinavir. 
Fourthly, this dissertation also reports on the use of genetic engineering as 
complimentary method during biosensor investigations, as source for continuous 
supply of  catalytically active biological recognition component. With respect to 
the preparation of the biosensors in particular, biosensor platform 1 was 
 
 
 
 
 iv 
 
constructed by entrapping the commercially sourced full-length, wild type 
CYP3A4 on a pre-formed electroactive carrier matrix, consisting of Co(Sep)
3+–
modified nafion membrane on a glassy carbon electrode. In this regard, the 
nafion-Co(Sep)
3+
 composite was prepared by integrating the Co(Sep)
3+
 species 
into a pre-formed nafion film through manual drop-coating and mixing methods. 
In addition to this, the so-formed biosensor was re-inforced by a thin nafion layer 
as outer-film. The complete biosensor may be denoted as GCE||naf|CME-
Co(Sep)
3+
|flCYP3A4|naf. Biosensor platform 2  on the other hand, was 
constructed by entrapment of the N-terminally modified human recombinant 
CYP3A4 (consisting only of the heme domain and the surrounding apoprotein), 
prepared locally through genetic engineering, as a histidine-tagged, catalytically 
active soluble construct, denoted nCYP3A4, in a biocompatible ionically 
crosslinked hydrogel-composite membrane. Enzyme immbilization in this case 
was also realized on a pre-formed nafion-Co(Sep)
3+
 carrier matrix film, however, 
in this case the electroactive carrier matrix was prepared by integrating the 
electroactive Co(Sep)
3+
 species deep within the nafion microstructure through 
potentiostatic electrodeposition method at a costant potential of +450 mV for 
1200 sec. The so prepared biosensor, is denoted GCE||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA. In this regard, biosensor for platform 2, 
different variables affecting the performance and stability of the biosensor were 
evaluated. Selected ex-situ characaterization methods, including scanning 
electrochemical microscopy (SEM), Fourier Transform Infrared (FTIR) and UV-
Vis spectroscopy was used as complimentary characterization methods.  , 
morphological and structural charaterization,  revealed  the formation of a highly 
stable electroactive composite film for the carrier matrix in biosensor platform 2 , 
exhibiting a compact nature and a smooth consistancy in which the electroactive 
Co(Sep)
3+
 mediating species was embedded deep within the microstructure of the 
pre-formed nafion film. Moreover, the method of preparation was highly 
reproducible, while voltammetric studies also corroborated the stability of the 
carrier matrix film. Overall, the design path used for this method was shown to be 
an improvement as compared to the design path used for biosensor platform 1, 
particularly with regard to the carrier matrix. Nevertheless, the proposed 
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substrates were successfully detected and quantified by the individual biosensor 
plaforms. In this regard, the dynamic linear  range of the GCE||naf|CME-
Co(Sep)
3+
|flCYP3A4|naf biosensor, for 2,4-DCP exhibited an upper limit of 45 
A, with the sensitivity determined as 0.038 A M-1. In addition to this, the 
LOD was calculated as 0.043 g L-1, which was lesser than the USA 
Environmental Protection Agency’s (EPA) drinking water equivalent level 
(DWEL) for 2.4-DCP. In the case of the GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-
PEI-PVA biosensor, the linear concentration range for indinavir was shown to be 
between 2.183 M  3.552 M, while the sensitivity was determined as 0.035 
A M-1. Morover, the LOD value, determined as 59.72 mg L-1 was suggested to 
be of signifiance with regard to the maximum plasma concentration, CMax, with 
respect to the ritonavir-boosted regimen, which is the proposed method of 
administering indinavir. This can also be of value for HIV/AIDS patients who are 
poor metabolizers, as they will have significantly elevated concentration of the 
drug, when administered with ritonavir as booster. Above and beoynd these 
results, the overpotential for the reduction of dioxygen, which is a crucial step in 
the catalytic cycle of the CYP3A4 enzyme, was significantly reduced by the 
GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA biosesnor, as compared to the 
other biosensor. 
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CHAPTER 1 
 
General Introduction 
 
 
1.1 Introduction 
 
This thesis describes the electrochemical dynamics of cytochrome P450-3A4 
isoenzyme biosensor for protease inhibitor (PI) antiretroviral drug. Chapter 1 gives a 
comprehensive overview of protease inhibitor antiretroviral (ARV) drugs and ARV 
agents in general. Special elaboration was dedicated to the  PI, indinavir, since it is 
the model drug that was used during the experimental investigation for this study. In 
addition, other relevant subjects, including cytochrome P450 isozymes, therapeutic 
drug monitoring, biosensors and drug assay methods were also discussed. Since 
endocrine disruptor compound, 2,4-dichlorophenol was also used in a subsection of 
the research investigation, relevant aspects surrounding the chemical was also 
elaborated on. The latter division of this chapter included the research questions, 
problem statements, rational/motivation, objectives and sub-objectives, followed by a 
layout of the thesis. 
 
 
1.2  Background  
 
1.2.1 Indinavir and HIV/AIDS: background overview and related aspects 
 
The HIV protease enzyme is a critical component of the replicative cycle 
of the virus. It processes polypepetides transcribed from the gag and pol genes late in 
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the viral replicative cycle – research has shown that this transcriptional process is 
essential for the assembly and maturation of infectious virions, and that inhibition of 
this enzyme leads to production of  immature non-infectious viral progeny [1]. In this 
regard, indinavir (L-735,524; MK-0639; Crixivan), a protease inhibitor (PI) 
antiretroviral (ARV), with high oral bioavailability, is a mechanism-based designed 
drug, explicitly formulated to interrupt this specific biochemical pathway of the viral 
replication cycle. A schematic representation of the HIV/AIDS virus and the 
mechanism of action of PI ARV, indinavir, is shown in Figure 1.1. 
 
 
 
 
Figure 1.1: HIV/AIDS virus and mechanism of action of action of protease inhibitor 
ARV, Indinavir  
 
As observed in Figure 1, indinavir functions by targeting the viral protease enzyme, 
inhibiting it and subsequently inactivating the enzyme, concomitantly leading to the 
production of immature non-infectious viral offspring [1-2], which in turn, keeps 
viral load at bay. Moreover, the qualitative attributes of indinavir is also exemplified 
in its ability to cross the blood-brain barrier (BBB) – this being a pivotal factor in 
treatment regiments, due to the highly probable risk factor of AIDS patients 
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developing behavioural disorders in the late stage of HIV infection, which results 
from the virus crossing the BBB and concomitantly affecting the individual’s nervous 
system [1]. A noteworthy fact, however, is that successful HIV protease inhibition 
requires sustained, optimally high drug levels in the blood, particularly at the site of 
replication. These optimum drug concentrations are critical, not only to suppress viral 
replication, but also to reduce viral mutations. Moreover, this pivotal factor is a 
prerequisit for successful application of all clinically available ARVs, which includes 
the PIs, nonnucleoside reverse transcriptase inhibitors (NNRTIs) and the nucleoside 
analogues (NAs). These optimum drug concentrations is of course highly reliant on 
the oral bioavailibility of the drug, which in turn depends on the rate of first pass 
metabolism, since the unique anatomical arrangement of our bodies is such that orally 
taken substances have to pass through the intestine and then liver, before reaching 
systematic circulation [3-6]. In this regard, overall, it is crucial that drug plasma 
concentrations are regularly measured to ensure optimum and sustained anti HIV 
effect [7].  
 
 
Review of current literature have shown that of the three basic categories of ARVs, 
the PIs and NNRTIs undergo extensive hepatic first pass metabolism  and as such 
share a similar metabolic pathway [2, 4, 8]. This essentially involves first pass 
oxidative metabolism by the cytochrome P450 (CYP450) enzymes present in the 
liver [2, 4], of which CYP450-3A4 (CYP3A4) is the most abundant isoform [3, 6, 9-
10], and is as such primarily responsible for their metabolism [2, 4]. With respect to 
indinavir in particular, prior research investigations, based on in vitro and in vivo 
studies with regard to the pharmacokinetic fate of the drug, has shown it to have 
minimal extra-hepatic biotransformation –  the drug actually determined to be 
exclusively metabolized by  CYP3A4 [1, 11]. However, the variation in the 
magtinute and/or rate of  first pass oxidative metabolism causes extensive inter-
individual and ethnic variability [3, 7, 10, 12] – a finding that is not restricted to 
indinavir only, but pertains to the metabolism of all PI and NNRTI ARVs [2, 4]. This 
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can result in significant unpredictability in the bioavailibility and systematic 
clearance of these drugs, and in this regard, dosage must be tailored to allow for 
maximum efficacy and munimum toxicity, because as earlier stated, sub-optimal 
concentrations of these  drugs will be in effective. On the  other hand, since 
HIV/AIDS is ubiquitously associated with a progressively deteriorating  immune 
system, with patients inevitably suffering from a constellation of   disorders – 
indinavir, like other PI drugs and ARVs in general, are always administered in 
combination regiments, as well as a plethora of other prescription drugs [2]. The 
combination therapy is referred to as Highly Active Antiretroviral Therapy (HAART) 
and since these drugs are administered at similar or overlapping time periods – the 
possibility of drug-drug interactions is highly probable. This is an especially crucial 
factor when the biotransformation of any two or more drugs share the same metabolic 
pathway, as they will thus compete for catalytic site binding on the same iso-enzyme 
[4, 10] -  invariably leading to antagonistic, additive and/or other undesirable drug 
interactions, catalyzed mainly by enzyme inhition or induction.  
 
The recommended standard of care for HIV/AIDS patients requires the inclusion of at 
least one PI within a course of HAART regimen [2, 7, 13-14], but often the beneficial 
effects of a particular drug combination approach is not sustained, necessitating a 
change in the prescribed drug permutation. Consequently it may be necessary to 
expose patients to various combinations of PIs and/or PI/NNRTIs  - which reiterates 
the inadvertent probability for unavoidably potentially dangerous pharmacokinetic 
interactions. On the other hand, these  (synergistic, antagonistic and/or additive drug) 
interaction effects may beneficially be used to purposely alter in vivo drug 
concentrations of specific drugs, however, this is strictly only possible with absolute 
measurement of endogenous drug concentration [2, 7]. 
 
 The cumulative effect of all the above factors complicates dosing of clinically 
diagnosed patients, and as such an urgent need for therapeutic drug monitoring 
(TDM) during HIV/AIDS treatment is highly emphasized and recommended. In view 
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of all the latter and preceding facts, the urgent need for TDM of indinavir and other 
ARV may be summarized as follows: 
 To reduce drug toxicity by decreasing drug dose, while still maintaining 
adequate trough plasma concentration, particularly in the case of PIs and 
NNRTIs. 
 To prevent adverse drug-drug interactions, by monitoring plasma 
concentration during multi-drug administration or prior to the addition of a 
new drug. 
 It can be used as an objective measurement for non-adherence, thereby 
attenuate and possibly alleviating resistant viral mutations. 
 To deliberately alter the concentration of a particular ARV during co 
administration.  
  
 
Currently available methods for quantifying indinavir and other ARVs, is done 
through centralized laboratory techniques, based on high performance liquid 
chromatography (HPLC) with ultra-violet detection and/or liquid chromatography-
mass spectrometry methods [7, 13, 15-16]. These techniques are very accurate 
indeed, but their preference is discouraged by their exceptionally expensive 
application and maintenance requirement, which includes amongst others, highly 
qualified personnel, rigorous sample preparation, expensive solvents and 
components, which concomitantly leads to long assay procedures and time 
consuming sensitive procedures [13, 15-16]. Overall, this causes long turn-around-
periods [7, 17], and the delay in results may affect timely commencement of proper 
dosage/regimen modulation – a factor that can be detrimental to the HIV/AIDS 
patient. There is therefore undoubtedly a great demand for alternative drug assay 
measurement techniques, with the practical utility being to provide decentralised 
analysis, preferably at the doctor’s office, emergency room or in the privacy of the 
patient’s own house.  
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Since, first pass metabolism with cytochrome P450-3A4 evidently is a pivotal factor 
in the successful application of indinavir and most ARVs, it is only appropriate to 
discuss this enzyme in greater detail. In this regard, a brief, but succinct overview on 
CYP450 enzymes with particular reference to CYP3A4 follows: 
 
 
1.2.2 Cytochrome P450 (3A4): Classification, structure and function 
CYP3A4 falls under the sub-group, (mono)oxygenase-type enzymes, 
which in turn forms part of the superfamily of proteins, collectively referred to as 
cytochromes P450 (CYPs) [3, 6, 8-10, 18-20], which are present in all forms of life 
(plants, bacteria and mammals). Human CYPs are essentially membrane-associated 
(microsomal) proteins, located either in the inner membrane of the mitochondria or 
the endoplasmic reticulum (ER) of cells [6, 18, 21], of which, the ER association is 
confirred by a characteristic stretch of residues, consisting of about 20-25 highly 
hydrophobic amino acids, known as the N-terminal region. In addition to this, these 
enzymes also contain a heme cofactor, situated at what is known as the C-terminus, 
and is flanked by a peripheral region of hydrophobic surrounding protein globule, 
functioing mainly to protect the heme from any unwanted reactions [22]. Thus, in 
essence, CYP450s can be considered as enzymes containing both an N-terminal 
domain, mainly functioning as a protein anchor, as well as a C-terminus, which 
contains the heme cofactor Considering the hydrophobic residues contained within 
both of these regions, these enzymes are understandibly considerably hydrophobic in 
nature. Also noteworthy, is that P450s are also known as heme-thiolate proteins, 
because in these proteins, the heme cofactor  is covalently linked to the surrounding  
apoprotein through a cystein group [21-24]. In this regard, they are similar proteins 
with the same porphyrin-heme complex as catalytic center, the so called “P450 
signiture”, but with different amio acid sequences, altering the topography of the 
active site [21-22, 24-25] – hence the term “isozyme”. In terms of function on the 
other hand, they are mixed function oxygenases (MFO), constituted by a multifarous 
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group of essential enzyme catalysts, which mainly function in the oxidative 
metabolism of various xeno- and endobiotic organic substances [22, 24, 26]. As such, 
collectively, these P450 isozymes play key roles in vital processes, such as steroid 
hormone biosynthesis, the activation and detoxification drugs and environmentally 
contaminating chemicals, the metabolism of polyunsaturated fatty acids, activation of 
vitamins A and D3 to biologically active hormones, etc [3, 20, 24, 26]. With reference 
to the aforementioned processes, the  reactions catalysed can be extremely diverse, 
such as, hydroxylations, N-, O- and S-dealkylations, sulphoxidations, opxidations, 
deaminations, desulphurations, dehalogenations, peroxidations [21, 24]. Moreover, 
many of the individual P450s catalyze multiple reactions, and since almost every 
P450 isoform’s selectivity  is so broad – collectively, their presence provides a 
general defense system in the body against  both synthetic and/or natural compounds, 
which are nearly unassailable to  the attack by other enzymes and that would, upon 
exposure to them, otherwise accumulate and be harmful, if not metabolized to 
hydrophilic products [19, 24].  
 
On the other hand, the liver is the major organ for the metabolism and detoxification 
of pharmaceutical drug-type xenobiotics [3, 6, 12, 24], an aspect that is crucial, since 
these drugs are normally lipophilic organic molecules, and as such has to undergo 
chemical modifications within the human body, either for drug activation and/or 
successful elimination. In this regard, the liver microsomal isozymes, are key players. 
With regard to CYP3A4 in particular, it is the major cytochrome P450 isoform and as 
such, the most influencial. As all other human CYPs, it is a  membrane-associated 
protein,  residing  primarily within the endoplasmic reticulum of the liver and 
contains a single iron protoporphyrin IX prosthetic group, (heme). Figure 1.2(a) 
shows the ribbon drawing of the secondary structure of human CYP3A4, whereas 
Figure 1.2(b)  shows an enlarged detailed view of the heme cofactor.  
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Figure 1.2:(a) Ribbon drawing, showing the distal face view of cytochrome P450-
3A4 (CYP3A4) secondary/tertiary structure (a);  (b)  Prosthetic group of 
CYP3A4, (b-type heme): an iron-(III) protoporphyrin-IX linked with a proximal 
cystein ligand (fifth ligand of the heme iron) 
 
From the ribbon drawing of the cytohrome P450 isozyme, CYP3A4, in Figure 1.2(a), 
one can observe the secondary structure of the enzyme, which mainly consists of  the 
heme (stick figures coloured in red) with its active site cavity (shown as a grey mesh) 
and the surrounding protein matrix (the apoprotein). On the other hand, Figure 1.2(b) 
shows the prosthetic group in greater detail – consisting of an iron (III) 
protoporphyrin-IX, which in terms of classification, is a b-type heme. The heme iron 
is ligated by a cystein group through its sulfur, and in this regard, overall, CYP3A4 
prosthetic group may be referred to as a cysteinato-iron(III) protoporphyrin-IX.  The 
prosthetic group is the active site of the enzyme, and as such, it is at this particular 
place that the enzyme interacts with the substrates to metabolise them.  The substrate 
list of CYP3A4 is not limited to a small number of chemical classes, but rather is 
structurally diverse. A large number of these chemicals are human pharmaceuticals of 
various pharmacological actions. Overall, multiple metabolic pathways are catalyzed 
by CYP3A4, the major pathways being C- and N-dealkylation, C-hydroxylation. 
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Others include dehalogenation, N-demethylation, as well as allylic  and benzyllic 
hydroxylations in steroid molecules. Overall, the natural catalytic process of 
CYP3A4-substrate interaction, involves an insertion of one atom of elemental oxygen 
into the substrate compound (monooxygenation) – a process that occurs through a 
series of reaction steps and involves the obligatory presence of electron transfer 
donors and other molecules. A schematic representation of the catalytic reaction steps 
for the membrane-bound CYP3A4 is shown in Figure 1.3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Natural catalytic cycle of human hepatic microsomal CYP3A4 
 
As shown in Figure 1.3, CYP3A4 reacts with substrates (R—H) at the active site 
(heme). Overall, success of the catalytic process requires the transfer of two electrons 
and the presence of molecular oxygen. The electrons are supplied at seperate 
intervales during the catalytic cycle, by the enzyme’s natural electron donor, 
NADPH-P450 oxidoreductase, through its reducing equivalents, FMN and FAD. It is 
noteworthy to add that, depending on the substrate being metabolised, CYP3A4 
sometimes also require the obligatory presence of  cytochrome b5 during supply of 
the second electron. The series of steps following the first electron transfer is such 
that it eventually results in the formation of water and a high-valent iron-oxo species 
(iron-oxo(ferryl)-complex), known as Compound I, which is capable of oxygen atom 
transfer and as such, functions in the actual substrate monooxygenation. A much 
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more comprehensive description of the catalytic reaction cycle is given in Chapter 2. 
In terms of the electron transfer redox partner involved, CYP3A4 may be classified as 
a classII cytochrome P450, whereas with respect to the fact that the enzyme requires 
an external reductant, it may be categorised as an external monooxygenase.  
 
Important considerations with regard to CYP3A4-substrate interaction include the 
fact that the enzyme is rather ‘promiscuous’ in its substrate selectivity and as such, 
known to metabolise a large variety of pharmaceutical compounds extensively 
varying in molecular weight, while  also having a spacious active site, capable of 
accomodating a diverse range of compounds. Moreover, the expression of CYP3A4 
varies between individuals, race and ethnic groups, while the enzyme is also subject 
to inhition and/or induction by a number of drugs, a factor that can be life threatening 
during concurrent and/or multi-drug administration. Considering these facts, the need 
for therapeutic drug monitoring (TDM) during treatment of chronic illnesses where 
CYP3A4 metabolism is the major drug biotransformation pathway, such as in 
HIV/AIDS, should be reiterated as highly recommended.  
 
 
 
 
1.2.3 Endocrine disruptor compound: 2,4-Dichlorophenol (2,4-DCP)  
 
As stated earlier, CYP3A4 is the most ubandantly expressed CYP450 
isozyme. In that context, it accounts for 60% of cytochrome enzymes in the liver 
and 70% of those in enterocytes in the gut wall, and appropriately, holds the 
dominant  position in phase I metabolism [3, 9-10, 27-28] – naturally having the 
largest substrate listing and as such, plays a pivatol role in the in detoxification of 
exogenous bioactive compounds and lipophillic xenobiotics, including prescription 
medicines, drugs, environmental pollutants, pesticides, herbicides, herbal 
medicaments, food supplements, steroids, etc [9-10, 23, 27-31]. Amongst the latter 
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list, of particular importance are compounds whith edocrine disrupting properties, 
because their effects are not only confounded to the individual exposed to them, but 
also their offspring, and as such cascades into transgenerational effects [32]. With 
regard to defintive context, endocrine disruption refers to a mechanism of toxicity 
that hinders the ability of cells, tissues and organs to communicate hormonally, 
resulting in a myriad of adverse health outcomes including reduced fertility and 
prolificity, spontaneous abortion, skewed sex ratios within the offspring of exposed 
communities, male and female reproductive tract abnormalities, polycystic ovarian 
syndrome, neuro-behavioural disorders, impaired immnune functions and various 
cancers [32-36]. 
 
Amongst the studied potential endocrine disruptor (ED) chemicals, pesticides (i.e. 
herbicides, bacteriocides, funagsides, insecticides, and rodentocides) and associated 
mono- and polychlorophenols were shown to be ubiquitously associated with most 
ralated endocrine disrupting subject areas [32]. Of particular interest, is the pervasive 
environmental pollutant – the chloronated phenol, 2,4-dichlorophenol (2,4-DCP), 
since it holds multiple industrial applications, including herbicide and pesticide 
production, feedstock for the manufacture of certain methyl compounds used in 
antiseptics and disenfectants, fungicides for use as wood preservatives, etc [37-38]. 
Moreover, it is a precursor for the synthesis of carcinogenic endocrine disruptor, 2,4-
dichlorophenoxyacetic acid (2,4-D), which is the active ingredient of more than 1500 
herbicides [39-40], while also being a major metabolite or degradation product of 2,4-
D and many phenoxy-based herbicides [32, 40-41]. Furthermore, 2,4-DCP also 
commonly ends up in drinking water as a by-product of chlorination, as biocides, or 
as degradation product of the commonly used phenoxy herbicides [39, 42-43]. The 
toxicity linked to 2,4-DCP exposure has been shown to contribute in the promotion of 
the growth of breast, ovarian and prostate cancer tumor cells, while also shown as 
major causative agent in specific endocrine related cancers and chronic conditions 
such as chloracne and porphyria in humans [32, 41, 44]. Consequently, it has been 
classified as a priority pollutant, especially in terms of the aquatic environment [45], a 
 
 
 
 
 Chapter 1   General Introduction  
 
12 
 
fact that is exacerbated by the knowledge that endocrine disrupting related chemicals 
are capable of exerting adverse effects on living organisms even in very small 
concentrations [32].   
 
Overall, the maximum safe limit for 2,4-DCP and/or other chlorophenols in river 
water, pre-treatment potable water and drinking water has been ruled as 50 – 
100µgL
−1
, 1 – 5µgL−1 and 100 – 500ngL−1, respectively [WHO, EPA, EU]. Thus, the 
monitoring of the environment to make sure that this pollutant remains within safe 
limits of concentration requires very sensitive analytical methods. To this end, 
conventional analytical methods for determination of 2,4-DCP in water samples are 
based on gas chromatography (GC) and/or  high performance liquid chromatography 
(HPLC), either applied directly in conjunction with mass spectrometry detection, or  
with solid-phase extraction (SPE)-electrospray ionization (ESI) assisted mass 
spectrometry detection [39, 43]. Other methods, based on advanced oxidation 
processes, such as O3/UV, O3/H2O2, UV/H2O2, Fenton and photo-Fenton, which 
functions by mineralizing the organic chemical, have also been applied [38]. 
Notwithstanding degree of accuracy and/or success of these methods, their popularity 
is restricted by numerous disadvantages, as well as the fact that they are not suitable 
for on-site application [38-39, 43], hence the compelling urgency for development of 
alternative assay methods. 
 
 
 
1.2.4 Indinavir vs 2,4-DCP: The common factor shared by these two subjects  
 
At this stage, the reader’s curiousity may be kindled, as to the common 
aspect of  
two such seemingly different subjects – PI ARV drug, indinavir vs priority 
pollutant/endocrine disruptor compound, 2,4-dichlorophenol. In this regard, the 
reader is requested ponder the following significant factors:  
 
 
 
 
 Chapter 1   General Introduction  
 
13 
 
On a global scale, South Africa has one of the highest HIV infection and AIDS 
related mortality percentages. Geologically, on the other hand, South Africa suffers 
from several water related challanges, which overall, may be summarised as follows: 
 
 There is an uneven spreading of ground- and other water resources across the 
country, due to its by-and-large arid/semi-arid nature –  with a select few 
regions having the great fortune of receiving moderately regular rainfall 
patterns. Moreover, chlorophenols and/or other toxic pollutants are bound to 
eventually end up in our waterways, both directly and indirectly from 
industrial processes, especially the electricity supply sector which is highly 
reliant on the use of coal fired power stations –  with the other major sector 
being the agricultural use of pesticides/herbicides for genetic modification of 
crops.  
 
Considering the latter information, it should become obvious that indinavir and 2,4-
dichlorophenol is directly related to two of our country’s most eminant concerns, 
which is HIV/AIDS and the issue of water . Moreover, with reference to the 
preceding sections, these two chemicals have also been shown to share a common 
rout of biotransformation, which involves monooxygenation by CYP3A4. On the 
other hand, knowing that CYP3A4 is such an influencially diverse enzyme catalyst, 
and the knowledge that this and other P450’s are promising enzymes for the 
applications of biosensing probes, the much emphasized alternative assay technique 
for quantification of 2,4-dichlorophenol and indinavir, is realizable through the 
application of a small analytical instrument, known as the biosensor.  
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1.2.5 Molecular models and probes for xenobiotic metabolic profiling  
 
1.2.5.1  Prospects of available biological probes for in vitro investigations with 
mammalian microsomal CYP 450s: advantages, drawbacks and new 
developments 
 
Before tackling the aspects surrounding  subjects of active in vitro models for 
studying CYP3A4 and other mammalian CYP450 enzymes, the reader is cautioned to 
consider the following factors:  
 
Considering that drug metabolism is the major determinant of drug 
clearance, the importance of mammalian CYP 450s and in particular, the determinant 
role of predominant isoform, CYP3A4, in the therapeutc efficiecy of most of the 
pharmaceutical drugs ingested by humans cannot be over estimated. Furthermore, it is 
the body’s ultimate defense mechanism, rendering otherwise carcinogenic 
compounds to harmless metabolites, for example,  the unprecedented role of 
CYP3A4’s detoxification ability to metabolise the human hepatocarcinogen, aflatoxin 
B1, to the harmless metabolite, the 3α-alcohol. Also noteworthy, is the aspect of the 
extensive interindividual differences in pharmacokinetics existing between 
individuals and ethnic groups, largely attributable to polymorphism, genotype-
phenotype relations within the isoenzymes, induction and overlapping drug 
selectivities of CYP3A4 and other mammalian CYP450 isoenzymes  of which 
these constricts  can confir differences of up to 90% in drug uptake and clearance 
beween individuals.(In this regard, polymorphism  referes to the variation in gene 
expression for particular isoenyzmes between individuals. In this regard, a small 
diefference in DNA sequence, within a population can lead to very significant 
differences in drug metabolism. Genenotype-phenotype differences, on the other 
hand, referes to the metabolising ability of individuals, in which some are poor-
metabolisers, intermediate-metabolisers and ultrafast-metabolisers). A final 
consideration factor, which is inhibition of CYP450s , particularly, CYP3A4, caused 
 
 
 
 
 Chapter 1   General Introduction  
 
15 
 
by competition between drugs taken concurrently and the enzyme’s promiscuity 
confirred by its ability to accomodate more than one substrate simultaneously can 
lead to severe advers drug effects, particularly metabolic drug interactions, caused by 
altering the disposition of a drug by the presence of another compound.   
 
The relevance of  all the aforementioned constricts/factors, is based on the fact that 
they all  have a direct consequence on the overall effect of pharmaceutical 
compounds, as well as other drug-type and/or carcenogenic xenobiotics entering the 
human metabolic system. In this regard, it is pivatol that in vitro models constituted 
by validated techniques are in place for the study and assessment of metabolic 
profiling of xenobiotics both pharmaceutical and otherwise, particularly in terms 
pharmacokinetics, therapeutic dose efficiency predictions, potential toxicity and 
potential enzyme- inducting or enzyme-inhibiting studies. In fact, with regard to 
pharmaceutical constituents, these studies play a significant role in preclinical drug 
devlopment, particularly since the evaluation of potential drug-drug interactions has 
become  mandatory for the registration of new drugs by most regulatory agencies.  
 
For this purpose, various models/probes, based on various cytochrome P450 sources, 
in technqiues which makes use of in vitro-based protocols, may be applied. These 
models include human  hepatocytes, which are normally primary cultured (i.e. fully 
differentiated) and/or encapsulated hepatocytes; liver slices; microsomal fractions, 
prepared from human liver tissue; or microsomal fractions and/or hepatocytes from 
animal tissue, such as rats. Athough these models has been in use for routine 
application, they are unfortunately all subject to various drawbacks. In this regard, 
with respect to hepatocytes in particular, primary culured intact cells are used, which 
essentially means that these sources contains complete endoplasmic reticulum 
membrane, metabolic pathways, physiogical cofactors, coenzymes and active gene 
expression. The particularly sigificant drawback of the aforementioned model, is that 
investigations with one particular isoenzyme is not really possible and for the 
requirement of such results, additional statistical analysis needs to accompany such  
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investigations, particularly since most CYP 450 isoenzymes exhibit distinct, but 
overlapping substrate selectivities   
 
Although, these models are based on viable catalytically active CYP450 sources, 
there shortfallings makes the need for alternative molecular models/probes an 
urgency. In this regard, biosensors can play a major role in replacing such systems.  
In the context of  bioelectrochemical systems and biosensors in particular, it is 
essential that a constant supply of  renewable sources of biological components are 
available. In this regard, genetically manipulated  cells, expressing the specified 
single CYP gene, through perminant transfection with the cDNA of the particular 
enzyme is a highly suitable method to eliquintly supply this constant demand, 
whereas any of the aforementioned models would not suffice.  
 
 
 
1.2.6 Biosensors: The ultamite molecular probe 
 
In the context of all the problem areas identified and elaborated in all the 
preceding sections within this chapter, one subject claims centrestage — the 
unprecedented urgency for alternative analytical devices for detection, qauntification 
and monitoring of specific chemical species, with the overall aim being diverse areas 
of application. The only proposed analytical device able to meet these requirements, 
are biosensors, as they have been proven effective for continuous, real-time in vivo 
and/or non-invasive monitoring, as well as field-testing and commercialization, and 
as such may be used to complement and/or replace centralized laboratory techniques. 
From a panoramic perspective, the rational behind biosensor design and application is 
based on the synergistic combination of molecular principles and bioelectrochemical 
dynamics, packaged as intelligent materials system in self contained integrated 
devices — capable of recognising stimuli, processing the information arising from the 
response to the stimuli and responding to it in an appropriate manner and time frame, 
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as such allowing virtually any complex to be screened with minimal assay 
development. Furthermore, research has shown promise in the potential of these 
devices to provide low-cost, rapid/real-time measurement and operationaly-simple 
analytical tools for diverse applications, including environmental monitoring, 
chemical measures in agriculture, food and drug industries, as well as clinical 
diagnostics, disease- and therapeutic drug monitoring applications. Among the 
available biosensor types, electrochemical biosensors are the most preferred. In this 
regard, amperometric electrochemical biosensors are considered the superior choice, 
because they are known to be reliable, cheaper and highly sensitive for clinical, 
environmental and industrial purposes [46]. 
 
 
From a defintive perspective, overall, biosensors consist of two major parts — a 
molecular recognition component, which is of biological origin,  and a transducer, 
whereas the major processes involved in any biosensor system are analyte 
recognition, signal transduction and readout. Since the clinical utility of such devices 
are highly dependent on the selectivity of the biodetector for the specific target 
analyte and to maintain this selectivity in the presence of other potentially, interfering 
species, enzymes have received the major attendtion as recognition components. In 
this regard, enzymes are known to have high specificty and hold the ability to enable 
reactions that would otherwise not occur, thus making them nature’s most preferred 
catalysts. Moreover, biotechnology have advanced to such an extent that any enzyme 
can be genetically engineered through the use of heterologous expression systems, 
such as mammalian-, yeast- (Saccharomyces cerevisiae), insect cells (Spodoptera 
frugiperuda, i.e. Sf9 or Sf21) and/or bacterial systems (Escherichia coli), via a 
combination of cloning, expression and purification methods. This has been a 
particularly significant milestone for the application for mammalian CYPs, since this 
process allows for the preparation of only the terminal oxidase/heme domain of the 
particular isozyme, which can subsequently be used in an appropriate biosensor 
configuration, and as such elleviates the need for the external natural electron 
transfer-donors. Moreover, N-terminal modification, during the enzyme 
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expression/purification process circumvent the problem of low activity and 
aggregation normally experienced by full-length microsomal P450 isozymes, and as 
such enables the preparation of more soluble enzyme constructs, with good catalytic 
activity.  A noteworthy fact to add, on the subject of enzymes, CYPs in particular, is 
that a key factor in the construction of such biosensors involve the development of 
suitable immobilization technologies for stable tethering of the enzyme to the 
transducer, the overall aim being, to provide durable and repetitive binding of the 
biological receptor to the transducer without imparing its catalytic activity and/or 
efficiency for the target analyte. This is of course only possible with well orchestrated 
transduction platforms, consisting of  judiciously chosen carrier matrices and 
interfacial enhancer materials, since the activity of immobilized biological molecules 
are known to be dependent upon a combination of factors, including surface area, 
porosity, hydrophilic/hydrophobic character of immobilization matrix, reaction 
conditions, the chosen immobilization method etc. Moreover, the thick protein shell 
surrounding the enzyme active center introduces a kinetic barrier for electron transfer. 
 
 
A popular method, that has proven effectual for enzyme immobilization, is a 
combination of entrapment and encapsulation. Effective entrapment materials which 
have shown immense success are polymer based. Polymers used for enzyme 
immobilization and development of modified electrode films for biosensor 
configurations may be devided into two major groups: ion exchange- (without 
electronic conductivity) and electron conducting polymers. The latter group also 
includes redox-active electron conducting polymers. Among the polymer matrices, 
the ion exchange  polymer, nafion, has become a popular choice, and as such, much 
research investigations has been devoted to its use in a wide variety of 
electrochemical applications. This   perfluorosulphonate ionomer is a tremendously 
versatile material, incurred by a  range of inherently unique properties, which 
includes the following: 
i) It allows for simplistic membrane formation by either dip-, spin- or drop-
coating; 
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ii) It has high adhession to electrode surface with low swelling in aqueous media; 
iii) Its fluorocarbon backbone allows formed polymer membranes to be highly 
thermal and chemically stable; 
iv) Nafion films feature internal segregation of hydrophilic and hydrophobic 
regions, as such improving physiological enzyme environment mimicking, a 
quality that can further stabilize the immobilized enzyme molecules. 
v) The polymer’s incredible affinity for complex cations enables the pre-
concentration of cationic redox-active species in the polymer; 
vi) The formed polymer confer perselectivity to the biosensor, particularly with 
regard to the exclusion of potentially interfering compounds, while 
similtaneously protecting the underlying electrode from fouling and also 
preventing non-specific binding of enzyme molecules to the electrode surface.  
Nafion’s ability to preconcentrate redox active species is an exceptionally pavitol 
factor, and as such, can be used for the preparation of mediator-based, reagentless 
biosensor configurations, which would allow simplified electron transfer between 
the enzyme active site and the transducer surface, through electron shuttling by the 
incorporated redox active mediator molecules. This is particularly beneficial in the 
case of cytochrome P450 enzymes who’s active sites are deeply burried within the 
surrounding apoprotein and do not readily exchange electrons with the underlying 
electrode, while also alleviating the additional complication of the obligatory 
presence of NADPH electron transfer donors.  The choice of encapsulation material, 
on the other hand, also plays a significant role  in successful enzyme-film formation, 
since appropriate material will enable longer lifetime of the immobilized enzyme, 
particularly in the case of microsomal CYP450 enzymes, who are known to be 
labile and requires a suitable environment for to retain activity and function. On the 
subject of encapsulation, the natural biopolymer, agarose, well known for its 
bioaffinity and biocompatibility, non-toxic nature, water permeability, high 
mechanical strength and biomembrane like film formation,  has been widely applied 
for enzyme-film formation, in which regard it has portrayed excellent enzyme 
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encapsulation with a superior degree of biological activity retention [47-48], 
particularly in the case of cytochrome P450 enzymes [49-50]. Moreover, agarose 
can be synergistically blendid with other non-toxic, biocompatible, water-soluble 
polymers, such as poly(vinyl chloride) yielding hydrogel composites that provides a 
biocompatible aqueous microenvironment for the immobilized enzyme [51].   
 
 
1.3 Refinement of Research and Research Questions 
 
The preceding sections gave a succinct, but detailed review of the pertinent 
subjects pertaining to this dissertation. In this regard, the reader was familiarized with 
HAART drugs and endocrine disruptor/priority pollutant chemicals. With regard to 
the ARVs, special reference was given to the protease inhibitor ARVs, indinavir in 
particular, while other important issues, such as adverse drug reaction considerations, 
drug assay methods, therapeutic drug monitoring and biotransformation was 
emphasized. In terms of the other subject area on the other hand, much of the 
discussion was devoted to 2,4-dichlorophenol, particularly with respect to aspects 
surrounding its sources, applications, health impacts and assay methods. Moreover, in 
addition to the latter subject areas, detailed deliberations with regard to cytochromes 
P450 and biosensors were given. In reference to the major aspects outlined in those 
sections, a summary of research questions can be formulated which directs the focus 
to the relevant problem areas and as such provides more focused enlightenment on 
the motivation/rational for the current study.  
 
 
 The PI ARV, indinavir is specifically designed to inhibit the HIV protease 
enzyme, leading to concomitant inactivation of virus particles. 
 In general, primary antiretroviral drugs are based on three groups which 
includes the PIs, the NNRTIs  and the NAs. 
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 Successful protease enzyme inhibition, and/or general anti HIV effect, require 
absolute optimum concentration of clinically available drugs at the site of 
replication.  
 Drug plasma concentration needs to be regularly monitored to ensure 
optimum sustained anti HIV effect.  
 The recommended standard of care for HIV/AIDS requires inclusion of at 
least one PI in a course of HAART regimen. 
 The requirement of regular drug regimen modulation to prevent viral 
mutations etc., expose patients to various combinations of PIs and/or 
NNRTIs.  
 PIs and NNRTIs share the same metabolic pathway, which primarily involves 
oxidative metabolism in the liver. The major enzyme involved is CYP3A4. 
 Combination PI therapy can result in adverse additive and/or antagonistic 
drug interactions mediated by induction or inhibition of CYP3A4. 
 Great subject variability in concentration of plasma PI levels, due to 
differences in each patient’s cytochrome P450-CYP3A4, necessitates tailored 
dosage regimens to allow for maximum efficacy and minimum toxicity, 
because sub-optimal concentrations of PIs will be in effective. 
 Indinavir may be considered a model substrate for CYP3A4 since it is 
exclusively metabolized by this enzyme. 
 Since drug clearance changes rapidly with age until adult stage is reached, 
TDM in pediatric patients, would tremendously aid the selection of correct 
dosing regimen. 
 Constant TDM during antiretroviral treatment is necessary so as to ensure 
optimum trough plasma drug concentrations and thus preventing toxicity and 
non-adherence.  
 HIV/AIDS patients are immuno-compromised and as such, in addition to 
ARVs, receive numerous other prescription drugs, and with CYP3A4 being 
the main isozyme responsible for metabolism of most ARVs and 
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pharmaceutical xenobiotics, potentially dangerous pharmacokinetic 
interactions are highly probable.  
 Therapeutic drug monitoring during the treatment of HIV/AIDS is highly 
recommended, the main reasons being, to prevent adverse drug interactions, 
improvement of inter-individual therapeutic efficiency, preventing non 
adherence and to avoid drug associated toxicity.  
 Current available assays for anti HIV drugs are based on centralized 
laboratory techniques whose advocation in regard to TDM is discouraged by 
numerous disadvantages, which overall causes long turn-around-periods, 
leading to delay in results and affects timely commencement of proper dosage 
regimen adjustment. This is potentially dangerous for the patient. 
 Smaller, faster and cheaper devices are highly desired for replacement of 
time-consuming laboratory-analysis. 
 CYP3A4 being the highest expressed mammalian hepatic and small intestinal 
isoform, it also plays a major role in metabolism and detoxification of 
environmental pollutants, one of which is the pertinent endocrine disruptor 
chemical, 2,4-dichlorophenol. 
 2,4-DCP is a ubiquitous priority pollutant, ever-increasingly finding its way 
into our waterways, concomitantly putting increased strain on an already 
water-stressed country. 
 Available detection and quantification methods for 2,4-DCP are laboratory-
based GC and/or HPLC methods used in conjunction with complicated 
detection methods inlcuding SPE or ESI. Moreover, these techniques are not 
structured to enable on-the-spot field testing. 
 As in the case of ARVs, alternative analytical devices for detection of 2,4-
DCP is needed. 
 Coupling of enzymes with deliberately modified electrodes, within a 
biosensor configuration, permits rapid, simple and direct determination of 
multifarious analytes, in complex biological fluids and/or environmental 
liquid samples. Such devices can be applied for single-use, intermittent-use or 
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continuous-monitoring applications. In this regard, cytochromes P450, 
particularly major isoform, CYP3A4, are promising recognition components, 
due to the extensive variety of substrate catalytic ability. 
 Amperometric enzyme electrodes, having a wider linear range and the 
advantage of being able to produce continuous readings, holds a leading 
position among available biosensors systems presently available. 
 Sensor is comprised of three essential components: the detector, which serves 
as recognition element; the transducer, which converts the stimulus to a useful 
invariable electronic, output; and the output system itself, which involves 
amplification, display, etc in an appropriate medium. 
 The interface between the detector and transducer is an important 
consideration during biosensor construction and often constitutes the major 
hurdle in the development of an optimum operating device. 
 Optimum biosensor performance is by-and-large depended with appropriate 
immobilization techniques. 
 Requirements for effective immobilization serves to: retain biological activity 
of enzyme when attached to sensor surface, tightly associate biological film 
with transducer whilst retaining its structure and function, induce long term 
stability and durability of immobilized biological films, and of retaining a 
high degree of specificity of the biological material to particular biological 
components. 
 Improvement of biocatalytic efficiency can be achieved through choosing 
carrier matrix materials with multifunctional features; tight immobilization of 
mediator molecules within the reagent layer; as well as creating 
biomembrane-like matrix to mimic physiological conditions.   
 Among the known immobilization methods, research has found enzyme 
entrapment-encapsulation to be superior. 
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With regard to the latter research questions and preceding literature 
surveyed information, which highlighted specific problem areas as it pertains to this 
dissertation. The main issues being HAART associated TDM and on-the-spot field 
assay methods for endocrine disruptor associated priority pollutants.  The main focus 
in terms of  the subject of TDM involves alternative analytical methods capable of 
decentralized analysis, and real-time measurements. The superior method for 
executing the task was shown to be enzyme-based amperometric biosensors, in which 
appropriate miniaturization of bio-recognition and transducer components (which 
includes carrier materials) is expected to allow for fast and accurate analysis. 
Considering these aspects, the motive for the current study was thus established.       
 
 
1.4 Scope of the thesis 
 
This dissertation presents and comprehensively discusses the obtained results 
for two separate biosensor platforms, biosensor platform 1 and biosensor platform 2, 
fabricated and applied for the detection of two distinctly different categories of 
substrates. With regard to the biosensor platforms in particular, they share four major 
commonality factors, the first of which is the category of bio-recognition component, 
which in both cases is the mammalian, microsomal heme-thiolate cytochrome P450 
3A4 isoenzyme (CYP3A4). The second common factor is the mediating species, 
which is the electroactive metal-centred mediator, cobalt(III) sepulchrate [Co(Sep)
3+
]. 
The other aspect is that both platforms have been designed and fabricated to mediate 
the enzyme-based bio-electrocatalytic reaction in a reagentless manner. The fourth 
and final common factor, is with regard to one of the major objectives of the 
biosensors, which was focused on working towards providing decentralized 
analytically-based method for detection and quantification of the selected substrates.  
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The first part of the thesis involves the electrocatalytic detection and 
quantification of endocrine disruptor compound, 2,4-dichlorophenol. The biosensor 
was realized through sandwich-configuration, consisting of commercially obtained 
full-length microsomal CYP3A4 within cobalt(III)sepulchrate-derivatized nafion 
membrane. Entrapment of the cobalt(III)sepulchrate mediator within the nafion 
membrane, was done through a manual pre-concentration method, which involved a 
combination of drop-coating and mixing. Electrochemical dynamics for this 
biosensor is based on amperometric transduction.  The results for this biosensor is 
presented and discussed in Chapter 4. This platform will be referred to as biosensor 
platform 1 in the subsequent sections of this chapter.  
 
 
The second part of this dissertation involves the electrocataltyic detection 
and quantification of PI ARV, indinavir. The recognition component for this 
particular biosensor is the heme-domain of N-terminally modified CYP3A4 
(nCYP3A4), manufactured through genetic engineering, the process of which was 
done by the investigator and as such, was not commercially obtained. Enzyme 
immobilization in this particular biosensor is based on a combination of entrapment, 
behind the electroactive solid polymer electrolyte inner film, and encapsulation in 
biocompatible ionic hydrogel blended membrane. Incorporation of the 
cobalt(III)sepulchrate mediator within the inner-nafion membrane, was achieved 
through a novel electrochemically-based method.   The results for this particular 
biosensor is presented and discussed in Chapters 5 A and B. This biosensor will be 
referred to as biosensor platform 2.  
 
It should also be noted that the specific techniques applied in preparation of biosensor 
platform 2, was carefully planned to serve as improvement as compared to biosensor 
platform 1, particularly with reference to the preparation of the electroactive carrier 
matrix. Moreover, the improvement in the design path was also focused on working 
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toward lowering the operating potential of the reduction of oxygen, as compared to 
biosensor platform 1. 
 
 
1.3.1 Specific objectives to achieve the overall goal 
In this regard, spesific key research questions for each biosensor platform was 
identified, which are subsequently elaborated. 
 
 
1.3.1.1  Biosensor platform 1 
 
i) prepare a pre-formed nafion film on the glassy carbon electrode surface. 
ii) modify the formed nafion film with the electroactive mediating cobalt(III) 
sepulchrate species, to form an electroactive carrier matrix. The approach 
used here should is kept simple, by applying manual techniques. 
iii) characterize the prepared Co(Sep)
3+–modified nafion film with appropriate 
electrochemical and ex-situ morphological and structural techniques. 
iv) monomerize the commercially obained full-langth CYP3A4 (flCYP3A4) with 
a suitable detergent, for easy immobilization without aggregation of enzyme. 
v) immobilize the enzyme on the electroactive carrier matrix by simple drop-
casting method. 
vi) re-inforce the reagent layer with a thin outer film, as to minimize leaching of 
any components. 
vii) Characterize the prepared biosensor with dc voltammetric techniques in 
appropriate buffer electrolyte medium. 
viii) Probe and investigate the electrochemical interactions of the enzyme-based 
biosensor with the selected model substrate.  
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\1.3.1.2  Biosensor platform 2 
 
i) prepare the N-terminally modified human recombinant soluble CYP3A4 
construct, to enable a constant locally available renewable source of biological 
component in a cheap simplified manner. 
ii) do the necessary structural characterization,  of the prepared enzyme. 
iii)  Prepare the pre-formed nafion film, however, the technqiue used here should 
an improvement to method used in platform 1, as to create a more uniform 
film. 
iv) incorporate the electroactive cationic Co(Sep)3+ into the nafion film through 
the appropriate electrochemically based method.  
v) characterize the prepared carrier matrix to evaluate and highlight possible 
improvements in the formed film, as compared to the carrier matrix of 
biosensor platform 1. 
vi) create a suitable biocompatible hydrogel that can serve as replacement outer 
layer for nafion and funstion as stable encapsulator for the immobilized 
enzyme. 
vii) Immobilize the prepared enzyme on the electroactive carrier matrix and 
prepare the complete biosensor with hydrogel outer layer. 
viii) do comprehensive voltammetric characterization of the electrochemical 
characteristics of the biosensor     
 
 
1.5 Other novel objectives 
 
It is hoped that the work presented in this dissertation will provide an 
enhanced insight into the specific interactions between the biorecognition element 
and the selected substrates and such, provide an enhanced understanding/insight into 
the catalytic reaction cycle for the major human hepatic CYP3A4 enzyme, when the 
natural electron delivery system has been replaced by an electromotive force. This 
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would be a great milestone for these enzymes, since there application has been 
limited by the obligatory presence of specialozed physiological electron transfer 
donors and other components which have proven to extensively complicate 
reconstitution systems and biosensor platforms for this isoenzyme category.   
 
 
1.6 Layout of thesis 
 
The thesis is devided into the following chapters: 
 
Chapter 1 The chapter generally serves as an introduction with particular 
reference to the aspects that are of relevance to the entire scope of the 
dissertation, entitled “Electrochemical dynamics of cytochrome P450-
3A4 isoenzyme biosensor for protease inhibitor antiretroviral drug”. 
Also discussed in this chapter is the main aims, objectives, as well as 
the layout of the dissertation. 
 
Chapter 2 A comprehensive review of the literature of science of biosensors, with 
particular attendtion given to the aspects of relevance to the 
dissertation is given. In this regard, transducer aspects, molecular 
recognition, principles and classification of the enzyme electrode, solid 
polymer electrolyte, mediated amperometric biosensors, biocompatible 
polymeric hydrogels and biomolecule solid-support tethering are all 
discussed. 
 
Chapter 3A This chapter comprehensively explains important theoretical aspects 
which are of relevance to the scope of the dissertation: The main aim 
here being to provide an enhanced understanding in the school of 
thought during data analysis of obatained results, and therefore 
provides enhanced understanding of the presented results. Discussed 
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here are the thermodynamic and kinetic parameters, performance 
factors, enzyme kinetics and genetic engineering aspects. 
 
Chapter 3B General experimental protocols pertaining to the entire scope of the 
dissertation, tabulated listings of materials and reagents used, general 
preparative protocols of samples and reagents, relavent calculations 
and sample preparation and procedures for selected specialized ex-situ 
analysis.   
 
Chapter 4 Here the results for biosensor platform 1, entitled, “Microsomal 
cytochrome P450-3A4 biosensor for the determination of 2,4-
dichlorophenol  an endocrine disruptor compound” is presented 
and comprehensively” discussed. The nafion-CMECo(Sep)3+ carrier 
matrix was also subjected to morphological and structural 
characterization investigations for which the results are exhibited and 
discussed. The electrode assembly of the biosensor, the electrocatalytic 
response to dioxygen and substrate, as well as the biosensor response 
in the presence of selected inhibtor was evaluated with voltammetric 
investigations, for which the results are shown and discussed. In 
addition to this a critical assessment of the observed results are also 
discussed, providing enhanced insight into the observed results, as well 
as additionals observations that was of sugnificance. 
 
Chapter 5A and B The results for the assembly, characterization and catalytic 
response for biosensor platform 2  is presented and discussed. 
 
Chapter 5A The results for the assembly and characterization of composite film 
consisting of nafion and electrochemically deposited cobalt(III) 
sepulchrate [El-Co(Sep)3+] is presented and discussed. 
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Chapter 5B The results for the N-terminally modified genetically engineered 
human recombinant P450-3A4 (nCYP3A4) biosensor for the 
determination of protease inhibitor ARV drug, Indinavir is presented 
and discussed. 
 
Chapter 6 This chapter summarizes all of the major findings as observed from the 
research investigation with respect to the results shown and discussed 
for biosensor platform 1 and biosensor platform 2. Important future 
recommendations are also given. 
 
Chapter 7 References 
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Biosensors: A Review of the relevant aspects 
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Chapter Prelude 
 
The current chapter provides a comprehensive literature surveyd directory, of the 
relevant aspects and subjects on the area of sensors and biosensors as pertaining to 
the span of this dissertation. From a general perspective, a systematic description of  a 
sensor and/or biosensor should include five features. These are (1) the detected, or 
measured parameter; (2) the working/operating principle of the transducer; (3) the 
physical and chemical/biochemical model (used to evaluate functional properties and 
quality of the sensor); (4) the area of application and (5) the technology and materials 
for sensor fabrication. These issues are discussed in great detail, with the key focus 
centering around approach, design and utility of biosensors from the cytochromes 
P450 viewpoint. Elaborated discussions of selected subject areas highlighted in 
chapter one,  is also featured in this chapter. 
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2.1 Introduction 
 
The human body is equipped with at least five sensors, including the nose, tongue, 
ears, eyes and fingers [1]. Each ‘sensory-body-part’ recognises a specific component, 
for example, the nose reconizes smells; the ear, sounds; the eyes colours and light, 
and the fingers reponds to physical touch – in effect, these recognition events may be 
referred to as a detection event. Concomitantly, the message from the detection event 
gets conveid to the brain, after which the body then, in turn, responds to the stimulus 
in an appropriate manner. In this context, a sensor may be defined as: 
“a device that detects or measures a physical property, and records, indicates or 
otherwise responds to it” [52]. 
Sensors may be devided into three types, which includes physical sensors, chemical 
sensors and biosensors. Since physical sensors are not within the scope of this 
dissertation, they will not be elaborated on. A chemical sensor on the other hand, has 
definate relevance to biosensors and as such may be defined as follows: 
“ A chemical sensor is a device which reponds to a particular analyte in a selective 
way through a chemical reaction and can be used for the qualitative or quantitative 
determination of the analyte” [52]. 
Biosensors, in turn,  may be regarded as a sub-section of chemical sensors, but are 
usually treated as a subject in their own right, and thus may be discussed as a seperate 
topic. 
 
 
2.2 Biosensors 
 
Biosensors have a potentially large market, covering areas of clinical 
diagnostics, therapeutic drug monitoring, process control, food, military and 
environmental monitoring [53-55]. These analytical devices are unique in the sence 
that they may be described as self contained, all parts being packed together within 
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the same unit, the recognition element being in direct spacial contact with the 
transducer component [54, 56-57], and as such, the term ‘biosensor’ implies  
miniaturization and electronics. However, the latter description is not really 
definitive.  
 
 
2.2.1 Biosensor structure and features 
 
Biosensors are small devices which employ biochemical molecular recognition 
properties as basis for selective analysis, by making use of biological molecules as 
recognition element [54, 57-59]. The biological material is either intimately 
connected to, or intigrated within a transducer device which in turn converts the 
biochemical signal into a useful invariably electronic output . A schematic description 
of biosensor in terms of key components and operating principles are shown in  
 
Figure 2.1 Schematic representation of biosensor components and operation 
 
As shown in Figure 2.1, the essential components of a biosensor is, the biological 
component, the analyte matrix, the transducer, the amplification, processing and 
displaying systems [53-55, 59-60]. The biological component selectively recognises 
an analyte or class of analytes of interest (i.e. the physical stimulus), and as such 
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functions as the recognition element. The recognition component itself, may be 
divided into two distinct sub-groups, which is catalytic and non-catalytic. The 
catalytic group includes enzymes, micro-organisms, whole cells and tissues, whereas 
the non-catalytic group may include anitbodies, receptors, nucleic acid, DNA etc 
[54]. In the context of this thesis, enzymes are applied as recognition element. On the 
subject of enzymes, an important fact to add, is that in terms research output and 
commercial application, they have enjoyed the major attendtion due to the fact that 
they are directly linked to the historical concept of the biosensor [17, 55-56], as well 
as their inherent qualities, the most eminent being their catalytic ability and substrate 
selective behaviour. The function of the transducer, on the other hand, is to convert 
the biological recognition event into a useful electrical signal/output [54, 58-59]. The 
convertion process cofers bi-directional signal transfer to and from the biological 
recognition element (non-electrical to electrical and vice versa); also noteworthy is 
the fact that the transducer part of the biosensor is also a detector, or electrode [57]. 
The output from the transducer is amplified, processed and displayed by an output 
system, consisting of an electrical amplifier in conjunction with data acquisition and 
display instrumentation [54, 58-59]. Furthermore, on the subject of transducers, it is 
noteworthy to add that it also plays a pavitol role in enzyme stabilization, which is 
achieved through an interfacial region, consisting of specific carrier matrix materials 
which are normally intimiately associated, or tightly bound to the transducer surface 
and as such, providing the matrix support for enzyme immobilization and electron 
transfer. With regard to the manifold functions of the transducer, it is irrefutable to 
admit that it plays a significant role in (bio)sensor functioning and application and in 
this regard may be discussed in greater detail. 
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2.2.2 The Transducer 
 
An important aspect of biosensors are their classification, which amongst 
others, is highly dependant on the transduction process. In this regard, the specific 
operation principle of the transducer is a key factor, since it tells us how the 
biological recognition process being monitored is converted and transduced to obtain 
a detectable signal. In view of the latter, the transducer makes use of a physical 
change accompanying the recognition reaction, which, depending on the type of 
biosensor, differs accordingly. These may be [59]:  
 The heat output (or absorbed) by the biochemical reaction: calorimetric 
biosensors; 
 changes in the distribution of charges causing the production of a electrical 
potential: potentiometric biosensors; 
 movement of electrons produced in a redox reaction: amperometric 
biosensors; 
  light output during the reaction or a light absorbance difference between the 
reactants and products: optical biosenosrs; or 
 Effects due to the mass of the reactants or products: piezo-electric biosensors.      
A compilation of biosensors classified in tems of their transduction method and 
application, respectively, is shown in Table 2.1. 
 
Table 2.1: Biosensor transduction systems and measurement modes 
Transducer 
Type 
Detection or 
measurement mode 
Transducer 
Type 
Detection or 
measurement mode 
Electrochemical 
Amperometric 
Potentiometric 
conductometric 
 
Optical 
Fluosence 
Luminescence 
Reflection 
Absorption 
Surface plasmon 
Resonance scattering 
    
Thermal Calorimetry Piezoelectric QCM 
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Enzyme thermastor 
(heat of reaction or 
absorption) 
SAW 
SH/APM 
Lamd wave 
 
 
 
Among the list tabulated in Table 2.1, biosensors with electrochemical transduction 
systems have been found to overcome most of the disadvantages wich inhibit the use 
of other types of biosensors, and as such have incurred the most attendtion, and 
appropriately, much research has been dedicated to this type of biosensor 
development. These devices can operate in complex (turbid) media, have comparable 
instrumental sensitivity and are more ammendable to miniaturization. In terms of the 
specific measurement mode, eletrochemical biosensors may be devided into 
conductometric, potentiometric and amperometric types. Amongst these, 
amperometric biosensor configurations are the most common, the main reasons being 
its high sensitivity and wide linear range.  
 
With regard to the practical aspects of investigation purposes, the transducer refers to 
an electrode, which is in intimate contact or integrated with the biological recognition 
component — otherwise known as the working electrode (WE). Research has shown 
that the rate of electron transfer across an electrode-solution interface is directly 
dependent on the physical and chemical properties of the working elecrode material. 
In this regard, the selection of WE is very important. Electrochemistry and electron 
transfer of proteins and/or enzymes has been invetsigated on various types of 
electrodes, including Au, Pt, metal oxide electrodes (such as In2O3), glassy carbon 
electrodes, pyrolytic graphite electrodes, etc. Amongst the latter list, glassy (or 
vitreous) carbon has shown tromendous promise because of its excellent mechanical 
properties, wide potential window, chemical intertness (highly solvent resistent), 
increased reversibility for several redox complexes and reactions involving 
subsequent proton transfer, as well as its relatively reproducible performance. 
Appropriately, glassy carbon electrode (GCE) was used as WE in the research 
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investigation outlined in the current dissertation. In particular, a GCE, deliberately 
modified with appropriate material including permselective membrane, 
electrochemically and/or manually pre-concentrated mediator species and  hybrid 
compsite biocompatible biopolymer hydrogels — in short chemically modified glassy 
carbon working electrode was used. Material types and specific techniques are 
discussed in greater detail in subsequent sections within this chapter and following 
chapters. 
 
Since the biosensor configurations in this thesis is based on amperometric 
measurement, this subject area will be discussed in greater detail, and all relevant 
subsections will be discussed in terms of this specific operating principle. 
 
 
2.2.2.1 Amperometric Biosensors 
 
The origin of the novel field of analytical biotechnology as whole, is 
directly linked to amperometric devices, and as such, this class of biosensors are the 
most prevelant, the most extensively researched — having the widest available 
configurations, while also being the most successfully commercialized devices of 
biomolecular electronics [17, 56]. The poineering work in the history of 
amperometric biosensors was done by Clark and Lyons [55, 61-62], who placed the 
enzyme, glucose oxidase, at the surface of the oxygen “Clark electrode” covered with 
a semi-permeable diallysis membrane, so creating an enzyme-based electrochemical-
amperometric biosensor configuration. In this regard, it can be unequivocally stated 
that they invented the concept of the “enzyme electrode”[17, 56]. Their work was 
further researched and developt by Updake and Hicks [17, 56, 63], and, overall, the 
combined efforts set the stage for the eventual realization of the first successful 
commercial biosensor, the eminent glucose sensor [17] – an indisputably valuable 
asset for sufferers of the chronic condition known as diabetes. Being small, portable 
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and with high specificity it enables the patient to do rapid routine blood and/or urine 
glucose level measurements, which in turn allows for manual adjustment of insulin 
dosage, and as such its development has revolutionized the health care and 
pharmaceutical industries. Since then, the scientific arena has witnessed a huge 
prolifiration of amperometric biosensor configurations, in diverse areas of 
application, including drug and metabolite measurement, clinical diagnostics, 
environmental monitoring, chemical measurements in agriculture and food, etc [58].  
 
In a definitive context, the principle of the amperometric technique is based on the 
measurement/monitoring of the current associated with the electrochemical oxidation 
or reduction of an electroactive species involved in the recognition process [55, 57-
58]. The process of amperometry is usually performed by maintaining a constant 
potential at a Pt, Au, or carbon based working electrode or on array of electrodes. The 
fact that a sufficient voltage across the working electrode is essential to allow a 
specific (oxidation/reduction) to take place requires a reference electrode with known, 
fixed and stable electrode potential to be included in the cell design, examples being 
silver-silver chloride- or calomel electrode. With regard to enzyme-based 
amperometric biosensors, the electrochemically reduced or oxidized enzyme 
catalytically converts electrochemically non-active analytes (substrates) into products 
at the working electrode at a specific potential with respect to the particular reference 
electrode. The resulting current is directly correlated to the bulk concentration of the 
analyte or its consumption rate within the area adjacent to the biocatalytic layer or to 
the product, since the product is proportional to the non-electroactive enzyme 
substrate. 
 
Due to the nature of their operational principle, amperometric sensors, including 
biocatalytic amperometric sensors, alter the concentration of the analyte in their 
vicinity; these sensors may reach a steady state but they never reach equilibrium. 
With regard to specific steps involved in the recognition process, multiple steps are 
known to occur during the biocatalytic reaction which includes the following [52]: 
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 The electron transfer reaction, which encompasses the transfer of electrons 
between the electrode surface and molecules in the analyte solution adjacent to 
the electrode surface. This process is heterogeneous. 
 The other process involves the transport of molecules from the bulk solution to 
the electrode surface, which normally involves the movement of material from a 
high-concentration region of the solution to a low concentration region (the 
electrode surface) and may thus also be referred to as diffusion. 
 Chemical reactions coupled to the electron transfer reaction. 
 
The rate of the overall reaction is generally determined by the rate of the slowest step, 
known as the rate limiting step, and as such, the actual response may thus reflect 
mass-transport or kinetic limitations. 
 
Overall, amperometric biosensors can be classified into three generations [52, 58, 64-
65]:  In the earliest or first generation biosensors (FGB), the normal product of the 
molecular recognition reaction diffuses to the transducer and causes electrical 
response (current induction). The original glucose electrode, which relied on 
molecular oxygen as the oxidizing agent belongs to this group of biosensors. The 
decrease in oxygen, or the formation of hydrogen peroxide is measured with a Clark 
oxygen electrode. This generation of biosensors, however, have some inherent 
drawbacks: 
a) The applied potential required is too high, resulting substantial interference 
from other species in complex matrices; 
b) The concentration of the dissolved oxygen is fluctuant, which leads to 
systematic convolution; 
c) The tenuity of the dissolved oxygen extensively decreases electrical currents, 
which in turn influences the detection limit. 
To circumvent the inherited drawbacks of first generation biosensors, the idea of 
electroactive, artificial compounds was proposed, giving rise to second generation 
bioensors (SGB). The operating principle of second generation biosensors involve 
soluble low molecular weight redox compounds, known as mediators, which shuttles 
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electrons between protein (enzyme) and transducer in order to generate an improved 
response. Common mediators are ferrocene complexes, whose structures consist of a 
sandwich of the cation between two cyclopentadienyl (Cp) anions. The result of using 
these articficial electron acceptors, is thar measurements become insensitive to 
oxygen fluctuation and can be performed at lower potentials that do may preclude 
reactions with interfering species. For this biosensor class, the mediator is normally 
contained within the test-solution, adjacent to the biocatalytic layer. Such devices 
have been commercialized, mostly as single-use testing format. The other group, 
third-generation biosensors (TGB), are signified by the progression from the use of 
freely diffusing mediator (O2 or artificial), to a system where the protein (enzyme) 
and mediator are co-immobilized at an electrode surface, making the biorecognition 
component an integral part of the electrode tranducer. Co-immobilization of the 
protein (enzyme) can be accomplished by different methods, such as redox mediator 
labeling of the enzyme followed by enzyme immobilization, enzyme immobilization 
in a redox active polymer, or enzyme and mediator immobilization in a conducting 
polymer. Overall, third-generation biosensors offer all the benefits of second-
generation sensors, with the inclusion of some modifications and new additions. 
These biosensors are self-contained in the sense that there is no need for adding 
additional mediators or enzyme. Therefore, this design ficilitates repeated 
measurements. Also noteworthy, in the context of third-generation biosensors, is that 
due to enzymes’ renowned  superior selectivity and high affinity toward substrates, 
direct electrical contact of enzyme to electrode has also been attempted and reported. 
This would obviously be the superior choice, since it would enable a lower operating 
potential and thus less susceptability to interfering reactions, however due to their 
physiological make-up (which will be discussed later, specifically in terms of 
microsomal CYP450 enzyme), most enzymes cannot exhibit direct electron transfer 
(DET) at normal electrode surfaces. Hence, achieving DET within the development 
of TGB has been a “bottleneck’, with success only achieved with a select few 
proteins (enzymes). One such protein, is cytochrome c.   
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The concept and principles of mediators and mediated-biosensors will be more 
comprehensively discussed within the context of amperometric configurations for 
microsomal P450 enzymes in subsequent sections. 
 
 
2.2.3 Molecular Recognition 
 
As highlighted in previous sections, an important aspect/feature of 
amperometric biosensors, is the molecular recognition event, which depending on the 
nature of the specific biological element (i.e. catalytic or non-catalytic), in turn 
determines the type of analyte or substrate to be measured/detected. In the case of the 
current dissertation, the recognition element is enzyme based, and as such catalytic 
in nature. In particular, the enzyme used is cytochrome P450 isozyme, CYP3A4. As 
discussed in Chapter 1, it is the major human hepatic cytochrome P450 isozyme, and 
as such, is the most important enzyme in the metabolism and detoxification of 
xenobiotics within the human body. A schematic representation of the contributions 
of CYP450 isozymes and non-CYP450 enzymes is illustrated in Figure 2.2.  
 
 
 
 
 
 
 
 
 
Figure 2.2 Contribution of major human hepatic cytochromes P450 isozymes ad 
non-P450 enzymes to phase I metabolism of all xenobiotics  
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As shown in the above figure, the major contribution to phase I metabolism is 
assigned to CYP3A4. The structure of CYP3A4 has already been comprehesively 
discussed in Chapter 1, and as such will not be elaborated on at this stage, but in 
short: CYP3A4 is a class II, microsomal heme thiolate enzyme, whose main function 
is the monooxygenative metabolism of lipophilic xenobiotics. A schematic 
representation, showing a comprehensive overview of the stepwise catalytic reaction 
cycle, of the monooxygenation process is illustrated in Figure 2.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Physiological catalytic reaction cycle of CYP3A4, showing enzyme-
substrate interaction and natural electron transfer (ET) donor source, with general 
equation shown. Also shown, is the alternative sources of ET for CYP3A4 substrate 
catalytic function 
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As observed from Figure 2.3: In the absence of a substrate, at the beginning of the 
cycle, CYP3A4 heme iron is in the hexacoordinated low spin Ferric (Fe
3+
) state with 
water being the sixth ligand. Substrate binding to the hexa-coordinated low-spin 
ferric enzyme displaces water ligand from the active site, resulting in a change to the 
5-coordinate high-spin state, which is accompanied by a marked positive shift in 
redox potential (± 130mV) [66], signifying the thermodynamic favourability of the 
first electron transfer step. It is noteworthy to add though, that in some instances, 
substrates may induce only partial spin shift thus resulting in a much smaller or even 
no redox potential shift.  The transfer of the first electron from native electron transfer 
donor, NADPH-P450 reductase (via FMN and FAD) follows, thus reducing the ferric 
iron to ferrous (Fe
III
 + e
-
 → FeII) state of heme. This can now bind molecular oxygen, 
forming a ferrous-dioxygen (-Fe
II
-O2) complex (also known as the oxy-ferrous 
complex). On this subject, it is important to add that the oxy-ferrous intermediate 
represents the first branching point between substrate turnover and the abortive decay 
with the formation of harmful radicals [67].  
 
After the formation of the oxy-ferrous intermediate, the second electron is transferred 
to produce a ferric peroxy anion, which is concurrently followed by protonation of 
the ferric peroxy anion, yielding an iron-hydroperoxo(Fe
III
-OOH) (intermediate) 
complex, which undergoes subsequent heterolytic (O—O) cleavage, to release a 
water molecule and a highly active iron-oxo ferryl species, formally equivalent to a 
Fe(V)═O species named, Compound I [23]. This compound (or a similar reactive, 
electrophilic iron-oxo intermediate) then ‘attacks’ the substrate, so placing one 
molcule of molecular oxygen into the substrate and as such yielding the hydroxylated 
product which dissociates to let the cycle start again. An important factor to bare in 
mind, during the second electron transfer step, is that, in addition to NADPH-
reductase, depending on the substrate, additional redox pathways involving 
cytochrome b5 may also be necessary. These can occur through the following 
scheme:  
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Although CYP450 enzymes’ catalytic cycle is always described in terms of subject 
binding being the intial step, electron transfer may of course also proceed without the 
presence of substrate, but the likelihood of reactive oxygen species, is more probable 
in such case.  
 
 
With regard to the overall catalytic reaction cycle for CYP3A4 and all microsomal 
CYP450 enzymes in general,  there are two possible major abortive reactions (shown 
in red and grey, respectively in Figure 2.3): (i) autooxidation of the oxy-ferrous 
enzyme intermediate with concomitant production of harmful radicals (a self 
inactivation process) and (ii) oxidase uncoupling with oxidation of the ferryl-oxo 
intermediate. Both of these reactions, known as uncoupling/decoupling reactions, 
produce highly active oxygen species (ROS) by autooxidation in vitro and in vivo, 
particularly without the presence of substrate and as such, extensively complicates the 
reaction cycle of this enzyme. With the regard to these uncoupling reactions, the first 
one has been documented as the most significant, because it was shown to be the first 
branching point in the catalytic cycle of microsomal cytochromes P450 enzymes, in 
which the efficiency of the substrate metabolism may be curtailed by the side reaction 
of autooxidation. In a definitive context, this particular uncoupling reaction is 
characterized by the release of superoxide within the enzyme, followed by its 
disproportionation and generation of hydrogen peroxide, a source of harmful 
hydroxyl radicals. In humans, such obortive decay reactions can induce apoptosis, a 
process which  may result in cell death and cancerous growths. In this regard,  this 
oxyferryl intermediated has been documented as being the most important natural 
determinant of CYP3A4 activity and/or human xenobiotic metabolism.  
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2.2.3.2 The enzyme electrode: Principles and classification from the 
microsomal cytochrome P450 viewpoint 
 
In light of preceding literature reviewed sections on the structure and 
function of CYP3A4, both in the current and previous chapter, one point is infallibly 
clear: Electron transfer (ET) is the key juncture to generating the necessary 
catalytically active species within the enzyme heme pocket for successful function 
and/or substrate metabolism — an aspect that pertains to all P450s, whether 
microsomal, mitocondrial, or bacterial.  As shown, in vivo, these pivotal ET steps are 
achieved through structured schemes with native freely dissociated NAD(P)H ET 
donors. However, the whole process is complicated and compromised by the 
possibility of uncoupling reactions, which may abort substrate monooxygenation. In 
this regard, being such a versatile and pivotal mammalian enzyme, with multipurpose 
in vitro studies being highly opportune, these complications needs to be taken into 
account and innovative techniques would have to be applied to prevent such 
occurances, since such studies is normally done with the obligatory presence of the 
ET donors, either in the form of fusion protein constructs (containing heme domain of 
P450 enzyme linked to flavoproetin domain of NADPH-P450), or seperately added 
within the enzyme reconstitution sample. Moreover, mammalian microsomal 
CYP450 enzymes are known to be labile, especially in reconstitution solutions, 
requiering several reagents, such as glycerol, dithiothreitol, phospholipids and 
protease inhibitors for some degree of stabilization, which means that such 
aforementioned complications would compromise the function of an already unstable 
enzyme. Furthermore, NAD(P)H is expensive, decomposis over time, gets exhausted 
after the first electron donation step and needs to be regenerated, but is difficult to 
recover once oxidized. 
 
One the other hand, the heme iron, may be regarded as a sink for receiving electrons, 
and in this regard, alternative sources of ET to the enzyme may be an option. 
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Interestingly, the so-called “shunt” reaction, which involves the application of 
peroxides, such as hydrogen peroxide, cumene hydroperoxide or tert-butyl 
hydroperoxide as alternative electron source has been documented [23, 68]. The 
reaction works on the principle of cytochrome P450-dependent catalytic substrate 
metabolism without the necessity of stepwise activation of molecular oxygen or 
interaction with native electron donating systems. Indeed, success in substrate 
turnover has been attained, however, this is at the expense of shortened enzyme 
activity [68-69], with enzyme denaturation observed within as short as one hour. 
Needless to say, for modern day requirements in healthcare, pharmaceutical, 
industrial and even (bio)catalytic chemistry-related research activities, this would be 
impracticle, and as such, alternative methods of electron sources has become a highly 
envisaged quest. One of the alternative methods of P450s reduction is 
electrochemical methods with an electrode as electron source. Enzyme electrodes 
based on P450s are promising for the application of biosensors and bioreactors. 
Moreover, enzyme-based biosensors function on the premise of an immobilized 
enzyme, an aspect in itself that, if done judiciously with carefully orchistrated 
interfactial enhancer marix material, would significantly stabilize the biological 
molecule, since the latter are generally known to have very short lifetime in solution. 
As earlier stated, electrochemical biosensors with amperometric transduction is the 
most preferred biosensor configuration. 
 
The design path and development of such an enzyme-based biosensor platform is not 
just a frivolous, extemporized putting together of components, but requires an 
absolute meticulous approach, particularly since the aim is the fabrication of a 
reagentless configuration in which the enzyme is integrated within the (electrode) 
transducer. In this regard, there are fundamental aspects that needs to be taken into 
consideration, as well as specific criteria that needs to be satisfied for the biosensor to 
be of practical use. These include the following: 
 The iron(III) protopohyrin-IX prosthetic group of the enzyme is deeply buried 
within the active site and surrounded by a thick protein shell. This is a natural 
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phenomenon, particularly in P450 enzymes, designed by nature to protect the 
redox state of the integrated cofactor, thus avoiding any unwanted processes 
with free-diffusing redox species. However, the thick protein shell introduces 
a kinetic barrier to electron transfer. The significance of this intrinsic property, 
is that direct transfer, involving a simplistic electron tunneling mechanism 
between the electrode and enzyme active site is not really feasible and as 
such, specialized ET mechanisms need to be used. 
 Proteins and enzymes tend to undergo rapid, non-specific and irreversible 
adsorption onto (metal) electrodes, coupled with conformational changes and 
the consequent loss of actvity (denaturation), the result of which is the 
formation of an insulating protein layer which hinders/prevents electron 
exchange with electrodes. Thus, appropriately, preventative measures needs to 
be inplace, to avoid such unwanted interactions. Such methods will be 
discussed in greater detail in subsequent sections. 
 During the course of the reactions sequence in amperometric biosensor 
operation, the redox state of the enzyme is altered and as such, has to be re-
generated at the electrode surface which is poised at a suitable potential. This 
can only occur if the enzyme is immobilized in a favourable, “productive” 
(anisotropic) orientation that will enable effective electron transfer to and 
from the enzyme’s prosthetic group. 
 According to the Marcus theory for biological electron transfer [ ], one of the 
major factors affecting electron transfer, is the distance between  the redox 
species, which in enzyme-based biosensors, is highly dependent on the 
accessibility of the enzyme’s redox site, as well as the specific orientation of 
the immobilized enzyme. In this regard, the deeply buried-electrically 
insulating nature of CYP3A4 prosthetic group  in itself lengthens the electron 
transfer distance between the enzyme and electrode. Moreover, the added 
effect of possible unfavourable enzyme orientation will further  drastically 
impede ET. This essentially means that innovative techniques is required to 
enable electrochemical communication between the enzyme prosthetic group, 
 
 
 
 
 Chapter 2  Biosensors: A review Of The Relevant Aspects
  
 
49 
 
while also allowing anisotropic orientation of the integrated enzyme atop the 
electrode surface. This can only be achieved through the inclusion of suitable 
electrode modifiers and ET enhancers, collectively known as interfacial 
enhancing material. 
 The other major factors which, according to Marcus’ theory directly affects 
the kinetics of electron transfer between two redox spcies, is the driving force 
(i.e. the potential difference) and the reorganizational energy. Of the 
aforementioned factors, the reoganizational energy qualitatively reflects the 
structural rigidity of the redox species and in terms of an immobilized 
enzyme, is decidedly determined by the immobilization method. Enzyme 
immobilization needs to be flexible enough to retain the structural and 
catalytic integrity of the enzyme, while also facilitating electron transfer to 
and from the electrode surface and allowing access to the active site for the 
specific substrate without requiring large reorganizational energy during 
electron transfer and/or electrocatalytic functioning. 
 Proteins and enzymes and most other biomolecules is vulnerable to extreme 
conditions such as temperature, pH and ionic strength and in this regard, the 
enzyme film needs to provide the necessary protective environment to 
maintain intrinsic properties of the immobilized biomolecule. 
 The immobilised biological film needs to have long term stability and 
duribility. 
 Reagentless biosensor configurations require tight fixation of all sensor 
components on the electrode surface, coupled with an ET pathway either by 
direct electron tunneling, or securely immobilised redox relays. Appropriately, 
sensor architecture have to be designed with this purpose in mind.    
   
In consideration of the preceding factors and to fulfill the criteria of designing an 
optimised enzyme(CYP3A4)- based amperometric biosensor, it is apparent that the 
main aim should be to increase the electronic coupling by using electrode 
architechtures with predefined ET pathways interconnecting the redox site within the 
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enzyme and the electrode surface and facilitating communication between the latter 
two species, while making the ET distance as short as possible. This is in turn 
critically dependent on the immobilization method and as such needs to be discussed 
in greater detail. 
 
 
2.2.3.1.2 Biomolecule solid-support tethering: Immobilization methods, 
biorecognition component coupling techniques, and other relevant 
aspects  
 
As discussed in the forgoing sections, an essential step in biosensor 
develpment is binding of the biological component to the transducer element. This 
immobilization feature will dictate the ultimate reliability and performance of the 
biosensor. Several methods can be used to tether biological molecules to solid 
electrode support, of which the main methods include adsorption, crosslinking, 
entrapment and covalent binding.  A schematic representation of these methods are 
shown in Figure 2.4. These methods may be used in combination with each other or 
in conjunction with other techniques – a thorough discussion of the various 
techniques follows subsequently. In this regard, subsequent discussion is based on a 
combination of documented literature [17, 53-54, 58, 64-65, 70] 
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Figure 2.4: Major immobilization methods for proteins, enzymes and other 
biological molecules onto solid (electrode) supports 
 
Amongst the above methods, the most simplistic and oldest involves adsorption. 
Adsorption of biomolecules from solution onto solid surfaces can proceed by means 
of either physical or chemical interactions. Physical adsorption involves van der 
Waals forces, ionic binding or hydrophobic forces, whereas in chemisorption on the 
other hand, there is a sharing or transfer of electrons to form a chemical bond. 
Adsorption has been successfully applied to couple proteins and/or enzymes to 
various solid supports, including derivatized glass, plastics, silicone rubber and most 
recently, conductive electrodes for biosensor application. The binding of such 
biological components through physical adsorption can be directly measured via a 
piezoelectric qaurtz crystal microbalance (QCM) or surface acoustic wave device 
which functions by detecting frequency changes, which are related to the amount of 
protein/enzyme bound onto the solid surface. In addition to the aforementioned 
methods, optical techniques of surface plasmon resonance (SPR) and ellipsometry 
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have also been employed to detect refractive index changes at the surface of a thin 
metal film as a result of biomolecule adsorption. Overall, the main advantage 
associated with adsorption, is that it is a simple method which can be performed 
under mild conditions. However, on the other hand, biomolecules tethered through 
adsorption were found to exhibit a certain degree of reversibility and furthermore, the 
forces involved in the binding are not very strong. In this regard, with respect to long 
term stability, duribility and tight association of the enzyme film, on its own, this 
particular method is not intirely conducive.  
 
One alternative approach to attachment of biomolecules to electrode surfaces is 
through covalent binding, which involves attachment onto the solid surface through 
the formation of defined linkages. This technique has been documented to result in 
minimal loss of biomolecule activity, and in addition, have been shown to overcome 
problems associated with instability, diffusion and aggregation, or inactivation of 
proteins commonly experienced when biomolecules are trapped on sensor surfaces by 
other methods. Bifunctional reagents and spacer molecules, such as gluteraldehyde, 
carbodiimide, succinimide esters, maleinimides and periodate are commonly used for 
this method. The principle of covalent binding is based on the premise that 
biomolecules such as proteins and enzymes have many functional groups present for 
covalent linkage onto surfaces; these include amino-acid side chains (e.g. lysine 
amino acid groups), carboxyl groups (e.g. aspartate and glutamate), sulfhydryl groups 
(e.g. cystein), phenolic, thiol and imidazole groups. The actual coupling procedure 
between the enzyme or the protein and the solid support is best achieved through 
functional groups on the biomolecule which are not required for its biological 
activity. On the other hand, the solid support is usually chemically modified, with 
specific reagents in order to introduce a functionality (also known as surface 
activation) which may then be coupled with the protein/enzyme. Covalent binding 
generally have the advantage that the biomolecule is usually strongly immobilized on 
the surface and therefore unlikely to detach from the surface during use. However, 
absolute care has to be taken that the reagents used in achieving immobilization of the 
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biomolecules on the surfaces do not result in a loss of activity due to reactions 
involving the functional groups. Moreover, although covalent coupling procedures 
have yielded a substantial degree of success for a number of biosensor systems, the 
drawbacks of this method and associated techniques have been documented as the 
production of randomly oriented, non-uniform structures of inactivated enzymes or 
protein molecules on the electrode (solid support or sensor) surface. This in turn 
highlights the need for immobilization methods which are capable of producing 
uniform, active layers of immobilized protein/enzyme.  
 
The next method which proved to compensate for short-comings observed in the 
aforementioned methods, envolves a procedure based on entrapment of the 
biomolecule. In this regard entrapment matrices include (semi)permeable membranes, 
polymers (including non conductive-, conductive and redox polymers), surfactants, 
sol-gels, biopolymer hydrogels and/or redox hydrogels  with redox centres such as 
[Os(bpy)2Cl]
+/2+
. In a definitive context, entrapment simply involves the confinement 
of the specific biological  molecule (e.g. a solution of enzyme, a suspension of cells, 
or a slice of tissue) as a thin film covering/integrated onto the transducer (electrode). 
With regard to membrane and/or non conductive-based polymer confinement, the 
negatively charged perfluorinated sulphonate polymer, Nafion™, has proven to be 
quite popular, particularly, due to its inherent property of reducing interference 
reactions through charge repulsion and as such, enabling it to also be utilized as 
semipermeable membrane. Overall, Nafion™ has been utilized in numerous 
biosensor configurations for enzyme/protein integration onto electrode surfaces. Since 
the specific protocols applied in this dissertation includes Nafion membrane 
confinement, the specific structure and function of Nafion is discussed in subsequent 
sections. A number of other polymers have been used for inclusion of proteins, 
enzymes, cells and organells. These include poly(vinyl-alcohol), polyvinyl chloride, 
cellulose acetate, polycarbonate and polyacrylamide. With regard to conductive 
polymer confinement on the other hand, the method of electropolymerization has 
widely been used to immobilize proteins in electrochemically formed polymer films 
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at electrode surfaces. This allows for electron transfer through molecular wiring of 
the protein/enzyme to the electrode and as such, has been of immense interest in 
electrochmemical biosensors. Various polymer films, have been created on electrodes 
using this approach, the most eminent being polypyrrole and polyaniline-based. 
Immobilization of the protein/enzyme in a polymer film at an electrode by 
polymerization can be performed in two ways: (i) electropolymerization from a 
solution containing protein or enzyme, mediator and monomer (one-step method); or 
electropolymerization from the monomer- (and mediator) containing solution, 
followed by drop-coating or electrochemical adsorption of the protein or enzyme 
(two-step method).  Entrapment of protein (enzymes) in thin bilayer lipid membrane 
films has become populer, since it is thought to provide a biomembrane-like 
environment, characterised by a liquid-crystal milieu. Such membranes can be 
fabricated by drop-coating or langmuir blodget (LB) deposition. Entrapment within 
self assembled monolayer films are also common. Overall, entrapment-based method 
do, however, suffer from the weakness of  leakage of biological species during use, 
resulting in some loss of activity. In this regard, additional re-inforcement through 
cross-linking usually alleviates the problem of biomolecule leakage.  
Cross-linking of biological molecules by means of multifactoriar reagents affords 
improved stability  of biological molecules, confined both as adsorbed, entrapped or 
covalently bound species. Gluteraldehyde, which couples with lysine amino groups of 
proteins (enzymes), is undoubtedly the most common cross-linking agent in 
biosensor applications. In addition to gluteraldehyde, other examples of cross-linking 
agents include hexamethylene di-isocyanate, 1,5-difluoro 2,4-dinitrobenzene and 
diazobenzidine-2,2’-disulphonic acid, etc. Indeed, as with any technique, there are of 
course a number of disadvantages associated with this method: (i) complete control of 
the reaction is difficult and tricky; (ii) the protein/enzyme layer formed is frequently 
gelatinous and not rigid; most often, large amounts of biological material are 
required; (iv) cross-linking can result in the formation of multilayers of 
protein/enzyme, which may result in low activity of the immobilized layers; (v) large 
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diffusional barriers to the transport of species may result, leading to retarded 
interactions. 
 
 
The other alternative method for the immobilization of biological molecules is 
encapsulation, which can be done in ceramics, glasses and other inorganic materials 
using sol-gel encapsulation technique. With respect to the sol-gel procedure, 
biological molecules are entrapped in an aqueous microenvironment in a porous 
matrix, an example being the polymeric oxo-bridged SiO2 network. In this regard, the 
matrices are porous wet gels formed by the hydrolysis and condensation-
polymerization of metal and semi-metal alkoxides, mostly SiO2 materials. Such 
matrices are optically transparent, so enabling the chemical interactions of the 
entrapped biological molecules to be optically monitored. The advantages of this 
particular technique is that it can be carried out at ambient temperature and that the 
conditions of the sol-gel process are reletively mild and thus do not normally 
denature the immobilized biomolecules. The drawbacks on the other hand are as 
follows: Although biomolecules immobilized with this procedure retain their activity 
to a large extend and are chemically, thermally and structurally stable, sol-gels with 
reproducible pore sizes are required, and problems due to diffusional limitations 
inside the porous network, brittleness of the glassy matrix, reproducibility and 
variations in the preparation procedures confer some degree of limitation and as such 
must be taken into cinsideration.  
 
Finally, other immobilization may also be achieved through bulk modification of 
entire electrode material, e.g. enzyme modified carbon paste or graphite epoxy resin. 
 
It is noteworthy to add, that in most aforementioned methods: (i) The biological 
material may also be immobilized together with carrier proteins, such as bovine 
serum albumin, which also functions to minimise non-specific binding of the 
biomolecule. (ii) A low molecular weight, redox inactive compound, known as a 
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promoter, which may or may not be further activated and/or modified, is in many 
cases initially adsorbed onto the solid surface, followed by enzyme linkage.   
 
Also worth mentioning, is that besides the reacting layer or membrane, many 
biosensors, especially those designed for biological or clinical applications, 
incorporate one or several inner and outer layers. Such membranes serves specific 
important functions [57]: 
 Protective barrier. The outer membrane prevents large molecules, such as 
proteins of the biological samples from interfering with the reaction layer. It 
also reduces leakage of the reacting layer components into the sample 
solution. Moreover, a properly selected membrane exhibits permselective 
properties which may be additionally beneficial to the biosensor function. It 
may decrease the influence of possible interfering species detected by the 
transducer. 
 Diffusional outer barrier for the substrate. As most enzymes follow some 
form of Michaelis-Menten kinetics, enzyme reaction rates are largely non-
linear with concentration. Nevertheless, linear dynamic ranges may be large if 
sensor response is controlled by the substrate diffusion through the 
membrane, rather than by enzyme kinetics. This control is achieved by 
placing a thin outer membrane over highly active layer. The thinner, the 
membrane, the shorter is the biosensor response time. 
 
Another intereseting aspect to add, still on the subject of biomolecule-electrode 
coupling, is, that in some cases the structure of carrier matrix materials have been 
further manipulated, usually done by a reduction in particle size and/or the inclusion 
of selected (conductive) nanoparticles within the matrix in order to try and improve 
biocatalytic efficiency of the immobilized biomolecule. The premise here is that in 
the case of surface attachment, smaller particles can provide a larger available surface 
area for attachment of proteins or enzymes, while providing enhanced conductivity, 
for example, in the case of gold nanoparticles. 
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A final noteworthy factor to add at this stage, with the emphasis on reiteration of the 
absolute need for maintaining the catalytic activity of the immobilized biomolecule, 
is that, bioelectrocatalytic and/or biosensor coupling efficiency assesment 
investigations may be complimented with in-situ and/or ex-situ spectroscopic studies, 
in order to provide a more in-depth examination of the integrity of the protein/enzyme 
conformational state and substrate binding ability. This is an especially pivotal aspect 
in the case of cytochromes P450 in particular, who have to maintain their active 
conformational state, guaranteed by the presence of a specific thiolate bond between 
the heme iron and the highly conserved cystein residue (see Figure 1.2(b))  [71-72]. 
In this regard, such an active state can be spectroscopically interrogated and identified 
as a reduced carbon monoxide complex with an absorbance maxima at 450 nm [24, 
71-72]. Weakening, or distortion of the heme-thiolate bond usually gives rise to the 
formation of an inactive species called P420 that is characterized by an absorbance 
maxima at 420 nm of its reduced CO complex (Fe
II
-CO), rather than the expected 
signature P450. In this context, such assesment studies, is a preferred accompaniment 
to electrochemical investigations, in order to distinguish the electrochemical 
behaviours of the active form from that of the inactive one when developing devices 
based on cytochromes P450. In terms of electrochemical studies in particular, on the 
other hand, CO Fe
III
/Fe
II
 complex formation is usually portrayed by cyclic 
voltammetric peak potential shift and current signal changes, based on the premise 
that CO is known to rapidly bind as a six ligand to the reduced heme iron [73]. 
However in the presence  of artificial mediating electron shuttlers, the 
exhibition/portrayal of CO-Fe
II
 complex formation is complicated by the fact that 
electron transfer occurs via the mediator to the enzyme prosthetic group. In this 
regard and to further elucidate enzyme catalytic activity, additional electrocataltyic 
studies with native model substrates, specifically known to be metabolized by a 
particular isoenzyme, accompanied by metabolite analysis and/or with inclusion of 
added electrochemical techniques, such as chronoamperometry and/or rotading disk 
electrochemistry can also be done. The aforemenioned electrochemical methods is 
known to provide essential information regarding the number of electrons utilized 
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during the required oxygen reduction, a prerequisite for successful substrate 
metabolism, and as such, also enables the investgator to conclusively identify any 
uncoupling reactions. Specific complimentary spectroscopic methods to investigate 
CO-binding in particular, include UV-spectrophotomeric studies, UV-Vis 
spectroscopic studies or cyclic voltabsorptometry (CVS) techniques. More on the 
subject of CO-binding, as well as complimentary spectroscopic and electrochemical 
methods, with emphasis on definitive aspects and method of operation is discussed in 
more detail in Chapter 3A and B. 
 
 
In the quest to perfect the art of biomolecule tethering to electrodes in 
biosensor configurations, numerous peer-reviewed reports with various methods of 
biomolecule linkage, based on latter and aforementioned techniques either 
individually or in combination protocols, has been published, some of which have 
been summarized in the discussion below:  
 
In a study conducted by Iwhuoa et al.., an amperometric biosensor with genetically 
engineered cytochrome P450cam as recognition component for the detection of 
camphor, adamantanone and fenchone, was constructed by entrapping the enzyme in 
the presence of BSA within vesicle dispersions of water-insoluble surfactant, 
didodecyldimethylammonium bromide (DDAB) on a glassy carbon electrode surface. 
The immobilization was reinforced by gluteraldehyde cross-linking, while cobalt (III) 
sepulchrate was used as diffusional electron transfer mediator for electrocatalytic 
experiments with substrate interactions [74]. In a different study, biosensor 
configurations were constructed with heme-proteins including myoglobin (Mb), 
hemoglobin (Hg) and horseradish peroxidase (HRP). In this regard, biomolecule 
immobilization was achieved by entrapment within N,N-dimethylformamide-agarose 
hydrogel composite, on an edge-plane pyrolytic graphite (EPG) electrode. The 
entrapped proteins portrayed direct and reversible electron transfer, corresponding to 
Fe
III
 + ℮−  FeII [48]. In yet another study, a reagentless, mediated biosensor was 
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prepared with HRP as recogntion component for the detection of hydrogen peroxide. 
The biosensor was constructed by galvanostatically electrodepositing polypyrrole in 
the presence of HRP on the surface of a carbon composite electrode which was 
derivatized with a ferrcenecarboxylic acid/sol-gel composite prior to the 
polymer/enzyme deposition [75]. The enzyme-based biosensor had good stability 
showing reversible electrochemistry and a formal potential of 275 mV. Other studies 
involving cytochrome P450 in particular, which includes bacterial, microsomal and 
mitochondrial, various methods, by different researchers were used. In this regard a 
comprehensive summary is given below: 
 
 In a study, conducted  by Paternolli et al. [76], three genetically engineered 
cytochrome P450 isoforms, CYP450-2B4, P450SCC (CYP11A1) and 
P4501A2,  prepared as fusion enzyme construct (glutathione S-transferase-
fused), N-terminally modified construct and low purity grade full-length 
isozyme construct, respectively, was used for biosensor construction. Two 
methods were evaluated for immobilization of the biological recognition 
elements, which included the langmuir blodged technique and entrapment 
within a biocompatible agarose hydrogel matrix. The enzyme-based biosensor 
configurations were then tested with regard to electrocatalytic response to 
respective substrates,  of which the findings showed that both methods proved 
to be successful. Hhowever, in terms of robustness, agarose hydrogel proved 
superior, and in this regard even portrayed effective for stabilization of low 
purity enzyme constructs, a task which is normally problematic due to 
hindrance of  ET by molecular impurities within such prepared enzymes. 
 In four different studies conducted by Shumyantseva et al. [77-80], different 
cytochrome P450 isoforms, were used as recognition elements for construction 
of various enzyme-based amperometric configurations: In the first study, 
semisynthetic flavocytochromes RfP450-1A2, RfP450-2B4 and RfP450-11A1, 
each consisting of the  microsomally-purified holoenzyme and a riboflavin (a 
synthetic flavin molecule containing FMN and FAD), conjugated to each other 
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by covalent binding, was immobilized onto screen printed rhodium-graphite 
electrodes (SPRGE) through gluteraldehyde cross-linking within vesicular 
dispersions of phospholipid surfactant films. Immobilization was done in the 
presence of   BSA carrier protein molecules, while the riboflavin molecules, 
functioned as electron transfer mediator during electrochemical investigations, 
and as such, served as electron-tunneling relay between the enzyme prosthetic 
group and the electrode. In the other study, purified CYP11A1 holoenzyme was 
immobilized onto a SPRGE either through glutaraldehyde cross-linking on a 
diloroylphosphatidylcholine (DLPC) derivatized electrode in the presence of 
BSA, or through agarose-hydrogel entrapment with concurrent vesicular DLPC 
dispersion. In both of the latter methods, the enzyme was tethered to the 
electrode together with the electrochical mediator, which in both cases was 
riboflavin. The third study involved microsomally purified CYP2B4, which was 
immobilized in a colloidal montmontrollite clay film in the presence of 
nonionic detergent, Tween80, which functioned to monomerise the 
hydrophobic enzyme for better immobilization and catalytic reactivity. The aim 
here was to produce an amperometric enzyme-based configuration for the 
detection and metabolic profiling of selected phenobarbital drugs. The drugs 
tested included aminopyrine and benzphetamine, and concomitant metabolite 
analysis corroborated electrochemical results.  In the forth investigation on the 
other hand, purified CYP2B4, CYP1A2 and CYP51b1 was immobilized on  
screen printed graphite electrodes through entrapment within a nano-structured 
liquid crystal film consisting of DDAB surfactant stabilized colloidal gold 
nanoparticle vesicular milileu. Substrates studied during electrocatalytic studies 
in this investigation include benphetamine and lanosterol.  
 In a study conducted by a different group [81], with regard to CYP3A4 in 
particular, genetically engineered, N-terminally modified CYP3A4 isoenzyme 
construct, either as fusion enzyme or heme domain only, was used for 
preparation of modified enzyme-based electrodes. The fusion constructs 
consisted of two parts, which were fused at genetic level during the engineering 
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process, and they include the heme domain of CYP3A4 isoenzyme and the 
soluble NADPH-dependent oxidoreductase domain from bacterial enzymes. 
Two methods were evaluated for enzyme linkage to the electrode, the first of 
which, involved electrostatic adsorption onto a PDDA polyelectrolyte-modified 
glassy carbon electrode. The other method was based on covalent coupling 
through reagents including 3-(Maleimido)propionic acid and N-
hydroxysuccinimide ester onto a cysteamine-modified gold electrode. Midpoint 
potentials (Em) obtained with regard to the Fe
III
/Fe
II
 redox transitions for the 
CYP3A4-modified electrodes determined by cyclic voltammetry, were -297 
and -357 mV vs Ag/AgCl on the GC and Au electrodes, respectively.  Em for 
the fusion construct on the other hand, were determined as  -345 and -341 mV 
on GC and Au electrodes, respectively. Electrocatalytic investigations for 
determining catalytic activity of the immobilized enzymes was investigated 
with native CYP3A4 substrate, the macrolide antibiotic, erythromycin. These 
results showed that both the immobilized heme domain and fusion enzyme 
were catalytically active, and as such, both yielding metabolism products, with 
higher coupling efficiency observed for the fusion enzyme-modified electrode 
configurations. 
 In a few other studies, the focus has been on the bacterial cytochrome P450, 
P450BM3 (CYP102A1) [71-73, 82], which in many aspects, resembles 
membrane-bound mammalian P450s [ ] and as such could be used as model 
recognition component for bioelectrochemical studies in various biosensor 
configurations. Various methods, by different research groups have been used 
to tether the enzyme to electrode surfaces for electrochemical studies: In one 
study, both the complete wild type holoenzyme, as well as the heme domain 
was each immobilized on edge-plain pyrolytic graphite (EPG) electrodes by 
entrapment within DDAB vesicle dispersions. Fe
IIIFeII redox transitions 
could be observed of which the Em for the heme domain was determined as -
500 mV (vs Ag/AgCl). Electrocatalytic studies in the presence of atmospheric 
oxygen showed markedly increased reduction currents. In a different study, 
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conducted by Udit et.al, the integrity and bonding properties of the immobilized 
P450BM3 heme was studied in more detail within DDAB liquid crystal films, 
with the aid of in situ spectrophotometric and FTIR spectroscopic 
measurements. The results showed that the a combination of a hydrophobic 
effect and enhanced H-bonding stabilizes the ferrous (Fe
II
) state of heme and 
cumulatively increases the redox potential, while also favoring a P420-state of 
heme. Furthermore, cyclic voltammograms did not show any significant 
increase in heme redox potential in the presence of CO. Overall, the findings in 
the latter study were that, on the one hand, the significant stabilization of the 
ferrous state coupled with a heme-carbonyl interaction produces a system where 
the added benefits of heme-π-back-bonding to CO are  greatly diminished, 
while on the other hand, the P420-like state of heme reduces overall success in 
achieving substrate turnover. Their conclusions were that similar perturbations 
of the heme environment within such surfactant films may be particularly 
exhibited by mammalian cytochrome P450s. In another study, also conducted 
by Udit et al.., the heme domain of wild-type cytochrome P450 BM3 was 
immobilized within a carrier matrix consisting of a liquid crystal-
polyelectrolyte film, which is a combination of surfactant vesicle dispersions, 
DDAB and anionic polyelectrolyte, polystyrenesulphonate (PSS). The 
surfactant-polyanion film, DDAPSS, proved to be a stable environment for the 
immobilized enzyme and Em for Fe
III
/Fe
II
 transitions was determined as ± -200 
mV vs Ag/AgCl. Moreover, results were consistant with surface confined 
species, whereas CO studies showed a marked positive  increase in redox 
potential. Furthermore, electrocatalytic studies in oxygen atmosphere, resulted 
in the signature increase in reduction current, whereas additional rotating disk 
electrochemical studies, on the other hand, revealed the formation of H2O2, 
which may have also contributed to the increased reduction current and also 
reveals the accompaniment of uncoupling reactions during electrocatalytic 
interactions of the immobilized enzyme. In yet another study, the main purpose 
here centred on the in depth characterization of the active/inactive state of heme 
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environment and conformational integrity of the immobilized P450BM3 — 
cyclic volatmmetry was combined with cyclic voltabsorptometry to elucidate 
the aforementioned aspects. In this investigation, the heme domain (BMP) of 
P450 BM3, prepared through genetic engineering, was immobilized within a 
polyelectrolyte film of either PDDA or PEI through electrostatic adsorption on 
a nanocrystalline SnO2-modified solid support. In these results, reduction 
potentials for the active P450 form immobilized on the  PDDA-SnO2 and PEI-
SnO2 electrodes were determined as -390 mV and -580 mV vs Ag/AgCl, 
respectively. Furthermore, voltabsorptometric experiments revealed that, 
depending on the environment of the carrier matrix, both the inactive P420, as 
well as the active P450 species may be present, and in such cases may both 
contribute to the observable background current in cyclic voltammograms. In 
particular, it was proposed that the local environment plays a direct role in 
inducing the P450-P420 transition either by dehydrating the substrate binding 
cavity or by interfering with the H-bonding network responsible for 
stabilization of the thiolate bond. 
 For the past few decades, Rusling and co-workers has done a significant 
amount of bioelectrocatalytic investigations with various heme proteins 
(enzymes), including hemoglobin, myoglobin and selected cytochromes P450, 
using different immobilization matrices, of  which the findings have been 
documented in various peer reviewed publications, some of which is 
subsequently discussed [83-86], the emphasis of course being P450-modified 
electrodes in particular. In one study, cytochrome P450cam was entrapped 
within a liquid crystal film, consisting of vesicle dispersions of either DDAB or 
dimyristoyl-L-α-phosphatidylcholine (DMPC) on pyrolytic graphite (PG) 
electrodes. The electrochemical behaviour of of both P450cam-modified PG 
electrodes exhibited reversible electrochemistry with Em determined as -213 
mV for the DMPC-film and -220 mV for the DDAB-film (vs Ag/AgCl), while 
the CO Fe
II
 interaction was accompanied by a anodic potential shift, as well as 
the signature P450 absorption spectra shown by accompanying UV-
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spectrophotometric studies. In electrocatalytic studies, interaction with oxygen 
and/or substrate, trichloroacetic acid (TCA) was investigated. In this regard, 
results showed that the electrochemically generated P450Fe
II
 reacted rapidly 
with dioxygen, which was signified by signicant increase in reduction current. 
Furthermore, substrate interaction induced an additional increase in reduction 
current, a phenomenon that was also observable in anaerobic atmosphere, 
whereas overall, the results did not suggest any autooxydation or uncoupling 
reactions, thus signifying the coupling efficiency of the enzyme-based film. In a 
second study, cytochrome P450cam was immobilized through onto polyion 
films, by making use of either posively charge polyelectroytes or negatively 
charged polyelectroytes. In the case of the cationic polyion film matrix, a 
combination of  PDDA and PEI was used, whereas in the case of the anionic 
matrix,  poly(styrenesulphonate) (PSS) was used. Depending on the charge of 
the polyelectrolyte, the enzyme was either immobilized through electrostatic 
adsorption, or with the  aid of DNA as bonding material, while, on the other 
hand, enzyme immobilization within the polyelectrolyte film was done on a 
mercpato-1-propanesulphonic acid self assembled monolayer-modified gold 
electrode. Overall, the results showed that in multilayer assemblies, only the 
first layer of polyelectrolyte/CYP450cam was electroactive, while the 
MPSPEI-PSSP450cam exhibited the best results in terms of electron transfer 
and electrocatalytic efficiency with substrate, styrene. Metabolite analysis for 
electrolysis experiments, further confirmed enzyme activity, while on the other 
hand, results also showed that a small percentage of H2O2 was formed which 
also contributed to the formation of one of the metabolites, i.e. benzaldehyde. 
This essentially means that the reduction of oxygen in the catalytic cycle of the 
immobilized enzyme, gave rise to the formation of reactive species, in this case, 
H2O2, which in itself, as discussed earlier can induce substrate metabolism on 
the one hand, but on the other hand, shortens the lifespan of the enzyme. In yet 
another study, also conducted by Rusling and coworkers, the heme domain of 
genetically engineered cytochrome P450-1A2 was used as recognition 
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component. In the platform used in these studies, the enzyme was immobilized 
through electrostatic adsorption in a PSS polyelectrolyte film on a carbon cloth 
electrode. The average Em for the enzyme-modified electrode was determined 
as -70 mV (vs NHE). Fe
II
-O2 interaction was signified by a characteristic 
increased reduction current, which in the presence of the substrate, styrene, 
exhibited an anticipated further increase. Although control experiments without 
CYP1A2 showed no detectable formation of the enzyme-catalyzed metabolite, 
styrene oxide, the addition of H2O2 scavenger, catalase, in the presence of 
immobilized enzyme, also resulted in no styrene oxide formation.  This 
essentially means that electrochemically produced H2O2 significantly 
contributed to the substrate turnover in bioelectrocatalytic experiments. In the 
next research investigation, microsomes, constituted by fusion proteins, 
consisting of selected genetically engineered cytochrome P450 isozyme heme 
domain, and cytochrome P450 reductase protein (with flavins, FAD and FMN), 
were the subjects of investigation in these bioelectrochemical studies. The P450 
isozymes studies were cytochromes P450 1A2 and 3A4, for which the prepared 
microsomes were denoted CYP1A2ms and CYP3A4ms. Once again, polyions 
were used as immobilization matrix for the enzyme-modified electrodes, while 
the flavin cofactors of reductase, functioned as mediator.  In this regard, clean 
gold electrode solid supports were initial modified with a ‘base layer’ 
consisting of PEIPSSPEI, followed by alternate adsorption of  the particular 
microsome and PEI, thus preparing six bilayers in a layer-by-layer fasion. In 
both cases, enzyme configurations exhibited qauzireversible thin film 
electrochemistry, with peak current proportional to scan rate () for up to 1000 
mV s
-1
. Moreover, Em for both enzyme-modified electrodes was determined as -
530 mV (vs Ag/AgCl). As earlier stated: upon reduction in the presence of CO, 
heme proteins form Fe
II
-CO complexes that is normally signified by a shift in 
Em via the influence of complexation following ET., however, cytochrome 
P450 reductases have flavin cofactors and are not influenced by CO. In this 
regard, upon addition of CO no observable change in peak potential or current 
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could be detected. Overall, the results revealed that electron transfer to the 
enzyme heme occurs via the reductase, and a such follow the natural ET 
pathway observed in native physiological systems. Moreover, electrocatalysis 
with substrates with or without the presence of H2O2 scavengers showed the 
formation of similar amount of metabolites, while only very small amounts of 
H2O2 could be detected in the microsomal-modified films. In this regard, it was 
concluded that oxygen reduction competed poorly with reduction of reductase, 
which essentially prevented the formation of reactive H2O2 species and as such 
showed adequate coupling efficiency.   
 
Finally, in light of all the preceding and aforementioned discussions, clearly a 
plethora of methods and techniques, each with its own attribues and shortcomings, 
are available to taylor biomolecule immobilization and electron transfer pathways for 
bioelectrochemical (sensor) configurations. Furthermore, secure immobilization may 
incur multifaceted privaleges, such as securing long term sensor stability, avoiding 
loss of biological recognition element to the bulk of the analyte solution, as well as 
predefining the overall sensor architecture and proposed signal transduction process. 
On the other hand, however, the type of immobilization and coupling method directly 
affects the operational stability of the enzyme-based sensor, as well the efficiency of 
ET from electrode (the coupling efficiency). Furthermore, the immobilization 
procedure is absolutely dictated by and adapted to the specific features of the 
biological recognition element, such as intrinsic stability, presence of available non-
essential functional groups for covalent binding, possible inhibition due to active site 
modification by reagent molecules, impact of binding mode on substrate diffusion to 
the enzyme active site (defining the linear range of the calibartion graph), the local 
concentration of the biorecognition element (defining the maximum signal), as well 
as the location of the biorecognition element with respect to the transducer surface. In 
the case of CYP3A4 in particular, recalling all of its structure, reconstitution and 
reaction cycle complexities,  very few research investigations endeavor utilizing it as 
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recognition component in sensor and/or bioelectrochemical studies. In this regard, of 
all the peer reviwed articles cited and and discussed in the preceding section, only 
three focussed on CYP3A4.   
As recap, being of microsomal origin and essentially membrane bound; highly 
hydrophobic; requiring the obligatory presence of specific external electron transfer 
donors and other specialized compounds in reconstitution systems; being labile and 
quite vulnerable to extremities; its prosthetic group hidden within a highly insulating 
protein shell. Moreover, the high probability of uncoupling reactions, mostly caused 
by autoxidation of oxyferrous Fe
II
-O2 complex (see Section 2.2.3),  giving rise to 
reactive oxygen species,  a phenomenon that is common amongst membrane-bound 
microsomal and mitochondrial mammalian cytochrome P450 enzymes, adds further 
constrictions. In this regard, clearly, electrode linkage and electron-transfer pathways 
in biosensor confgurations for this enzyme is obviously quite a challanging task, as 
such requiering  considerable enginuity with regard to platform design.  In the same 
breath, however, according to documented literature findings, it has been suggested 
that biosensors based on such enzymes fall under the category of disposable ones [64, 
87].  On the other hand, for practicle application, the prosthetic group would have to 
be recycled during such P450-enzyme sensor operation – a task that some people 
have tried to overcome by co-immobilization of native NAD(P)H cofactor. However, 
NADPH has known inherent complications, some of which was discussed in Section 
3.2.1.1. In this regard, it is expensive, is known have a high likelihood of inhibiting 
the enzyme without the presence of substrate, direct regeneration of NADPH requires 
substantially high overpotentials. Furthermore, regeneration occurs through  via a two 
step intemediate radicals that tend to dimerize under the formation of insoluble 
products, which in many cases leads to electrode fouling [88], as well as its expensive 
nature, its application would be impracticle. Moreover,  it would defeat the main 
purpose of biosensors, which of course is providing alternative, cheaper methods to 
compliment and/or compete with existing analytical techniques. While 
electrochemical, chemical, enzymatic and whole cell systems for regenerating 
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NAD(P)H are available, these approaches are frequently inefficient or difficult to 
implement on  a practicle scale [89].  
 
In view of the latter and preceding issues and based on peer reviewed documented  
research, it is suggested that harnassing membrane bound P450s and heme thiolate 
proteins in general, is best approached with electrochemical systems by utilizing 
soluble or co-immobilized surrogate, articfial mediators. Appropriately, the approach 
in research design in this dissertation is based on mediated enzyme-based biosensor 
configuration. 
 
 
2.2.4 Mediated Amperometric Biosensors 
 
Mediators are artificial electron transferring agents that can readily 
participate in the redox reaction with the biological component, and a such, assist in 
the rapid electron transfer. In this regard, in a more defintive context, it is a low 
molecular weight redox couple, which shuttles electrons from the surface of the 
electrode to the redox center of the enzyme. During the catalytic reaction, the 
electrochemically reduced/oxidized mediator reacts with the enzyme, to reduce/oxize 
it and then diffuses back to the electrode surface to undergo rapid electron tranfer 
again. An ouline of the this process is illustrated in Figure 2.5.  
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Figure 2.5: Principle of operation of amperometric mediated biosensor 
 
 
As shown in Figure 2.5, during the mediator facilited electron transfer of the enzyme 
(protein/biological molecule), the mediator is cycled between its  reduced and 
oxidized forms. Overall, the process is thermodynamically, but not kinetically 
favourable. The following equations shows a more detailed sequential flow of the 
overall sequence of events with and without medtiated electron transfer to get an idea 
of the main benefit of the presence of the mediator, 
  MOx+ e−  MR  electrochemical  
 2.1(a) 
  EOx + e−  ER  electrochemical (very slow reaction)
 2.1(b) 
  MR + EOx  MOx + ER chemical   
 2.1(c) 
where MOx and EOx are the oxidized forms and MR and ER are the reduced forms of 
the mediator and enzyme, respectively. In a bioelectrochemical setup, the overall 
electrochemical reaction occurs at the characteristic potential of the mediator. The 
MOx is thus regenerated close to the electrode surface and does not have to diffuse 
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very far to again undergo rapid electron tansfer. In this regard, thus, a significant 
enhancement of the current may be observed for only a small amount of EOx present, 
provided the chemical reaction with the mediator is rapid. The observed current may 
be related to the concentration of EOx present, and therefore the mediator approach 
has been widely applied for the fabrication of biosensors with various biological 
compounds as recogntion component. Since reaction of the electrogenerated MR is 
not very specific however, care must be thus taken to exclude other potential oxidants 
that can compete with EOx, so that mediator can successfully and efficiently divert the 
flow of electrons between the electrode and enzyme active site. On the subject of 
effectiveness and efficiency, to confir successful mediation, a mediator species 
should preferentially fulfill certain criteria, including the following:  
 A mediator should be stable under required working conditions and should not 
participate in the side reactions during electron transfer. 
 The mediator should preferentially have a lower redox potential than the other 
electrochemically active interferents in the sample. 
 The redox potential of the mediator should provide an suitable potential 
gradient gradient for electron transfer between th enzyme’s active site and 
electrode 
 The redox potential of the mediator (compared to the redox poetntial of the 
enzyme prosthetic group (active site)) should be more negative for reductive 
biocatalysis or more postive for oxidative biocatalysis.  
 A suitable mediator has to be able to regenerate the active site of the enzyme 
with fast kinetics, to diffuse back to the electrode to be converted there to its 
initial stage. 
 The redox mediator has to be stable in both oxidation states and should not 
have a toxic nature. 
 The mediator have to diffuse with high diffusion coefficient between the 
enzyme and electrode. 
 The overpotential for the regeneration of the mediator should be pH 
independent. 
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Overall one other aspect surrounding the characteristics of an ideal mediator, is that 
in its reduced form, it should preferentially not react with oxygen, however, since 
many mediators exhibit some degree of oxygen interaction, if indeed it does, the 
reaction should be slow enough to not compete with the electron transfer kinetics of 
mediator-enzyme interaction, since it may otherwise leed to false signals. There are 
many available mediating species which may be used in electrochemical systems, the 
most common being ferrocene and its derivatives, quinones, tetrafuvalene, Os-
complexes and conducting salts [46, 56, 90]. With regard to cytochromes P450 
enzymes in particular, research conducted by Estabrook and co-workers has identified 
the compound, cobalt(III) sepulchrate as an effective electron shuttle for these 
enzymes. In this regard cobalt(III)(sepulchrate-mediated (electro)catalysis with a 
variety of P450s, including mammalian (membrane bound) and bacterial, with rates 
approaching that of native NAD(P)H-driven systems have been realized.   
 
Generally, cobalt(III) sepulchrate [Co(sep)
3+
] is a cage compound. The term cage 
compound refers to the class of transition metal complexes enclosed by encapsulating 
ligands (‘cages’).  Generally, these encapsulating cages are macro-multicyclic 
ligands, which consist of a non-planar arrangement of three arms enclosing a 3D 
space, into which donor atoms have been incorporated, which in turn allows 
encapsulation of metal ions within these cages. Examples of cage-type macrocycles, 
are ‘clathrochelates’, ‘cryptans’ and ‘bis-tren derivitives’, where the latter two 
contains mixed N-O donor atoms, while the former one contains unsaturated N-
donors within the 3D space. Sepulchrate, on the other hand, is a class of saturated 
amine-donor macrobicycles (1,3,6,8,10,13,16,19-octaazabicyclo[6.6.6]eicosane), 
called ‘cage amines’, of which a graphical illustration is shown in Figure 2.5(a). 
Incorporation of the metal ion (Co
3+
) into the sepulchrate cage results in a 
thermodynamically and kinetically inert complex [Co(sep)
3+
], in which the metal ion 
is not easily released. A graphical illustration of  Co(Sep)
3+
] is shown in Figure 
2.5(b) 
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Figure 2.6 (a)The cage-type N-donor macrbicycle: Sepulchrate 
    (b)Sepulchrate with incorporated Co(III) transition metal ion:  
  Cobalt(III)sepulchrate  
 
The distinctiveness about the these cage complexes, is the excellent reversible metal-
based electrochemistry in aqueous and other solvents, which is particularly interesting 
for applications as electron relays in electrocatalysis. With regard to Co(Sep)
3+
 in 
particular,   which according to research findings was shown to have a formal 
potential (Eº) of between ± -550 to -700 mV (vs Ag/AgCl) which of course is a 
sufficiently negative potential to be able in turn reduce the ferric ion of the 
cytochromes P450 enzyme heme group, hence the polularity of applying this 
particular compound as surrogate mediator for these enzymes, to couple them to an 
electrode.  
 
 
In a general context, mediation may be homogeneous or heterogeneous. Since 
homogeneous reactions refers to both the medatior and enzyme freely diffusing in 
solution, it will not be further discussed, as it falls out of the scope of this thesis. With 
regard to to heterogeneous mediation on the other hand, particulary in terms of 
amperometric biosensor configurations – depending on the level of integration of the 
mediating species within the transducer surface, the biosensor may be secondary or 
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reagentless and/or tertiary configuration. In secondary biosensor configurations, as 
mentioned in Section 2.2.2.1, the mediator is added to the bulk of the solution. 
Reagentless configurations on the other hand, requires mediator confinement as close 
as possible to the electrode, along all other necessary components. Moreover, tight 
fixation of the mediating species is important, while architechture should to be such 
that leakage is prevented, which is crucial, since mediator leakage will obviously 
directlty affect the obtained signal. Moreover, such leakage will concomitantly affect 
the long-term biosensor stability, while inadvertently, can also lead to contamination 
of the adjacent sample. On the other hand, movemement of the mediator is an 
absolute prerequisite for productive and successful electron transfer in amperometric 
biosensor configurations. In addition to this, most mediators are small molecules, 
with molecular weights close to that of the enzymes’ subtrates, which makes retaining 
them at the electrode surface more difficult, as lng-term leaking is highly probable. 
Taking into consideration the latter and aforementioned constricts, options for 
confirring effective retainment of mediators at electrode surface, while concurrently 
allowing mass diffusional movement of mediator, as well as rapid electrochemical 
communication are fairly limited. In this regard, techniques based on different 
mechanisms have indeed been formulated. (i) A relatively easy approach is based on 
simply mixing the mediator into a carbon paste, followed by enzyme immobilization 
on top of the carbon paste surface. Further modification with additives, such as 
stabilizers or polyelectrolytes may also be added. (ii) Another approach involves 
modification of the enzyme (protein) itself with covalently bound redox mediators, as 
such forming ‘electroenzymes’. The premise here is that the covalently bound redox 
relays are supposed to shorten the electron transfer distance between the deeply 
burried active site and the enzyme surface by allowing an “elecctron hopping” via the 
enzyme-bound artificial mediators. A third approach combines flexibility with 
binding of the redox mediator by covalent attachment of the redox mediator 
molecules via long spacer chains, either to the electrode surface (seaweed 
mechanism), a suitable matrix, or the outer surface of the enzyme itself (whip 
mechanism). Alternatively, covalent binding of redox species to the backbone the 
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immobilized matrix, such as a conductive polymer, can be done, thus creating a redox 
polymer which is then used to wire the enzyme to the electrode. “Redox hydrogels” 
consisting of a poly(vinyl imidazole), a poly(vinyl pyridine), a poly(acrylic acid) or 
poly(allylamine) backbone with covalently bound osmium-complexes or 
poly(siloxane) backbones with covalently bound ferrocene units have also been 
applied to provide an increased local concentration of redox mediator. 
 
Although theretically, these techniques are promising, in practise, as with any subject 
area, they are each assocoiated with some constricts or drawbacks, for instance,  
techniques are only successful when the enzyme is in solution, while most suffer 
from mediator leakage from the reagent layer. Moreover many of these methods 
involves modification of the enzyme/protein  itself, which can only be successful for 
highly stable enzymes, a demand which is essentially unrealistic, while some 
techniques also require extremely technically complex and expensive approaches. 
Furthermore, covalent mediator attachment, theoretically identified as the most 
attractive method – in practise have not been able to  ensure coupling of redox groups 
close enough to the enzyme’s redox center to ensure fast enough electron transfer in 
order to effectively compete with molecular oxygen.  Nonetheless, in spite of such 
complications and drawbacks, with regard to the aforementioned techniques, some 
degree of success was indeed attained. Altgough at this stage, choosing an 
appropriate mediator confiment technique may seem like an excercise in futility; a 
good approach is still realizable, by choosing a multifaceted matrix that not only 
allows fairly simplistic mediator uptake/coupling, but also contributes to sensor 
performance by promoting permselectivity. In this regard, in terms of versatility, 
permselectvity, as well as numerous other inherently novel attributes, the superior 
choice would be the eminent polymer electrolyte, nafion

. 
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2.2.5  Nafion 
 
Nafion

 is a solid polymer electrolyte with a linear structure.  It is a 
copolymer with the main skeleton structure based on a polytetrafluoroethylene 
(PTFE) backbone. Nafion was originally created by Dupont de Nemours in 1962 and 
is the first class synthetic polymers with ionic properties and are called ionomers. In a 
defintive context, an ionomer refers to a polyelectrolyte that comprises copolymers 
containing both electrically neutral repeating units and a fraction of ionized sulphonic 
acid units/groups, which in turn amounts to no more than 15% ionizable groups per 
monomer nafion unit. Thus, basically, in its full description, nafion may be described 
as a sulphonated tetrafluorethylene copolymer consisting of a PTFE backbone with 
regular-spaced perfuorinated vinyl ether side-groups that are each terminated with a 
sulphonic acid group or its salt (sulphonic ionic group), which in turn are covalently 
attcahed to the fluorocarbon backbone. A schematic representation of the structure 
nafion is   shown in Figure 2.6.1 
 
 
 
 
 
 
 
 
Figure 2.7: The structure of Nafion  
 
Where, M
+
 is the counter ion (H
+
, Na
+
), which is dissociable and thus,  exchangeable 
for other (electroactive) cationic species from a contacting solution phase; the  –
SO3−Na
+
 form of nafion, is referred to as its neutral or salt form, whereas the –
SO3‾H
 
form is the acid form. Due to the fluorocarbon backbone, these polymers are 
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chemically and thermally very stable, mostly due to an absence of sites for attack by 
reactive oxygen radicals, since C–F bonds generally cannot react with hydroxyl (OH) 
and other radicals even at elevated temperatures. Moreover, the unique anatomical 
combination and arrangement of the PTFE, the fluorocarbons and the ionized 
sulphonic acid groups, confirs a unqiue heterogeneity to nafion, complimented by 
numerous inherent peculiar features such as ion exchange selectivity, good wetting 
properties, self-organization in hydrophobic/hydrophilic domains, chemical and 
biological inertness, thus enabling the polymer to have numerous and diversified 
applications that is unparalleled by most other polymers, whether electron 
conductive, non-conductive and/or electropolymerized. To fully understand and 
appreciate these features, the microscopic structure of nafion is further elucidated. 
The first eminent structural unique quality of nafion, is the fact that nafion films 
feature internal segregation of hydrophobic and hydrophilic domains: On a 
microscopic level, this ion containing polymer is known to seperate into different 
phases, including ionic, organic and interfacial  regions –  resulting from a unique 
cluster type structure containing “water-filled pockets” and aqueous ions embedded 
in a continuous hydrophobic fluorocabon surrounding. The first phase constitutes the 
hydrophilic ionic cluster phase which contains the sulfo ion groups, the dissociable 
counter ions and hydrated water, of which the latter in its properties do not differ 
from water that occurs in the bulk of the solution. The second phase is the teflon-like 
fluorocarbon framework (backbone) surrounding these clusters and is essentially 
hydrophobic. The third phase on the other hand, refers to the minor subsidiary area 
between the hydrophobic backbone and the hydrophilic ionic clusters which mainly 
consists of a flexible amorphous part of the perfluorocarbon backbone and in general 
constituted by an intermediate hydrophilic phase. A schematic representation of the 
phase segregation in a nafion membrane is shown in  Figure 2.6.2. 
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Figure 2.8: Nafion structure showing schematic presentation of the different 
phases observable in a nafion membrane. The sulfo groups are clustered in 
hydrophilic inclusions, referred to as phase A. Phase B referes to the teflon-like 
fluorocarbon backbone, and is essentially hydrophobic. Phase C is intermediate in 
hydrophilicity. 
 
 
 
With regard to the physical characteristics of the ionic clusters, different models by 
various researchers has been proposed, but generally ― they are roughly spherical in 
nature with a diameter of ± 40-50 Å (4-5 nm), which varies with water content, as 
well as the equivalent weight of the particular nafion membrane and the type of 
cation (counter ion) contained within the clusters. Generally, these clusters are 
randomly distributed throughout the backbone tetrafluoroethylene (TFE) polymer and 
they are inter-connected by small channels of approximately 10 Å (1 nm) in diameter. 
It has also been proposed that the average cluster contains about 70 exchange sites 
and approximately 1000 water molecules.  A graphical illustration of the cluster 
network, highlighting the physical characteristsics of the sulfo ionic clusters is shown 
in Figure 2.6.3. 
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Figure 2.9: The characteristic ionic sulfo cluster network in a Nafion membrane 
 
The channels connecting the ionic clusters are generally thermodynamically stable 
and they function mainly in determining the transport properties of the ions (counter-
ions) and water, while the water content/degree of hydration is of great importance 
since it by-and-large dictates the properties of  Nafion polymer membrane/film. The 
water content is in turn determined by the type of counter-ion contained within the 
ionic cluster phase. On the subject of the water content and the type of counter-ion ― 
in these nafion ionomer films, the water increases the free volume of and decreases 
the PTFE polymer chain concentration in the ionic cluster, and as such, in this 
context, the water of hydration acts as a placticizer for the ionic cluster region in 
nafion and ionic polymers in general. On the other hand, though, the water content of 
the ionic clusters decreases as the size of the counter-ions increases, and since Nafion 
is known to have a high preference for large organic cations relative to smaller 
organic and inorganic cations, this is not an uncommon phenomenon. In this regard, 
thus, as the water content of the cluster decreases, the polymer chain material must 
unequivocally play an increasingly significant role in determining the chemical 
environment of the cluster region. Since the TFE backbone in nafion is highly 
hydrophobic and has an extremely low dielectric constant, this essentially means, 
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that, in the case when a large organic cation is the counter-ion and as its concentration 
increases, the ionic cluster resembles a lipophilic phase; conversely, when  a small 
cation is the counter ion, the water decrease is considerably less, and as such, in such 
cases, the ionic clusters in nafion remain essentially hydrophilic. An important aspect 
to add in the context of counter ions, is that nafion’s high affinity for (large) 
hydrophobic cationic counter ion species is contrary to the characteristics exhhibited 
by conventional ion-exchange material. Moreover, research has conclusively shown 
that nafion’s method of retention/pre-concentration of cationic species within the 
polymer is dictated by hydrophobic interactions, which differs considerably from 
conventional ion-exchange resins and/or electrostatic binding polymers, in which 
electrostatic forces dominate the retention interactions. These fundamental 
differences in exchange characteristics between nafion and other ion-exchange 
materials/polymers is best explained by highlighting the eminant structural 
differences between the them: Firstly, conventional ion-echange resins are covalently 
crosslinked while nafion is not. In this regard, the Gibbs-Donnan eqation, which is 
the fundamental thermodynamics equation for exchange reactions, accounts for the 
effect of crosslinking through inclusion of the so called PV term, which is a term that 
functions to discrminate against ions of large size. Since nafion is not cross-linked, 
there is no PV-based discriminating against large ions, and thus, such ionic species 
may be partitioned into nafion without the thermodynamic penalty inherent in the 
Gibbs-Donnan equation. The second significant structural difference, is that in nafion 
only about one in eight monomer units is sulphonated, conventional ion-exchange 
resins are close to 100% sulphonated. This essentially means that the large segments 
of uncharged chain material allow for hydrophobic interactions which drive ion-
exchange reactions for cations in nafion. Other inherent dissimilarities between 
nafion and electrostatically binding  polymers which are of significance in this 
subject area is the difference in dielectric constant of the chain material and  the 
charge density divergence: nafion has a very low dielectric constant, as well as a 
fairly low charge density, whereas the converse is exhibited by the other 
electrostatically binding polymers. 
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One other area of significance,  is the subject of transport properties within nafion 
polymer films, which is a pertinent aspect, especially since the ionomer is known to 
take up electroactive counter ions, a feature that is of particular relevance in the 
application of electrochemical studies and biosensors.  In this context, unlike in other 
membranes where transport, in accordance with the Donnan equilibrium,  is a one-
dimensional process; in Nafion, transport does not comply with the Donnan effect 
and actually occurs through a three dimensional process, largely controlled by an 
effect known as  percolation. The actual mechanism of charge transport in nafion 
polymer films (in the absence of chemical kinetic complications), consist of mass 
transport (diffusion) of the electroactive species, electron hopping and migration of  
counter ions. However, research has conclusively determined the electron hopping 
pocess to be equivalent to diffusion, and as such, the overall mechanism of charge 
transfer within nafion polymer films, in the absence of chemical kinetic 
complications, is by-and-large dictated by difussion and as such, the overall rate can 
be described by an apparent diffusion coefficient (Dapp). On the other hand, 
depending on the thickness of the formed nafion film, regions of monolayer (thin-
layer) behaviour may or may not be observed, for example, in a study conducted by 
Bard and coworkers, a nafion film with thickness 0.1m with incorporated 
Ru(byp)3
2+
 on a glassy carbon electrode exhbited thin-layer behaviour below 30 mVs
-
1
, accompanied by a small seperation between anodic and cathodic peak potential 
(Ep), which was independent of  scan rate () and a linear behaviour of peak current 
(Ip) vs ; whereas  nafion film thicker than 2 m with incorporated Ru(bpy)3
2+
 
exhibited no region of monolayer behaviour.    
 
The aforementioned segments provided important insight into nafion’s perculiar 
structural characteristics and subsequent distinctiveness in behaviour and function 
relative to  other ionic-, ion-exchange- and electrostatically-binding polymers and/or 
materials. As gathered by these discussions, considerable differences are eminent, 
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which of course would profoundly affect anticipated results at chemically modified 
electrodes based on nafion as apposed to other  ionic polymer and coordinating 
polymer electrodes, some of which was highlighted and discussed.  In this regard, a 
last few relevant variations are highlighted, which provides more insightful incentive 
for the polymer’s popularity of application. Firstly, research has shown that nafion-
based films has a greater lifetime than other electrodes of this type. Moreover, the the 
retention of the electroactive molecule is more stable, while the counter ion species is 
retained and film stays on for longer. Such etxtended lifetime is of course highly 
beneficial in possible applications. Secondly, nafion polymer films shows no 
difference in observed electrochemical properties irrespective of preparation method, 
i.e. wether one-step- or multiple-step coating procedure, which is unlike what can be 
observed for a coordinating polyme, which exhibits large variation in electrochemical 
properties, depending on the preparation procedure. It has been proposed that the 
difference can be attributable to the presence of only comparatively weak electrostatic 
interaction in nafion and to the ionic unique interchannel-connected ionic cluster 
morphology which allows for easier diffusion.     
 
In a final note, based nafion’s diverse areas of application, its peculiar structural 
features, coupled with its simplistic film formation, which simply involves traditional 
dip-, spin-coating or casting procedures from the ionomer solution, known 
biocompatibility and its unparalelled discrimination ability bewteen postitively and 
negativele charged species, creates an easy comprehension of its popularity in 
polymer film/membrane application. Moreover, the fact that electroactive mediating 
species can be stably incoporated into its matrix allows for close proximation to 
subsequently immobilized enzymes in bioanalytical applications, which in itself is 
invaluable for electrochemical communication purposes.   
 
 
At this stage, to recapitulate ― latter and previous sections provided 
comprehensive insight into important aspects of tayloring electrode architecture for 
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stable CYP450-3A4 tethering, with special reference to enzyme structural and 
functional features and requirement constricts, immobilization methods, mediator 
aspects etc. In view of the extensive elaboration on these aspects, there is not much 
left to discuss, however,  one final important aspiration for biosensor to be of 
practical use, is that that once formed, the biological film must be adaptable to 
different environments. In particular, the immobilized films need to be resistant to a 
wide range of physiological pHs, maintaining their stability and activity with changes 
in temperature, ionic strength and chemical composition [59]. In this regard, 
polymeric hydrogels, in particular has proven to be tromendously beneficial, 
especially in the case of membrane-bound CYP450 isoenzymes. In this regard, they 
exhibit various physical and chemical phenomena, such as bending and volume 
change in the presence of external stimuli (such as changes in pH, solvent 
composition, ionic strength, temperature and electric field [60].  Moreover, these gels 
can undergo considerable swelling and collapsing as a function of their environment, 
up to 1000 times in volume, which is one of their most eminent qualities. 
 
 
 
 
2.3.6 Polymeric hydrogels   
 
The inherent biocompatibility of polymeric hydrogels together with their ability to 
simulate natural tissues makes them potentially important electrode-coating materials, 
and as such, they are excellent carriers of biomolecules, which can be immobilized 
within the hydrogel matrices.   
 
 Hydrogels are three-dimensional, hydrophilic, polymeric networks capable of 
absorbing large amounts of water or biological fluids. The networks are composed of 
homopolymers or copolymers and are insoluble in water, through the presence of 
chemical cross-links, otherwise known as tie-points or junctions; physical crosslinks, 
 
 
 
 
 Chapter 2  Biosensors: A review Of The Relevant Aspects
  
 
83 
 
such as perminent entanglements; and/or ionic interactions. These hydrogels exhibit a 
thermodynamic compatibility with water which enables them to not dissolve in water 
at physiological pH, but allows them to swell considerably in aqueous media. 
Moreover, gel volume transitions can be induced by temperature, pH, or ionic 
strength among other stimuli, and collectively these phenomena has inspired research 
investigations for applications of these gels as potential actuators, artificial muscles, 
in sensors, controllable separation membranes and drug delivery vehicles. With 
regard to sensor application in particular, hydrogels can either be used in the interior 
of sensors, as a gel matrix to imbed bio-recognition proteins, such as enzymes; or 
they may be applied to the exterior of the sensor. As exterior coatings, the polar, 
(un)charged, water swellable, flexible materials mask the underlying surfaces by 
producing a hydrophilic interface between the solid surface and aqueous bulk.   
With respect to known labile isoenzymes, membrane-bound CYP450s in particular, it 
was documented that a soft hydrogel is the most suitable environment to retain the 
enzyme’s activity and integrity. In this regard, the greatest promise was shown with 
water soluble agarose. Moreover, agarose can be blendid with other water soluble 
non-toxic polymers, such as poly(vinyl alcohol) (PVA), to create biopolymeric gel 
that ensures stable enzyme encapsulation and catalytic retention.   Both agarose and 
PVA are promising outer membrane coatings for sensors, because water-soluble 
analytes can readily diffuse through the water-swollen polymer gel layer. The degree 
of analyte diffusion is readily modulated by controlling crosslink density of the gel, 
which in turn controls the gel water content and openness of the polymer network.  
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2.3.6.1 Agarose and related relevant subjects 
 
Agarose is a highly prominent natural biopolymer, which has a long-
standing application in the separation and/or purification of various biological 
molecules, including enzymes, polysaccharides, nucleic acids and proteins, usually 
done through gel permeation- and/or affinity chromatography methods. This polymer 
is a naturally occurring polysaccharide, and in a definitive context, it is a neutral 
component of polygalatoside agar; in particular, it is one of the two major 
components of agar, with the other major component being agaropectine. The 
strucure of agarose is based on a linear polymer consisting of repeating units of 
alternating 1,4-linked 3,6-anhydro-α-L-galactopyranose and 1,3 linked β–D–
galatopyranose. A schematc illustration of the structure of agarose is exhbited in 
Figure 2.7.1.  
Figure 2.10: Structure of Agarose 
 
When dissolved in water, agarose forms thermoreversible gels, the characteristics of 
which essentially involves a temperature controlled liquid-to-gel forming process. In 
this regard, in a hot solution, agarose chains exist in stiff and disordered 
configuration, whereas upon cooling below ±40 ºC, the coils form orderly helices 
which subsequently aggregates into thick bundles through forming inter- and 
intramolecular hydrogen bonds. These bundles contain large pores of water, and are 
characterized by a soft porous gel consistency, of which the pore size can be 
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controlled by the concentration of the agarose. In general, agarose gel matrices 
exhibit considerable elasticisity and high turbidity, complimented by an aqueous 
microenvironment and significant bioaffinity, and the cumulative effects of these 
features makes it an ideal biopolymer for the immobilization of biological molecules 
on solid substrates, including electrodes. In fact, agarose has proven to be the superior 
polymer gel for preserving enzyme activity in bioreactor-based electrochemical 
studies with microsomal CYP450, compared with other tested gels, such as 
polyacrylamide, calcium alginate and prepolymerized polyacrylamide hydrazide ― 
which, overall is highly significant study, since suitable immobilization methods for 
mammalian microsomal P450 enzymes are not well established, because these 
enzymes are labile.  Moreover, it was documented that gel-entrapment is the 
preferred immobilization method if the purpose is the construction of reusable 
bioreactor and/or biosensor.  
 
The beneficial aspects of agarose can be further exploited by combining it with other 
biocompatible polymers, in the form of blends, copolymers and/or interpnenetrating 
polymer networks or gels. Moreover, polymer blending is one of the most effective 
methods for providing highly specialized composite materials that combine the 
physicochemical qualities of both components and overcome their individual 
shortcomings. In this regard, the hydrophilic polymer, poly(vinyl alcohol) (PVA), 
which is non-toxic, is frequently used in biomedical applications and protein 
immobilization, has numerous industrial applications and is equilly well-known for 
its good membrane forming ability has proved highly compatible in combinaton with 
other polymeric materials. In fact, agarose and PVA are often used to form bi-
composite matrix for enzyme immobilization. 
 
Generally, in a definitive context, PVA is an uncharged, water soluble polymer which 
is commercially prepared by the hydrolysis of poly(vinyl acetate). A schematic 
illustration of PVA is shown in Figure 2.7.2.  
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Figure 2.11 Structure of Poly(vinyl alcohol) 
 
In a general context, different ‘grades’ of PVA are commercially available with 
varying degrees of hydrolysis and a range of molecular weights; however, 
irrespective of grade and/or molecular weight, their hydrophilicity and chemical 
intertness remains an essential part of the polymer’s structural integrity, which are 
two aspects that play an eminant role in their biocompatibility. In fact, a thin thin 
surface coating of PVA is frequently applied in biosensors to ensure the prevention of 
non-specific binding of protein molecules, which in itself, is a fundamental 
prerequisite for success of performance criteria in such devices. Above and beyond, 
the afformentioned attributes, PVA hydrogels can easily be formed by polymer-
grafting, or simple ionic complexation and/or crosslinking with suitable reagents, 
such as poly(acrlic acid), citric acid, glutaraldehyde and acid catalysts, or 
polyelectrolytes. Moreover, the aforementioned interactions concurrently confers 
insolubilization of PVA during hydrogel formation and as such, alleviates its poor 
instability in aqueous medium, (which is a known weakness of ‘pure’ PVA), while 
simultaneously enhancing the structural porosity, mechanical stability and robustness 
of PVA.  A particular popular choice among these blending-crosslinking agents, is 
amine-containing polyelectrolyte, polyethyleneimine (PEI), which induces hydrogel 
formation in PVA through ionic interactions.  
 
Generally PEI is a charge modifier which has found widespread application as 
membrane surface modifier, by blending it with the interfacial enhancing matrix 
material. Its contribution to the improvement of biosensor performance is a 
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particularly interesting area of application, and in this regard, it confers mulitionic 
bonding interactions between reagent-layer components, while concurrently 
improving hydrophilicity on electrode surfaces, and its presence also contributes to 
providing unique microenvironment for the immobilized enzyme.  In a defintive 
context, PEI is a branched chain cationic hydrophilic polymer with an abundance of 
amine groups, which at physiological pH, are highly protonated, thus conferring 
multiple interactive functional sites to ionically interact with other polymer species 
with anionic groups. A schematic representation of the structure of PEI is shown in 
Figure 2.7.3. 
    
 
 
 
 
 
Figure 2.12 Structure of Polyethyleneimine (PEI) 
 
With reference to the interaction between PVA and PEI in particular ― the 
interaction during the blending of the two homopolymers is highly ionic in nature, 
resulting from ion complexation between the anion (CO
2-
) group of the PVA and the 
cationic (NH3
+
C) of the PEI, of which the overall result is an ionically crosslinked 
composite, which is insoluble. The so produced blend, is highly hydrophilic and 
preferentially absorbs water, due to the extensive interaction arising from intra and 
inter molecular hydrogen bonding and dipole-dipole interactions between water and 
the functional groups of PVA/PEI such as amine, acetal and hydroxyl, as well as 
some unreacted amine moieties. 
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In all analytical techniques, as is the case in any  (bio)sensor, based on molecular 
recognition, standard protocols for evaluation of performance criteria, in accordance 
with standard IUPAC definitions needs to be examined.  Amongst these criteria are: 
  
(i) Calibration characteristics which; are based on sensitivity, working and linear 
concentration range, detection and quantitative determination limits;  
(ii) precision, accuracy and repeatability;.  
(iii)  Selectivity and reliability; and finally, 
(iv)  time factors, which includes response times, recovery times and lifetime of 
the biosensor.  
 
It has already been established that the optimisation of biosensors is by and large 
dependant on the immobilization technique used, however, as biosensors are self-
contained, all parts being packed together in the same unit, elegant research on new 
sensing concepts, coupled with numerous technological innovations, has opened the 
door to achieving higher sensitivity, specificity, simplicity and inherent 
miniaturization of modern electrical bioassays permitting them to rival the most 
advanced protocols  
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CHAPTER 3 
 
 
Variables of Investigation, Practical Aspects and  
General Protocols 
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Chapter Prelude 
This chapter consists of two parts. Part A takes a much closer look at the specific 
variables which needs to be considered during the application of cytochrome P450-
3A4 biosensors as applied in the scope of current dissertation. In this regard, the 
aspects covered in this chapter is aimed at forming the basis of the experimental 
methods of investigation, particularly in terms of biosensor configurations including 
thermodynamic parameters, kinetic parameters, as well as performance factors which 
include range, linear range, detection limits, time factors, precision, accuracy and 
repeatibility. Furthermore, the significance of this review is that it aims at providing 
the reader an anhanced understanding of obtained results, since it comprehesively 
explains and defines important aspects, as it applies to the enzyme-based 
electrochemical and/or bioelectrocatalytic factors in this study. The second part, gives 
a succinct overview of general experimental protocols as pertaining to the dissertation 
as a whole. Also included are all the materials and reagents used throughout the 
conduction of the PhD research, including general preparative protocols of samples 
and reagents. In addition to this, the school of thought with regard to relevant 
calculations of specific parameters are also provided. 
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3A Variables of Investigation 
 
3A.1 Introduction 
 
A biosensor in the context of this thesis may be described as a (bio)analytical device 
which exhibits the chemistry of the immobilized biological component, with respect 
to its electron tranfers processes, its reduction and oxidation, adsorption pehomena, 
kinetics of eletron transfer and reaction mechanisms and catalytic interactions – by  
through electrochemical methods and by making use of analytical tools. To 
effectively determine the aforementioned phenomena, the type of transduction 
method is a key juncture, which according to the scope of the current dissertation is 
electrochemically based. Generally, electrochemical transduction operates on the fact 
that during a bio-interaction process, electrochemical species such as electrons are 
consumed or generated, and as such, producing a measurable electrochemical signal.  
In this regard, it is evident that evaluation of all of the relevant aspects and 
parameters pertaining to the operation, and performance of the prepared biosensors 
are by-and-large based on analytical electrochemistry methods, which are collectively 
referred to as Electroanalysis. Appropriately, this subject, together with all relevant 
related topics are subsequently defined and discussed.   
 
 
 
 
3A.2 Electroanalysis (Electroanalytical Chemistry): Theoretical Aspects 
 
On a broad scale, electroanalysis may be described as the science of 
carrying out analytical chemistry by making use of electrochemistry. At the core of 
this subject area, are two prominent electroanalytical observables, which includes 
potential (E) (also called voltage) and the current (I) (or its integral, i.e. charge (Q)). 
During electroanalytical analysis experiments, the interplay between these 
observables (E, I) and  chemical parameters are observed, assessed and subsequently 
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exhibited in appropriate configuration.    It is noteworthy to also add that since 
current is expressed per unit time (current (i) = amperes (A); i.e. coulombs/second) – 
time also plays a significant role in electroanalytical techniques. Generally within the 
context of electroanalsysis, potential measured is referred to as potentiometry, while 
current measurement done in association with amperometry and its main co-topic, 
voltammetry. In a more descriptive  context, potentiometric detection requires two 
electrodes, which includes the working electrode and the reference electrode and 
measurements is made at thermodynamic equilibrium conditions, which essentially 
involves conditions with no current flow. The potential difference, measured between 
the two electrodes is then related to the quantity of the electroactive species/analyte. 
In  current measurement detection techniques on the other hand, the focus is on the 
current passing through a polarizable electrode, which is generally measured as a 
function of careful potential manipulation (controlled potential methods). The 
magnitude of the current is directly proportional to the conentration of the 
electroanalyte species in the electrolyte solution. Compared to potentiometry, 
amperometric techniques has high precision and accuracy, and is much more 
versatile. Moreover, a complete study of an electrode process requires measurments 
of kinteics, as well as thermodynamics, for which potentiometry is inadequite, while 
amperometric based techniques on the other hand can be applied to determine all 
parameters catagorized under kinetics and thermodynamics.  
 
Generally, the chemical questions that can be answered by such use of electrical 
measurements in amperometric techniques include (1) the standard potentials (E
º
) of 
the copound’s oxidation-reduction reactions, (2) evaluation of thermodynamics of the 
compound, (3) determination of the electron stoichiometry, (4) evaluation of the 
heterogeneous eletron-transfer kinetics and mechanisms of the compound, (5) study 
of pre- and postchemical reactions, heterogeneous (thermodynamics and kinetics) that 
are associated with the electron transfer of a reaction, (6) study of effects of the 
solvent, supporting electrolyte and solution acidity on oxidation-reduction reactions 
and (7) study of reaction and product formation in relation to heterogeneous catalysis.  
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It is not possible to measure current during a homogeneous reaction, since an 
electrode and an electrolyte solution is required, which each represents a different 
phase. Moreover, amperometric type electroanalytical measurements takes place 
across an electrode-solution interface, and as such these methods are based on 
heterogeneous electron-transfer reactions. Also noteworthy, is that since 
amperometric analysis does not occur at equilibrium, these techniques are dynamic in 
nature, and as such is accompanied by compositional changes in the electrochemical 
cell material. The most common techniques directly associated with amperometry is 
polarography (when a mercury electrode is used) and voltammetry. 
 
 
3A.2.1  Voltammetry 
 
 
Voltammetry has its roots from the discovery of polarography in 1922 by 
the Czech chemist, Jaroslay Heyrovsky, for which he was subsequently honored by 
the 1959 Nobel Prize in chemistry. In this regard, voltammmetry is based on exactly 
the same principles that pertains to polarography. In a more definitive context, 
generally, the common feature shared by all voltammetric techniques is the 
application of potential (E) to the working electrode and the monitoring of the 
resulting current (I) flowing through  the electrochemical cell. Depending on the 
particular type of voltammetric technique, the potential may either be scanned 
between selected potentials (E1 and E2), or the potential of the working electrode may 
be changed instantaneously, whereas the resulting current may monitored as a 
function of potential or time (depending  on the type of voltammetric technique). 
Thus, overall, one can conclusively say that all voltammetric techniques can be 
described in terms of some function of E, I and time. With reference to the applied 
potential in particular, depending on the desired effect, it can be used to derive an 
overall reduction or oxidative process. In effect, here, the potential is used to force the 
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electraoctive species to either gain or lose an electron, which essentially happens in a 
potential region that makes electron transfer thermodynamically and kinetically 
favorable. Thus at the core or voltammetry, is also the transfer of electrons: 
Ox + ne¯⇌ R     3A.1 
where Ox and R refers to the oxidized and reduced forms of the redox couple, 
respectively. Such oxidation/reduction reactions, derived by electron transfer, is 
governed by Faraday’s law (i.e., the amount of chemical reaction caused by the flow 
of I is proportional to the amount of electricity passed). In this regard, the resultant 
observable voltammetric response, exhibited as the Faradaic current, is directly 
proportional to the concentration of the electroactive (analyte) species (    
    
 ). 
Moreover, the surface concentrations of the analyte species involved in the Faradaic 
processes are related to the electrode potential by the thermodynamic Nernst 
equation: 
  E = Eº´ + 
     
  
 log 
    
 
   
        3A.2 
Where (Eº) is the standard potential for the redox reaction, R is the universal gas 
constant (8.314 J K
-1
 mol
-1
), T is the Kelvin temperature and F is the Faraday 
constant (96,487).  As the electrode is polarized and Faradaic current is passed, the 
potential is in effect moved away from the equilibrium and a concurrent change in the 
concentration of     
    
   is enforced, however, for a system that is controlled by the 
laws of thermodynamics (Nernstian  conditions), equilibrium needs to be 
continuously re-established as changes are made, and as such, the potential and the 
surface concentrations are always kept at equilibrium with each other by fast charge-
transfer process. In effect, the potential forces the respective concentrations of Ox and 
R at the surface of the electrode to a ratio that is in compliance with the Nernst 
equation, which essentially means that, changing the applied potential will 
concurrently induce a change in the ratio of  
    
 
   
  , so as to satisfy Equation 3A2. On 
the other hand, due to the fact that the applied potential enforces a gaining or losing 
of electrons, it may be viewed as “electron pressure”, and as such, the faradic current 
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also reflects the rate at which electrons move across the electrode-solution interface. 
In this regard, the rate of reaction can be described by the Butler-volmer equation, 
which is one of the prominent laws that describe voltammetry: 
  
 
   
 = k
º
{   
  exp[-αθ]-  
  exp[(1-α)θ]}   3A.3 
where θ = nF(E-Eº)/RT, kº is the heterogeneous rate constant, α is the transfer 
coefficient, and A is the area of the electrode. As can be observed from Equation 
3A.4, the Butler-volmer equation links the variables for current, potential and 
concentration, which is a very useful relationship for the benefit of many 
voltammetric techniques. Moreover, it allows one to determine the values of the two 
analytically important parameters, I and k
º
.   Another noteworthy fact is, that charge 
transfer (current flow) is always accompanied by diffusional-mass transfer. This 
essentially happens, since no equilibrium exist between the surface- and the bulk-
solution concentrations, because, as the reagent is consumed or the product is formed 
during the redox reaction of Ox and R,, concentration gradients between the locality 
of the interface and  the bulk solution arise, which in effect, induces diffusion, and as 
such, reactants or products are continuously transported to, or away from the 
electrode surface (or to/from the bulk of the solution) by diffusion. This concentration 
gradient and mass transport is described by Fick’s law, which essentially describes 
the amount of material impinging on the electrode’s surface per unit time. In 
particular, Fick’s law states, that the flux of matter (electroactive/analyte species) (Φ) 
is directly proportional to the change in concentration of species as a function of the 
distance, x, away from the electrode surface (concentration gradient): 
 Φ = -ADOx(cO/x) 3A.4 
where DO is the diffusion coefficient of Ox and x is the distance from the electrode 
surface. An analogous equation can be written for R. It is important to note that since 
voltammetric electrochemical processes always involves consumption of 
electroactive species and formation of product occurring at the same time that current 
is flowing, these processes will always be accompanied by the formation of such 
concentration gradients and as such, mass-transport induced and flux plays a 
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significant role. In effect, the flux of Ox and R at the electrode surface controls the 
rate of reaction and thus the Faradaic current flowing through the cell. In addition to 
diffusion, mass-transport may also occur through migration or convection. 
Convection involves the movement/transport of species  by a forceful physical 
movement, in which such fluid flow occurs with controlled-stirring or flow-through 
of the solution, as well as with rotation or vibration of the working electrode (i.e. 
forced convection), or due to density gradients. Migration on the other hand, refers to 
the movement of  charged particles under the action of an electric field (a gradient of 
electrical potential). In effect, it may be simply described as the movement of charge-
carrying ions in the solution during an electrode process: the positive ions are 
attracted by the negatively charged electrode (cathode), while the negative ions are 
attracted by the positively charged electrode (anode). The rate of migration depends 
on the charge on the ion (transference number), the size of the ion (including its full 
salvation spheres) and on the strength of the interaction between the ion and electric 
field. A stronger field will of course form at an electrode bearing a larger potential. In 
voltammetry, however, the effects of migration is attenuated by using an electrolyte 
which contains an excess of un-reactive ionic salt, known as a swamping electrolyte. 
More on this subject is discussed in Section 3.3.1.2. 
 
 
From  a general perspective, a voltammetric electrode reaction can be quite complex 
and takes place in a sequence that involves several steps. In the simplest case, only 
mass transport of the electroactive species to the electrode surface; the electron 
transfer across the interface and the transport of the product back to the bulk of the 
electrolyte solution is involved. More complex reactions include additional chemical 
and surface processes that precede or follow the actual electron transfer. The net rate 
of the reaction, and hence the measured current value may be limited either by the 
mass transport of the reactant or by the rate of electron transfer ― the slower process 
will be the rate determining step. Overall, whether a given reaction is mass-transport 
or electron transfer controlled, is determined by various parameters, including the 
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type and concentration of the redox-active compound being measured; the size, shape 
and material of the electrode; the electrolyte solution resistance; operating potential; 
mode of mass transport; number of electrons transferred; time scale, etc. Thus, in 
effect, these parameters also determine the measured current signal. When the overall 
reaction is controlled exclusively by the rate at which the electroactive species reach 
the surface, the current signal is said to be mass transport limited. Such reactions are 
labeled Nernstian  or reversible, since they obey thermodynamic relationships.  
 
 
Commonly, results obtained from voltammetric analysis are displayed in terms of  a 
voltammogram, which, in the most general form is a plot of current signal versus 
excitation potential. In fact, this current-potential plot is used to exhibit results 
obtained from the most popular and widely used voltammetric technique, i.e., cyclic 
voltammetry.    
 
 
 
 
3A.2.1.1  Cyclic Voltammetry 
 
Cyclic voltammetry is undoubtedly, the most widely used electroanalytical 
technique and is highly beneficial in diverse areas of scientific research application, 
mainly due its exceptional ability for providing qualitative information about redox 
processes. In particular, it provides rapid information with regard to the 
thermodynamics of redox processes, on the kinetics of heterogeneous electron-
transfer reactions, and on coupled chemical reactions or adsorption processes, 
including understanding reaction intermediates and for obtaining stability of reaction 
products. In fact, cyclic voltammetry is normally the first experiment performed in an 
electrochemical study, since it enables rapid location of redox potentials of the 
electroactive species, as well as simplistic evaluation of the effect of media upon the 
redox process.  
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The technique itself is based on linearly scanning the applied potential of a stationary 
working electrode (in an unstirred solution) in a triangular waveform with time. The 
form of the potential-time impulse is exhibited in Figure 3A.1. 
 
 
Figure 3A.1 Potential-time excitation signal in cyclic voltammetric experiment 
 
During the process of potential scanning, the potential is varied with time, in a linear 
manner at a specific scan rate, up to a pre-defined limit (known as the switch 
potential), and then reversed to the initial value. The parameters which are of 
significance during the actual sweep scan, are the initial potential (Ei), the initial 
sweep direction, the sweep rate (), the final potential (Ei) and the switch potential. 
Depending on the particular experiment being conducted, the initial/forward sweep 
may be in the negative or positive direction, whereas the reverse scan, being the 
inverted sweep, will then obviously be in the opposite direction. Moreover, 
depending on the information sought, such as the potential at which the redox process 
occur, or the concentration of the electroactive species, or the presence of preceding 
or following chemical complications – a partial cycle, full cycle, or multiple cycles 
can be performed. During the potential sweep, the current signal resulting from the 
applied potential is measured by the potentiostat, whereas the overall response is 
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collected as a resulting current versus potential plot, known as the cyclic 
voltammogram. An illustration of the expected typical cyclic voltammetric response 
of a FeCN
IIIII
 redox couple during a single full potential cycle, is exhibited in 
Figure 3A.2.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3A.2 Basic parameters for a cyclic voltammogram: Epa refers to the 
potential of the anodic (forward) peak; Epc represents the potential of the cathodic 
(reverse) peak; E is the potential value at the inversion of the scan direction (switch 
potential); Ipa represents the current of the forward peak with respect to its baseline; 
ipc is the cathodic (reverse) peak current with respect to its baseline; (if)0 is the current 
at the inversion potential with respect to the zero current baseline 
 
With the assumption that only the reduced form is present initially. Thus 
appropriately, a positive potential scan is chosen for the first half-cycle, which starts 
from a value where no oxidation occurs. As the applied potential approaches the 
characteristic Eº for the redox process, an anodic current signal begins to increase, 
until a peak is reached. After passing through the potential region where the oxidation 
process takes, the direction of the potential sweep is reversed. During the reverse 
scan, Ox molecules (generated in the forward half cycle), and accrued near the 
electrode surface) are reduced back to R and a cathodic peak results. 
 
 
 
 
 Chapter 5   Variables of investigation and general protocols  
 
100 
 
 
Generally, as shown in Figure 3A.2 the prominent observable parameters in a cyclic 
voltammogram are the peak potentials (Epc, Epa), the peak currents (Ipc, Ipa) of the 
cathodic and anodic peaks, respectively; the switch potential (Eλ) and the peak 
potential difference (∆Ep). In terms of data interpretation in particular, of these 
parameters, the most important are the two peak currents and peak potentials, which, 
based on the theory developed by Nicholson and Shain (“the theory of stationary 
electrode polarography”) is used to analyze the cyclic voltammetric response. In this 
regard, these parameters are applied as diagnostics for determining whether the 
system is electrochemically reversible, quasi-reversible, or irreversible, as well as for 
the study and determination of other relevant aspects, such as coupled chemical 
reactions and adsorption processes. In a reaction which is electrochemically 
reversible, i.e., a reaction in which the electron transfer is fast, compared with mass 
transfer (such as diffusion)  the peak current is given by the Randles-Sevcik 
equation:  
 Ip = (2.69 x 10
5
)n
3/2
ACD
½ν½ 3A.5 
 
where n is the number of electrons, A is the electrode area (in cm
₂), C is the 
concentration (in mol cm
-3), D is the diffusion coefficient (in cm2s-1) and   is the 
scan rate (in V s
-1
). As observed in equation 3A.5, the current is directly proportional 
to the concentration, and furthermore, peak current increases with square root of scan 
rate. What is more, for a simple reversible reaction, the ratio of the reverse-to-forward 
peak currents     /     is unity. On the other hand, the aforementioned peak ratio can 
be strongly affected by chemical reactions coupled to the redox process (more on this 
subject will be discussed in following sections). The positions of the peaks on the 
potential axis is related to the formal potential of the redox process. In particular, the 
formal potential for a reversible couple is centred between Ep,a and Ep,c: 
 Eº = 
         
 
  3A.6  
  
 
 
 
 
 Chapter 5   Variables of investigation and general protocols  
 
101 
 
The separation between the peak potentials (for a reversible couple) is given by: 
 ∆Ep = ׀Ep,a – Ep,c׀ = 2.303 RT/nF 3A.7a 
Which at 25ºC becomes: 
 ∆Ep = 
     
 
 3A.7b 
In this regard, the peak separation can be used to determine the number of electrons 
transferred, and as a criterion for Nernstian behaviour. Hence, a fast one-electron 
process exhibits a ∆Ep of about 59 mV and such value maintains constant with scan 
rate. Thus for reversible electrochemical reaction, both the cathodic and anodic peak 
potentials are independent of scan rate. It must be noted though, that in practice, a 
value of 59 mV ∆Ep is indeed very difficult to attain, because of small distortions 
caused by solution resistance, so an error variable of about 10-15 mV is still regarded 
as acceptable.  
 
 
Unlike, the electrochemical behaviour for reversible redox processes, in “non-ideal” 
redox processes, such as irreversible and quasi-reversible processes, in which the 
electron transfer is slow, or coupled with a chemical reaction, a very different 
situation presents itself.  Such processes are actually of greatest chemical interest and 
for which the investigative ingenuity of cyclic voltammetry is most valuable.  
 
In terms of irreversible, electrochemical processes in particular (those with sluggish 
electron exchange), in general, the commonality is that the rate of the electron 
transfer is lower than the rate of the mass transport. One of the eminent characteristics 
features of irreversible processes is that individual peaks are smaller in size and are 
widely separated from each other (Figure 3A.3, curve A). In fact, in many cases, the 
separation between the forward- and reverse peak is so large that the reverse peak is 
undetected.  This essentially happens, because the forward peak, compared to its 
standard thermodynamic potential, is located at potentials more negative than if it 
were a reversible reaction. Moreover, the forward peak potential, Ep,f  shifts with scan 
rate, such that for reduction processes,  the shifting will be toward more cathodic 
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values. At 25 ºC (298 K), the shift is approximately      ⁄  mV for a tenfold 
increase of the scan rate. Overall, the precise dependence of peak potential (Ep) on 
scan rate, , is expressed by: 
 Ep = Eº ― 
  
      
 [ 0.78 ― ln
  
  
  + ln
       
  
½] 3A.8 
where α is the transfer coefficient and na is the number of electrons involved in the 
charge-transfer step. Thus, Ep occurs at potentials higher than the standard 
thermodynamic potential (Eº), with the overpotential is related to the heterogeneous 
standard rate constant, kº, and the transfer coefficient, α. However, independent of the 
value of kº, an appropriate change in scan rate, can compensate for the displacement 
in peak potential. Also noteworthy, is that if the half-peak potential (Ep/2) is the value 
at half-height peak current, Ip/2, it holds that at 25 ºC: 
 Ep ― Ep/2 = 
         
       
 = 
  
     
 (in mV) 3A.9 
Thus, as observed in equation 3A.9, at 25 ºC, the peak potential and the half-peak 
potential will differ by a magnitude 48/αn mV. This essentially means that the 
voltammogram becomes more drawn-out as αn increases. With regard to the peak 
current on the other hand, given by: 
             
           
        
         3A.10 
it is still proportional to the concentration, but will be lower in magnitude, with the 
actual peak current height depending on the value of the α (since the relationship 
shown in equation 3A.10 shows that Ip depends on the square root of α). In this 
regard, assuming a value of 0.5 for α, the peak current for an irreversible process has 
a magnitude of about 78-80% of the peak for a reversible one, which amounts to a 
ratio of reversible-to-irreversible current peaks of approximately 1.25-1.27. Another 
noteworthy aspect with regard to the peak current for irreversible processes includes 
the fact that no current ratio for Ip,r/Ip,f exists. In this respect, however, it must also be 
taken into account that the lack of any reverse response is not sufficient to 
conclusively diagnose an electrochemically irreversible step, since the presence of 
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chemical reactions involving the electrogenerated species can attenuate the reverse 
response. 
 
 
Figure 3A.3 Cyclic voltammograms for irreversible (curve A) and quasi-
reversible (curve B) redox processes. 
 
The other foreseeable type of redox electron transfer process, the quasi-reversible 
reaction, involves processes in the transition zone between reversible and irreversible 
behaviour. In such reactions, the shape of the cyclic voltammogram is a function of  
kº/√aD (where a = nF/RT)  thus as kº/√aD increases (i.e., at very fast scan 
rates), the system potrays irreversible behaviour. Therefore, in such reactions, it is not 
uncommon that at low scan rates, the redox couple exhibits reversible electron 
transfer behaviour, whereas at high scan rates the process behaves irreversibly. 
Generally, quasi-reversible systems, occurs when the rate of the electron transfer (of 
the redox reaction) is of the same order of magnitude as the mass transport and as 
such, consequently, the current is controlled by both the charge transfer and the mass 
transport. Another point also noteworthy is that it is commonly assumed that an 
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electron transfer behaves quasi-reversibly when the standard rate constant lies within 
the values expressed as a function of the highest and lowest scan rates , i.e.:  
 3 x 10
-3
   ½  kº  2 x 10-7 ∙ ½ 
where kº is expressed in m s
-1
 and  in V s-1. From a more practical perspective, one 
of the most eminent readily observable aspects of a quasi-reversible redox reaction is 
the separation between the forward and reverse peaks (i.e., Ep)  which in this 
case, is much greater than that of a reversible process. Moreover, the peak height is 
not directly proportional to ½. Also noteworthy is that the peak shapes and peak-to-
peak separation (Ep) depend, through a complex mathematical function  (known 
as the rate parameter), on α, kº and: 
   =  
  
 
        
   
  
 3A.11 
The above relation holds under the assumption that α = 0.5; DOx = DRed = D. 
Considering the latter and aforementioned aspects, it becomes evident that for 
diagnostic characterisation of a quasi-reversible process, the parameters of relevance 
includes the thermodynamic parameter Eº, and the kinetic parameters α and kº. In 
this regard, the parameter Eº can be efficiently calculated as the average between the 
forward and reverse peaks, given that 0.3 < α < 0.7; whereas kº can be calculated if 
both D and α are known. In this regard, α is generally assumed to be approximately 
0.5, however, one can also roughly evaluate the value of α by taking into account the 
effect of α on the shape of the cyclic voltammogram: 
 For the case of α > 0.5, the forward peak is sharper than the reverse peak, and 
as such, Ip,f > Ip.r; 
 For α < 0.5, the opposite is evident  
Other noteworthy factors with regard to the potential and current which are also of 
significance in qausi-reversible processes include the following:  
 The forward peak (Ep,f) shifts with , i.e., toward more negative Ep values for 
reduction process; 
 At 25 ºC, the peak-to-peak potential difference is higher than 59.0/n, of which 
the difference become much more prominent with increasing ; 
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 The forward peak current Ip,f increases with ½, but the dependence may not 
be linear. 
 The current ratio Ip,f/Ip,r equals 1 only if α = 0.5. Otherwise, if  
 
To sum up the aspects of reversibility, irreversibilility and quasi reversibility, Table 
3.2 highlights the important aspects that may be applied as diagnostic tools for the 
correct classification of electrochemical reactions during experimental investigations.  
 
Table3.2 Summary of diagnostic criteria for electrochemical reversibility, 
irreversibility and quasi-reversibility of a redox couple, obtainable 
from cyclic voltammetric investigation 
  
Property Reversible Quasi-
Reversible 
Irreversible 
For Diffusion Controlled processes 
Properties 
of the 
Potential 
∆Ep =    ⁄  for 
an n-electron 
couple 
Peak potential, 
Ep,c and Ep,a are 
independent of  ν 
Peak-to-Peak 
separation, ∆Ep is 
independent of ν;  
plot of ∆Ep vs ν  
= linear 
E
0
 = (Ep,a + 
Ep,c)/2 
Ep varies with  
Ep ≠ 57.0/n mV 
(departure from 
59/n becomes 
very significant at 
higher ) 
Ep,f varies 
with  
Properties 
of the 
Current 
Ipc = Ipa 
Ip is proportional 
to ν½ ; plot of Ip 
vs ν½ = linear 
Ipa/Ipc = 1 
 
Ip,f increases with 
ν½ , but the 
dependence may 
be non-linear; 
Ip,r/Ip,f = 1 only if 
α < 0.5 
(otherwise, if α > 
0.5: Ip,r/Ip,f < 1; if 
α < 0.5: Ip,r/Ip,f >1 
plot of Ip 
vs ν½ = 
linear; 
Ipa/Ipc  Ip,a 
or Ip,c (no 
current 
ratio of  
Ipa/Ipc exist) 
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So far, the application of cyclic voltammetry was discussed with respect to 
the response of diffusive solution systems. However, the explorative diagnostic 
ability of cyclic voltammetry can also be used to investigate redox processes for 
electron transfer across the electrode/film interface involving (electroactive) 
species/molecules adsorbed onto, or confined to a thin layer close to the electrode 
surface. For such redox-active interfacial supramolecular assemblies, a distinctly 
different observable electrochemical behaviour is exhibited. Firstly, for such 
confinement/immobilization of electroactive species, the redox-active material 
normally does not have to diffuse to or from the electrode surface, which 
concomitantly leads to changes in the shape of the cyclic voltammograms, i.e., peaks 
are more Gaussian in shape. Moreover, the separation between the peak potentials is 
also much smaller than expected for solution-phase processes, which become more 
evident at slow scan rates where the species is exhaustively oxidized or reduced. In 
fact, ideal Nernstian behaviour of surface-confined non-reacting species (species with 
no lateral interaction between redox centres, or in which interactions are independent 
of surface coverage), is characterised by symmetrical voltammetric peaks (see Figure 
3A.4), with an ideal peak-to-peak potential difference of zero (Ep = 0). Moreover, 
the peak current is directly proportional to the potential scan rate (), as shown in the 
following relation: 
 
  Ip = 
     
   
 AΓ 3A.12 
where n, F, R and T has its usual meanings, A is the area of the electrode and Γ is the 
surface coverage or concentration of the redox active molecule (in mol cm
2
). If one 
recalls from aforementioned sections, that Nernstian behaviour of diffusing species 
yields a ½ dependence. Conversely, as shown in Equation 3A.12, surface confined 
species exhibits a linear scan rate dependence () and not ½. Also noteworthy, as 
shown in the relation exhibited by the above equation, is the fact that the peak current 
is directly proportional to the surface coverage. Moreover, the area under the peak 
corresponds to the charge associated with the reduction of the adsorbed species and in 
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this regard, the surface coverage and the quantity of charge consumed during 
reduction or adsorption of the adsorbed/confined layer is related in a very useful 
equation: 
  Q = nFAΓ 3A.13 
In effect, the above relation shows that by measuring the Faradaic current passed 
during exhaustive electrolysis of the adsorbed/surface confined layer, the surface 
coverage of the latter can be determined, which in turn, can be used to calculate the 
area occupied by the adsorbed molecule. From a practical perspective, this may be 
done through slow scan rate voltammetry, or by using bulk electrolysis with 
chronocoulometry. Overall, essentially, this can be used to calculate the area 
occupied by the adsorbed species. Generally, for a species exhibiting an ideal 
Nernstian  behaviour, in which there are no lateral interaction between redox centres, 
or where interactions are independent of surface coverage, the surface confined 
species will commonly adhere to the following relationships: 
 FWHM = 3.53 
  
   
 = 
    
 
 mV, 3A.14 
   Ep,a = Ep,c 3A.15 
  
where FWHM is the full width at half maximum of the cathodic or anodic wave. On a 
final note, ideally, for species exhibiting the relations described by Equations 3A.12 
– 3A.15, the type of adsorption of the adsorbed redox active species can be described 
by the Langmuir isotherm: 
 Γ = Γm (
  
    
)  3A.16  
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Figure 3A.4 Ideal cyclic voltammatric behaviour for reduction and oxidation of 
adsorbed/surface confined species. The surface coverage, Γ, can be obtained from the 
area under the peak 
 
 
 
 
3A.2.1.1.2 Aspects of chemical reactions coupled to electron transfer 
 
As mentioned in preceding sections, heterogeneous electron transfer 
processes in voltammetric reactions can be quite complex due to the common 
occurrence of homogenous preceding or following chemical reactions. The presence 
of such reactions will concomitantly affect the shape of the cyclic voltammograms, 
and thus will inevitably appreciably perturb the diagnostic investigations for electron 
transfer processes. In this regard, the chemical complications are categorized as: 
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 Preceding (the electron transfer) chemical reactions 
 Following (the electron transfer) chemical reactions 
With regard to specific classifications, these reactions may be catalytic or just 
coupled homogeneous chemical reactions. A specific example, with reference to 
catalytically coupled chemical reactions in CYP450-based electrochemical 
investigations in particular, the reduced product formed from the forward scan are 
normally, in the presence of oxygen, used up in very fast follow-up chemical 
reaction, hence the lack of the reverse scan, particularly evident at low scan rates. 
Indeed there are many aspects to consider in evaluating such reactions, however, that 
will not be further elaborated on at this stage. For more information regarding this 
subjects areas, the listed textbooks may be consulted [91-92].   
 
 
3A.2.1.2 Pulsed Voltammetric Techniques 
 
From a general perspective, in terms of the analytical sensitivity in 
classical cyclic voltammetry, detection limits can go down to approximately 10
-5
 mol 
dm
-3
 concentration level. However, at very low concentrations of analyte, the current 
perturbation caused by double layer effects or other non-Faradaic sources induces a 
substantial compromise in the accuracy. As an example, consider the case of electron 
transfer processes in cyclic voltammetry complicated by consecutive electron transfer 
process, with the electrode potentials separated by < 100 mV  the resulting 
overlapping peak systems are very difficult to be resolved in order to obtain the 
precise formal electrode potential for each step. Moreover, during the study of 
catalytic electrochemical experiments, in which electron transfer processes are 
complicated by follow-up chemical interactions, a more accurate measure of 
electrode potential with preferably lower signal-to-noise ratio is required. In the latter 
and aforementioned cases, it is convenient to make use of pulsed techniques. These 
methods all ‘accentuate/amplify’ the Faradaic current, while greatly minimizing the 
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capacitive (charging) current. This is essentially achieved by applying a sequence of 
potential steps to the working electrode which enables the experimenter to exploit the 
variation in decaying rate of Faradaic current as opposed to the charging capacitive 
current. In this regard, after the potential is stepped, the charging current decays 
rapidly (exponentially with time) to a negligible value, while the Faradaic current 
decays rather slowly. Thus, after triggering the electron transfer by potential 
application across the working electrode, and sampling the current late in the pulse 
life, effectively discriminates against the charging current, and as such, the observed 
current is by-and-large Faradaic. 
Overall, in this regard, the two techniques which are particularly useful and also as 
pertaining to the scope of the dissertation include: 
 Square-wave voltammetry  
 Differential pulse voltammetry 
 
 
3A.2.1.2.1 Square-Wave Voltammetry (SWV) 
 
Square wave voltammetry is originally invented by Ramaley and Krause 
and subsequently extensively further developed by Osteryoung and co-workers into 
the modern analytical tool which is often regarded more popular than normal- or 
differential pulse voltammetry. In fact, the technique itself can be viewed as a 
synergistic combination of the best aspects of several pulse voltammetric techniques, 
including background discrimination and superior sensitivity of differential pulse 
voltammetry, the diagnostic competence of  normal pulse voltammetry and the 
capability of direct interrogation of products in the same manner as reverse pulse 
voltammetry, hence the popularity of the method. 
 
Essentially, SWV is a large-amplitude differential technique, developed through the 
combination of the high-amplitude, high frequency square wave with the fast 
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staircase waveform, and by making use of computer-controlled electroanalytical 
instrument in preference to analogue hardware. With regard to practical aspects, it is 
normally applied to a stationary electrode, and involves the application of a potential 
waveform to the working electrode. In particular, the waveform composed of a 
symmetrical square wave, superimposed on a base staircase potential, is applied to 
the working electrode. With respect to the interpretation of results, it is best to 
consider the waveform as consisting of a staircase scan, of which each tread is 
superimposed by a symmetrical double pulse, one in the forward direction and one in 
the reverse. In general, the principle parameters associated with a square wave 
include a pulse height, Ep, which is measured with respect to the corresponding 
tread of the staircase, and the pulse width, tp. The pulse width can also be expressed 
in terms of the square wave frequency, f  = 1/2tp. The scan rate v = Es/2tp = fEs, 
which is based on the fact that the staircase shifts by Es at the start of each cycle. 
Figure 3A.5 exhibits the waveform and measurement scheme, including the principle 
parameters, for square wave voltammetry. 
 
 
 
 
 
 
 
 Chapter 5   Variables of investigation and general protocols  
 
112 
 
Figure 3A.5 Time-potential waveform profile for square wave voltammetry. 
Showing initial potential, Ei; pulse height (amplitude), Ep; step height, Esh; pulse 
width, tp (also known as square wave period), forward current- and reverse current 
sample. 
 
From Figure 3A.5, one can see distinguish a number of important parameters. Firstly, 
the square wave scan begins at an initial potential, Ei, which is applied for a 
subjective time to initialize the system. Another significant parameter is the pulse 
height/amplitude, Ep, which is measured with respect to the corresponding tread of 
the staircase, as well as the pulse width/square wave period, tp. During each square 
wave cycle, the current is sampled twice, i.e., at the end of the forward pulse (at tf) 
and at the end of the reverse pulse (at tR).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3A.6 Typical square wave voltammogram exhibiting reversible electrochemistry 
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3A.2.1.2.2 Differential Pulse Voltammetry (DPV) 
 
In DPV a succession of pulses of fixed magnitude, which is superimposed 
on a linear potential ramp, are applied to a working electrode. Here, the current is 
monitored (sampled) twice per drop, i.e.: The first sample is taken just before the rise 
in potential, at the beginning of the pulse, whereas the second sample is taken late in 
the current pulse life just before it decreases back to the baseline (when the charging 
current is decayed). The difference between these two currents, which is 
instrumentally subtracted, is thus essentially ΔIpulse. The differential pulse 
voltammogram is then subsequently plotted as a current vs potential graph. A 
noteworthy factor to also add, is that since the difference between the Faradaic 
components of the two current samples is usually negligible, in practice ΔIpulse is zero, 
unless a legitimate redox activity occurs. From a practical perspective, during 
investigations involving DPV, the important parameters include:  
 the pulse amplitude (ΔEpulse), which is the magnitude (height) of the applied 
potential pulse; 
 the pulse width, which is the time duration (in ms) in which the pulse is 
maintained; 
 the sample width, which corresponds to the time (in ms) at which the current 
is measured after the application of the potential pulse; 
 the pulse period, which is the time required to complete one cycle of variation 
of potential.  
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Figure 3A.7 Potential wave form and time-dependence of applied potential in 
differential pulse voltammetry   
 
 
3A.3  Practical considerations 
 
3A.3.1  Voltammetric investigations: Instrumentation and general practical 
requirements 
 
From a general perspective, the basic requirements for the conduction of a 
voltammetric electrochemical investigation include an electrochemical cell – fully 
equipped with a three-electrode system, a voltammetric analyzer (consisting of a 
potentiostatic circuitry, including a voltage ramp generator), while the other 
component is an X-Y-t recorder/plotter (X-Y: for current-potential measurements and 
X-t: for current-time/concentration measurements). Also noteworthy is the fact that 
the complete system should be kept in a location that is free from disturbing 
vibrations and drastic fluctuations in temperature, since these aspects can 
substantially influence the obtained results. 
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3A.3.1.1 The electrochemical cell 
 
Generally, voltammetric experimental investigations are commonly 
conducted in a glass electrochemical cell, equipped with a three electrode system. A 
typical electrochemical cell is exhibited in Figure 3A.8. The general volume capacity 
of such cells range from 5 to 50 mL and it is usually fitted with a teflon cover, 
equipped with o-ring adaptors to hold the three electrodes, which includes the 
working electrode (WE), the reference electrode (RE) and the counter electrode (CE) 
(or auxiliary electrode). In this regard, the WE is the electrode that is usually 
modified with the appropriately chosen interfacial enhancers and is the electrode at 
which the reaction of interest occurs. Various materials can be used as working 
electrodes, and based on origin, these may be metals, carbonaceous materials, 
semiconductors and organic conducting salts. With regard to the scope of this 
dissertation, carbonaceous WE was used. In particular, glassy carbon WE was used, 
the characteristics of which will be elaborated on in more details in subsequent 
section. The RE consist of an inner solution of constant composition of both forms of 
its redox couple and as such, is resistant against potential changes which enables it to 
provide a stable and reproducible potential, independent of sample composition. 
Common reference electrodes are saturated calomel (Hg/Hg2Cl2) and silver-silver 
chloride (Ag/AgCl) electrodes, of which the latter was used in this dissertation.  With 
regard to the counter electrode on the other hand, an inert conducting material, 
usually a platinum wire is used. During the performance of the actual voltammetric 
experiments, these electrodes are immersed in the solvent and supporting electrolyte. 
In addition to this, depending on the type of voltammetric experiment, the solution 
may be quiescent, or may require stirring, for which a stirrer bar is included in the 
cell. Moreover, the tube used for bubbling the inert deoxygenating gas is also 
supported in the holes of the teflon cover. 
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Figure 3A.8 A typical electrochemical cell used during a routine 
electrochemical investigation 
 
 
The relative positions of the electrodes are important and should be payed close 
attention, while their connection to the electrochemical analyzer should also be 
closely monitored. Also noteworthy is the fact that in techniques where the potential 
for high background currents exist, such as chronoamperometry and bulk electrolysis, 
the CE can be separated in a glass-frit, in order to alleviate interference by 
electrolysis products.  
 
 
 
 
 
 
 
 Chapter 5   Variables of investigation and general protocols  
 
117 
 
3A.3.1.2  Solvents and supporting electrolytes  
 
Akin to common chemical reactions, the electrolytic medium, which is 
generally constituted by the solvent and the supporting electrolyte, plays a pivotal 
role in the success of an electrochemical measurement [93-94]. In this regard, the 
choice of solvent in particular is limited by a combination of prerequisites to 
adequately facilitate the heterogeneous electron transfer to and from the electrode and 
solution. In this regard, the solvent should not react with the analyte and should not 
undergo electrochemical reactions over a wide potential range, but should be 
adequately electrically conductive. to dissolve the analyte under study, but to be 
chemically inert with respect to it. Other requirements with respect to the solvent 
include the following: 
 to dissolve considerably high amounts of supporting electrolyte, with the 
overall aim of  improving the electrical conductivity of the electrolyte 
solution, while concomitantly reducing its resistance; 
 impurities which have the potential to interact with the analyte under study or 
interfere with the electrochemical process must be easily removable and as 
such, the solvent should be easily purified; 
 since enzyme-based modified electrodes are very sensitive and susceptible to 
fouling, the solvent should not process any toxic constituents. 
Generally, water is the most common solvent used, but, depending on the specific 
requirements of the electrochemical investigation, non-aqueous media may also be 
used. As for the supporting electrolyte on the other hand, overall, its presence in 
controlled-potential electrochemical investigations are required to decrease the 
resistance of the solution, to attenuate electro-migration effects and to maintain a 
constant ionic strength. It is important that the concentration of the supporting 
electrolyte is sufficiently high, so as to “swamp out” the effect of variable amounts 
of naturally occurring electrolyte (migration effects). In this regard, the usual 
concentration is 0.05  1.0 M, in other words in excess of the concentration of all 
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electroactive species. In terms of specific constituents, the inert supporting 
electrolyte may an inorganic salt, a mineral acid, or a buffer system, of which the 
latter is used when a pH control is essential. With regard to the current dissertation, 
with specific reference to the sensitive nature of the biologically based recognition 
component, all supporting electrolytes were prepared with phosphate buffer 
systems, prepared at predetermined pH of 7.4.  
 
 
3A.3.1.3 Conditions for requirement of oxygen removal  
 
From a general perspective molecular oxygen (dioxygen, O2) is chemically 
reactive with numerous substances, but more importantly, during electrochemical 
experiments, at cathodic potentials, O2 is electrochemically reducible. This can be 
highly problematic, since the reduction of O2 can result in series of electroactive 
intermediary products which of course could have dramatic effects on the electrode 
reaction being studied. In a more descriptive context, a detailed outline of the possible 
electrochemically base reactions and intermediates is subsequently discussed:  
 
The ground state of molecular oxygen (O2, 3g

) has two unpaired electrons in 
degenerate 2g orbitals. Essentially, atmospheric dioxygen dissolves in water to a 
concentration of approximately 1 x 10
-3
 M. Thus in un-degassed supporting 
electrolyte solution, at sufficiently cathodic potentials, the dioxygen will be reduced 
by the electron transfer process, the effect of which can, via reduction, hydrolysis and 
disproportionation steps, result in the formation of a series of intermediate basic 
dioxygen and monooxygen species, that may take up one or two hydronium ions 
(H3O
+
) from the electrolyte media (O2

, HOO

, H2O2, HOO

, HO

, H2O, HO

). With 
regard to the overall general significance on electrochemical and electrocatalysis 
investigations in particular, the formation of hydrogen peroxide and water is the 
important branching points. Considering  the two main branching points in the overall 
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reduction of oxygen, the formation of H2O2 and H2O proceeds via two well-separated 
two-electron steps, respectively. The first step corresponds to the formation of 
hydrogen peroxide: 
 O2 + 2H
+
 + 2e  H2O2 3A.18 
The hydrogen peroxide formed above is essentially also electroactive and thus a 
second reduction step occurs: 
 H2O2 + 2H
+
 + 2e  2H2O 3A.19 
Thus overall, since electrons are being consumed here, the associated non-Faradaic 
current can result in large background current accruing from this stepwise oxygen 
reduction, and will in effect interfere with the measurement of many reducible 
analytes. Moreover, the products of the oxygen reduction can affect the 
electrochemical process being investigated. Considering these aspects, during 
investigation of the electrochemical behaviour of a redox process, ideally, oxygen has 
to be removed/excluded, which can be done through degassing with an appropriate 
inert gas prior to the experiment, while a blanket of gas should also be maintained 
atop the solution during the experiment. 
 
At this stage, it should also be said that in cases where the presence of dioxygen is 
essential, such as during normal electrocatalysis studies, particularly with regard to 
CYP450-based platforms, the possible formation and interference of reactive oxygen 
species can be limited/avoided by working at a lower operating potential and/or 
working under conditions of low oxygen tension. Moreover, in reagentless mediated 
biosensor platforms, most reduced mediating species poses the potential of reacting 
with oxygen resulting in the formation of H2O2 through dismutation of superoxide, so 
care has to be taken in this regard also.   
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3A.3.1.4 Working electrodes  
 
Essentially, the working electrode (WE) is the electrode where the redox 
reaction of electroactive species takes place and where the charge transfer occurs. In 
this regard, from a practical perspective, the electrochemical performance aspects are 
influenced by the characteristics of the WE. In this context, the ideal WE should 
operate at a wide potential window, provide a high signal-to-noise ratio; confer low 
resistance and adequate conductivity, while also yielding a reproducible response. 
Generally, several types of materials can be used as WE, of which the most popular 
are those involving mercury, carbon, or noble metals (especially platinum and gold). 
A significant factor to consider during application of a solid WE is the dependence of 
the response on the surface state of the electrode. Therefore, appropriately, the 
application of these electrodes requires specialized pretreatment and polishing 
procedures to obtain reproducible results. The nature of the pretreatment protocol is 
highly dependent on the type of electrode material involved. To this end, mechanical 
polishing (to a smooth mirror-like finish) and potential cycling are common effectors, 
while various thermal, chemical, or electrochemical protocol steps may be added for 
activating surfaces. In this regard, carbon-based surfaces benefit especially from 
specific ‘activating’ pretreatment steps. While on the subject of carbon-based 
electrodes, amongst available ones, the glassy carbon electrode is the most popular 
and in the context of this dissertation, is the electrode used for all electrochemical 
investigations and prepared platforms.  
 
 
3A.3.1.4.1 Glassy carbon electrodes 
 
Glassy carbon  (GC), as does all other carbon electrode material, share the 
basic structure of a six-membered aromatic ring sp
2
 bonding. In its full description, 
GC is also called vitreous carbon and is a popular choice for WE based on its wide 
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potential window, chemical inertness, as well as providing a  relatively reproducible 
performance. With regard to the specific structure of GCEs, it consist thin, tangled 
ribbons of cross-linked graphite-like sheets. With regard to the actual use of GCEs, 
usually a surface pre-treatment is employed, mainly functioning to activate the 
electrode surface group, while also enhancing their analytical performance. In this 
regard, the most basic step of course involves polishing procedures. However, 
additional steps, have also been used to enhance performance factors.   
 
 
 
3A.3.2  Human cytochrome P450 genetic engineering: Important theoretical 
pre-emptive and research design considerations 
 
3A.3.2.1  Foreword 
 
Based on the fact that a significant part  of the success of the research 
investigation exhibited and discussed in this dissertation centred around 
understanding and physically applying the intricate process of preparing a 
catalytically active enzyme-based biorecognition source for the purpose of 
conducting successful experimental protocols, it is only appropriate to enlighten  the 
reader’s understanding with regard to this subject. This subject matter is particularly 
important to get a complete grasp of the experimental aspects and results 
interpretation of Chapter 5B, since the recognition component for these biosensors 
were prepared ‘locally’ by the author and not sourced from commercial domains, as 
in the case of recognition component used in Chapter 4 .  
 
  
3A.3.2.2 The road to getting started: Important considerations 
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As emphasized in Chapter 1, for the study of enzyme-drug interactions 
and drug metabolic profiling investigations with cytochrome P450 enzymes and/or 
CYP3A4 in particular, a viable catalytically active enzyme source is a prerequisite. 
As already stated, these sources can be either cell cultured and tissue-based systems, 
liver microsomal systems, or genetically manipulated recombinant systems, 
expressing single CYP isoenzymes. In both the case of liver microsomal fractions and 
cell/tissue-based systems, the enzymes sources are directly obtained from human 
origin, and as such, are part of complex systems, which may contain other 
isoenzymes, native electron transfer mediator complex components, and these 
isoenzymes are largely bound to cell membranes, which, for the purpose of 
bioelectrochemical studies, makes the systems essentially difficult to use, since the 
study of a particular isoenzyme’s specificity for substrates, kinetic parameters for 
reaction and possible means of regulation, preferentially requires the isolation of the 
isoezyme. This would require extensive purification procedures, which involves 
disruption of the cell membranes, and other biochemical procedures, such as column 
chromatography, etc., of which these procedures are highly time-consuming, and 
expensive, while the isolated isoenzyme may be inactive in the absence of 
phospholipids or detergent and as such, catalytic reconstitution systems would need 
to contain all such additional components [95], particularly in the case of CYP3A4. 
Moreover these sources are highly sensitive and decay rapidly, which means that 
fresh supplies would have to be sourced very regularly an human liver 
tissues/fraction/slices are not always readily available. In addition to this, many of the 
isoenzymes within a family,  share extensive homology with each other in their 
amino acid sequence identity, some of which have been shown up to 97%, and as 
such, their substrate selectivities overlap considerably [96], which means that 
additional methods of analysis would be required for the interpretation of the results 
in terms of one particular isoenzyme (more on this particular subject is elaborated in 
Chapter 1). 
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For the purpose of electrochemically-based, biosensor-type, enzyme-modified 
electrodes for drug metabolism studies in particular though, where the focus usually 
is on the study and investigation of the interaction of selected drug(s) with a single 
biorecognition component, hosted within appropriate interfacial carrier matrix, it is 
essential that prepared enzyme constructs be purified and isolated, rather than mixed 
enzyme-constructs or crude preparations, molecular impurities and/or other 
‘unwanted’ (electrochemically active) species will interfere with electron transfer and 
catalytic activity. This may occur by preferencial non-specific binding of impurities 
and/or blocking and fouling the modified electrode, or inadvertently leading to false 
signals which complicates the analysis and interpretation of the observed 
voltammetric result output. For this purpose, genetically engineered, recombinant 
CYP450 construct systems are highly recommended, since such methods can 
generate sufficient quantities of highly purified enzyme preparations, without 
compromising selectivity or activity. Moreover, and perhaps more importantly, these 
enzymes can be  prepared as the heme-domain and surrounding protein, without the 
inclusion of the native electron transfer mediator complex (CPR: NADPH 
cytochrome P450 oxidoreductase) fused to the enzyme, which for the scope of the 
dissertation is absolutely necessary, since the purpose is using the modified electrode, 
with appropriately chosen interfacial enhancers as electron transfer donor, rather than 
the native CPR electron transfer donor system.   
 
 
 
3A.3.2.3  Practical research design aspects and considerations for genetic 
engineering: cloning, purification and expression 
 
From a very broad perspective, protein genetic engineering is generally 
understood to involve the use of site-directed or random mutagenesis to alter the 
properties of a protein or enzyme. In this regard, in terms of the scope of this 
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dissertation, the definition may be extended and tailored to encompass the 
modification of the N-terminal membrane anchor and fusion tagging of recombinant 
cytochrome P450 3A4 to facilitate over expression for the investigation of protein 
targeting with respect to enzyme- substrate interaction [97].  
 
Generally, all human microsomal P450s are essentially membrane bound, unlike their 
bacterial and mitochondrial counterparts, who are soluble and thus confounded to the 
cytosol. In general, the expression of recombinant  (human) full length, wild type 
CYP3A4 in particular, is quite a difficult endeavour, because the enzyme’s 
complicated structural and catalytic requirements, based on its membrane-bound 
nature  causes a combination of constricts. In this regard, firstly, a full length wild 
type CYP3A4 usually expresses at very low levels coupled with equally low activity; 
secondly, when considering the highly hydrophobic character of the enzyme, the host 
cell would require cellular organelles, because the enzyme is essentially membrane-
bound and would preferentially be confounded to the endoplasmic reticulum of the 
host cell. Also important, is the requirement of additional monomerisation methods 
and reagents during application of the prepared enzyme, due to its aggregation prone 
nature. On the other hand, research has shown that CYP3A4 and other microsomal 
P450s contain a sequence of 15-25 amino acids spanning across the N-terminus, 
which provide the major hydrophobic interaction with the endoplasmic reticulum, 
and in this regard, this stretch of amino acids are the major determinant of the 
enzyme’s membrane binding nature. Moreover, and perhaps more importantly, it was 
determined that this particular region does not play an active role the catalytic 
activity, substrate interaction, or electron-donor interaction of the enzyme, and as 
such, its modification holds no potential for damage to the enzyme. The significance 
of latter and aforementioned aspects, are that during preparation of recombinant 
CYP3A4, specific manipulations to this particular region has enabled  the evolution 
of innovative techniques, based on site-directed genetic manipulation, which 
significantly enhanced the preparation of soluble, heterologously expressed enzyme 
constructs that are catalytically active. These methods can include either the 
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truncation of the N-terminal membrane anchor domain, or N-terminal sequence 
modifications, or complete removal of the hydrophobic N-terminal anchors sequence.  
 
 
 
In terms of the practical aspects of the genetic preparation of recombinant CYP3A4 in 
particular, with the overall aim being the preparation of an N-terminally modified 
CYP3A4 construct (nCYP3A4)  the experimental protocol followed should 
provide the highest soluble protein expression, and in this regard  a number of   
requirements and factors needs to be considered and addressed, in order to have a 
successful expression and purification process. These include the following: 
  
 The type of host and the particular host strain which will be used for the 
heterologous expression of the enzyme. Available hosts, which can be used 
include Escherichia coli (E coli), yeast, mammalian cells and insect cells, of 
which, based on financial, time, user friendliness and potential for increased 
protein yield considerations, E-coli are the preferred expression host, of which 
available strains may be. With regard to the particular E-coli strain,  the D5α 
and JM109 strains are known for their increased insert stability and good yield 
and as such, more popular choices.    
 Choosing and obtaining the host (parent) expression vector, with plasmids 
containing the amplified cDNA (complimentary DNA) of the particular 
isoenzyme, as well as promoter elements. Moreover, coding sequences for any 
additional fusion tag components are also cloned into these vectors, and 
overall, the prepared vector is then used to initiate the whole heterologous 
enzyme expression process. 
 The choice of co-expressing charged soluble proteins tags, as fusion adducts, 
which functions to further enhance the soluble yield of the genetically 
prepared recombinant construct, by enhancing the protein targeting expression 
to specific cellular or extracellular compartments, and as such increasing the 
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cytosolic (soluble) expression. In this regard, the placement position of the tag 
plays a significant role. Also important, is that the tags should preferably be of 
a small enough nature, as to not interfere with the correct folding of the 
protein during expression, or enzyme-electron donor interactions during 
catalysis application. The most popular tags which may be used in E. coli 
expression systems are NusA (E coli N-utilisation substance protein A), His 
(polyhistidine, usually His6: containing 6 residues), BMP (maltose binding 
protein), GST (glutathione S-transferase). In this regard, his-tag is the 
preferable choice, since in addition to confirring increased solubility to the 
protein, it has reversible binding ability and a considerable affinity for Ni
2+
, of 
which these attributes can be used to simplify the purification step with N
2+
-
affinity chromatography without denaturing the protein.  
 Investigating/evaluating which prefered specific method to choose for 
modification of the N-terminal region. This is an important aspect, since 
without such modification; the N-terminus of the expressed construct will 
target the protein to be anchored into the inner endoplasmic membrane of the 
host cell, with only the active site facing the cytosol. The overall implications 
of this would obviously be at the cost of the soluble yield of the prepared 
enzyme, which defeats the purpose as it pertains to the scope of this 
dissertation.  
 As CYP3A4 and other human CYP450 enzymes also contain hydrophobic 
amino acids at other regions of the protein, distinct from the N-terminal 
domain, such as areas of the catalytic domain, which is distinct from the N-
terminus, addition of other reagents may be added to further increase the 
soluble yield of the prepared construct. In this regard, the use of detergents, 
particularly non-ionic detergents (at a final concentration of 0.1-0.2% (v/v) 
was shown to be of great benefit.  
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3A.3.3 Enzyme kinetics  
 
Generally, enzymes may be regarded as biological catalysts. In effect, they 
possess active sites that function to bind to the substrate, which essentially leads to 
the catalytic production of product, P. In this regard, enzymes are able to act on 
substrates and produce product with the overall effect of lowering the activation 
energy required for product formation. In a more descriptive context, the theory 
behind enzyme catalysis are all based on the pioneering work of Michaelis and 
Menten, postulated the formation of the enzyme-substrate complex (ES), based on 
their studies regarding the substrate concentration dependence of enzyme reactions 
[98-99]. According to the Michaelis Menten (MM) theory, the rate or velocity () of 
catalysis by enzymes varies with substrate concentration. In this regard, the velocity 
increases with the increase in substrate concentration up to certain point and then 
becomes constant, thus reaching a maximum velocity Vm, as shown in Figure 3A.9.     
 
 
  
 
   
 
 
 
 
 
 
 
 
 
Figure 3A.9 Initial velocity i as a function of substrate concentration [S] for 
enzyme-catalyzed reaction following MichaelisMenten kinetics. 
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According to  the plot of Vi as a function of [S], the following findings is made: 
 At low values of [S], the initial velocity, Vi, rises in a linear fashion in 
association with increasing [S]. 
 However, as [S] increases, the gains Vi level off (forming what looks like a 
rectangular hyperbola). 
 In this regard, the asymptote represents the maximum velocity of the reaction, 
known as Vmax. 
  The substrate concentration that produce a Vi which is one-half of Vmax is 
designated the MM constant, Km.  
With regard to the Km in particular, it is noteworthy to also add that it is an inverse 
measure of the affinity f strength of binding between the enzyme and its substrate. 
This essentially means that the lower the Km, the greater the affinity (thus, the lower 
the concentration of substrate needed to achieve a given rate). Furthermore, the MM 
model further postulates that the ES is temporary and as such,  can either dissociate 
back to E and S or proceed to form a product, P. The interaction, based on the MM 
model is shown in Scheme 1: 
   
                                         3A.20  
          
The maximum rate (Vmax) will be observed when all the enzyme is in the form of the 
ES complex. The kinetics  of the reaction shown in Scheme 1can then be described 
by the fundamental Michaelis-Menten equation, shown as follows: 
  = 
        
     
                     3A.21  
where ν is the initial rate (moles/time), Vmax is the maximum rate of catalysis, Km is 
the apparent Michaelis-Menten constant and [S] is the substrate concentration.  
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3A.3.3.1 Treatment of data  
 
Due to the difficulty of determining the limiting value of specific 
parameters, such as Km directly from the plot of V vs. [S], the MM equation can be 
rearranged in either of three different ways, to yield a linear graphical representation. 
These are known as the LineweaverBurk equation, the Eadie-Hofstee equation or 
the Hanse equation. In this regard, in the first case, Lineweaver and Burk converted 
the MM equation (3A.22) into straight line form by taking the reciprocals of each 
side of the equation and rearranging terms to obtain:  
 
 
 = 
  
  
 [
 
   
]   
 
  
    3A.22   
 
Thus a plot of 
 

 vs 
 
   
 gives a straghtline with a slope of 
  
  
⁄  and a y-intercept of 
 
  
⁄   
 
 
 
 
 
 
 
 
 
Figure 3A.10 Lineweaver-Burk double reciprocal plot of   ⁄  vs 
 
   ⁄  for the 
dependence of enzyme-catalyzed reaction velocity on substrate concentration. 
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3A.3.3.2 Enzyme inhibition  
 
Noncovalent binding of inhibitors can reversibly or irreversibly decrease the activity 
of the enzyme.  This is a particularly eminent factor in the case of CYP450 enzymes, 
which are known to have specific compounds that act as inhibitors of these enzymes.  
 
3A.3.5 Biosensor performance aspects  
 
In the context of the overall scope of this dissertation, the investigation of the 
electrochemical behaviour of the fabricated biosensors is the main theme, and as 
such, an important factor is also the evaluation of the biosensor response with respect 
to performance factors. In effect, the evaluated operating parameters may indicate the 
nature of the rate-limiting steps (e.g. transport or reaction factors), and can facilitate 
biosensor optimisation in a given matrix.  In this regard, a list of parameters are 
denoted and described: 
 
3A.3.5.1 Sensor calibration: sensitivity, working and linear concentration 
range, detection determination limits [52, 57] 
 
Calibration of sensor, from a general perspective is usually done by adding standard 
solutions of the analyte (substrate) and by plotting the (steady-state) responses Rrs, 
possibly corrected for a blank (usually referred to as the background) signal Rbl, 
versus the substrate concentration ([S]). The sensitivity and linear concentration range 
of the calibration curves are then determined by plotting the change in concentration 
(Rrs  Rbl) versus [S]. Thus, in this regard, the sensitivity is determined within the 
linear concentration range of the biosensor calibration curve, obtained from the slope 
of the particular linear plot.   
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Electrochemical biosensors normally have an upper limit of the linear concentration 
range, of which this limit is directly related to the biocatalytic or biocomplexing 
properties of the biochemical or biological recognition component. A noteworthy 
aspect in this regard, is that in the case of enzyme-based biosensors that has an 
additional outer-layer films, the linear dynamics may be larger if the sensor response 
if controlled by the diffusion of substrate through the outer membrane and not by the 
enzyme kinetics. Having said that, the compromise for such an extension will 
obviously be at the cost of sensor sensitivity, with the latter showing an associated 
decrease. Nevertheless, still on the subject of the linear concentration range and upper 
limit, the parameters for Michaelis-Menten kinetics can then subsequently be 
determined, of which, as described in Section 3A3.3, the most notable parameters are 
Km and Vmax. In this regard, whe the Km is much larger than its value for soluble 
enzyme, it signifies that either a significant barrier to the diffusion of substrate is 
present between the sample and the reaction layer, or that the rate of reaction of the 
co-substrate with the enzyme is increased.  
 
On a final note, the limit of detection (LOD) is also of significance, where 
determination of this parameter takes into account the blank and the signal 
fluctuation. The exact method used for determination of the LOD in the context of 
this dissertation is shown in the appropriate section in Chapter 3B. 
 
 
3A.3.5.2 Reproducibility, stability and lifetime 
 
Reproducibility may be described as a measure of the scatter or drift in a series of 
results performed over a period of time. The operational stability of the sensor on the 
other hand, can vary significantly, depending on the method of sensor preparation, the 
applied recognition component and the transducer used. Moreover it is also 
dependent on the response rate limiting factor, and furthermore, it may vary 
considerably depending on the operational conditions. In the case of storage stability 
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assessment, the parameters that requires clear distinction when reporting on this 
parameter, is the state of storage, i.e. dry or wet, the atmosphere composition, which 
usually refers to air, or under inert gas (e.g. nitrogen), pH, buffer composition and the 
presence of additives.   
 
 
 
3B General Experimental: Protocols and Methods of Investigation 
 
 
3B.1  Introduction 
 
This chapter gives a succinct, but detailed overview on the following: 
 Materials: Describing sources and preparative methods for all reagents and raw 
materials as pertaining to the context of the dissertation as a whole. 
 Platform(s) modification methods: In this regard, a general flow diagram of the 
design for each biosensor platform used in the overall research investigation of 
this dissertation is given, with particular reference to highlighting the 
differences in overall preparation. A more in-depth description of the 
modification steps in research design of each enzyme-based biosensor platform 
is given at the end of the relevant results chapters. 
 Morphological and structural characterization methods:  Since the techniques 
used in the characterization methods are common to the dissertation as a whole, 
all morphological and structural characterization methods applied are described 
in terms of relevant preparative methods. 
 Voltammetric instrumentation and techniques: All general methods and 
protocols used in voltammetric investigations are described. 
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It is noteworthy to remind the reader that this dissertation reports on results obtained 
from two different enzyme based biosensor platforms (i.e. biosensor platform 1 and 
biosensor platform 2 ), each based on a distinctly unique design protocol – with 
common features being the mediating species and category of enzyme, i.e. 
microsomal mammalian cytochrome P450 3A4 enzyme. In this regard, the methods 
and techniques described in this chapter serves as a general prelude to coincide with 
obtained results in the context in the relevant forthcoming chapters. However, in 
terms of specific step-wise sequential modifications and protocols applied    at the 
end of each of the results chapters (i.e. Chapter 4, Chapter 5A and Chapter 5B) a 
comprehensive description with relevant subsections pertaining to each procedural 
outline is given. 
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3B.2 Materials and reagents 
 
Table 3.1 shows a list of all general materials and reagents used in the 
course of the  research investigations of this dissertation. All reagents were of 
analytical grade: 
 
Table 3B.1 A complete comprehensive list of all materials used during the 
conduction of this PhD research investigation; listed also are sources 
and specific information 
 
Materials/Reagents Source Information Specific Information 
Milli-Q water 
Milli-Pore filter 
system  
Nafion Sigma Aldrich 
Supplied as a 5% (w/v) 
solution in lower 
aliphatic alcohols; 
Equivalent weight = 
1100 g mol
-1
; wet 
density =0.87 g cm
-3
 
Cobalt(III) sepulchrate 
trichloride Sigma Aldrich 95% purity 
Potassium Ferricyanide 
(K3Fe(CN)6) Sigma Aldrich  
Ruthenium(III) hexaamine 
chloride Sigma Aldrich  
2,4-Dichlorophenol   
Potassium dihydrogen 
phospahate (KH2PO4) Sigma Aldrich 
Analytica grade 99.99% 
Purity 
Quantofix hydroperoxo sticks Sigma Aldrich  
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Low melting point Agarose Hispan agar  
Ethanol   
Methanol Merck HPCL grade 
Carbon monoxide Specialty Gases 99% Pur, gas form 
Oxygen Specialty Gases 99+% Pure, gas  
Erythromycin Sigma Aldrich 916 g mg-1 
Quinidine hydrochloride 
monohydrate Sigma Aldrich  
Glutaraldehyde Sigma Aldrich 
Supplied as 25% (v/v) 
stock 
Polyvinyl alcohol (PVA)   
Indinavir Crixivan 
Supplied as tablets 
containing 400mg 
indinavir sulphate 
Polyethylene diamine (PEI) Sigma Aldrich  
Eastman AQ (EAQ)-55 Eastman Supplied as pellets 
L-glutamic acid Sigma Aldrich 99.5% 
L-asparagine anhhydrous Sigma Aldrich 99.5%  
Bovine liver catalase Sigma Aldrich  
Full-legth wild type CYP3A4 Merck South Africa  
Glassy Carbon Basi 
Teflon shrouded; 
geometrical area = 
0.071cm
2
 
Reagents and materials for Electrolyte buffer media 
Sodium phosphate buffer 
solution (PBS) 
Na2HPO4, NaH2PO4 H2O (Sigma Alrdich) 
Prepared as 50 mM solution (pH7.4) 
Sodium phosphate buffer saline 
(PBL) 
Na2HPO4, NaH2PO4 H2O Prepared as 50 mM 
solution containing 100 mM KCl (pH 7.4) 
Materials for enzyme expression and purification of N-terminally modified 
CYP34 
CYP3A4  Parent vector 
pBJW102.2 and 
PMD004 UK 
Ampicilin (Amp)   
Glycerol Sigma Aldrich  
-aminolevolunic acid (ALA)   
MgCl2 Sigma Aldrich  
   
Detergents: Igepal CA-3600, 
{3-[(3-
cholamidopropyl)dimethylammoni
o-1-propanesulphonate} (CHAPS), 
Triton X-100   
PD-10 Columns GE Healthcare,  
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USA 
Polyhistidine (His6)  As soluble his tagg 
Ni-TED resin 
Macherey-Nagel, 
Germany  
Centriprep YM-10 columns Millipore, Island  
Milli-Q water   
Zeba column Pierce, USA  
Bovine serum albumin (BSA) Sigma Aldrich  
Bio-Rad protein assay dye Bio-Rad, USA 
Based on Bradford 
assay 
DNase I 
New England 
Biolabs 500 Units supply stock 
Mercapto ethanol  Sigma Aldrich  
Thiamine   
Isopropyl thiogalactose pyranoside 
(IPTG)   
Glycerol stock  
It consist of the E-Coli cells containing the plasmid with 
the enzyme DNA-sequence . (Stored at -80 °C) 
Lysis buffer, pH 7.4 
Constituents:  K2HPO4 & KH2PO4 (20 mM), glycerol 
(20%, v/v), -mercaptoethanol (10 mM) 
Terrific broth Constituents (per litre of solution): K2HPO4 (2.31g) & 
KH2PO4 (12.54g), yeast extract (24g), tryptone (12g), 
glycerol (4 ml) 
Phosphate buffer saline Constituents: Na2HPO4 H2O, KH2PO4, NaCl, KCl 
10 x phosphate buffer 
saline (PBL) pH 7.4  
Constuents: K2HPO4 2H2O (4.3 mM), NaCl (147 mM), 
KCl (2.7 mM), KH2PO4 (1.8 mM)  
Trace elements (per 
100 mL) 
Constuents: FeCl3 6H2O (2.7g), ZnCl 4H2O (0.2g), 
CoCl2 6H2O (0.2g), Na2MoO4 2H2O, CaCl2 2H2O 
(0.13g), H3BO3 (0.05g), CuCl2 6H2O (0.1g), conc. HCl 
(10 ml) 
Luria Bertani media 
(LB) 
Constuents (per 500 mL stock): tryptone (5 g); yeast 
extract (2.5 g); NaCl (2.5 g) 
 
Purified nCYP3A4 
storage buffer: 100 mM 
potassium phosphate 
buffer storage solution 
(KPBST): pH 7.4 
Constituents: K2HPO4 2H2O and KH2PO4 (100 mM); 
20% glycerol (v/v); 0.2 mM EDTA; 1 mM DTT 
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3B.2.2 Solutions 
 
All chemical solutions were prepared using ultra pure water obtained from 
a Milli-Q Water System (Millipore Corp., Bedford, MA, USA). 
 
 
3B.2.2.1 Preparation of electrolyte buffer solutions 
  
All biosensor investigations done throughout the course of the research 
investigaions were conducted in aqueous solutions, with phosphate buffer as 
supporting electrolyte. In this regard, 50 mM sodium phosphate buffer (pH 7.45), 
containing  AnalaR grade Na2HPO4, NaH2PO4 was prepared with milli-Q water. 
These electrolyte buffers, prepared without the addition of the inorganic salt, KCl are 
referred to as phosphate buffer solutions (i.e. PBS). On the other hand, saline 
phosphate buffer solutions, prepared as above, but with the inclusion of 100 mM KCl 
is denoted as PBL.   Generally, all electrochemically-based voltammetric experiments 
conducted with control and enzyme-based biosensors were either conducted in PBL 
or PBS. In this regard, the author specifically specifies the type of electrolyte used 
when describing the various experimental protocols. 
 
 
 
3B2.2.2 Preparation of redox probes 
 
1 mM hexaamine ruthenium(III) chloride working solution was prepared in 
100 mM aqueous KCl solution, by dissolving the appropriate mass in the KCl 
solution in a suitably calibrated volumetric flask. In addition to this, the Ferricyanide 
[K3Fe(CN)6] redox probe was prepared as a 1mM working solution in an aqueous 
KCl solution, by dissolving the appropriate amount in a calibrated volumetric flask 
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3B.2.2.3 Preparation of working solutions for casting components for 
biosensor platform 1 and biosensor platform 2  
 
3B.2.2.3.1 Preparation of Nafion casting solution 
 
1% nafion solution (v/v) was prepared by diluting the appropriate volume 
of a 5% nafion

 stock [supplied as a 5% solution (w/v) in lower aliphatic alcohols] 
with milli-Q water in a calibrated volumetric flask. The pH of the so prepared nafion 
solution was adjusted to prepare a working solution of pH 7.45. This was done by 
adding approximately 2-3 drops of  a previously prepared pH 12.0  potassium 
phosphate buffer solution (of concentration 100 mM), with intermediate pH 
measurements until the desired pH of 7.45 was obtained. The final nafion solution, 
was then subsequently used for casting. Care was taken not to store the nafion casting 
solutions for long periods, since evaporation of alcohol may change the 
concentration, as well as precipitation reactions that may take place.  
 
 
3B.2.2.3.2  Preparation of electrolyte solution of cobalt(III) sepulchrate 
species for electrodeposition (for preparation of biosensor 
platform 2 ) 
1 mM Cobalt(III) sepulchrate [Co(Sep)
3+
] was prepared as an aqueous 
buffered saline saline solution, by dissolving the appropriate amount of cobalt(III) 
sepulchrate trichloride  in 100 mM potassium phosphate buffer (pH 7.45, containing 
100 mM KCl)  in a calibrated volumetric flask. The prepared electrolyte solution was 
then subsequently used for the formation of the nafion-El-Co(Sep)
3+
 carrier matrix, as 
well as for the preparation of the nCYP3A4-based biosensor platform. 
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3B.2.2.3.3 Preparation of Eastman-AQ casting aqueous dispersion 
A EAQ concentrated aqueous dispersion (15%, w/v) stock was prepared 
according established methods [100-101]. In this regard, stock was prepared by 
treating the appropriate amount of as obtained Eastman-AQ 55 in H2O at 45  °C, 
under vigorous stirring, until a transparent, colourless and homogeneous phase was 
obtained. A 3% EAQ working aqueous dispersion was then subsequently prepared by 
appropriate dilution of the stock. When required, the 3% solution was used for 
casting during biosensor construction, but before use, the aqueous dispersion was 
always sonicated for  at least  20 min, to obtain a smooth consistency for better film 
preparation. 
 
 
 
3B2.2.3.4 Preparation of 1% agarose (w/v)  
 
The preparation for the agarose working solution was done according to 
standard methods [102]. In this regard, 100 mL Milli-Q water was brought to boiling 
point on a temperature controlled hotplate, equipped with an inbuilt magnetic stirrer. 
The appropriate amount of low melting agarose was then weighed out, after which 
the agarose powder was very slowly added to the boiling water. This was done while 
vigorously stirring  the solution, and after all the agarose was added, the solution was 
stirred at the same temperature until complete dissolving of the agarose, at which 
point a solution with a clear consistency was obtained. The formed agarose solution 
was then removed from the heat and stored at 4 C when not in use. It is noteworthy 
to add that working solutions of agarose was strictly only used for a maximum of two 
or three times, after which fresh solutions were prepared. 
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3B.2.2.3.5 Preparation of aqueous poly(vinyl alcohol) solution 
 
A concentrated stock solution of PVA was prepared according to standard 
methods [103]. Milli-Q water was heated to 70 C on a thermostated hotplate, after 
which an appropriate amount of PVA was slowly added to obtain a final stock 
concentration of 25% (w/v). The addition was done with vigorous stirring and the 
stirring was continued until complete dissolution of the PVA, at which time a clear 
colourless solution was obtained. The next step, involved the preparation of the 
working solution of PVA, which was subsequently used in the casting outer-layer 
composite solution preparation. In this regard, a 5% PVA solution in 0.1 M potassium 
phosphate buffer (pH 7.4) was prepared by appropriate dilution of the 25% stock.    
 
 
3B.2.2.3.6 Preparation of aqueous polyethyleneimine solution  
A working solution of PEI was prepared by dissolving 2 g of PEI in 20 mL of 0.1 M 
potassium phosphate buffer solution. The solution was thoroughly mixed and stored 
at room temperature until required.  
 
 
3B.2.2.3.6 Preparation of outer-film polymer blend casting solution for 
biosensor platform 2  (Results and discussion: Chapter 5B)    
 
Equal volumes of the 5% PVA working solution and  the 1% agrs solution 
placed in a pre-heated eppendorf tube and blended together by hand-mixing. The so-
formed solution may be referred to as solution A. Following this, a volume of the 
prepared PEI solution was added to solution A, such that the final ratio of PEI to 
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PVA-Agrs (PEI:PVA-Agrs) was  0.2 : 1. This solution was then subsequently used for 
casting. 
 
 
 
3B.2.2.4.3 Preparation of Indinavir stock and working solutions 
 
1 Capsule of indinavir, as obtained from the manufacturers was opened up 
and placed in a 25 mL volumetric flask, made up to the mark with 50 mM sodium 
phosphate buffer solution. The active ingredient was attracted and undissolved 
components removed by filtering the formed suspension through a Whatman 
polytetrfluoroethylene syringe filter (pore size 0.3 m) into a clean glass storage 
bottle. The so prepared indinavir solution had a concentration of 28,095 M of 
indinavir sulphate. This solution was then used as stock indinavir solution, from 
which all other working solutions were prepared, by making the appropriate dilutions 
with 50 mM sodium phosphate buffer.  
 
3B.3  Voltametric investigations 
 
3B.3.1 Instrumentation, apparatus and general procedures 
 
Generally, all of the voltammetric experiments in this dissertation were 
conducted in a 20 mL volume capacity glass electrochemical cell containing the 
required volume of supporting electrolyte and a conventional three electrode system, 
consisting of a glassy carbon working electrode (GCE, 0.33 cm diameter), a Ag/AgCl  
(3 M NaCl) as pseudo reference electrode, and a platinum wire as counter electrode 
(CE). Unless otherwise stated, all experiments conducted in the three-electrode 
electrochemical cells were done at at 25 ºC. 
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All voltammetric experiments and measurements, including cyclic voltammetric 
(CV), Osteryoung square wave voltammetry (OSWV) and differential pulse 
voltammetric (DPV) measurements were obtained with a BioAnalytical System 
(BAS) 100 B/W Electrochemical Workstation. During substrate interaction 
experiments, conducted with OSWV, convective transport during measurements was 
achieved with the use of a magnetic stirrer bar, and stirring was done at 
predetermined rate. 
 
 
3B.3.1.1 Pre-treatment of the glassy-carbon working electrode 
 
Prior to all electrochemical investigations, all working electrodes 
(modified and unmodified) were activated by following a specific protocol in 
accordance with selected literature procedures  modified and customized for the 
requirements of the practical aspects of the current dissertation. Generally, this 
entailed the polishing of the GCE with 3 μm diamond paste for 1 min, followed by 
rinsing with methanol and water, respectively. The polished electrode was then 
ultrasonicated for 2 min. Then the electrode was polished consecutively, with 
aqueous slurries of 1.0, 0.3 and 0.05 μm alumina, for 1 min on a microcloth pad 
(Buehler). Residual polishing material was removed by ultrasonication for 3 min after 
each polishing step. Finally, the pre-treated GCE was sonicated in absolute ethanol 
for 2–3 min, rinsed with water, dried for 5min and immediately used. Surface 
cleanliness and electro-analytical reproducibility was always verified for all cleaned 
electrodes by standardization and calibration with ‘universal’ redox probe, 1mM 
Fe(CN)6
3−
, and known standard solutions. It is also noteworthy to add that, when 
additional cleaning or polishing of the surfaces were required,  a more vigorous 
cleaning was done with diamond paste polishing kit, by following the same general 
procedure as described above.  
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3B.4 Specific methods for important calculations of electrochemical 
parameters 
 
 
 
3B.4.1 Determination of film thickness 
 
 
 
In the context of this dissertation, the approach for the determination of 
film thickness  was based on taking into consideration the volume of the drop of 
nafion-solution, the density of the Nafion® solution and the area of the electrode, 
according to the following equation [104-105]: 
 h = ν/s =   /    x S = mdrop x ω/    x S    3B-1 
where h is the thickness of the film, ν is the volume of the solution applied to the 
surface of the electrode,      is the denisty of the nafion (g cm
-3
), ω is the fractional 
concentration of nafion in the solution,    is the calculated mass of nafion, and S is 
the surface area of the electrode.  
 
 
3B.5 Complimentary ex-situ characterisation analysis 
 
 
3B.5.1 Scanning Electron Microscopy (SEM)  
 
Scanning electron microscopy was used to characterize the morphology of 
the prepared films, including the following: 
 the unmodified nafion film prepared for each biosensor platform; 
 the naf-CME-Co(Sep)3+ composite film; 
  the naf-El-Co(Sep)3+ 
The SEM images were captured with an Hitachi X-650 analyzer employing the 
secondary electron (SE) mode with interchangeable accelerating voltages of 25 
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kV electron  microscope  All samples prepared for SEM characterization were 
adequately dried before analysis. Screen printed carbon electrodes were used for 
preparation of films for SEM analysis. The modified electrodes were fixed onto a 
SEM mounting stage with low resistance carbon transfer adhesive. For cross-
sectional views, electrodes were fractured with a sharp surgical blade. Prior to 
SEM analysis, each sample was gold-coated with a Polaron sputter coater. As a 
control, for comparison purposes, a blank screen printed electrode was always 
analysed in addition to the modified electrodes. 
 
 
3B.5.2 Fourier Transform Infrared Spectroscopy (FTIR) 
 
 
All the FTIR spectra of samples were recorded on a PerkinElmer Spectrum 
100, FT-IR spectrometer. All FTIR spectra recordings were done with small amount 
of dried, or wet samples without KBR mixing. Moreover, all spectra were obtained 
against the air background spectrum. With regard to the specific methods used: In the 
case of the spectral analysis for the prepared films, the samples were first prepared on 
the electrode surface, following the specific procedures for the particular platform (as 
outlined in the methodology section of the relevant results chapters), after which the 
samples were gently scraped off the surface, followed by desiccator drying. The dried 
samples were then used for recording of the spectra, as shown in Figure 3B.1. In the 
case of FTIR spectral analysis for the enzyme solutions on the other hand, the wet 
samples were used, as described in the experimental section of the relevant results 
chapter. 
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Figure 3B.1 Showing method of FTIR analysis with high-pressure anvil cell for 
dry samples 
 
 
3B.5.3 UV-Vis Absorption Spectroscopy 
 
All UV-Vis absorption spectroscopic analysis were done with a Nicolet-    
Evolution UV-visible scanning spectrophotometer (Thermo Electron Corporation, 
UK) using 1-cm path length quartz cells. The exact protocols followed for the 
specific analysis experiments are discussed in the Experimental outline of the relevant 
results chapter. 
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CHAPTER 4 
 
 
 
RESULTS AND DISCUSSION: Biosensor Platform 1 
 
 
 
 
 
Chapter Prelude 
The results presented in the current chapter were published in Electrochimica Acta, 
2009, 54, 1925-1931. In the context of the dissertation as a whole, the biosensor 
platform presented and discussed in this chapter, serves as a potrayel of an initial 
attempt in the creation of a reagentless biosensor mediated by the electroactive cage-
type mediating species, cobalt(III) sepulchrate, in which the mediator was integrated 
into the reagent layer. Generally,  this initial  approach was more ‘unrefined’, 
consisting of casting and mixing was applied in creating this particular biosensor 
platform  the main focus here was to observe the electrocatalytic behaviour of the 
of the immobilized enzyme with its co-substrate (molecular oxygen) and selected 
substrates. This could also be done, since the commercially sourced, wild type, full-
length CYP450 3A4 used on the current platform, is more stable than their N-
terminally modified genetically engineered counter-parts, which was used as 
recognition component in the  platform presented and discussed in Chapter 5A and B. 
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CHAPTER 4 
 
Microsomal cytochrome P450-3A4 (CYP3A4) biosensor for the 
determination of 2,4-dichlorophenol — An endocrine disruptor 
compound 
 
 
Abstract 
Cytochrome P450-3A4 (CYP3A4) is a monooxygenase enzyme that plays a major 
role in the detoxification of bioactive compounds and hydrophobic xenobiotics (e.g. 
medicines, drugs, environmental pollutants, food supplements and steroids). A unique 
CYP3A4 biosensor system that essentially simplified the enzymatic redox processes 
by allowing electron transfer between the electrode and the enzyme redox centre to 
occur, without any need for the enzyme’s natural physiological redox partners, was 
developed and tested with respect to analyte detection, by using  2,4-dichlorophenol 
(2,4-DCP), a priority environmental pollutant and an endocrine disruptor as substrate. 
The biosensor, GCE||NafCMECo(Sep)3+|flCYP3A4|Naf, was constructed by 
entrapping commercially obtained wild type full length cytochrome P450 3A4 
(flCYP3A4) on a pre-formed electroactive carrier matrix, consisting of a Cobalt(III) 
sepulchrate-modified nafion membrane on a glassy carbon (GC) electrode. The 
responses of the biosensor to 2,4-dichlorophenol, erythromycin (CYP3A4 native 
substrate) and ketoconazole (CYP 3A4 natural inhibitor) were studied by cyclic and 
square wave voltammetric techniques. The detection limit (DL) of the biosensor for 
2,4-dichlorophenol was 0.043 gL−1, which is by an order of magnitude lower than 
the EU limit (0.3 gL−1) for any pesticide compound in ground water. The 
biosensor’s DL is lower than the U.S. Environmental Protection Agency’s drinking 
water equivalent level (DWEL) value for 2,4-DCP, which is 2 gL−1. 
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4.1 Introduction 
 
The pervasiveness and incapacitatingly negative impact of 2,4-dichlorophenol (2,4-
DCP) both on the environment (particularly our waterways), as well as on human 
beings are well known and exhaustively documented in many peer reviewed literature 
[32-36, 41, 44]. Most of these aspects were already discussed in Chapter 1, Section 
1.2.3, and as such need not be elaborated on in its entirety this time. However, it will 
be said, that in terms of the multiple catastrophic effects of this pollutant, it is the 
endocrine disrupting properties that poses the biggest threat, affecting not only the 
exposed person, but also their generational offspring [32]. Overall, with regard to 
curbing the effects of 2,4-DCP, safety limits have been set, as 50 – 100µgL−1, 1 – 
5µgL
−1
 and 100 – 500ngL−1 for river water, pre-treatment potable water and drinking 
water, respectively (WHO, EPA, EU). Conventional analytical methods, used for 
determination of 2,4-DCP and other chlorophenols indeed have high accuracy  
obtaining detection limits ranging from 0.01 to 0.5 μg L−1, and linearity of up to 2–3 
orders of magnitude [32], but all fall short in terms of the requirement of extensive 
sample preparation and time-consuming pre-concentration steps. Moreover, onsite 
real-time measurements are out of the question. In contrast, it is known that biosensor 
devices based on electrochemical principles can offer analytical solutions with low 
cost, simplicity and fast sample throughputs, while being suitable for on-the-spot 
testing of environmental samples [53-54, 106]. The biosensors reported so far for the 
determination of chlorinated phenols are mostly based on indirect recognition of the 
analyte, and rely on the inhibition of enzymes such as horseradish peroxidase, 
tyrosinase or cholinesterase immobilized over an electrode surface [32, 43, 107]. This 
preference may be due to limitations in the availability of oxido-reductase enzymes 
which can act on these pollutants. Nevertheless, biosensors based on enzyme catalysis 
would operate on “signal-on” transduction basis and, thus, possess better detection 
limits. Amongst the possible enzyme ‘candidates’, the cytochrome P450 iso-enzyme, 
CYP3A4, is the most catalytically versatile, having the ability to catalyze the 
oxidative metabolism of various lipophilic xenobiotic compounds which includes 
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chlorophenols, pesticides, carcinogens, etc. [3, 64, 66, 108] and thus can be used for 
the development of non-inhibition based biosensor for these pollutants. In fact, based 
on the ability of CYP3A4 and many other microsomal CYP450s to break down  
highly toxic hydrophobic compounds to harmless water soluble products, such as 
aromatic hydrocarbons, afflatoxins, etc., their proposed future significance in 
industrial applications have long been predicted [109]. Notwithstanding all these 
factors, to this end, no biosensors have been reported for 2,4-DCP and/or other 
chlorophenols using CYP3A4 as the enzymatic recognition component. Nevertheless, 
in considering such an endeavor, based on the unique and highly complex nature of 
CYP3A4 enzymes, very versatile and innovative electron transfer mechanisms is 
required support this membrane bound, microsomal mammalian heme thiolate protein 
chemistry – the overall challenge being designing a system that has a good electrode-
enzyme electronic coupling that, in turn, would drive catalytic turnover at relatively 
high rates. In this regard, the integration of a mediator into the reagent layer has 
proven highly beneficial in functioning as electron transfer shuttle to and from the 
deeply buried enzyme active site. Amongst available mediating species, with specific 
reference to microsomal CYP450 enzymes, cobalt(III) sepulchrate [(Co(Sep)
3+
] is 
shown to be the better choice. 
 
In this study, firstly, wild type full-length CYP3A4 was monomerized through 
treatment with nonionic 3-[(3-chlolamidopropyl)dimethylammonio]-1-
propanesulphonate (CHAPS), which prevented aggregation of the enzyme units and 
enabled simplified casting of the enzyme. The biosensor was constructed by 
immobilizing the enzyme on a carrier matrix consisting of a nafion-cobalt (III) 
sepulchrate composite film. The choice of nafion as base matrix, was due to the 
multifaceted inherent features of the ionomer, including its unique cation pre-
concentration ability that is distinct from most other ionic polymers and conventional 
ion exchanges, its high chemical stability, as well as its microscopic 
hydrophobic/hydrophilic phase segregation. These qualities was applied to firstly 
extract and stably pre-concentrated the mediating species in the overall carrier matrix, 
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while secondly providing the suitable platform in which the immobilized flCYP3A4 
could interact with the pseudo-donor electron platform through its required   
hydrophobic/hydrophilic interactions that it normally use in native in-vitro and in-
vivo systems. In order to re-enforce the stability of the reagent-layer film and protect 
the underlying components, an additional thin layer of nafion was used as outer film 
throughout all experimental investigations. 
 
 
4.2  Morphological and structural characterization of the nafion-
CMECo(Sep)
3+
 film (carrier matrix) formed on the GCE [GCE 
(GCEnafCMECo(Sep)3+] 
 
Before the application of the carrier matrix in the fabrication of the 
flCYP3A4-based biosensor, some morphological and structural analysis of the 
formed film was done. In this regard, morphological studies were done through 
Scanning Electron Microscopic (SEM) analysis, while the structural analysis of the 
films was done with Fourier Transform Infrared (FTIR) Spectroscopy. 
 
 
 
4.2.1 Morphological characterization: Scanning Electron Microscopy (SEM) 
 
Figure 4.1 a  c shows the top sectional view of the blank, un-modified 
electrode (bl-E), the nafion-modified electrode, as well as the nafion-modified 
electrode containing the incorporated Co(Sep)
3+
 species. The nafion film displays 
more of an island-type feature, containing random void-type areas, thus overall not 
does not really have a smooth consistency. This may probably be due to the argon 
flow used during the drying of the nafion film, which could have possibly slightly 
perturbed the nafion during film formation. On the other hand, one must bear in mind 
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that nafion is known for its high chemical stability and in this regard, is still expected 
to provide an acceptable inner-film for the incorporation and/or immobilization of the 
other reagent-layer constituents. Moreover, according to documented literature, actual 
decomposition of a nafion film is signified by visible pore holes which is evident in 
cross-sectional views [110]. In this regard, the cross sectional images taken of the 
formed film, exhibited an intact film, devoid of any such pores. The Co(Sep)
3+
-
modified nafion film, of which the SEM image is shown in Figure (c) also exhibits 
an island-like film, which does not really have a smooth consistency , but rather 
resembles a ‘cauliflower-type’ surface.     
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Figure 4.1 Top scanning electrochemical image of electrode (a) blank electrode (bl-
E); (b) nafion modified electrode (Naf-E); (c) Naf-E with pre-concentrated Co(Sep)
3+
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4.2.2 Structural characterization: Fourier Transform Infrared (FTIR) 
Spectroscopy  
 
Figure 4.2 a  c exhibits the FTIR spectra of the  nafion membrane, 
commercially attained pure cobalt(III) sepulchrate trichloride, and the chemically  
prepared nafCMECo(Sep)3+ composite film, respectively. In this regard it shows the 
structural features, exhibited as vibrational fingerprints, associated with each 
component within an analyzed film. The assignment of vibrational bands thus assists 
in identification of species. In terms of the nafion membrane, in particular, shown in 
Spectra a, characteristic bands associated with the structure of pure nafion, identified 
as the CF2 assymetric stretching (1207 cm
-1
), CF2 symmetric stretching (11490 cm
-1
), 
S-O symmetric stretching (1058 cm
-1
), C-O-C stretching (981, 862 cm
-1
), and C-F 
stretching (630 cm
-1
) are shown and appropriately highlighted [110-114]. With regard 
to the pure un-modified cobalt(III) sepulchrate [Co(Sep)
3+
], shown in Spectra b, the 
exhibited absorption bands, associated with the associated with methylene groups 
(733, 834, 2850, 3034 cm
-1
), and secondary amines (1055, 1130, 1168, 1335, 1366, 
1444, 3415, 3520 cm
-1
) are in fact characteristic functional groups in the structure of 
of Co(Sep)
3+
 [115], and as such, may be regarded as an efficient fingerprint 
identification of the unique structural features of the compound. With regard to the 
chemically prepared nafion-Co(Sep)
3+
 composite film on the other hand, shown in 
Spectra c, from a general perspective, most of the characteristic fingerprint bands 
associated with the structural features of nafion can be seen. However, closer 
evaluation of the spectra revealed the presence of new vibrational bands, as well as 
slight positional shifts in some of the original bands as seen in Spectra a. 
Cumulatively, these observations of course suggest the modification of the 
microstructure of nafion, which in the current case is due to the pre-concentration of 
the chemically deposited Co(Sep)
3+
 within the pre-formed nafion membrane. Thus 
appropriately, the changes in vibrational absorption bands associated with the 
incorporation of the Co(Sep)
3+
 have been indicated by coloured arrows on the 
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spectrum, with the likely functional group involved in the change also suitably 
marked on Spectra b. In this regard, in the modified nafion membrane, the appearance 
of vibrational band located at 854 cm
-1
 (indicated by the magenta colour arrow) may 
be ascribed to methylene groups associated with the Co(Sep)
3+
 structure. Moreover, 
the appearance of bands in association with secondary amines, located at 1240 and 
1462 cm
-1
, (indicated by the blue and green arrows, respectively) also signify the 
presence of Co(Sep)
3+
 within the nafion membrane. Also, it is notable that the peaks 
centred at 2892- and 2997 cm
-1
, associated with methylene functional groups of the 
Co(Sep)
3+
 structure. Interestingly, it is noteworthy that the water content of the 
modified nafion membrane, signified by the broad peak for stretching vibration of 
water molecules centred at between  2630 – 3740 cm-1, is still very high, as 
compared to the untreated nafion membrane. On the one hand, to some extent, this 
phenomenon may be partly ascribed to the blending vibration of molecularly 
adsorbed water in the membrane [116]. On the other hand, since the Co(Sep)
3+
 was 
manually casted and allowed to mix with the pre-formed nafion membrane, which in 
itslf is known to contain an appreciable amount of water molecules, which functions 
as plasticizer around the sulphonic cluster region [117]   this could indicate that 
while some of the Co(Sep)
3+
 molecules were indeed taken up within the lower density 
ionic cluster phase, some were probably still concentrated near the surface of the bulk 
polymer phase. The reasoning for the school of thought here is based on the fact that 
from a general perspective, the water of hydration contained within the nafion is 
normally reduced in direct association with the increase in the uptake of the amount 
of counter ions, particularly in the case of counter ion species which contains 
hydrophobic ligands, such as is the case with Co(Sep)
3+
 [117-118]. Nevertheless, 
overall, the results shown in the FTIR spectra does indeed confirm the existence of 
the electroactive Co(Sep)
3+
 mediating species in the nafion membrane, which of 
course is the more important factor. Moreover, due to nafion’s unique method of 
extraction of cationic species that, as described in Chapter 2, Section  is quite distinct 
from other ionic polymers and/or conventional cation exchangers, and as such, is 
known to stably retain these species for much longer time frames [119]. (More on the 
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subject of the aforementioned aspects surrounding the water molecules etc., is 
comprehensively discussed in Chapter 5A.)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Fourier Transform Infrared Spectroscopic (FTIR) spectra of (a) un-
modified nafion membrane; (b) commercially obtained, pure cobalt (III) sepulchrate 
only; the nafion membrane modified with the chemically deposited Naf-Co(Sep)
3+
-
composite film nafCMECo(Sep)3+) 
 
 
 
On a final note, regarding the latter and afore-showed characterization results: 
Although the morphology of the formed films were not exactly visually ideal, the 
structural analysis of the formed films still showed the presence of the expected 
functional groups and as such, the method of preparation may be regarded as 
acceptable.  
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4.3 Voltammetric characterization of the modified electrode 
 
Before commencing with the electrochemical results, it is noteworthy to bring 
to the reader’s attention that to reinforce the stability of the carrier matrix and/or 
enzyme-based reagent layer, a thin layer of nafion film was used as outer film.   
   
 
 
4.3.1  Electrode Assembly  
 
In order to ascertain whether the proposed electroactive compound, i.e., 
Co(Sep)
3+
, can effectively function as mediating species within the flCYP3A4-
derivatized biosensor  platform, background studies first have to be conducted. The 
specific aim here being  the determination of whether the mediator exhibits a redox 
response at a sufficiently negative potential to be able to, in turn, reduce the enzyme 
ferric iron (Fe
3+
) for the initiation of its catalytic reaction cycle and concomitant 
electrocatalytic interaction with its co-substrate, molecular oxygen, and/or selected 
analytes (substrates) [74, 120].   The results for these studies are shown in Figure 4.1. 
In particular, Figure 4.1 shows the cyclic voltammogram of 1 mM cobalt sepulchrate 
on a bare GCE working electrode performed at 10mVs
−1
 in argon-degassed PBL. The 
voltammogram exhibited a cathodic peak (Ep,c = −640mV/Ag/AgCl, Ip,c =−3.74µA) 
and an anodic peak (Ep,a = −579, Ip,a = 3.54µA). Moreover, both the cathodic and 
anodic waves consisted of one peak each,  which is indicative of only one redox 
species, and can thus be ascribed to the  metal-centred, one-electron process due to 
Co
3+
/Co
2+
 with a E determined as  610 (± 10) mV. The peak separation (ΔEp) value 
was 61mV±3mV, whereas the Ip,a/Ip,c value was 0.95±0.05µA. In this regard, in terms 
of theoretically based values,  the aforementioned  ΔEp and Ip,a/Ip,c values are well 
within the range for fast diffusion controlled reversible one electron cyclic 
voltammetric processes (i.e. ΔEp = 59 and Ip,a/Ipc = 1) [74, 121] and as such, imply 
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rapid electron transfer . In addition to this, the inset in Figure 4.1 exhibits the square 
wave response the GCE in the 1 mM Co(Sep)
3+
, shown as the difference square 
wave,  for which a signal was obtained at -640 ±5 mV.  In this regard, as compared to 
the E obtained for the CV, there is approximately 30 mV difference between the 
values obtained from the two respective voltammetric techniques. However,  as 
explained in Chapter 3A, Section 3A.2.1.2.1, square wave voltammetry is eminent 
for its lower signal-to-noise ratio and as such, variation  in obtained results from the 
two techniques are indeed expected. Nevertheless, in terms of specific assessment, 
both of these values are sufficiently cathodic, to   be able to, in turn, reduce the 
enzyme heme ferric ion (Fe
3+
) to its active Fe
2+
 form for its electro-catalytic function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Cyclic voltammogram of bare GCE in phosphate buffer saline (PBL, 
pH 7.4) containing 1 mM Co(Sep)
3+
. Inset shows the square wave (SW) voltammetric 
response of the GCE in 1 mM Co(Sep)
3+
, exhibited as the difference SW. 
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The stepwise modification of the GCE was monitored by electrochemical studies in 
order to investigate the variation in the voltammetric characteristics in association 
with the progression from the nafion-modified GCE, to the reagentless, mediator-
containing flCYP3A4-derivatized biosensor platform 
(GCnafCMECo(Sep)3+flCYP3A4naf). A major main aim here, was also to confirm 
electron flow from the electrode to the flCYP3A4 via the( nafion pre-concentrated) 
Co(Sep)
3+
 mediator. In this regard, Figure 4.4(a) shows the cyclic voltammograms of 
the nafion-modified GCE (GCEnaf) and the Co(Sep)3+-entrapped nafion film 
(GCEnafCo(Sep)3+). In addition to this, the difference SW voltammogram of the 
GCEnafCo(Sep)3+  is shown in Figure 4.4(b). With regard to evaluation of the CVs 
exhibited in Figure 4.4(a), the nafion-modified electrode did not exhibit any 
discernable electrochemistry. Essentially, this is not an unexpected phenomenon, 
since nafion is not itself electroactive but due to its unusually high ion-exchange 
ability and/or affinity for large (hydrophobic) cations it may be used to pre-
concentrate [52, 122], or simply physically absorb electroactive cationic molecules in 
a thin membrane-layer, onto a suitable electrode, as is the case in the current study. 
This usually done by contacting a pre-formed nafion film with an aqueous solution 
containing the specific counter ion species, in accordance wih the following equation 
[52]: 
 C
n+
 (aq) + Naf
+
 (film)   C n+ (film) + nNa+ (aq)    4.1 
On the other hand, in biosensor preparation in particular, based on its unique physical 
and structural characteristics,  nafion may be used as an electrode coating for the 
stable incorporation and immobilization of biomolecules, while simultaneously 
preventing biofouling [52, 122-123]. Considering aforementioned characteristics of 
nafion with regard to its superior counter-ion pre-concentration ability, it is thus not 
surprising that in the CV for the GCNafCMECo(Sep)3+ electrode, a pair of well 
defined symmetrically shaped redox peaks can be observed. In terms of the context of 
the current research investigation, the peaks can be ascribed to the reversible one 
electron transfer reaction of the metal-centred surface-confined redox species 
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Co(Sep)
3+
/Co(Sep)
2+
 and as such, also exhibits fast electron tunnelling process 
through the Nafion layer, to and from the underlying GCE. Closer evaulation of the 
redox couple showed that they consist of cathodic peak (Ep,c = −609 mV (vs 
Ag/AgCl),  Ip,c = −1.048 μA) and an anodic peak (Ep,a = −534 mV (vs Ag/AgCl), Ip,a 
= 0.848 μA) with a midpoint potential, Em of −571 ±5 mV. Compared to the 
electrochemistry of Co(Sep)
3+
 on bare GCE, GCNaf-Co(Sep)3+ showed a decrease in 
the magnitude of the Ip,c and Ip,a and an anodic shift in the Ep,a value by approximately 
23mV. Interestingly, in previously documented literature, other researchers report a 
cathodic potential shift in the Em value of GCNaf-Co(Sep)
3+
 as compared to that 
observed for the bare elecrode [124].In this regard, unlike the physical casting/mixing 
technique of Co(Sep)
3+
-nafion interaction used in the current investigation, in the 
aforementioned study, incorporation of Co(Sep)
3+
 within the pre-formed nafion 
membrane was done through potentiodynamic cycling in the contacting solution. The 
significant difference in applied technique could thus possibly confer a variation in 
the interaction and/or distribution of the Co(Sep)
3+ 
counter ion species within the 
microstrucure of the nafion film. Moreover, considering that the redox potential of 
Co(Sep)
3+
 depends on the specific experimental conditions, such as the nature of the 
film, pH, supporting electrolyte, etc., the results are well within experimental 
variability. Another noteworthy factor with regard to the exhibited CV for the 
GCNaf|CMECo(Sep)3+ is that the anodic peak current is slightly smaller in 
magnitude than the corresponding cathodic peak current, by a value of about 0.20 μA. 
This is not an uncommon phenomenon and can be ascribed to the fact that the 
electroactive species was entrapped in the Nafion film in its oxidized form Co(Sep)
3+
 
[91]. With regard to the difference SW voltammogram  shown in Figure 4.4(b) for 
the GCNaf-Co(Sep)3+ electrode, the signal is observed at -570 mV, which, as in the 
case of the results obtained for the CVs, shows an anodic shift as compared to the 
obtained Ep observed for the difference SW of the bare GCE, by a magnitude of 
approximately 70 mV.  
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Figure 4.4: (a) Cyclic voltammetric response for the nafion-coated GCE 
(GCEnaf), and the cobalt(III)sepulchrate modified- GCEnaf (i.e., 
GCnafCMECo(Sep)3+naf ) for experiments conducted  in argon-degassed  (Ar) 50 
mM PBL at 10 mV s
-1
. (b) Square wave voltammetric response of the 
GCnafCMECo(Sep)3+naf also in ArPBL, presented as the difference spectrum. 
Experimental conditions: StepE = 4 mV; amplitude = 75 mV;  
 
In terms of the fabricated biosensor, the results for the cyclic and square-wave 
voltammetric responses for the GC|nafCMECo(Sep)3+flCYP3A4naf  electrode for 
an experiment conducted in ArPBL, is shown in Figure 4.5 (a) and (b), respectively. 
In the absence of substrate (indinavir), and/or co-substrate (molecular oxygen), the 
immobilized enzyme gives no catalytic response, and as such, the electrochemistry 
observed is essentially dictated by the the Co(Sep)
3+
 mediator [125]. In this regard, 
with respect to the CV in particular, the anodic and cathodic peak potentials for the 
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reaction was −555 and −625 mV, respectively, corresponding to the Co3+ + 1e− ⇄ 
Co
2+
 redox system. Moreover, the cathodic and anodic peak currents (Ip,c = −1.322 
μA; Ip,a = 0.717 μA), were fairly symmetrical, with the Ip,c exhibited for the fabricated 
biosensor (GCEnafCMECo(Sep)3+flCYP3A4naf) shown to be higher in magnitude, 
than the Ip,c of the Nafion-entrapped CMECo(Sep)
3+ 
modified GCE (i.e. 
GCEnafCMECo(Sep)3+) [Figure 4.4(a)], by almost 2 orders of magnitude. Prior 
research has established Nafion as a perfluorinated polymer with a micellar pore 
structure, that is able to stably bind or incorporate surfactants and other molecules to 
and/or into its bulk membrane through coulombic and/or hydrophobic interactions, 
depending on the charge and hydrophobic nature of the compound [122, 126]. Thus, 
the increase in Ip,c, may be ascribed to the favourable interaction between the Nafion 
and the  CHAPS monomerized-flCYP3A4 without the need  for any additional 
coupling reagents and/or bifunctional linking molecules to re-enforce stable enzyme 
immobilization. The overall result is effective electron shuttling between the reduced 
mediator and the enzyme heme group yielding Ip,a/Ip,c and ΔEp values of 0.9 and 70 
mV, respectively. The ΔEp value is close to 65mV indicating the presence of a 
surface-bound electroactive species undergoing fast reversible electron transfer at the 
electrode [74]. In this context, the GC|NafCMECo(Sep)3+ is therefore a better 
electrode system than the Nafion-entrapped mediators reported by some other 
researchers. For example, Nafion-entrapped [cobalt(II)phthalocyanine-
cobalt(II)tetra(5-phenoxy-10,15,20-triphenylporphyrin)] — pentamer, also done 
through a casting/mixing technique, showed  a ΔEp value of 200mV [127]. Figure 
4.5(b) shows the squarewave response of the 
GCnafCMECo(Sep)3+flCYP3A4 naf  electrode, for which signals was 
obtained at −600 ±5 mV. Compared to the results shown for the nafion-entrapped 
CMECo(Sep)
3+
 and the bare GCE in Co(Sep)
3+
, the signal shifted anodically by 
approximately 40 mV and 30 mV, respectively. These results are comparable with 
those obtained in cyclic voltammetric studies and thus corroborate those findings. 
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Figure 4.5: (a) Cyclic voltammetric response for the flCYP3A4 based biosensor, 
i.e., nafflCYP3A4Co(Sep)3+nafGC electrode, for experiment conducted  in argon-
degassed  (Ar) 50 mM PBL at 10 mV s
-1
. (b) Square wave voltammetric response of the 
nafflCYP3A4Co(Sep)3+nafGC electrode in ArPBL, presented as the difference 
spectrum. (Plot shows the net current of the forward and reverse SWV response for a 
scan that was done cathodically). Experimental conditions are: square-wave 
amplitude 75 mV; potential step 4 mV. Step E = 4 mV; amplitude = 75 mV; 
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4.3.2  Electrochemical behaviour of the 
GCnafCMECo(Sep)3+flCYP3A4naf biosensor  
 
 To ascertain and identify the type of current involved in the redox process, 
the dependence of the peak current on scan rate was investigated over the potential 
range scanned (-350  -850 mV). In this regard, scan rate studies for the 
GCENafCo(Sep)3+CYP3A4Naf biosensor was conducted in argon-degassed PBS 
(50 mM, pH 7.4), from which the obtained voltammetric results were fitted by linear 
regression analysis, of which the results are shown in Figure 4.6. In this regard, the 
current function, Ip/ν
½
 exhibited a constant value for all the scan rates within the 
range of 201500mV, essentially implying that the charge transfer at the electrode-
film interface, in the absence of oxygen and substrate in the higher scan rate region 
(20–1500 mVs−1), is diffusion-kinetic-controlled and as such, governed by semi-
infinite conditions at all the scan rates employed [119, 125, 128-129].  In the context 
of electrochemical characteristics, generally, this behaviour suggest the possibility of 
kinetic effects for bulk and/or surface processes. However, according to documented 
literature, the unique phase segregation in the micro-domain of nafion membranes, 
confer electron transfer and/or charge transport in such membranes to be equivalent 
to a diffusion process. As such, these results does not necessarily reflect kinetic 
limitations, but more on the subject on the type of charge transport and electron 
transfer in nafion membranes  is comprehensively discussed in Chapter 5A, which 
will give the reader a more in depth view on this subject. Nevertheless, as is common 
with many films showing diffusion controlled current, a region of monolayer 
behaviour may be exhibited at low scan rates, in which thin layer electrochemistry 
behaviour is  mimicked and exhaustive electrolysis of the electroactive species is 
possible. In this regard, at low scan rates, ν < 9 mV s-1, the surface coverage of the 
Co(Sep)
3+
, Γ (mol cm−2), was determined by  measuring the Faradaic charge (Q) 
passed during exhaustive electrolysis of the assembly, using slow scan rate 
voltammetry [91, 119, 129]. This is based on the equation [92, 129-130]: 
Γ =Q/nFA        4-1 
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 where n is the number of electrons transferred and F is Faraday’s constant, A is the 
area of the electrode. The surface coverage was calculated to be 9.8×10
−8
 mol cm
−2
. 
On the other hand, with regard to the least squares regression results shown for the 
higher scan regions (Figure 4.6 Inset), the linear regression equations for the cathodic 
and anodic peaks, based on peak current versus ν½ plots for diffusion kinetically-
controlled scan rates were determined as: Ip = −0.1593 ν
½
 = −0.07335 (r = 0.996) and 
Ip =0.1148 ν
½
 = –0.2027 (r = 0.99854), respectively. Concomitantly, the slopes of 
these graphs could then be used to determine the charge transfer diffusion coefficient, 
Dct (cm
2
 s
−1
), in the films by Randle Sevcik analysis, as shown in equation: 
 
Ip = (2.69 × 105)ν
1/2
Dct 
  
 
     4-2 
 
 
The volume of the film (l×A) was determined from the molecular volumes and 
amounts of Nafion and Co(Sep)
3+
 deposited in the film [128, 131]. The electron 
diffusion coefficient, Dct for the electroactive film was estimated as 3.6×10
−8
 cm
2
 s
−1
. 
The Dct value is subject to error of 0.5×10
−8
 cm
2
 s
−1
 due to the uncertainty in film 
thickness [130, 132].  
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Figure 4.6 Cyclic voltammograms of NafCYP3A4Co(III)Sep-Naf-film in 
phosphate buffer saline (pH 7.4) at scan rates 20 – 1500 mVs-1. Inset: Plot of cathodic 
and anodic peak current vs ½. 
 
 
With regard to the operational stability of the film within the context of an 
experimental setup, when the GCNafCMECo(Sep)3+CYP3A4Naf electrode 
(biosensor) was scanned continuously in 50mMPBL (pH 7.4), the voltammetric 
response decreased gradually with increasing cycles. The peak current remained 
approximately 90% of the initial response after 20–30 cycles. In terms of storage 
stability, on the other hand: Upon storage of the biosensor in buffer solution, 
followed by subsequent electrochemical cycling in fresh PBL, under the same 
experimental conditions used in the study, a gradual decline in signal, equivalent to 
approximately 6-10% per day could be observed. The decline is an indication of 
gradual leaching of the mediator species from the reagent layer, since as discussed 
earlier, in argon-degassed PBL, in the absence of substrate and/or oxygen, the 
observed electrochemistry is essentially dominated by the  Co(Sep)
3+
 mediator. 
 
 
4.3.3  Electrocatalytic investigations of the fabricated biosensor 
(GCEnafCMECo(Sep)3+flCYP3A4naf) 
 
4.3.3.1  (Electro)catalytic responses to co-substrate (oxygen) and substrate 2,4-
dichlorophenol (2,4-DCP)  
 
One of the major disadvantages of nafion is its extremely acidic nature 
which usually limits its usefulness as an enzyme immobilization agent. However, in 
 
 
 
 
 Chapter 5   Results and Discussion: Biosensor Plaform 1 
 
166 
 
this study the pH of Nafion was adjusted to 7.4 before the incorporation of CYP3A4. 
The responses of the biosensor under anaerobic or aerobic conditions are shown in 
Fig. 4.7 for experiments carried out at a potential scan rate of 10mVs
−1
 in PBL. The 
biosensor response in argon-degassed substrate-free PBL (voltammogram (a) of 
Figure 4.7) shows that in the absence of substrate, the observed charge transfer is by-
and-large dictated by the Co(Sep)
3+
/Co(Sep)
2+
 electrochemistry. In the presence of 
11.04 μM 2,4-DCP in anaerobic PBS (voltammogram (b)),  there was an increase in 
the cathodic peak current (Ip,c) and a small cathodic shift in reduction potential. 
Compared to the substrate-free CV in anaerobic PBS, the Ip,c in the presence of the 
substrate (2,4-DCP) increased by 317 nA (0.317 μA) and the Ep,c shifted cathodically 
by approximately 5 mV. The increase in Ip,c value upon substrate binding illustrates 
the typical response of ferri-heme-containing enzyme biosensors, in which the 
reduction of the heme group (Fe
3+
 +1e
−→ Fe2+) is coupled to monooxygenation 
(hydroxylation) of the substrate. Oxygen binding to ferrous P-450 enzymes are 
known to be very rapid, even at low oxygen tension, such as found in the liver [12]. 
With regard to CYP3A4 in particular, according to documented findings, binding of 
oxygen to the reduced heme iron, Fe
II
 occurs at an estimated rate of 350  400 s-1[67]. 
Considering the latter and aforementioned aspects, it may be concluded that the 
residual oxygen contained in the injected substrate containing solution, was sufficient 
for the formation of the activated ferro–oxo complex, which in turn functioned in 
substrate metabolism. In fact, the observed Ip,c increase in the presence of substrate 
under anaerobic conditions, is in agreement with previous findings involving P450cam 
reported by Iwuoha et al.. [74]. The shift in peak potential on the other hand, may be 
attributed to substrate docking via weak hydrophilic interactions between distant 
prosthetic group amino acids, followed by binding to active site functional groups 
[25]. In this regard, substrate binding is accompanied by the displacement of water 
(originally bound to CYP3A4 as the sixth axial ligand), concomitantly resulting in the 
conversion of the heme to high spin, while sufficient oxygen was present for substrate 
hydroxylation. However, with limited residual oxygen present, only the partial 
displacement of water at the enzyme active site was possible, hence the small shift in 
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Ep,c [25, 74, 133]. It is noteworthy though, that the absence of cathodic shift in the 
Ep,c values on changing from substrate-free sensor to substrate-bound sensor under 
anaerobic conditions does not necessarily imply a lack of heme–substrate interaction  
[73, 134]. Previous studies suggested that in the absence of oxygen, the effect of 
substrate on the heme electronic environment may be negligible. This, however, in 
turn depends on the nature of the substrate [133]. The voltammetric response of the 
biosensor in substrate-free oxygenated PBS is shown in volatmmogram (c) of Fig. 
4.7. Oxygen is the natural co-substrate of CYP3A4 and binds to the ferrous iron 
(Fe
2+)
 at a very fast rate, usually more rapid than substrate binding (> 106 M
-1
s
-1
) [74, 
77, 135]. Therefore, voltammogram (c) is essentially the electrocatalytic response of 
the enzyme heme redox centre to dioxygen. In this regard, the most likely equation 
which can adequately describe the aforementioned oxygen interaction is as follows: 
flCYP3A4FeII + O2  flCYP3A4FeO2  4-2 
Figure 4.7 CV (d) on the other hand,  shows the biosensor response to 11.04 μM  
2,4-DCP in oxygenated PBL. The presence of substrate, in this case 2,4-DCP, 
increases the rate of dioxygen binding to the heme, which is exemplified by the 
increase in the electro-reduction current (Ip,c) shown in the cyclic voltammogram. 
Moreover, the flCYP3A4-oxygen and/or flCYP3A4-oxgen/substrate interaction is 
essentially a chemical reaction and as such, irreversible. In terms of an 
electrochemical perspective this means that the heme-Fe
II 
of the flCYP3A4 produced 
during the cathodic scan, was consumed in the fast follow-up chemical reaction, thus 
making it unavailable for re-oxidation during the anodic scan ,  In this regard, the 
background capacitative-current subtracted CVs specifically showing the 
electrocatalytic response of the enzyme based biosensor to substrate and/or oxygen 
exhibited in Figure 4.8, essentially shows that this was accompanied by a complete 
attenuation of the anodic peak current (Ip,a).  
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Figure 4.7: Cyclic voltammograms of GCEnafCMECo(Sep)3+naf 
(biosensor) in 50 mM PBS at 10 mV s
-1
, showing: (a) biosensor in anaerobic PBS 
with 0 μM 2,4-DCP; (b) anaerobic PBL with 11.04 μM 2,4-DCP; (c) air-saturated 
PBS containing 0 μM 2,4-DCP; (d) air-saturated PBL containing 11.04 μM 2,4-DCP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Voltammetric response of the GCEnafCMECo(Sep)3+naf biosensor, 
showing  background capacitive current-subtracted CVs in: (a) the presence of 11.04 
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μM 2,4-DCP in argon-degassed PBS; (b) substrate-free un-degassed PBL; (c) in un-
degassed PBL in the presence of 11.04 μM 2,4-DCP. 
 
 
On a final note, with regard to the catalytic response profile of the biosensor exhibited 
in Figure 4.7 CV(d) and Figure 4.8  this is typical of cytochrome P450 enzymes in 
particular, and heme enzymes in general, thereby suggesting  the metabolism of 2,4-
DCP by CYP3A4 [74, 135]. It is noteworthy though to also add that, as discussed in 
Chapter 2, Section 2.2.3, the catalytic cycle of P450 enzymes are frequently 
complicated by uncoupling reactions, such as the formation of superoxide and 
concomitantly produced peroxide, which of course can complicate the interpretation 
of exhibited results. However, based on documented literature, it has been shown that 
the substrate has a stabilizing effect on the oxygenated P450 enzyme, which in turn 
could minimize side reactions that could generate superoxide and peroxide [67]. 
Having said that, however, this does not preclude the possible contribution of 
peroxide to the observed electrocatalytic response, especially considering the large 
difference between the catalytic oxygen reduction current in the absence and in the 
presence of 2,4-DCP, of which such a phenomenon has been thought to indicate the 
possibility of the contribution of what is known as the peroxide shunt pathway [77, 
136]. On this note,  Section 4.3.2.5, gives more insight into the enzyme-substrate 
interaction, with inclusion of some perspective of reactive oxygen species. On the 
other hand, it is also noteworthy to bring to the reader’s attention that Section 
5B.3.3.1.1, in Chapter 5B gives an even more comprehensive overview all of the 
possible envisaged reaction pathways in relation to electrocatalytic investigations 
with this category of enzyme, including the effects of reactive oxygen species, both 
with specific reference to the enzyme, as well as in consideration of the mediating 
species. In this regard, detailed equations are also provided. 
 
 
The response of the GCEnafCMECo(Sep)3+naf biosensor in the presence 
of increasing  concentrations of 2,4-DCP was subsequently investigated and the 
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results recorded with square wave voltammetry. In the presence of increasing 2,4-
DCP concentrations, an eminent increase in peak catalytic current, in a  linear 
fashion, with each consecutive addition, up to a final concentration of 1600 μM was 
observed. These results are shown in  Figure 4.9. In addition to this, the calibration 
curve for 2,4-DCP was also constructed, by the plot of Ip of 2,4-DCP versus their 
concentrations, of which the results are shown in Figure 4.10. Also shown in the 
inset of Figure 4.10, is the linear range of the biosensor. In this regard, the dynamic 
linear range for 2,4-DCP had an upper limit of 45 A and a sensitivity of 0.038 A 
M-1. Moreover, the corresponding detection limit, calculated as  the concentration 
giving a signal equal to three times the standard deviation of the blank signal divided 
by the sensitivity [3(S/N) = 3], was determined as 0.043 g L-1. 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9  Square wave voltammetric response of 
GCEnafCMECo(Sep)3+flCYP3A4naf biosensor in 50 mM un-degassed PBL containing 
0 264 μM 2,4-DCP  
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Figure 4.10 (b)Dependence of catalytic peak current  
GCEnafCMECo(Sep)3+flCYP3A4naf biosensor  for 2,4-DCP for experiment 
performed in un-degassed 50 mM PBL. 
 
 
4.3.3.2  (Electro)catalytic response to native marker CYP450 3A4 substrate: 
Erythromycin  
 
In order to re-affirm and corroborate that the response of 
GCEnafCMECo(Sep)3+flCYP3A4naf  biosensor is due to flCYP3A4 enzyme, 
experiments were carried out with erythromycin, which is a macrolide antibiotic that 
is frequently used in in-vitro studies as standard substrate for testing and confirming 
CYP3A4 activity [12]. The responses of the biosensor under anaerobic and aerobic 
conditions, in the presence and absence of erythromycin (ERM) are shown in 
voltammograms (a)–(d) of Fig. 4.11, for experiments carried out at a potential scan 
rate of 10 mVs
−1
 in 50mM PBL, pH 7.4. The cyclic voltammetric responses in the 
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absence and presence of 2.18 mM ERM under anaerobic conditions are shown in 
CVs (a) and (b) of Fig. 4.11, respectively. CVs (c) and (d) on the other hand, shows 
the cyclic voltammetric responses of biosensor in the absence or presence of 2.18 
mM ERM, in the presence of dissolved oxygen. The sensing of ERM in anaerobic 
PBS caused an increase in Ip,c value (by 0.1462 μA) and an anodic shift (by 14mV) 
Ep,c value. The voltammetric response of the biosensor in substrate-free oxygenated 
PBS is shown in Fig. 4.11  CV (c). The CV portraying the biosensor response in 
oxygenated PBL (Fig. 4.11 c) displays a distinct increase in Ip,c value due to the 
coupling of the ferri-/ferro-heme reaction to the binding of dioxygen to the reduced 
heme (Fe
II
) [74, 135]. Biosensor response to 2.18 mM ERM in oxygenated PBL is 
shown in Fig. 4.11 CV (d). The Ip,c value increased by 0.64 μA over the response of 
erythromycin-free oxygenated solution. The results for the voltammetric studies with 
ERM exemplify a response profile which is in complete agreement with those 
obtained for 2,4-DCP, thus corroborating and confirming the latter as a substrate of 
flCYP3A4. 
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Figure4.11 Cyclic voltammograms of GCEnafCMECo(Sep)3+flCYP3A4naf 
biosensor in 50 mM PBS at 10 mV s
-1
, showing: (a) biosensor in anaerobic PBS with 
0 mM erythromycin (ERM); (b) anaerobic PBS with 2.18 mM ERM; (c) air-sarurated 
PBS containing 0 mM ERM; (d) air-saturated PBS containing 2.18 mM ERM 
 
 
As in the case of 2,4-DCP, response of the GCEnafCMECo(Sep)3+flCYP3A4naf 
biosensor to  increasing ERM concentrations was also investigated. This was done by 
successively adding ERM in conjunction with intermittent stirring of the solution in 
un-degassed PBL under optimized conditions followed by subsequent voltammetric 
recording of  the response. The results showing the SW voltammetric response of the 
biosensor to ERM up to 164.0 μM is shown in Figure 4.12.  The voltammograms 
shown represent the difference SWVs, for scans done cathodically. Overall, a 
periodic increase in peak current in conjunction with each consecutive addition of 
ERM up to a final concentration of 164 μM can be observed. A full calibration curve 
was then subsequently constructed. In this regard, Figure, 4.13 exhibits the 
dependence of catalytic peak current on ERM concentration (0  292 μM), showing 
an upper limit for the dynamic linear range of 53.7 μA. A linear plot was obtained for 
ERM over the 4.63  26.4 μM concentration range, (R2 = 0.9987, slope = 0.0323 A 
μM; intercept = 1.9212 μA. The limit of detection for ERM, was determined as 1.271 
x 10
-5
 M. 
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Figure 4.12 Square wave voltammetric response of GCEnafCMECo(Sep)3+flCYP3A4naf 
biosensor in 50 mM un-degassed PBS containing 0 164.4 μM erythromycin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 Full ccalibration plot for response of GCEnafCMECo(Sep)3+naf  biosensor  
to ERM for experiment performed in un-degassed 50 mM PBS. Inset: Linear curve 
for 2,4-DCP. 
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4.3.2.3  Electrocatalytic behaviour in the presence of inhibitor: ketoconazole 
 
Voltammetric experiments were conducted to ascertain the effect of heme-
inhibitor interactions on the electro-catalytic metabolism of 2,4-DCP. In this regard, 
the effect of ketoconazole, a known CYP3A4 inhibitor, on the response of the 
CYP3A4 biosensor to 2,4-DCP was studied by square-wave voltammetry. 
Voltammogram (a) of Fig. 4.14 depicts the SWV of the flCYP3A4 biosensor in PBL 
containing 245 μM DCP, with no ketoconazole present. The peak cathodic current for 
this SWV was determined as 11.8 μA. After 15min incubation with 94 μM 
ketoconazole, the square wave voltammetric signal was reduced by 12% 
(voltammogram (b)). 188 μM ketokonazole decreased the response by 27% 
(voltammogram (c)) and 36% for 15 and 30 min incubation periods, respectively. 
These results agree with the finding of Joseph et al.. [135] for which 500 μM 
ketoconazole induced an 80% decrease in CYP3A4 activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Square wave voltammogras of GCEnafCMECo(Sep)3+flCYP3A4naf 
biosensor in 50 mM air-saturated PBS: showing biosensor response to 2,4-DCP 
before (a) and after incubations with enzyme inhibitor, ketoconazole (b – d) . 
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4.3.2.5 Critical assessment and additional observations of electrocatalytic 
behaviour of biosensor: A closer look at the bio-electrocatalytic response  
 
The results obtained for the electrocatalytic response of the 
GCEnafCMECo(Sep)3+flCYP3A4naf  biosensor  with respect to oxygen, as well as 
the investigated substrates, i.e., 2,4-DCP and ERM were comprehensively compared 
and assessed, to reveal additional findings which may contribute to the overall 
understanding of the dynamic mechanism of the enzyme-based detection process. In 
this regard, the following findings were made: Firstly, with respect to the cyclic 
voltammetric studies exhibiting the biosensor response in the absence and presence of 
2,4-DCP or ERM, as shown in Figure 4.7 and 4.11, respectively, a peculiar 
phenomenon presents itself: The augmentation of the Ip,c by the additional catalytic 
response to ERM was accompanied by a marked anodic (positive) shift in Ep,c, 
corresponding to a magnitude of 17 mV, whereas the in the case of 2,4-DCP a small 
cathodic Ep,c shift was found. These results, seemingly contradictory can actually be 
moderately well explained by understanding particular aspects of the unique nature of 
the structure and substrate interaction aspects of CYP3A4 active site. Firstly,  from a 
general perspective, the metabolism of CYP3A4 and/or P450 isoenzymes is governed 
by three generic rules [25]: 
 The topography of the active site. 
 The measure of steric hindrance of the access of the iron-oxygen complex to 
the possible sites for metabolism on the substrate. 
 The possible ease of hydrogen or electron abstraction from the various 
carbons or heteroatoms of the substrate. 
In view of the aforementioned aspects, with regard to the more specific characteristics 
and specifications of  CYP3A4 in particular, firstly the initial motion of substrates to 
within the vicinity of the enzyme’s active site is enabled by weak hydrophillic 
interactions. However, actual substrate binding to the enzyme’s active site, which 
consist mainly of hydrophobic residues is by-and-large governed by highly  lipophilic 
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forces, and as such, also requires the removal/stripping of any water molecules 
associated with any of the functional groups on the substrate molecule, a process 
which requires a considerable amount of energy. Moreover, favourable substrate 
binding governed by lipophilic forces results in the preferential expulsion of water 
from the active site, which in turn provides the driving force for the enzyme spin state 
change and hence the formation of the catalytic oxy-complex, [(FeO)
3+
], unit. Also 
noteworthy is the fact that the substrate can adopt more than one orientation in the 
active site, of which, the eventual product is governed by the interaction between one 
of these orientations and the enzyme catalytic (FeO)
3+
 unit. In addition to the above 
aspects, with specific reference to substrate-turnover and the formation of the 
catalytically-active oxy-complex of the enzyme, important documented findings have 
been made [67]: From a general perspective, in bacterial P450 counterparts, such as 
P450cam, substrate turn-over rates are typically much faster than the autoxidation of 
the catalytic oxy-complex, [(FeO)
3+
] in substrate-free oxygenated solution. 
Conversely, in human CYP450s, the catalytically active oxy-complex is highly 
unstable and, once formed can decompose at a rapid rate. In fact, product formation, 
particularly in the case of  CYP3A4, is much more slower and significantly lower 
than the rates for spontaneous decomposition of the FeO)
3+
, which decomposes at a 
rate of 2-3 orders of magnitude faster than in other CYP450s. This poses the potential 
threat of rapid uncoupling reactions during catalytic studies with this enzyme. On the 
other hand, saturation of CYP3A4 with substrate, confer a marked stabilization of the 
catalytically active oxy-ferrous intermediate of the enzyme. This unique stabilization 
ability of CYP3A4 substrates presumably occurs through modulating the escape of 
superoxide or hydroperoxyl radical from the distal binding pocket of the enzyme. 
Cumulatively, the unique stabilization ability of substrates can result in the 
acceleration of the reduction rate, concomitantly attributing to a positive shift of the 
redox potential in response to substrate binding to the enzyme. On this note, it must 
also be remembered though, that the percent contribution of stabilization and/or 
increased reduction, is highly dependent on the type of substrate. 
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Keeping in mind all of the aforementioned aspects, both these compounds are 
essentially hydrophobic in nature, however ERM holds the additional advantage of 
being a significantly large molecule, thus avoiding the possible occurrence of 
randomly unfavourable oriented conformations within the enzyme active site, while 
being large enough to possibly effectively confer the expulsion of the sixth water 
ligand from the active site, thus effectively driving the required spin state change of 
the enzyme to rapidly drive the formation of the catalytic (FeO)
3+
 unit. Moreover, 
during phase I reaction with CYP3A4, this compound is known to undergo N-
dealkylation. This requires the abstraction of an electron from the ERM molecule, a 
phenomenon which could have a synergistic effect on the transfer of the second 
electron required in the catalytic cycle of the enzyme. In addition to this, the fact that 
this particular electrocatalytic interaction of substrate addition was investigated in 
argon degassed- PBL, coupled with the fairly high injected concentration of ERM, 
held an advantage: In this regard, binding of the substrate probably occurred at a fast 
rate, thus essentially stabilizing the enzyme, while the undegassed substrate solution 
provided sufficient residual oxygen to effectively drive the required oxygen 
activation and subsequent substrate turnover. Moreover, ERM being the larger 
substrate probably enabled a ERM-CYP3A4 complex that minimized available active 
site volume to any uncoupling intermediates.  The cumulative effects of these 
attributes would of course favourably affect the metabolism of ERM, which, from an 
electrochemical point of view, can greatly contribute to the observed positive 
potential shift in association with the electrochemically-based substrate interaction. 
The small nature of the 2,4-DCP molecule on the other hand, could induce random 
orientations of the substrate in the enzyme active site, which, in turn, could confer an 
initial unfavourable orientation, thus slightly impeding interaction with the catalytic 
(FeO)
3+
 unit, while also resulting in partial expulsion of water from the active site. 
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4.3.4 Performance aspects: reproducibility and stability 
 
Some selected aspects regarding the repeatability and stability of the 
GCEnafCMECo(Sep)3+flCYP3A4naf  biosensor with respect to 2,4-DCP was 
considered. Firstly, the repeatability of the measurements of the biosensor-based 
electrocatalytic response was evaluated by measuring the response of freshly 
prepared biosensor to 24 μM 2,4-DCP within the first six hours of preparation, 
consecutively, at ± 1 hr time intervals, with intermittent rinsing and storing of the 
biosensor at 4 C after each measurement. In this regard, Figure 4.15, exhibits the 
obtained current responses for the biosensor for five consecutive measurements taken 
within the first five hours. Assessment of the results reveals that a fairly consistent 
response was obtained, declining very gradually, by a magnitude of approximately 
5% with each measurement, up to the fourth measurement, after which a much more 
eminent decline, corresponding to a magnitude of about 44% was observed. Overall, 
in its completeness, the evaluation of the repeatability of measurements exhibited a 
relative standard deviation (R.S.D) value of 5.5%, indicating good repeatability. In 
another evaluation, the biosensor’s storage lifetime (storage stability) was 
investigated, by monitoring its response to 2,4-DCP at pre-determined time-intervals. 
In this regard cyclic and square wave voltammograms were recorded using the same 
biosensor after storing in PBS at 4 ◦C for 0h, 12h, 24h, 2 days, 4 days and 1 week. 
The peak current decreased with increase in storage time; however, the biosensor still 
retained 65% of its initial response after 1 week of storage. A R.D.S. value of 5.2% 
for n = 3 was obtained for the 1 week stability study (where n is the number of 
biosensors tested).  
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Figure 4.15 Repeatability of measurements: Showing response of 
GCEnafCMECo(Sep)3+flCYP3A4naf  biosensor  in oxygenated PBS to 24 μM for five 
consecutive measurements, with intermittent rinsing   
 
 
 
 
 
4.4 Conclusions 
 
Nafion-entrapped cobalt (III) sepulchrate provided stable matrix for the 
immobilized CYP3A4. The film permitted fast reversible electrochemistry of 
Co(Sep)3+ which was coupled to the reduction of ferri-heme to ferro-heme and the 
resultant monoxygenation reaction steps responsible for the amperometric detection 
and quantification of 2,4-DCP. The proposed reaction scheme is shown in Fig. 4.16. 
The sensor exhibits high sensitivity and a detection limit for 2,4-dichlorophenol far 
below the EU requirement for pesticides in ground water. The sensitivity, detection 
limit, as well as the wide dynamic linear range associated with this sensor system 
makes it very promising for environmental monitoring. With an upper linear range 
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value of 45mM the biosensor may, in future be used to determine and thereby control 
the amount of 2,4-DCP in industrial effluents from pesticide plants where the 
concentration of the compound is expected to be high. Since exposure to 2,4-DCP 
contamination can only occur through drinking water it is important to compare our 
results with the USA Environmental Protection Agency’s (EPA) drinking water 
equivalent level (DWEL) [44,45]. The DWEL value is the daily intake that will not 
cause any deleterious effect to a 70- kg adult exposed over a lifetime period and 
drinking 2 L of water per day, which for 2,4-DCP is 2 g L−1. The detection limit 
calculated for the GC/Naf-Co(Sep)
3+
/CYP3A4/Naf biosensor system reported in this 
study is 0.043 g L−1. This demonstrates the potential of the sensor as an easy to use 
device for possible regular testing of drinking water since it can detect concentrations 
of 2,4-DCP well below the DWEL value. 
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4.5 Experimental protocols 
 
4.5.1 Reagents and Materials 
 
Wilde type genetically engineered cytochrome P450-3A4 (CYP3A4), 
purified from a full length human CYP3A4 cDNA clone and over expressed in 
Escherichia coli cells [137], consisting of only the terminal oxidase (heme domain) 
and surrounding protein, was purchased from Merck South Africa. Upon receipt, the 
original enzyme stock, supplied as a 38 μM suspension, was immediately aliquoted 
into 5 μL portions, each of which was always stored at −70 ◦C until used. Nafion (5% 
(w/v) alcoholic solution), cobalt(III)sepulchrate trichloride {Co(Sep)
3+
} and 3-[(3-
chlolamidopropyl)dimethylammonio]-1-propanesulphonate (CHAPS) were the 
products of Sigma–Aldrich. Di-potassium hydrogen phosphate (K2HPO4), potassium 
dihydrogen phosphate (KH2PO4) monohydrate salts, and KCl were purchased from 
Sigma and used to prepare phosphate buffer saline (PBS) (50mM, pH 7.4, 
100mMKCl) used as supporting electrolyte. All solutions were prepared with water 
obtained from a Millipore Milli-Q purification system. 
 
 
4.5.2  Preparation of biosensor for voltammetric analysis 
 
4.5.2.1  Pre-treatment of working electrode 
 
The conditioning and pre-treatment of the WE were done exactly as outlined in the 
general experimental Chapter, i.e. Chapter 3B, Section 3B2.2. 
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4.5.2.2  Preparation of GCEnafCMECo(Sep)3+flCYP3A4naf biosensor 
 
Nafion stock solution was diluted to 1% (w/v) and the pH adjusted with 
PBS, yielding a 1% solution (pH 7.4) or solution A. This was followed by the 
preparation of a 1-mM solution of Co(Sep)
3+
 in PBS, yielding solution B. 5 μL of the 
38 μM CYP3A4 enzyme stock suspension was solubilised in CDPS followed by the 
addition of 100mM PBS to give solution C containing 3.8 μM monomeric CYP3A4 
enzyme and 0.8mM CDPS. The following coating procedure yielded the best 
electrochemical reversibility for the Co
3+
/Co
2+
 process: 4 μL of solution A was drop-
coated onto the clean GCE and dried for 10 min under a gentle flow of argon, in order 
to evaporate the excess ethanol. Care was taken to avoid the complete drying out of 
the Nafion layer. Then 4_L of solution B was drop-coated onto the Nafion-modified 
GCE and allowed to stand for 20 min under argon, during which time Co(Sep)3+ 
diffused into the Nafion layer to form Nafion-entrapped cobalt(III)sepulchrate-
modified GCE (GC/Naf-Co(Sep
3+
). The next step involved the drop-coating of 5 μL 
of solution C onto the Nafion-entrapped Co(Sep)
3+
 layer, and argon-dried for 20 min. 
Finally, approximately 2 μL of solution A was drop-coated onto the enzyme-modified 
GCE, to keep the enzyme film stable, whilst protecting the enzyme from biofouling. 
The resultant enzyme-modified electrode is denoted as 
GCEnafCMECo(Sep)3+flCYP3A4naf. 
 
 
4.5.3  Biosensor response experiments 
 
Biosensor responses to 2,4-DCP (analyte of interest), ketoconazole (a CYP3A4 
inhibitor) and erythromycin, ERM (a native CYP3A4 substrate) were studied by 
cyclic and square wave voltammetry in the presence and absence of the substances. 
All the electrochemical measurements with the biosensor were carried out at 25 
◦
C in 
either degassed or un-degassed 50mM potassium phosphate buffer solution pH 7.4, 
100mM KCl. Anaerobic condition was ensured by passing argon gas through the 
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electrolyte for at least 15min before measurements and maintaining an argon 
atmosphere atop the solution throughout the duration of the particular experiment. 
Cyclic voltammetry (CV) and Osteryoung-type square-wave voltammetry (SWV) 
were run in the presence and absence of oxygen and/or substrate to probe the 
enzyme–oxygen–substrate interaction. 
 
4.5.3.1 Inhibition Experiments with Ketoconazole 
 
The inhibitory experiments were performed with 250 μM 2,4-DCP. In the 
method, 250 μM 2,4-DCP was added to the PBS, under aerobic conditions and the 
voltammetric response of the CYP3A4 biosensor was recorded. This was then 
followed by the addition of known concentration of ketoconazole. The CYP3A4 
biosensor was incubated with ketoconazole for a specific time, under constant 
stirring, after which the voltammetric response was again taken. The ketoconazole 
concentrations, as well as the incubation time were varied and the cyclic and square-
wave voltammetric signals recorded, after each incubation session.  
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Chapter prelude 
In the context of the dissertation as a whole, the current chapter serves as an 
improved version of the biosensor platform presented and discussed in Chapter 4, in 
which the platform was up-scaled and customized for the current purpose. Particular 
attention was focussed on a more sophisticated and reproducible method  of 
preparation   of the carrier matrix, while simultaneously pre-concentrating a larger 
percentile of the mediating species deep within the microstructure of the nafion film, 
thus attenuating  potential pre-mature and/or long term leaching of the small 
mediating species from the reagent layer. The other important focus points were 
lowering of the operating potential, as well as down-scaling on financial burden of 
expensive commercially sourced biosensor components, such as nafion and biological 
recognition component. In terms of layout, this chapter consists of two parts: In the 
first part, Chapter 5A, the results for the synthesis and characterization of the base-
composite film (carrier matrix for enzyme-derivatised platform) are presented and 
discussed. In the second part, Chapter 5B, the results for the preparation, 
optimisation, electrochemical and catalytic performance of the enzyme-derivatised 
biosensor platform is presented and discussed. From a panoramic perspective, overall, 
platform improvement was done with a multifaceted approach: Firstly, 34.8 μg was 
casted in the current platform, instead of 34 μg, as used in the platform presented in 
Chapter 4. Moreover, dried nafion film formation was done under vacuum conditions, 
rather than under argon-flow as used in Chapter 4.  In addition to this, the Co(Sep)
3+
 
mediator was not immobilized through manual casting technique, but rather, was 
incorporated within the base-nafion film through electrochemical deposition method. 
Secondly, the enzyme used for this particular biosensor platform, is the heme-domain 
of the N-terminally modified,  human recombinant microsomal CYP3A4 isoenzyme 
(nCYP3A4), expressed as a catalytically-active His-tagged enzyme construct, 
prepared  in-house, by the investigator, through genetic engineering; unlike the full-
length hydrophobically-based, commercially attained counter-part  used in Chapter 4. 
In the third aspect, unlike the biosensor used in Chapter 4, where an additional 
nafion-layer was used as outer membrane, in this particular biosensor, a hydrogel-
film based on a biocompatible hydrogel-type composite membrane was used as outer 
layer. Lastly, the analyte detected in this study is a pharmaceutical drug, extensively 
used as part of the HAART treatment regime.  
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CHAPTER 5A 
 
 
Assembly and characterization of composite film consisting of nafion 
and electrochemically deposited cobalt(III) sepulchrate [El-Co(sep)
3+
]  
   
Abstract 
In the current chapter, the incorporation of electrochemically active transition metal 
complex, cobalt (III)sepulchrate (Co(Sep)
3+
 into preformed ionomer nafion polymer 
film, prepared on a glassy carbon electrode surface is presented and discussed. Based 
on the hydrophobic nature of the sepulchrate ligand and nafion’s exceptional affinity 
for hydrophobic compounds,  pre-concentration of Co(Sep)
3+
 was easily achieved 
through potentiostatic electrodeposition method, by applying a constant potential of  
450 mV for 1200 seconds (20 min) in aqueous solution, with cobalt (III) sepulchrate 
trichloride (1,3,6,8,10,13,16,19-octaazabicyclo[6.6.6]eicosainecobalt trichloride) as 
starting material. In this regard, the nafion base-film, of thickness 3.1 μm, provided 
an efficient matrix for the incorporation of Co(Sep)
3+
 and a stable functional 
electroactive composite (Naf|El-Co(Sep)
3+
)  film was prepared, for which the surface 
concentration (Γ) of the Co(Sep)3+ was determined as 1.537 x 10-5 mol cm-2). Thus, 
the Co(Sep)
3+
 species was preferentially incorporated into the ionic cluster 
microdomain of the polymer, and the formed Naf|El-Co(Sep)
3+
 film exhibited, 
diffusion controlled electrochemistry with a formal potential (Eº') of -615 mV. 
Moreover, electrochemical behaviour exhibited by the electroactive film was in line 
with the unique inherent charge transfer charactersitics of nafion, while the obtained 
charge transfer coefficient determined as 2.63 x 10
-7
 cm
2
 s
-1
.  In addition to this, the 
composite film was highly stable. 
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5A.1 Introduction 
 
 
Although polymers, particularly of the ion exchange type, are popular 
choices for fabrication  of composite electroactive platforms for electroacatalytic 
studies and/or creation of carrier matrices for mediated biosensor construction, a 
major limitation is their short lifetime caused by low ionic mobility in the polymer 
film and/or easy loss of electroactive species from the inner phase of the membrane 
[117-118]. Attempts have been  made to fix such problems through covalent 
attachment of selective ligands to polymers, however, these techniques require the 
addition of plastizers which tend to leach and thus leads to demise of the formed 
films. On the contrary, the non-electroactive, ion-containing polymer, nafion, have 
the ability to circumvent such problems, based on its very unique characteristics, 
which includes phase segregation, with phases consisting of components which are 
highly hydrophic in nature;  containing no water leachable components; having an 
inherent ability for charge-exclusion and being chemically inert;  and also having 
unparalleled affinity for cation  species, particularly of hydrophobic nature, as well as 
unique cation pre-concentration features.  In this context, the unique features of 
nafion is combined with novel electrocatalytic technqiue, to afford an electroactive 
coating that is highly chemically stable, and preoperatively easily reproducible, while 
also subsequently serving as effective carrier matrix for the coupling of the prepared 
enzyme to the electrode in the creation of biosensor platform 2.  
 
As for the overall aim of the current investigation, the emphasis was on the creation 
of a stable Co(Sep)
3+
-modified, electroactive nafion membrane which, as mentioned 
in the prelude to Chapter 5 A and B, would subsequently serve as carrier matrix for  
fabrication of an enzyme-based biosensor. On the other hand, notwithstanding the 
fact that the composite film is based on the same starting components as in Chapter 4, 
a major focus point of the current study was the improvement of the matrix, 
particularly in terms of repeatability, structural morphology and ease of preparation. 
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This required a multifaceted approach and in this regard – firstly, 0.045 mg cm-2 
nafion   was used as the base layer, as opposed to the 0.35 mg cm
-2
 used in the 
platform prepared in Chapter 4. This was done in an overall quest to provide better 
coverage on the underlying GCE. Secondly, a more evenly dispersed nafion layer was 
formed by using a specialized short-structured micro-tip for casting, while drying of 
the nafion film was not done under argon flow, but rather under a tightly fitted cover 
which provided a vacuum effect. Lastly, and perhaps more importantly, as already 
elaborated, a potentiostatic technique was used for Co(Sep)
3+
 incorporation, rather 
than the manual casting/mixing method used in the previous chapter.  In addition to 
voltammetric characterization, the assembly of the prepared matrix was characterized 
with selected ex-situ methods, of which the results are subsequently shown and 
comprehensively discussed. 
 
 
 
 
5A.2 Assembly: Electrochemical characterisation of the GCE|Naf|El-Co(Sep)
3+
 
 
 
As explained in the outline of the experimental protocols described in 
Section 5A.5, the cobalt(III) sepulchrate was deposited  on a pre-formed nafion 
matrix on a glassy carbon working electrode. The step-wise modification of the GCE 
was monitored with voltammetry and in this regard, the findings are appropriately 
exhibited and discussed. In this context, an important noteworthy aspect to emphasize 
is that all cyclic voltammetric results are obtained from scans taken after repeated 
cycling when a steady state response was attained. Moreover, all reported values, for 
determined parameters, such as formal potential (Eº') , are reported as mean  
standard deviation for 3-4 experiments. In addition to this, the results presented and 
discussed in this chapter are all based on an optimized nafion-cobalt(III) sepulchrate 
composite [GCE||Naf|El-Co(Sep)
3+
]  film,  in which optimisation was done with 
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respect to electrocatalytic response of the CYP450 enzyme-modified electrode [138], 
since the Co(Sep)
3+
-modified nafion platform was  created with the overall aim to 
eventually fabricate a nCYP3A4-based biosensor for detection of HAART associated 
drug, indinavir.  In this regard, results for optimisation is not shown in this Chapter, 
but are exhibited and comprehensively discussed in Chapter 5B. 
 
The cyclic voltammogram of the nafion-modified GCE, GCE||naf, in 
anaerobic PBS (50 mM; pH 7.4)  is shown in Figure 5A.1, for an experiment 
conducted at a scan rate of 10 mV s
-1
. Essentially, the voltammogram obtained for the 
nafion-modified GCE is similar to that for bare GCE (not shown), with the 
fundamental difference being that the background current is appreciably reduced, 
which indicates that some active sites have been filled in by the smooth nafion film. 
In fact, according  to literature findings, the proportion of active sites blocked by 
nafion ranges from 15 to 20% [139].  Moreover, the lack of observable 
eletrochemistry is in complete agreement with studies based on nafion modified 
electrodes [104, 122, 140]. The important fact here is that the presence of the nafion 
does not substantially modify or block electron transfer with respect to the underlying 
electrode, and as such the nafion film may be effectively used as matrix for 
subsequent incorporation of cationic (mediating) species, as well as additional layers.  
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Figure 5A.1 Cyclic  voltammogram of GCE|Naf at 10 mV s
-1
 in argon-degassed 
phosphate buffer (50 mM, pH 7.45) 
 
 
The thickness of the nafion film was also determined, of which the calculations were 
done according to established methods, in conjunction with relevant theoretically 
based equations, from already published data [104-105, 128, 132]. In particular, 
calculations were done according to methodology outlined by equation 3B-1 in 
Chapter 3B. In short, however, essentially, the relation takes into consideration the 
fractional concentration of the nafion added, the density of the Nafion

 stock 
solution, as well as the density of the dry film and the area of the electrode. The 
nafion film thickness estimated by this method, was determined as 3.1 μm. In this 
regard, considering that the nafion film essentially served as inner layer, for the 
eventual assembly of an enzyme-based biosensor, the thickness value is in fairly good 
agreement with other research investigations which utilized nafion for similar 
purpose [122].  
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The cobalt(III) sepulchrate, which was loaded into the nafion membrane though 
potentiostatic deposition, on the other hand, exhibited a completely different 
electrochemical behaviour.  Figure 5A.2 displays the voltammetric response of the 
GC||naf|El-Co(Sep)
3
, for scans taken in argon-degassed PBS.  In particular, the cyclic 
voltammogram for the GC|naf|El-Co(Sep)
3+
 shown in Figure 5A.2(a), for an 
experiment conducted at  scan rate of  3 mV s
-1
  shows a pair of well-defined 
symmetrically shaped redox peaks, consisting of a cathodic and anodic wave. In this 
regard, considering that an oxygen-free medium was used and that fact that only one 
pair of redox waves, the cathodic and anodic peak of the CV can be ascribed to the 
Co(Sep)
3+
/Co(Sep)
2+
 redox couple. The reduction (cathodic, Ep,c) and oxidation 
(anodic, Ep,a) peak potential values were determined as -654 and -575 mV, 
respectively, while a peak separation, ΔEp, of 79 ( 3) mV was determined.  The 
formal potential (Eº’), determined as the midpoint potential (Emid), estimtated from 
the cyclic voltammetric data, was found to be  -615 mV,   and in addition to this, the 
ratio of anodic to cathodic peak current (Ip,a/Ip,c) was estimated to be 1.2.  In fact, the 
values of Emid, Ep and Ip,a/Ip,c, from CVs between 2 and 10 mV s
-1
, determined as 
averaged values corresponded to -611 mV, 77 and 1.1. Moreover, the variation in Ep 
for  these scan rates were negligible. In this regard, in terms of the theoretical aspects 
of electrochemical reversibility, a value of 1.0 for Ip,a/Ip,c corroborates the reversibility 
of the electron transfer reaction at the electrode surface, while a value of lower than 
65 mV for ΔEp is an indication of a surface-bound electroactive species which 
undergo fast reversible electron transfer at the electrode [74]. In practice however, the 
exact values for these parameters are difficult to attain, and as such, room is made for 
experimental error of approximately  10%, which essentially means that the results 
obtained for the current electrochemical system shows adequate promise in terms of 
ideal proximity. Another noteworthy point to emphasize at this stage, is that repeated 
CV scans recorded at half hour or one hour intervals, up to three/four hours after 
assembly of the GC||Naf|El-Co(Sep)
3
 exhibited stable background currents, with no 
indication of instability or reduction of  peak current  a factor which also 
corroborates the findings of the stability and reversibility of the prepared film. The 
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total surface coverage/concentration (Γ) of the Co(Sep)3+ cationic species in the 
nafion film was calculated by measuring the Faradaic charge (Q) passed at slow scan 
rate, where exhaustive electrolysis of the film occurs [129, 141]. In particular, the  Γ 
was calculated by integrating the cathodic charge under the voltammetric peak 
recorded at  = 2 mV s-1, by using the equation, Γ = 
 
   
, where n is the number of 
electrons of the redox reaction, A is the geometric electrode area (0.071 
cm
2
) ,  and F is the Faraday constant (96  500 C mol
-1
). Considering n = 1, Γ 
of the Co(Sep)
3+
 was calculated to be 1.537 x 10
-5
 mol cm
-2
. Since the Γ of the 
electroactive Co(Sep)
3+
 species may be regarded as a reflection of the amount of 
cationic species incorporated into the pre-formed nafion film  it is important to 
accentuate that, the technique used in the current study enabled the incorporation of 
the highest possible percentile of electroactive species within the nafion membrane in 
the shortest possible time. In fact, it is highly comparable to previously published 
studies involving metal centred and/or cage complexes, for example, in a study 
conducted by Dewald et al.. [124], the maximum loading for Co(Sep)
3+
 into a 36 μm 
pre-formed nafion film, was only 2 x 10
-4
 mol cm
-2
, obtained by potentiodynamic 
cycling method over a two hour period. In this regard, the method used in the current 
study (i.e. potentiostatic deposition) may be revered as an effective technique for pre-
concentration of counter-ion species in nafion and/or other ion-based polymer films.  
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Figure 5A.2 Voltammetric response of the nafion-cobalt(III) sepulchrate composite 
film, GC|Naf|El-Co(Sep)
3
 in argon-degassed PBS. Cyclic voltammogram taken at 3 
mV s
-1
, with cathodic and anodic waves indicated by negative and positive currents, 
respectively. Experimental conditions for square wave: StepE = 4 mV; S.W. 
amplitude = 25 mV; frequency = 1 Hz 
 
The effectiveness of pulsed techniques such as square wave voltammetry to 
accentuate the Faradaic current while discriminating against capacitive (charging) 
current cannot be over estimated. In this regard, Osteryoung square wave (OSW) 
voltammetry was employed to compliment cyclic voltammetry, particularly in terms 
of a more accurate measure of the Eº’ for the  Co(Sep)3+/Co(Sep)2+ redox couple.  
Thus appropriately, Figure 5A.2 (b) depicts the SWV responses of the  GC|Naf|El-
Co(Sep)
3
, with the main graph showing the net (difference) SWV response and the 
inset showing the forward (negative wave) and reverse (positive) SW responses. The 
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value of the net SW response as determined from SW data is -620 ( 5) mV, while 
the forward and reverse potential values was determined as -616 and -624  ( 5) mV, 
respectively. Moreover, these results revealed a small Ep, corresponding to a value 
of only 8 mV. On the other hand, the forward and reverse waves, although fairly 
symmetric in shape, revealed that, the magnitude of the reduction SW is higher than 
that of the anodic SW, by approximately one order of magnitude. In fact, these 
findings, although with a smaller difference, was also found in CV and this 
essentially means that the metal centred electroactive species was incorporated into 
the nafion film in its   Co(Sep)
3+
 form. This is indeed a true representation of the 
electrode reaction, since the Co(Sep)
3+ 
 was potentiostatically deposited at a 
sufficiently anodic potential (i.e. +450 mV), which means it was taken up into the 
nafion layer in its original  Co(Sep)
3+
 form. Overall, the Eº’, as determined from the 
aforementioned  results shows values that are significantly more cathodic in 
magnitude (by at least  65 mV)  as compared to results obtained for Co(Sep)3+ at 
bare electrodes in similar aqueous solution and potential scan conditions. This finding 
was also reported in  some previous research investigations  [124, 142], involving the 
incorporation of other   metal-centred cationic electroactive species, into nafion films. 
In fact, it has been determined by prior research investigations, that this type of 
cathodic potential shift suggest a strong affinity of nafion for the particular cationic 
species [143], and as such incurs uptake and retention of the cobalt(III) sepulchrate 
species within the nafion structure, through strong hydrophobic interactions between 
the two species. In this regard, to substantiate the aforementioned proposed method of 
retention, it is noteworthy to some of the structural unique attributes of nafion [117, 
119, 143]:    
 Firstly, unlike conventional ion exchange resins which are all 100% 
sulphonated, in nafion, only about one in every eight monomer units is 
sulphonated, and consequently, the large segments of uncharged chain 
material enable an enhanced ability of hydrophobic interaction, and these 
hydrophobic interactions dominate ion exchange reactions for cation species 
in nafion membranes/films. 
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 Secondly, unlike other ion exchange polymers, such as PVP
+
, nafion has a 
very low dielectric constant, as well as a low charge density and the 
implications of these factors is that hydrophobic interactions dominate 
retention in nafion polymers, whereas electrostatic forces are the critical 
component in other ion exchange polymers.  
 Thirdly, unlike Co(Sep)
3+
, nafion has very little affinity for many other 
trivalent species, such as Fe
3+
, Eu
3+
 and Ru(bpy)3
3+
, which essentially indicate 
that enhanced electrostatic interaction based on charge, is not the only or 
dominant factor responsible for nafion’s strong retention of any particular 
cationic species. In fact, it has been shown that solvation of the hydrophobic 
parts of a cationic complex by nafion’s organic chain material is a major 
determining factor for uptake and retention of cations, and considering the 
hydrophobic nature of the sepulchrate  ligand (containing at least  3 
methylene groups, see Figure 2.5(a)), this type of interaction is definitely 
highly possible.  
 Fouthly, nafion is eminent for its microscopic phase segregation, which is 
mainly constituted by the bulk polymer phase and the much lower density 
ionic cluster phase.   Electroactive counter ions are present in the ionic cluster 
phase and charge-based ion-pair formation, although present to some extent, 
is not significant in these polymers. In fact, it has been proposed that due to 
nafion’s high preference for organic cations, the ionic cluster regions must be 
regarded as a rather lipophilic environment, while the water contained within 
these regions acts a plasticizer, functioning to increase the free volume of and 
decrease the polymer chain concentration in the ionic cluster. 
 
Considering all the aforementioned unique structural attributes of nafion, the most 
fundamental conclusion that can be drawn at this stage is that the mechanism of 
retention of electroactive ions in nafion membranes are significantly different, as 
compared to conventional ion exchange polymers  nafion being largely dominated 
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by hydrophobic interactions, rather than the normal electrostatic forces. This also 
confirms and reiterates the proposed mechanism of uptake and retention for 
Co(Sep)
3+
 as described above. 
 
 
Another noteworthy finding, as determined from the voltammetric results exhibited 
for the GC|Naf|El-Co(Sep)
3+
 in the current study, is that the Epº’,  determined as -615 
( 5) mV, varies quite significantly from the value determined for the previous 
platform presented in Chapter 4 (-571  5 mV) but is quite similar to previously 
reported value obtained for a different investigation, conducted by Dewald and Chen   
(i.e., () -600 mV), which also involved a nafion-cobalt(III) sepulchrate composite 
film. In this regard, the composite film presented and discussed in Chapter 4, 
involved chemical  preparation methods, in which the Co(Sep)
3+
 was manually mixed 
with the pre-formed nafion film, whereas the protocol used by Dewald and Chen, on 
the other hand was based on potentiodynamic technique, in which Co(Sep)
3+
 was 
incorporated into the nafion film through electrochemical cycling in a contacting 
solution, containing the electroactive species. The overall fundamental deduction that 
can possibly be made from these findings is that electrochemical pre-concentration of 
cobalt(III) sepulchrate and/or other metal centred electroactive species in ion-
containing polymer films, such as nafion is a more effective method for producing 
stable composite films, as opposed to chemically preparative methods.  
 
  
Overall, a critical evaluation of the above presented and discussed voltammetric 
results for the GC|Naf|El-Co(Sep)
3+
 system, in terms of the determined Ip,a/Ip,c  ( 1); 
Ep (close to 65/n mV); Ep and variation with scan rates (negligible for  = 3→10 
mV), corresponds to a reversible system [74, 131]. On the other hand, for ideal 
Nernstian  electrochemical reversibility of a surface-confined  electroactive species,  
the relationship, Ep,c = Ep,a should be satisfied and in this regard, the difference in 
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peak potential, which was determined as an average value of 77 ( 5) mV, is 
consistent with semi-infinite linear diffusion, and not with ideal Nernstian  
electrochemical surface confined species for which peak potentials should coincide 
[130, 144].  In fact, the results obtained for the investigation of peak current on scan 
rate, of which the results are exhibited in Figure 5A.3, revealed a perfectly linear 
relation for the Ip/
½
  for both the cathodic and anodic peak currents, as shown in the 
inset of Figure 5A.3, with correlation coefficients obtained from linear regression for 
both  Ip,c/
½
 and Ip,a/
½
 functions determined as 0.9994. This finding essentially 
corroborates diffusion controlled electrochemistry for the GCE|Naf|El-Co(Sep)
3+
 
system. On the other hand, when looking at the cyclic voltammograms shown in 
Figure 5A.3, the reduction and oxidation waves were fairly symmetrically shaped 
and increased gradually with the scan the scan rates studied ( = 4  50 mV s-1), 
with no visible tailing observed. Such results, would normally indicate thin layer 
electrochemistry, usually accompanied by a linear Ip,c/ function, which is not the 
case here, as shown by the linear relation between peak current and square root of 
scan rate. These results, although seemingly baffling, can be perfectly explained and 
envisaged if one understands the peculiar nature of the mechanism of charge transport 
in ion-containing nafion films: Unlike conventional polymers,  containing 
electroactive sites along their polymer backbone, for which charge transport is a one 
dimensional process (Donnan equilibrium), mainly constituted by electron hopping in 
which electrons are transferred from reduced to oxidized sites in the film, play a 
major role in charge transfer within the films    in ion-containing polymers such as 
nafion, for which phase segregation and water of hydration in microdomains are the 
characteristic features, a significantly different model for charge transport has been 
shown [117-119]. Electroactive counter ions taken up by nafion, is by-and-large 
present in the randomly distributed low density ion cluster regions in nafion films. 
These clusters are inter-connected by small channels, and as such charge transport 
within such films in the absence of any chemical kinetic complications actually 
occurs through a three dimensional process, consisting of diffusional mass transport 
 
 
 
 
 Chapter 5   Results and Discussion: Biosensor Platform 2 
 
199 
 
of species through these channels,  largely controlled by what is known as the 
percholation effect, which proposes that the short channels connecting two 
neighboring clusters are thermodynamically stable. In fact, it has been documented 
that in nafion membranes, all electron hopping processes has been shown to be 
equivalent to a diffusion process and as such the overall rate of charge transport can 
be described in terms of an apparent diffusion coefficient [119]. What is more, in a 
previously documented study conducted by a different research group [124], in which 
Co(Sep)
3+
 was pre-concentrated through potentiodynamic cycling into a pre-formed  
nafion film, the current function, Ip/
½
 also exhibited a constant value at different 
scan rates, which essentially corroborates the results obtained in the current research 
investigation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5A.3: Cyclic voltammograms of  GC|Naf|El-Co(Sep)
3
 showing voltammetric 
response in argon-degassed PB with increasing scan rate (4 – 50 mV s-1). Inset: 
Influence of scan rate on cathodic (Ip,c) and anodic (Ip,c) peak current 
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With regard to the charge transfer diffusion coefficient  (Dct) for this study in 
particular, the Randle Sevcik behaviour of the cyclic voltammetric peak currents, as 
exhibited in Figure 5A.3, was used to evaluate Dct from the slope of the straight line 
obtained from the Ip,c vs 
½
 plot [129, 131], by using the equation,  
  
 
 = 
                           
 
 
= slope, where A is the geometric surface area of the electrode, Γ is the surface 
concentration of the El-Co(Sep)
3+
 (1.537 x 10
-5
 mol cm
-2
) and L is the thickness of 
the film (3.10 x 10
-3
 cm). Based on this method, using the already calculated 
aforementioned values for Γ and L, the Dc,t for this study was determined as 
2.64 x 10
-7
 cm
2 
s
-1
.  Compared to other metal-centred cationic species incorporated 
within nafion films of similar thickness, i.e. Ru(bpy)3
2+
[119] [141]; Ru(NH3)6
3+
 
[143]; [Os(bpy)2(PVP)10Cl]Cl [145], the aforementioned value of Dc,t obtained in 
the current study is in the higher region. In fact, it is comparable to 
previously reported values  obtained for smaller counter -ion species, 
Na
+
 (9 x 10
-7
 cm
2
 s
-1
) [143], which is eminently known for its fast diffusion 
through nafion films, as compared to many other pre-concentrated cationic 
counter-ion species. Moreover, it has been documented that a larger Dc,t is a 
reflection of a more homogeneous distribution of the cationic species within the 
microstructure of the polymer film [119].  The cumulative significance of the latter 
and aforementined findings, once again is of course to exemplify and reiterate the 
effectiveness of the technique used in the current study for pre-concentration of the 
cationic species within the nafion film.     
 
In addition to the above results exhibited for scan rate studies, the plot of  logIp vs log 
 for both anodic and cathodic peak currents, revealed slopes of 0.47 and 0.52 for log 
Ip,a/log  and log Ip,c/log  respectively.  Both these values are close to the theoretical 
value of 0.5 for diffusion controlled electrode processes [122] and as such, 
corroborates the above findings. The results for these plots are shown in Figure 5A.4.  
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Figure 5A.4: Plots of log Ip vs log  for cathodic and anodic peak currents, to show 
influence of scan rate on peak current for GC|Naf|El-Co(Sep)
3+
 films 
 
 
 
5A.2.1 Long-term stability of the GC|Naf|El-Co(Sep)
3+
 film 
 
Due to nafion’s unique method of cation extraction and uptake, which, as 
described in aforementioned and preceding sections is distinctly different and more 
effective than conventional ion-exchange resins and/or electrostatic binding polymers 
[118-119], combined with its  phase segregation enabled three-dimensional charge 
transport network, providing molecular accessibility and rapid diffusional mass 
transport of electroactive species [104-105, 118, 143], as well as its renowned 
superior chemical and thermal stability [146-147], a factor that remains, even in the 
presence of strong oxidants at elevated temperatures  nafion-based electrodes has 
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been shown to have a greater lifetime, while retaining electroactive species for longer 
times than other ionic polymer and/or coordinating polymer based electrodes. In this 
regard, to illustrate long term stability, the storage stability of the  nafionEl-
Co(Sep)
3+
 film was investigated, of which the results are exhibited in Figure 5A.5, in 
which Day 0, refers to the day of fabrication of the GC|Naf|El-Co(Sep)
3+
 film, and as 
such, considered as time 0.  A close evaluation of the results depicted in Figure 5A.5 
revealed the following: 
 On the third day, there was a 13% and 8.8% decline in the magnitude of Ip,c 
and Ip,a, respectively. This was accompanied by a cathodic peak potential 
shift for both Ep,c and Ep,a by a magnitude of 16 mV and 9 mV, respectively. 
In addition to this, the formal potential (Eº') for GC|Naf|El-Co(Sep)
3+
 
shifted cathodically by  13 mV, as compared to the original CV exhibited 
for Day 0. 
 On the fifth day of storage, there was a 14.3% decline in the magnitude of  Ip,c. 
On the other hand, the no measurable change in Ip,a was observed, as 
compared to what was determined for the third day. As for Ep,c and Ep,a, once 
again a cathodic shift was observed corresponding to a magnitude of 30 mV 
and 24 mV for Ep,c and Ep,a, respectively. Similarly, the Eº' shifted 
cathodically by a magnitude of 27 mV, as compared to the original 
results for the GC|Naf|El-Co(Sep)
3+
 film observed on Day 0. 
 
Overall, the above electrochemical results for the GC|naf|El-Co(Sep)
3+
 system 
showed that, upon storage for up to one week in dry conditions at ambient 
temperature (23 3 ºC), the film still retained 73% of its original 
electrochemical signal, without the need for storage and/or physical contact 
with the Co(Sep)
3+
-containing supporting electrolyte. Moreover, the 
presented CVs were recorded after repeated cycling, when a steady state in 
Ip,c and Ip,a were attained, in which these cycles were completely identical and 
showed no loss of signal, which are all indications of a stable film.  
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Figure 5A.5 Cyclic voltammetric reponse showing variation in Faradaic current 
and peak parameters (Ip,c; Ip,a; Ep,c; Ep,a) of the GC|Naf|El-Co(Sep)
3+
 films with 
numbers on the curves denoting days elapsed after fabrication. The voltammograms 
were recorded in anaerobic PB (50 mM; pH 7.45) 
 
 
 
The cumulative implications of all the preceding and aforementioned 
results with regard to the Co(Sep)
3+
 loading, voltammetric behaviour, as well 
as the stability of the composite nafion-El-Co(Sep)
3+
, is quite significant, since 
it not only accentuates improvement as compared to techniques applied in 
numerous previously conducted research investigations involving incorporation 
of metal-centred cationic species into nafion films, but also exhibits 
enhancement in terms of long term stability, as opposed to some of these 
studies: 
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 Firstly, loading methods used by most previously conducted research 
investigations involved either physical equilibration with the solution, which 
were usually done from a few hours up 24 hours to ensure adequate loading or 
in some cases,  potentiodynamic techniques using potential cycling for up to 
2-3 hours in the supporting electrolyte containing the metal centred cationic 
species (analyte solution) [124, 143].  To recall, the technique applied in the 
current study on the other hand, involved potentiostatic deposition of the 
Co(Sep)
3+
 at +450 mV for 20 min, which overall, resulted in a highly stable 
composite film. In this context, with regard to Co(Sep)
3+
 in particular, the  
rate of loading for the current research investigation was considerably faster 
(by  a  factor of 6), as compared to rate observed for Co(Sep)
3+
 loading for a 
study conducted by Dewald and Chen [124] who used the potential cycling 
pre-concentration technique.  
 Secondly, the composite nafion-El-Co(Sep)3+- (GC|naf|El-Co(Sep)3+) film 
exhibited well defined, stable voltammetric behaviour, upon repeated cycling  
in the PB supporting electrolyte containing no Co(Sep)
3+
 analyte. In some 
other studies, conducted by other research investigators involving composite 
nafion/metal centred cation species, however, stable CVs were only possible 
in electrolyte solutions containing the cationic analyte [143, 148].  
 Thirdly, under the experimental conditions applied for the current study, the 
GC|naf|El-Co(Sep)
3+
  film maintained at least 73% of its original signal after 
five days of storage, whereas for methods based on pre-concentration of metal 
centred cationic species (analyte) through physical equilibration techniques 
especially   maintaining adequate signal response of the composite film was 
only possible in conjunction with storage in the supporting electrolyte [119].   
 
Before commencing with subsequent discussions, a final important subject 
to also address, is the implications of the exhibited voltammetric behaviour of the  
naf|El-Co(Sep)
3+
  composite film with regard to its proposed application, i.e., as 
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mediating-carrier matrix platform for amperometric biosensor construction with the 
synthesized  n-terminally modified recombinant CYP3A4 (n-CYP3A4). As already 
accentuated and discussed in Section 2.2.4 in Chapter 2,  creating a successful 
reagentless amperometric mediated biosensor requires effective retention of the 
mediator at the electrode surface, and, perhaps more importantly, allowing 
simultaneous free diffusional movement of the mediating species, as well as rapid 
electrochemical communication to-and-from the electrode surface. In fact, according  
to relevant literature survey, it has been recorded that the diffusional movement of the 
mediator is an essential prerequisite for a productive electron transfer [65, 149] in 
mediated biosensors. Taking into consideration the latter and aforementioned  
criteria: Based on the results exhibited and discussed in terms of electrochemical 
performance factors of the composite film, as well as critical comparisons to relevant 
literature findings, the suitability of the prepared naf-El-Co(Sep)
3+
  film with regard 
to suitability for biosensor construction was critically assessed and the findings 
summarized. In this regard, firstly, as corroborated by previous findings, nafion was 
shown to retain and incorporate the electroactive cation mediator distinctly different 
from other ion exchange polymers/resins, which resulted in a more stable film, 
exhibiting good reversible electrochemistry. Secondly, also as corroborated by 
previous findings, in the absence of any kinetic complications, the electrochemistry of 
the film is dominated by diffusional movement, which as elaborated above, is 
fundamental for productive electron transfer.  Thirdly, due to nafion’s considerably 
lipophilic nature, essentially containing no water leachable components, formed 
membranes/films consequently should have  much longer lifetime, particularly with 
regard to incorporated electroactive counter-ion species [118] [117]. In fact, research 
has shown that unlike conventional polymer membrane ion selective electrodes 
(PMISEs), which require plasticizers and covalently attached ligands to increase ionic 
mobility in the polymer membrane, as well as preventing loss of electroactive species 
from the membranes, ion containing polymers, like nafion, requires no additional 
components and films containing ionic species have shown stability for up to six 
months [117]. In this context, as evaluated by the results exhibited and discussed for 
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long term stability, the  Naf|El-Co(Sep)
3+
film corroborated the aforementioned 
findings and thus maintained a high electronic signal after storage for up to one week.    
 
 
 
5A.2.2  Electrochemical behaviour of GCE|Naf|Co(Sep)
3+
 with Ruthenium(III) 
hexaamine redox probe 
 
It is an eminent fact that nafion has an unusually high affinity for 
ruthenium(III) hexamine. In this regard, thus it seemed appropriate to further 
investigate the integrity and charge-transfer behaviour of the naf|Co(Sep)
3+
 film by 
using Ru(NH3)6Cl3 as a redox probe, for which the studies were done in PB 
containing 1 mM Ru(NH3)6Cl3. Upon initial potentiodynamic cycling  in the  
Ru(NH3)6Cl3 containing PB with the GCE|naf|Co(Sep)
3+
 electrode, there was a 
gradual increase in Ip,c and Ip,a with time, of which steady state background current 
was obtained after approximately five hours. The CVs are shown in Figure 5A.6, for 
0 – 5 hour equilibration time. The results, in terms of increasing Ip,c and Ip,a is 
completely in accordance with previous findings, and in this regard, usually 
signifies the extraction and pre-concentration of the  Ru(NH3)6
3+
 into the film  
a process which, for a 1 μm thick nafion film, normally takes up to one day for 
completion. However, the uptake of the Ru(NH3)6
3+
  into the film can only be 
conclusively deduced, with the aid of additional investigations, such as determination 
of distribution coefficients (kD), etc., however such parameters were not determined 
at this stage, since it is not required for the scope of the dissertation.   With regard to 
further evaluation of the CVs presented in Figure 5A.6, a fairly well-defined redox 
couple  can be observed,  which corresponds to the oxidation and reduction of the 
Ru(NH3)6
3+
/Ru(NH3)6
2+ 
 couple.
 
The specific peak parameter values for Ep,c; Ep,a; Eº', 
for the redox couple were determined as -210 mV; -145  mV and -176 mV ( 5 mV) 
respectively. These were determined as mean standard deviation at low scan rates, 
where exhaustive electrolysis were possible, as such converting all of the  Ru(NH3)6
3+
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to Ru(NH3)6
2+
.  Furthermore, |Ip,c/Ip,a| was determined as 1.4, while a peak potential 
difference (ΔEp)  of 60 ( 2) mV  signified semi-infinite linear diffusion, as it is close 
to the theoretical value of 57 mV for a diffusion controlled system.   Diffusion control 
was confirmed by varying the scan rate, as shown in  Figure 5A.7 which exhibits the 
cyclic voltammomatric responses, as well as a linear relationship of Ip,c and Ip,a with 
½  of  Ru(NH3)6Cl3 at the GC|Naf|El-Co(Sep)
3+
 electrode for scan rates from 10 
to 150 mV s
-1
. A closer evaluation of the exhibited CVs, shows a gradual 
increase in both Ip,c and Ip,a with each scan rate, up to 150 mV s
-1
, coupled with 
a very small cathodic and anodic peak shifts for the cathodic wave and anodic 
wave, respectively, with each scan rate (by a magnitude of  5 mV). The 
Randles-Sevcik relation for a one-electron reaction was applied to determine 
the apparent diffusion coefficient, based on the following equation:  
 Ip = (2.687 x 10
5
)n
3/2½ Dapp
½ 
AC 
Where Ip is the peak current, n is the number of electrons transferred,  is the 
scan rate (V s
-1
), A is the electrode are (cm
2
), C is the bulk concentration Dapp 
is the Ru
3+
/Ru
2+
 diffusion coefficient (mol cm
-3
). In this regard, by using the slope of 
the straight line obtained from the Ip,a vs 
½
 plot, and applying it in the Randles-
Sevcik equation (Equation ), Dapp was determined as 7.982 x 10
-10
 cm
2
 s
-1
. It is 
noteworthy to add though, that the obtained  Dapp is slightly on the low side, but is 
not entirely unexpected, since usually smaller ions like Na have, is expected 
and indeed does exhibited larger diffusion coefficients [143]; on the other 
hand, research has shown that diffusion of Ru(NH3)6
3+
 into pre-formed nafion 
films can take up to 24 hours to reach equilibrium, while equilibration for 
Ru(NH3)6
2+
 uptake can take up to one week [117, 143], which essentially 
translates into corresponding generally lower Dapp values. That being said, 
considering the preformed nafion film already contained a counter-ion 
(Co(Sep)
3+
), which were quite stably retained,, as well as the fairly good 
charge transfer/electrochemical behaviour of the film with respect to the  
Ru(NH3)6Cl3 redox probe, including the fact that equilibration with RuNH6
3+
 took  5 
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h  to attain a steady state – the obtained Dapp are well within reason. Moreover, the 
value obtained for Dapp for Ru
3+
/Ru
2+
 in this study is actually completely in line 
with literature reported values for nafion film of similar thickness (i.e. ≈ 1x10-10 – 
25x10
-10
 cm
2
 s
-1
).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 5A.6 Cyclic voltammograms (5 mV s-1) of the GC|Naf|El-Co(Sep)
3+
 
electrode in anaerobic PB containing 1 mM ruthenium(III) hexamine chloride 
[Ru(NH3)6Cl3]. Voltammograms at 0-, 1-, 3-, and 6 hours are shown 
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Figure 5A.7 Cyclic voltammograms showing the influence of scan rate on 
oxidation and reduction peak current for 1 mM  ruthenium(III) hexamine chloride 
[Ru(NH3)6Cl3], in 50 mM PBS (pH 7.4) at the GC|Naf|El-Co(Sep)
3+
 electrode. 
Scan rates in order of increasing peak height are 10, 20, 30, 40, 50, 60, 70, 80, 
90, 100, 110, 120, 130, 140 and 150 mV s
-1
. In set shows the linear 
relationship between peak current (Ip,c and Ip,a) and 
½
, with determined slopes 
 
 
 
 
5A.3 Morphological and structural characterization of the Naf-El-Co(Sep)
3+
 
film 
 
To get a complete comprehensive overview of a prepared platform, morphological 
and structural investigation of the film is also required, of which these investigations 
may be conducted through various spectroscopic and microscopic techniques, but the 
most eminent being, normally done through Scanning Electron Microscopic (SEM) 
analysis and Fourier Transform Infrared (FTIR) Spectroscopy, respectively. In this 
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regard, obtained FTIR spectra enables the assignment of unique characteristic 
vibrational signals, which allows for easy structural analysis of compounds. 
Similarly, changes in chemical environments due to incorporated chemical 
components, etc. induces vibrational peak shifts, which may aid in structural 
characterization of composite material.  On the other hand, SEM analysis allows for 
top-sectional and/or cross-sectional views, revealing more detailed information on 
film morphology, and integrity of film constituents. 
 
 
5A.3.1 Morphological characterization: Scanning Electron Microscopy (SEM)
  
 
Figure 5A.8 a – c shows top view SEM images of the blank screen printed 
electrode (bSPE), nafion-modified SPE (nafSPE), as well as the Co(Sep)3+ modified 
electrode (SPE||naf|El-Co(Sep)
3+
). Compared to the rough surface observed for the 
bSPE, the surface morphology exhibited by the nafion film on the other hand, 
revealed a microstructure with a smooth consistency, which indicates a chemically 
stable membrane that covers and protects the underlying electrode. In this regard, 
according to research findings, nafion is known to maintain its chemical stability 
under extreme conditions – proven to maintain characteristic structural bonds even 
when exposed to radical producing H2 or O2 environment for up to 1000 hours [111]. 
The incorporated Co(Sep)
3+
 cation species did not induce any noticeably visible 
changes  to the nafion-derivatised film, but rather also exhibited a fairly smooth film, 
as shown in Figure 5A.8 (c). The notable similarity of the composite naf|El-
Co(Sep)
3+
-film to the film consisting only of nafion is indeed an interesting feature, 
not an entirely unexpected phenomenon, since as described in preceding sections 
within this chapter, once exposed to the Co(Sep)
3+
, the nafion extracts the cation 
species and it subsequently taken up within the nafion microstructure, which 
essentially means that, although inherent structural changes within the nafion 
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microstructure occur, this does not necessarily translate into visible changes and as 
such, not much visible changes of the film surface is really expected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5A.8: Top Scanning electrochemical microscopy images of electrode and 
films: (a) blank screen printed electrode (bSPE); (b) Naf modified SPE (nafSPE); (c) 
nafSPE with pre-concentrated Co(Sep)
3+
 (SPE||naf|El-Co(Sep)
3+
)   
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At this stage, still on the subject of the exhibited SEM-images, an important aspect to 
bring to the reader’s attention, is the fundamentally unequivocal dissimilarity in the 
surface morphology with respect to the pre-formed nafion membrane, as well as the 
Co(Sep)
3+
-modified nafion membrane in the current study, as compared to what was 
observed for the study presented and discussed in Chapter 4. In this regard, for the 
current study, both films exhibited a compact nature with a highly smooth 
consistency, whereas those observed in the previous chapter was highly unevenly 
distributed films with very little signs of compactness. This finding is quite 
significant, since firstly, the compact nature and smooth consistency of the nafion 
film, in turn allows for a better coverage and/or protection of the underlying 
electrode. Secondly, the marked similarity of the modified and un-modified nafion 
films, essentially portrays a good extraction and uptake of the incorporated Co(Sep)
3+
 
within the nafion microstructure. The cumulative sub-conclusion which may be 
drawn from these findings point to the improvement in technique used for film 
preparation, as compared to the experimenter’s initial approach used for the design of 
biosensor platform 1  in Chapter 4. The observed improvement may be attributed to 
the different approach taken in terms of design parameters, with particular reference 
to the amount of nafion cast, the technique used for nafion film formation, as well as 
the specific technique used for incorporation of the Co(sep)
3+
 species, as compared to 
the design path used in the preparation of the carrier matrix for the preparation of 
biosensor platform 1.         
 
 
 
5A3.2 Structural characterization: Fourier Transform Infrared Spectroscopy 
(FTIR) 
 
Figure 5A.9 a – c shows the FTIR spectra of nafion used in this study, 
commercially obtained cobalt(III) sepulchrate trichloride, as well as the 
electrochemically prepared nafion/El-Co(Sep)
3+
 composite membrane, respectively. 
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In this regard, the spectra exhibits the major vibrational fingerprints associated with 
each singular and/or composite compound, of which the assignment of vibrational 
bands was based on relevant already published data, as well as theoretically 
established IR correlation charts. With regard to the un-modified ‘pure’ nafion 
membrane exhibited in Spectra a, characteristic absorption bands associated with 
CF2 asymmetric stretching (1207 cm
-1
), CF2 symmetric stretching (11490 cm
-1
), S-O 
symmetric stretching (1058 cm
-1
), C-O-C stretching (981, 862 cm
-1
), and C-F 
stretching (630 cm
-1
) are shown and identified within the graph [111-114, 116, 150]. 
In terms of the pure Co(Sep)
3+
 exhibited in Spectra b, absorption bands associated 
with methylene groups (733, 834, 2850, 3034 cm
-1
), and secondary amines (1055, 
1130, 1168, 1335, 1366, 1444, 3415, 3520 cm
-1
), associated with the characteristic 
structural features of Co(Sep)
3+
 (see Figure 2.5, Chapter 2)  is shown [115].   
 
 
With regard to the Co(Sep)
3+
-modified nafion film (naf|El-Co(Sep)
3+
), shown in 
Figure 5A.9 (c), most of the major vibrational fingerprint bands associated with the 
nafion are also exhibited; however, positional shifts in vibrational bands, as well as 
new vibrational bands is exhibited in the FTIR spectra. This is an unequivocal 
indication of structural changes within the microstructure of the nafion membrane and 
can broadly be ascribed to the incorporation of the electrochemically deposited 
Co(Sep)
3+
 within the membrane. In this regard, vibrational absorption bands 
associated with the structure of Co(Sep)
3+
 are indicated/highlighted by differently 
coloured arrows in Spectra b and c of Figure 5A.9. Thus, in a more descriptive 
context regarding Spectra c, in terms of a more in-depth investigation of the presence 
of Co(Sep)
3+
 in the modified nafion membrane in particular, firstly, the appearance of 
vibrational bands located at 735-, 835 and 971 cm
-1
 (highlighted by the red arrows) 
can be ascribed to the methylene groups associated with the structure of Co(Sep)
3+
. 
Secondly, the appearance of absorption peaks for secondary amine groups, located at 
1367 and 1448 cm
-1
, indicated by green arrows as shown in Spectra c, once again 
signifying and confirming the presence of Co(Sep)
3+
 within the nafion membrane. 
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Another very noteworthy aspect is that the FTIR spectra for the unmodified nafion 
membrane (Spectra a) exhibited a notable amount of inherent water content signified 
by the broad peak for stretching vibration of water molecules ranging from ≈ 2620 – 
3740 cm
-1
, whereas no such observable peaks in this region for the Co(Sep)
3+
-
modified nafion membrane can be seen in Spectra c. This is not unexpected, since 
un-evacuated/un-heat-treated, pure nafion membranes are known to contain an 
appreciable amount of water, constituted by hydrogen bonded, partially hydrogen 
bonded and non-hydrogen bonded water molecules [114]   of which these water 
molecules decreases relative to the increase in concentration of and/or size of 
counter-ion species (particularly hydrophobic cation species) [118] and considering 
that on average, each prepared nafion membrane used in the current research 
investigation (thickness ≈ 3.1 μm) contain ed at least    1.5 x10 -5  mol 
cm
-2
 extracted/pre-concentrated Co(Sep)
3+
 counter-ion species, a significant decrease 
of water content are within experimental expectancy. Moreover the intensity of the 
CF2 absorption bands, as well as  for the sulphonic group (1055 cm
-1
) in the 
Co(Sep)
3+
 modified nafion membrane shown in Spectra c are more intense and 
slightly shifted as compared to the bands observed for the unmodified nafion 
membrane shown in Spectra a. Considering the afore-discussed visibly reduced 
water content associated with the modified nafion membrane, this is certainly not an 
unexpected phenomenon: Generally each sulphonic cluster region in an unmodified 
nafion membrane contains water filled pockets consisting of approximately 1000 
water molecules and the ensuing interaction of the sulphonate ion groups with these 
water molecules results in less intense SO (SO3

) absorption bands (as seen in 
Spectra a ≈ 1058 cm-1). Moreover, these water molecules is known to function as a 
plasticiser, thus increasing the free volume (and decreases the concentration of the 
polymer chain) in the sulphonic clusters [117]. However, as the concentration and/or 
size of the counter-ion species increases during ion pre-concentration and/or 
modification of the nafion membrane, a the cumulative effect concomitantly results in  
loss of water molecules (dehydration) from the sulphonic cluster regions, with a 
simultaneous increase in the role of the CF2 groups, thus leading to more intense 
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FTIR absorption bands for these groups . Furthermore, another prominent finding as 
observed from the current spectra, is the appearance of a new absorption band of 
quite  strong intensity at 1742 cm
-1
 which is likely to also be associated with the 
structural changes due to the blending vibration of the incorporated cationic 
Co(Sep)
3+
 species, which, based on the upward shift of the frequency as compared to 
position of absorption band observed in that vicinity (see Spectra a) for the 
unmodified nafion membrane, this may be attributed to the resultant effect of specific 
interactions such as  strong hydrogen bond interactions between the Co(Sep)
3+
 and 
structural groups in the nafion microstructure [114, 118].       
 
 
 
Figure 5A.9: Fourier Transform Infrared Spectroscopy (FTIR) spectra of (a) 
unmodified nafion membrane; (b) commercially obtained cobalt sepulchrate   
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On a sub-conclusive note, in a conclusive observation regarding the afore-presented 
and discussed FTIR results, an interesting feature to once again bring to the reader’s 
attention, is the conspicuous variation in the mictrostructure of the Co(Sep)
3+
 
modified nafion membrane, compared to that observed for ‘pure’ nafion, particularly 
with regard to the marked difference in water molecules and associated structural 
vibrations. In a critical comparative evaluation, with specific reference to the FTIR 
results exhibited for the nafion-CMECo(Sep)
3+
 carrier matrix in Chapter 4, for which 
a chemically-based modification technique was applied, the results were significantly 
different. In the context of the explanative significance of these findings, the reader’s 
attention  is drawn to the following facts: Generally, the change in the chemical 
nature of the ionic domains associated with the nafion structure, is caused by the 
increasing uptake and incorporation of the  cationic species, particularly in the case of 
compounds with hydrophobic ligands. This behaviour is caused by a change in 
polarity of the microenvironment surrounding a portion of the sulphonate groups 
from hydrated, inverted micelle type domains to a more hydrophobic, low dielectric 
medium. As the content of the  counter-ion species increases, the ionic clusters 
become increasingly dehydrated and the quantity of the other linkages which 
penetrate into the polar interior of the ionic clusters decreases while the quantity of 
ether groups surrounded by the less polar regions of the ionomer increases. Hence, in 
this regard, the fundamental structural changes observed in accordance with the 
modified nafion microstructure, is in fact a good indication of the effective uptake of 
the counter-ion mediator species, which in turn signify the superior efficiency of the 
electrochemically-based technique, as opposed to the chemically-based, manual 
casting/mixing technique used in Chapter 4.  
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5A.4 Conclusions 
 
The cationic species, Co(Sep)
3+
, was successfully incorporated into the 
microstructure of the pre-formed nafion film through potentiostatic electrochemical 
deposition method. Moreover, FTIR spectroscopic studies confirmed the 
incorporation of the e Co(Sep)
3+
 species deep within the microstructure of the nafion 
membrane. In addition to this SEM analysis revealed that the formed composite has a 
exceedingly smooth consistency with a highly compact structure. In addition to this, 
results obtained from electrochemical investigations all pointed to a stably prepared 
electroactive film, which exhibited excellent electrochemical characteristics, 
particularly in terms of fast reversible electron transfer with the underlying electrode 
as well as stability and reproducibility. Compared to other pre-concentration methods 
involving metal-centred electroactive species, the technique applied in this study 
enabled the incorporation of the highest possible percentile of electroactive counter-
ion species within the shortest possible time,  with a   Γ value  of the incorporated 
counter ion species. Similarly, a fairly high obtained charge transfer diffusion 
coefficient, 2.64 x 10
-7
, was evidence of a fast uptake of cationic species, as well as 
the ease of preparation using the proposed method.  
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CHAPTER 5B 
 
 
 
 N-terminally modified genetically engineered human 
recombinant P450-3A4 (nCYP3A4) biosensor for the 
determination of protease inhibitor ARV drug, Indinavir:  
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Abstract 
A catalytically active N-terminally modified human recombinant CYP3A4 isoenzyme 
was successfully prepared through genetic engineering, as a catalytically active 
histdine-tagged N-terminally modified soluble construct. The active P450 content 
was corroborated with The catalytically active P450 content was confirmed by the 
absorption maximum of the reduced CO-bound complex at 450 nm. A reagentless 
mediated biosensor was constructed with cobalt(III) sepulchrate [Co(Sep)
3+
] as 
mediating species, integrated within the microstructure of a pre-formed nafion base 
film by potentiostatic deposition, and the  prepared  enzyme  was used as the bio-
recognition component. Stable enzyme immobilization was ensured by a combination 
of entrapment and encapsulation.  In this regard, to ensure enzyme stabilization and 
retention of catalytic activity, the immobilized enzyme was encapsulated with a ionic 
hydrogel-composite membrane. The hydrogel was prepared through pre-blending, via 
the combination of agarose (Agrs) hydrogel with hydrophilic polymer, poly(vinyl 
alcohol) (PVA) and cationic polyelectrolyte, polyethylene amine (PEI). The 
combination of PVA and agarose , while the addition of PEI enabled the ionic cross 
linking of the biocompatible Agrs-PVA composite hydrogel, and thus confirming  
reduction in the swelling index of both polymers, while also inducing ionic cross 
linking of the polymers, thus ensuring a more stable insoluble hydrogel blend, with a 
porous meshwork that still freely allowed the diffusion of the substrates into the 
reagent layer. The prepared biosensor, GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-
PVA, exhibited a low operating potential for oxygen reduction, determined as -365 
mV. The biosensor successfully detected and quantified the selected model substrate, 
indinavir. In this regard, the biosensor showed a linear range between 2.183 x10
-6
  
3.552 x 10
-6
 M, a sensitivity of 0.0349 A M-1, while the LOD was determined as 
59.72 mg L
-1
. The LOD was shown to be of significance in the CMax of the ritonavir-
boosted regimen, as well as for poor metabolisers. Control experiments corroborated 
the bio-electrocatalytic response from the active enzyme.   
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5B.1 Introduction 
 
The PI ARV, indinavir is given either by itself, or in association with 
booster-PI ARV, ritonavir. An important problem associated with the standard 
singular and/or boosted regiment is the manifold side effects, which is in direct 
relation to drug-induced toxicity, in association with the P450 3A4 first pass 
biotransformation pathway. Therefore, therapeutic drug monitoring (TDM) is always 
a highly recommended fundamental aspect of indinavir treatment, which normally 
involves blood samples taken and sent for analysis with standard centralized 
techniques by trained personnel  in effect boiling down to a tedious and expensive 
endeavour.   However, the often overlooked, but clearly pivotal subject-area during 
such treatment regimes,  is finding alternative, cheaper, decentralized techniques for 
TDM of indinavir and/or other HAART associated drugs. In fact, during the initial 
comprehensive literature survey, approximately one journal, focussing on cheaper 
alternative detection/quantification method for selected HAART drug, nevirapine, 
based on the development of a immunochromatographic (IC) strip test, was found 
[16]. In contrast, all other available literature focussed on enhancing centralized 
methods of detection and analysis, particularly, HPLC  a technique which in spite 
of its precision, is highly expensive, requiring tedious sample preparation with trained 
personnel. In this regard, biosensors is the only analytical device that have the 
potential to parallel the detection and quantification ability of these centralized 
methods, the difference here of course being a much more simplified analysis 
technique and real-time analysis. Moreover, due to the complexity and unique nature 
of CYP3A4 enzymes, substantially multifaceted electron transfer machinery is 
required to support this membrane bound, microsomal mammalian heme thiolate 
enzyme chemistry, and in this regard, the electrochemical platform provided by 
biosensor configurations can substitute for many of these needed components. On the 
other hand, genetically manipulated cells expressing single CYP genes/isoenzymes, 
can be an effective way of providing a continuous supply of biological recognition 
component for these biosensor platforms. In such configurations, an important 
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aspects is enzyme immobilization. In this regard, although immobilization methods 
for mammalian microsomal P450 isoenzymes are not as yet entirely well established, 
gel-entrapment has been documented as the least damaging to such enzymes and can 
even be used in methods when reusable enzyme-based sensor platforms are required. 
The high preference for hydrogel material is based on collective inherent favourable 
attributes, of which the most eminent include their considerable water imbibing 
ability, and soft consistency which is similar to natural tissue. In fact, hydrogels 
resemble natural living tissue more than any other class of (synthetic) biomaterials, 
and are thus considered highly biocompatible 
 
In this study, the favourable interaction between the ionomer, nafion, and the 
Co(Sep)
3+
 mediating species was further explored and harnessed for utilization in the 
creation of alternative analytic tool for decentralized method of therapeutic drug 
monitoring, specifically aimed at selected HAART associated drug components. This 
was done through the creation of a sophisticated, robust reagentless-type mediated 
biosensor, prepared through the innovative combination of potentiostatic deposition 
technique, combined with genetic engineering technology and complimented by the 
application of three-dimensional biocompatible hydrogel blend-membrane creativity. 
In this regard, firstly a highly stable and reproducible electroactive carrier matrix was 
prepared  through potentiostatic electrodeposition of Co(Sep)
3+
 onto a pre-formed 
nafion membrane, for which the results were presented and comprehensively 
discussed in Chapter 5A. Secondly, a reagentless, mediated enzyme-based biosensor 
was constructed, by using the heme domain of mammalian microsomal CYP3A4 
(expressed as a catalytically-active histidine-tagged, N-terminally modified soluble 
construct) as bio-recognition component. In addition to this, stable enzyme 
immobilisation was ensured by its mild entrapment in an ionically-based three-
dimensional hydrogel blend, consisting of agarose, polyvinyl alcohol and 
polyethyleneimine. In keeping with the main aim of the biosensor, the HAART 
associated protease inhibitor ARV drug, indinavir, was used as model substrate, in 
order to evaluate its performance in the detection and quantification of ARV drug 
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components. As elaborated in the Prelude of Chapter 5,  a major aim of the current 
biosensor was to improve the characteristics of the Co(Sep)
3+
 biosensor (designed and 
created in the research investigation presented and discussed in Chapter 4), with 
particular reference to pre-determined aspects, of which the most fundamental was 
the following: 
 Designing a reproducible method of preparation of the carrier matrix, 
especially in terms of preventing/alleviating pre-mature and/or long-term 
leaching of medating species; 
  Pre-concentrating a larger percentile of mediating species in the nafion 
microstrucure to allow faster enzyme/electrode interaction at the shortest 
distance; 
 Lowering the operating potential (to a less cathodic value), especially in terms 
of the reduction of dioxygen, which plays a pivotal role in the reaction cycle 
of nCYP3A4’s electrcatalytic response to the substrate. Moreover a less 
negative oxygen reduction potential would also  considerably alleviate any 
air-sensitivity/reactivity of the Co(Sep)
3+
 mediating species within the 
nCYP3A4-based biosensor configuration, a process that would strongly 
curtail the potential formation of reactive intermediate species that could 
affect the efficiency of the bio-electrocatalytic activity of the enzyme to 
oxygen and selected substrates ;  
 Incorporating cheaper alternatives for selected reagent-layer components, 
sourced commercially. 
On the subject of improving the operating potential with respect of reduction of 
dioxygen in particular  the results obtained for biosensor-platform1, presented and 
discussed in Chapter 4, was used as primary reference point, and as such obtained 
results on this factor was comparatively evaluated. Thus, with all the proposed 
criteria in mind, design and optimisation of the nCYP3A4-based biosensor with 
regard to major objectives and sub-problems were conducted accordingly. 
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5B.2 Structural aspects of the genetically engineered his6-tagged N-terminally 
modified recombinant CYP3A4 (nCYP3A4) 
 
Before commencing with presentation and discussion of the 
electrochemical results, the synthesized nCYP3A4 enzyme was subject to specific 
characterization studies, to verify and corroborate certain characteristics associated 
with CYP450 enzymes, for which the results are subsequently presented and 
discussed.  
In general, cytochrome P450 (CYP450) enzymes, in their naturally 
oxidised resting state, portray inherently unique trait-specific conformational and/or 
structural features, which are easily distinguishable by specific complimentary in-
situ/ex-situ spectrophotometric, spectroscopic and/or biophysical techniques. 
Moreover, in their reduced and/or excited state, these enzymes undergo characteristic 
conformational changes which are also discernible through the application of such 
complimentary methods. The significance of such techniques also allows 
experimenter to assess the success of expression/synthesis methods used for 
preparation of these enzymes with genetic engineering, since secondary/tertiary 
enzyme structure exhibit unique characteristics, which are easily determined by these 
methods. In this regard, depending on the specific purpose, there are a number of 
possible techniques that can and have been applied, which include Fourier transform 
infrared (FTIR) spectroscopy, Utraviolet-Visible (UV-Vis) absorption spectroscopy, 
Circular dichroism (CD), Resonance Raman spectroscopy. In the interest of the scope 
of this dissertation however, only results for FTIR and UV-Vis spectroscopic analysis 
are shown and discussed, since these two techniques are basic exploration methods 
which can provide sufficient information regarding the secondary structure of 
CYP450 enzymes. For a more comprehensive outline regarding the structure-function 
and other biophysical properties of these enzymes, the reader is encouraged to read 
the PhD dissertation of Natasha Beeton-Kempton .  
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5B.2.1 Fourier transform infrared spectroscopy  (FTIR) characterization [151-
152] 
 
The characteristic shape and positions of amide and/or other bands 
observed in FTIR spectrum can be used as fingerprint identification of 
enzymes/proteins, while simultaneously providing information on the secondary 
structure of the polypeptide chains of these compounds, and as such, is an age-old,  
invaluable tool for studying their structure-function relationships. In this regard, FTIR 
spectroscopy was used for conformational studies of the prepared enzyme 
(nCYP3A4), of which the results are exhibited in the spectrum shown in Figure 5B.1. 
Before commencing with the discussion of the observed results, an important 
noteworthy factor should first be brought to the reader’s attention: Generally, in 
principle, in FTIR analysis of CYP450 and/or other heme proteins, all of the 
components in the sample contribute to the observed spectrum This essentially means 
that the full spectrum, as obtained from the original FTIR scan, consist of absorption 
bands from (i) the surrounding apo-protein part; (ii) the heme (prosethic group) 
component and heme ligands; (iii) interactions between the heme and the surrounding 
apo-protein; and (iv) the water and other components of the buffer solution, 
particularly those from the phosphate group. Thus considering the aforementioned 
aspects, with regard to the results exhibited in Figure 5B.1   the inset shows the 
full spectrum as obtained from the original FTIR scan, whereas the main graph is an 
enhanced graphical presentation of the relevant absorption bands restricted to the 
components of enzyme itself,  i.e., the spectral region of 2200 cm
-1
 to 1300 cm
-1
.     
 
In terms of specific band assignments, firstly, the distinctive absorption band marked 
as ±1630 cm
-1
, may be attributed to overlapping contributions from the  surrounding 
apo-protein groups (protein component), as well as heme associated groups. With 
regard to the protein component in particular, it may be ascribed to the Amide I band, 
primarily from the stretch vibration of the peptide CO. With regard to the 
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contribution from the heme, on the other hand, it may be ascribed to the CC 
stretching from the vinyl group in the protoporphyrin IX  (Normally, distinctive 
porphoryn vibrational modes are difficult to detect in isolation, because of their low 
intensity and their overlap with amide bands from the surrounding apo-protein). 
Secondly, the smaller and much less distinctive band, highlighted at position ± 1459 
cm
-1
 may be attributed to the Amide II absorption band, of which the latter arises 
from NH bending coupled with CN stretching. According to documented reviews, 
the positioning of this particular band is normally centred around ± 1550 cm
-1
, 
however, FTIR reflects the degree and strength of hydrogen bonding, a phenomenon 
which is known to be strongly influenced by sources other than changes in the protein 
secondary structure, including different sampling techniques, the surrounding water- 
and other molecules from the protein storage solution; stress factors such as 
lyophilisation of the protein, etc. These constricts, thus essentially shifts the modes to 
higher/lower frequencies, and as such, the results within this research investigation 
are well within experimental variability. The absorption band positioned at ± 1328 
cm
-1
 may be ascribed to the protein-associated Amide III band, while the other bands 
of equally small intensity in the surrounding area (highlighted by red arrows), can be 
ascribed to the α-helices and β-sheets as induced by the protein secondary structure, 
as well as the infrared absorption of amino acid side chains.  
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Figure 5B.1 Fourier transform infrared (FTIR) spectra of the pure synthesized N-
terminally modified CYP3A4 construct (nCYP3A4). Inset shows full spectrum as 
obtained directly from FTIR analysis. Main spectrum shows the relevant spectral 
range for bands associated solely from nCYP3A4, restricted to the region of 1830 cm
-
1
  1140 cm-1.    
 
 
 
5B.2.2 Spectrophotometric characterization: UV-Vis Spectroscopy 
 
The inherent advantage of the presence of the spectroscopically rich heme 
in the active site of CYP450 enzymes can easily serve as an in situ probe – exhibiting 
characteristic visible and near-ultraviolet absorption band changes for recognition of 
protein, and in association with interaction of the protein/enzyme with various 
effectors [153-154]. In this regard, the results of the UV-Vis analysis of the 
synthesized CYP450 3A4 enzyme (nCYP3A4), are shown in Figure 5B.2(a) and (b). 
Figure 5B.2 (a) in particular, is the absolute UV-Vis absorption spectrum of the pure, 
substrate-free  nCYP3A4, from which a distinct peak  with a Soret maximum (λmax) at 
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424 nm is observed. This is essentially characteristic of  P450 enzymes in their 
resting state and as such, exhibits a low-spin state of the water-ligated six-coordinate 
heme, in which the heme-iron is in its ferric (Fe
III
) oxidation state [83, 155-156]. No 
additional shoulder peak at ~ 390 nm can be observed, which, if present, would have 
indicated a mixed spin heme, of which a proportion would be in the high-spin state.  
Moreover, the smaller shoulder peak and two slightly broad troughs, located at ± 358, 
536 and 570 nm, respectively, exhibits spectral properties typical for members of the 
P450 enzyme class, and as such, are always observed in CYP4503A4Fe
III
 absolute 
spectra [153, 155-156]. Moreover, these peaks may be attributed to the instrinsic 
apoprotein absorbance of the surrounding protein molecule, thus confirming the 
overall structural integrity of the synthesized enzyme construct. In terms of specific 
classification, these peaks may be ascribed to the δ-band (358 nm), α-band (570 nm) 
and the β-band (536 nm), respectively.  Reduction of the nCYP3A4 enzyme and 
addition of carbon monoxide (CO) gave the characteristic CYP450n3A4Fe
IICO band, 
exibited in the difference spectrum with a soret maximum at  ± 449 nm, as shown in 
Figure 5B.2 (b).  With regard to the displayed CYP450n3A4Fe
IICO complex, the 
structure of CYP450 enzymes is such that, in general, the enzyme’s prosthetic group 
is constituted of an iron(III), protoporhyrin-IX which is covalently linked to the 
surrounding apoprotein by the sulphur atom of a proximal cystein (see Figure 1.2 a 
and b, Chapter 1) [22-24, 72]. Moreover, the catalytically active conformational 
state of these enzymes are guaranteed/corroborated by the presence of  the 
aforementioned specific thiolate bond between the heme iron and the highly 
conserved cysteine residue (the fifth ligand of the heme), of which such an active 
state may be spectroscopically identified as a reduced CYP450Fe
IICO complex [21, 
23-24, 137] (formed upon reduction of the heme iron and exposure to CO gas),  as 
shown in Figure 5B.2 b. Thus in essence, the UV-Vis absorption spectrum shown for 
the reduced CO-complex of the prepared enzyme is very significant, since it 
contributes to the corroboration of the success of the preparation of a catalytically 
active enzyme construct [72, 156-158].  
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On the other hand, still on the subject of the CO-difference spectrum, it is noteworthy 
to also add, that the full spectrum (shown in Figure A-1, Appendix A) also exhibited 
an additional absorbance peak at ± 419 nm, albeit a peak maxima of smaller intensity, 
as compared to the P450 peak. This is also a finding that requires its own merit of 
attention, since ideally, the carbon-monoxide difference spectrum produced from 
reduction and CO treatment of pure catalytically active; CYP450 enzymes should 
produce an ‘abrupt’ absorption maximum, with no additional peaks at 420 nm [24, 
72, 159]. Observation of a peak at 420 nm in this context, would thus imply a 
proportion of the protein being denatured [24, 72, 83, 156]. Based on the 
aforementioned criteria, such a result, as it stands, imply that the synthesized enzyme 
contains a mixture of spectral species  with a proportion being in its native 
catalytically active state, and a proportion being denatured. That being said, based on 
documented findings regarding genetically engineered N-terminally modified soluble 
CYP450 constructs and other constricts known to contribute to trouble shooting in 
this area in such enzymes, the reader is cautioned to consider the following [24, 158-
159]: 
 Prior research has shown that mammalian microsomal P450s, particularly 
CYP3A4 has a rather unstable conformational nature, with the enzyme easily 
being denatured during treatment with various effectors. In fact, it has been 
shown that research has shown that the P450-complex in these enzymes are 
unstable, with P450 very easily converting to the inactive P420 form within 
minutes of formation of the complex. Similarly, the agitation brought about 
by excess dithionite treatment and/or CO bubbling also can cause 
distortion/loss of the heme-thiolate ligation, which in effect will cause 
denaturing of the protein.  
 The sensitivity of N-terminally modified CYP450s as compared to their full-
length wild-type enzyme equivalents are generally well known – the protein 
structure being easily disconcerted, and as such, easy loss of cystein ligation 
could be an artefact of the genetic engineering process. 
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 To obtain sufficient yields of soluble purified protein, the application of 
detergents during the genetic engineering process is crucial, however, it has 
been documented that they do have a percentile of destabilising effect on the 
so produced enzymes, thus once again enzyme sensitivity with loss of 
cyteinate could be an artefact of the preparation process. 
Based on the preceding facts, it is evident that the number of constricts could have 
contributed to the inactive ‘P420 form’ during CO studies.  Nevertheless, the results 
does indeed show structurally intact, catalytically active native enzyme construct. 
Moreover, the sensitivity of the so produced enzyme construct is not uncommon, 
since all proteins/enzyme suffer a percentile of this fate, which is always taken into 
consideration during biosensor construction, particularly in terms of optimum 
immobilization and coupling efficiency.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.2 Electronic absorption spectra for the synthesized, N-terminally 
modified CYP450 3A4 (nCYP3A4). The UV-Vis absorption spectrum for pure 
nCYP3A4 (concentration μM) showing (a) nCYP3A4 in its resting low-spin FeIII 
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state; inset (b) nCYP3A4-Fe
IIcarbon monoxide, prepared by reducing nCYP3A4FeIII 
with excess sodium dithionite and saturating with CO by bubbling for 2 min. Spectra 
in (b) were difference spectra taken against references of reduced nCYP3A4 before 
addition of CO. Working solution of nCYP3A4 was 20 mM potassium phosphate 
buffer, pH 7.40, 20% glycerol, EDTA, DTT. 
 
 
 
 
5B.3  Assembly and electrochemical characterization of the hydrogel-based 
enzyme biosensors prepared on glassy carbon electrode  
 
 
5B.3.1 Electrode Assembly: Optimisation of the variables concerning the 
indinavir amperometric biosensor assembly and behaviour 
 
 
5B.3.1.1 The effect of carrier matrix assembly: Optimisation of constituents 
and method of preparation 
 
With the ‘research spotlight’ on the main objectives and sub-problems for 
the current investigation, as elaborated in the Prelude of Chapter 5, as well as the 
aspects highlighted in the introduction of the current chapter  the investigation in 
the initial studies were focussed on three important aspects during the biosensor 
construction. Firstly, the feasibility of using the   poly(ester sulphonic acid) cation 
exchanger, Eastman-AQ55 (EAQ), as cheaper alternative to the more expensive 
nafion membrane as base film was explored. Secondly, in the quest to design a more, 
reproducible method of preparing the electroactive carrier matrix composite, the 
Co(Sep)
3+
 mediating species was incorporated into the EAQ through electrochemical 
deposition. With regard, to the time aspect of the potentiostatic deposition process in 
particular, an electro deposition time of 1200 s was regarded as an optimal period to 
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accumulate sufficient mediating species within the pre-formed polymer film. The 
selection was based on a series of experimental trial investigations in which the 
stability of the background signal was evaluated. In the third aspect, the investigation 
of a suitable aqueous biocompatible hydrogel as outer layer, instead of the more 
expensive nafion film was conducted. In this regard, as an initial possible 
replacement, the hydrophilic, non-toxic, biocompatible polymer, poly(vinyl alcohol) 
(PVA) was evaluated. However, PVA has a considerably high swelling index and 
dissolves readily in water when not cross-linked, and as such, during the fabrication 
of the biosensor, the PVA was cross-linked with gluteraldehyde (GA) under acid 
catalysis, denoted clPVA. (A comprehensive step-wise description of the 
experimental protocols used in the preparation of the biosensor is elaborated in 
Section 5B in the current chapter.)    As a sensitivity criterion, the prepared 
biosensor, denoted GCEEAQCo(Sep)3+nCYP3A4clPVA, was evaluated with 
regard to the stability of the prepared platform, as well as electrocatalytic response 
both in terms of the enzyme’s co-substrate (i.e. molecular oxygen, O2) and the 
substrate (indinavir), paying particular attention to the operating potential for 
electrocatalysis.      
 
The obtained results for the GCEEAQCo(Sep)3+nCYP3A4clPVA biosensor is 
exhibited in Figure 5B.3. In the first aspect, the stability of the reagent-layer coating 
was evaluated both visually (i.e. by observing the integrity of the coating in the 
aqueous buffer electrolyte) and voltammetrically (i.e. by observing the stability and 
reproducibility of the obtained voltammetric signals). When the prepared biosensor 
was placed in the argon-degassed electrolyte buffer, the film took on an opaque 
appearance, also exhibiting a substantial amount of swelling, a finding which is 
characteristic of EAQ-coatings and in agreement with previous studies. However, 
upon close visual examination, a sizeable percentage of reagent-layer component 
leaching could be seen after initial placing of the biosensor in the electrolyte solution. 
Moreover, the film appeared unstable. These observations were in fact mirrored  by 
the voltammetric behaviour exhibited by the biosensor, as shown in plot I of Figure 
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5B.3. In this regard, the obtained cyclic voltammograms showed a distinct decrease in 
Ip,c and Ip,a in direct accordance with increased equilibration time, observed during 
repeated cycling, a phenomenon which lasted at least 50-60 min after initial placing 
in the electrolyte. In terms of magnitude, the highest decrease in Ip was seen in terms 
of the cathodic peak current, and thus points to the loss of electroactive Co(Sep)
3+
 
species from the reagent layer (which is pre-concentrated in the oxidized form)  
essentially meaning that with each scan, there are less available Co(Sep)
3+
 for 
reduction. Similar observations and findings regarding leaching behaviour and 
instability of EAQ-films have been observed in previous research investigations 
[160].  In terms of a plausible explanation for the current investigation, these 
observations can perhaps be explained in terms of the literature-based unique 
structural aspects of Eastman AQ. Firstly, EAQ is known to take up huge amounts of 
water, swelling to 4-5 times its original dry volume after hydration [161-162]. In fact 
EAS films with or without electroactive and/or enzyme species have been shown to 
contain at least 87% water, following hydration after being placed in electrolyte 
solutions. Moreover, EAS films, in their characteristics, have been compared to 
biomembrane-like surfactant-based films, of which the latter is known to exhibit 
fragility in aqueous solutions, while also showing a certain degree of leaching 
behaviour after initial equilibration. In a comparative context, swelling in nafion 
membranes are not that extensive, with dry films shown to contain only up to 
approximately 28% after soaking in aqueous solutions [161].  In addition to this, and 
perhaps more importantly, with regard to the uptake and pre-concentration of cation 
species,  research has shown that, EAQ has other inherent structure-functional 
features that are distinctly different from those observed for nafion:  Firstly, AES’s 
method of cationic retention/pre-concentration, occurs largely in accordance with the 
Gibbs-Donnan equation, which essentially means that ionic charge, and as such 
electrostatic binding, rather than  hydrophobic interactions plays the determinant role 
in cationic retention [163]. With nafion on the other hand, counter ion retention/pre-
concentration is dictated by hydrophobic interactions, whereas the Gibbs-Donnan 
equation does not play a role with this polymer [118-119]. Moreover, based on 
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documented  literature, transport in accordance with the Donnan equilibrium is a one 
dimensional process, which would be the case in EAS, whereas in the case of nafion, 
who does not comply to the Donnan equilibrium, transport is a three dimensional 
process [118-119]. This of course has highly significant implications, since it would 
mean faster charge transport in the case of electraoctive platforms created with 
nafion, as compared to the use of EAQ.    The general implications of these factors, 
points to nafion being far more superior for application in the current purpose, as 
opposed to EAQ. Thus, cumulatively, all of aforementioned literature-based factors 
gives some insight into the observed instability with regard to the   
GCEEAQCo(Sep)3+nCYP3A4clPVA biosensor.  
 
The next aspect was of course the evaluation of the electrocatalytic response of the 
GCEEAQCo(Sep)3+nCYP3A4clPVA biosensor, the results of which is shown in 
plots II and III of  Figure 5B.3. In this regard, plot II shows the cyclic voltammetric 
responses of the prepared biosensor in argon-degassed phosphate buffer solution (pH 
7.45) (a); in response to dissolved oxygen (b); and in response to 0.5 M indinavir 
(c). Indeed in the presence of molecular dioxygen, the reduction peak was distinctly 
augmented by the marked increase in peak current caused by the catalytic response of 
the immobilized enzyme to its co-substrate oxygen, and a concomitant decrease in 
Ip,a. Similarly, the response to indinavir was signified by a further increase in the Ip,c 
and accompanied by a further decline in the Ip,a. These results were corroborated by 
the square wave voltammetric response of the biosensor in the presence of oxygen 
and indinavir, as shown in plot III of Figure 5B.3. These results are characteristic 
behaviour of CYP450 enzymes, and thus suggest the reduction of oxygen by the 
reduced heme iron (i.e. Fe
II
), a reaction which is increased in the presence of the 
substrate, as shown by the additional Ip,c increase in response to indinavir. Having 
said, analysis of the obtained voltammetric results revealed that oxygen reduction 
occurred at an average operating potential of -650 10 mV, while, average response 
to indinavir occurred at -630 ( 15) mV. In this regard, the operating potential 
attained with this biosensor is quite high, in fact, reduction of oxygen and substrate 
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detection both occurred at more cathodic potentials, as compared the results obtained 
for biosensor  platform1, presented in Chapter 4 
(CGE|naf|CMECo(Sep)
3+
|flCYP3A4|naf), for which reduction of oxygen occurred at 
an average Ep of -600 ( 5mV), while the average operating Ep for the substrates was 
-585 mV for erythromycin and  -590 ( 5mV) for 2,4-dochlorophenol  (as determined 
from SWV), respectively. Moreover, a more cathodic potential can increase the 
likelihood of reactive oxygen intermediate species, such as superoxide anion and 
H2O2, through a process known as uncoupling reaction, which in itself could have 
contributed to the observed increase in Ip,c. (More on this subject and a deeper insight 
into the process of oxygen reduction is given in Section 5B.3.3.1.1  of the current 
chapter). Moreover, the obtained electrochemical and electrocatalytic response did 
not exhibit sufficient reproducibility, which could be due to a combination of the 
instability and leaching  incurred by using the EAQ as base layer, as well as the acid-
catalyzed cross-linking of the PVA, of which the latter could have negatively 
impacted the integrity of the delicate enzyme. With regard to the latter constrict, 
CYP3A4 constructs produced through N-terminal modification is generally known to 
be more sensitive than its wild type full-length counterpart, and as such, reagent layer 
preparation methods needs to be mild enough as to ensure the absolute integrity of the 
immobilized enzyme, as to obtain the highest possible activity for the longest 
possible time. In this regard, a more stable crosslinked PVA film was only possible if 
the acid-catalyzed glutaraldehyde crosslinking was done after casting of the PVA on 
the electrode surface, so it is possible that, although extreme care was taken,  some of 
the active cast enzyme units could have been affected by the residual traces of  acid.   
 
On a final note, in keeping with the original objectives, as outlined in preceding 
sections in this chapter, in light of the instability and leaching behaviour incurred by 
the fragile nature of the EAQ-film, as well as the high operating potential, and the 
non-reproducibility of the signal obtained, the method of biosensor preparation based 
on the using EAQ in creating the current platform was not taken forward.                                                                       
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Figure 5B.3(I-III) Voltammetric behaviour and electrocatalytic response of the 
nCYP3A4-based biosensor, fabricated from Eastman AQ(EAQ)-Co(Sep)
3+
 carrier 
matrix (i.e. GCEEAQCo(Sep)3+nCYP3A4): plot I: CVs illustrating the biosensor in 
argon-degassed phosphate buffer solution (ArPBS) with increased equilibration time; 
plot II: cyclic voltammetric response of the biosensor in ArPBS (a), in the presence of 
dissolved oxygen (b), in the presence of 0.5 M indinavir in un-degassed PBS (c); 
plot III: square wave voltammetric response to dissolved oxygen (b) and indinavir (c). 
Co(Sep)
3+
 was pre-concentrated on pre-formed ionomer ionic polymer (nafion or 
EAQ film, respectively) by potentiostatic deposition at +450 mV.  Arrows show the 
trend of the variation in peak current. 
 
 
With it now clear that the compromise on nafion as base layer  may not be 
a suitable rout for improving on the Co(Sep)
3+ mediated biosensor, the next step was 
to re-strategize the biosensor design to further explore and optimize on this variable. 
In this regard, the biosensor was  fabricated by following the same general protocol as 
used for the EAQ-Co(Sep)
3+
 platform, but with nafion as base matrix.  The fabricated 
biosensor is denoted, GCE|naf|El-Co(Sep)
3+
|nCYP3A4|clPVA. Indeed, the obtained 
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results, both in terms of general voltammetric response, particularly with regard to the 
stability of the signal response showed by the biosensor, as well as electrocatalytic 
response, proved to be a definite improvement as compared to the results obtained for 
the EAS-platform. Figure 5B.4 shows the voltammetric response of the GCE||naf|El-
Co(Sep)
3+
|nCYP3A4|clPVA biosensor, prepared with the electroactive nafion-
Co(Sep)
3+
 composite as carrier matrix, in which Co(Sep)
3+
 potentiostatic 
electrodeposition was done for 1200 sec. The results presented are for an experiment 
conducted in argon-degassed PBS, at 5 mV s
-1
. Thus, when the GCE, coated with the 
complete reagent-layer film components were placed in argon-degassed buffer 
solution, repetitive scanning revealed a single redox couple, exhibiting a stable 
background  current, consisting of a cathodic and anodic peak, with an overall E’ 
determined as -600 ( 3) mV. Moreover, the integrity of the coating remained stable 
in the aqueous electrolyte buffer, exhibiting negligible leaching behaviour. In 
addition to this, the stability of the background Ip,c and Ip,a signal remained stable 
throughout the equilibration time, i.e., from initial placing in the buffer up to 60 min,  
exhibiting a very small, almost negligible increase in Ip,c and Ip,a in association with 
increased equilibration time. 
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Figure 5B.4 Cyclic voltammetric response of the GCE|naf|El-
Co(Sep)
3+
|nCYP3A4|clPVA biosensor in argon-degassed PBS, showing Ep,c and Ip,a 
variation with increased equilibration time, from 0 up to 60 min. Arrows show the 
trend of the variation in Ip. 
 
 
The electrocatalytic response of the biosensor was also investigated, of which the 
results are shown in Figure 5B.5 III. In this regard, in graph I, plot (a) – (c) shows 
the  cyclic voltammetric response of the biosensor in argon-degassed PBS; in the 
presence of dissolved oxygen in the PBS containing no indinavir; and in un-degassed 
PBS containing 22.45 M indinavir, respectively. Thus as shown in plot (b), the 
interaction with dissolved oxygen is signified by a marked increase in the cathodic 
peak current (Ip,c) and associated decrease in the anodic peak current. In this regard, 
these results therefore suggest the rapid interaction of the  electrochemically 
generated CYP3A4Fe
II
  with dioxygen, followed by the reduction of the 
CYP3A4
IIO2, as such, leaving a very small amount of the reduced heme Fe
II
 species 
available for re-oxidation, during the reverse scan, hence the significant decrease in  
Ip,a in the reverse scan. 
 
The presence of indinavir, increases the rate of oxygen binding and subsequent 
reduction, as shown by the dramatic increase in Ip,c in response to  22.45 M 
indinavir. In terms of the specific operating potential, the biosensor response to 
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molecularly dissolved oxygen was determined to occur at an average Ep of -615 ( 
10) mV, whereas the response to indinavir occurred at an average of -595 ( 10 mV) 
mV.  The response of the biosensor to increasing indinavir concentrations was also 
evaluated and in this regard, Figure5B.5 II shows the dependence of current change 
on increasing concentrations from 0.05 up to 96.95 M indinavir. A linear calibration 
curve was also constructed, as shown in the inset of Figure 5B.5 II, which reveals a 
linear concentration range from 2.15 x 10
-6
 – 18.25 x 10-6 M (r = 0.9903) and a 
sensitivity of 0.02932 A M-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.5 (I): Voltammetric response of  GCnafEl-Co(Sep)3+nCYP3A4Cl-
PVA electrode in (a) argon-degassed PBS; (b) un-degassed PBS; OxPBS containing 
22.45 M indinavir. (II): Biosensor response to indinavir at concentrations ranging 
from 0.05 up to 96.95 M. Inset shows the linear calibration curve for the biosensor. 
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5B.3.1.2 Outer layer optimisation: Effect of film constituents and/or ratio 
 
The school of thought here, was to create a biocompatible composite film, 
for which low-melting point agarose served as the base component, while polyvinyl 
alcohol (PVA) and polyethyleneimine (PEI) functioned as enhancing/supporting 
components. The overall emphasis was to provide a mild entrapment-based outer 
layer for the nCYP3A4-derivatized biosensor platform. These components were 
comprehensively evaluated in terms of their own merit, as well as their contributory 
factor in combination, paying particular attention to their optimum working- 
performance- ratio. The evaluation criterion for optimisation on this particular 
variable was done firstly, with regard to efficient reduction of oxygen, and secondly,  
in terms of substrate interaction, paying particular attention to achieving the lowest 
operating potential.  With regard to PEI in particular, its inclusion in hydrogel blend 
membranes enables the effective formation of polyion complex membranes, which 
exhibit a high degree of stability and structural strength [164-165]. In fact, according 
to documented findings, it has been shown to improve the sensitivity and other 
enzyme-based biosensor performance factors, by favourable modification of the 
electrochemical properties, as well as the stability and activity of the biocomponents, 
if included in the reagent-layer film preparation [74, 121].  However, establishing the 
correct ratio of PEI in association with the other components of the outer layer film 
was a critical aspect.  In the initial evaluation, a ratio for PEI:PVA-Agrs of above  0.2 : 1, 
substantially impeded the electrochemical  interaction of the mediating species with 
the underlying electrode,  as well as its concomitant interaction with the immobilized 
nCYP3A4 in the reagent layer. In this regard, Figure 5B.6 shows the obtained 
voltammetric response for a biosensor, based on a 0.25 : 1 ratio of  PEI:PVA-Agrs. In 
argon-degassed PBS shown in plot (a), a CV consisting of only an oxidation peak 
centred at -560 mV, while no observable reduction peak could be seen. This 
essentially suggests the difficulty of the required electrochemical reduction of the 
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Co
III
 metal ion within the mediating species to the required Co
II
, which in  turn, is 
necessary to effectually reduce the heme iron of the immobilized enzyme (Fe
III
/Fe
II
). 
In effect, this phenomenon will of course concomitantly negatively affect the bio-
electrocatalytic ability of the immobilized enzyme, due to the inability of generating 
the necessary active oxidation-state conformation in order to initiate its catalytic 
reaction cycle.  Indeed as shown in Figure 5B.6 (b), which represents the response of 
the biosensor to molecular oxygen in un-degassed PBS, for a scan taken after a 60 
min equilibration time in oxygenated PBS,  no observable reduction peak current is 
seen. Oxygen is the co-substrate of CYP450 enzymes, and interaction of the reduced 
enzyme with molecular oxygen  encompass a catalytic-type interaction, a 
phenomenon which,  from an electrochemical perspective, is signified by an 
additional cathodically-based catalytic current [74, 83]. Moreover, still on this 
subject, an observable electrocatalytic  response to molecular oxygen could only be 
seen after an equilibration time of at least ±210 min (i.e. ± 3.5 h) in un-degassed PBS, 
as shown in the inset in Figure 5B.6. The implications of these results of course 
points to the impracticality of applying this particular ratio of PEI in the blend 
hydrogel outer-layer membrane, and as such, the ratio had to be appropriately 
adjusted.  On the other hand, let us draw our attention to the  providing a plausible 
explanation for the aforementioned  exhibited unfavourable biosensor responses. PEI 
is a cationic hydrophilic polymer, which essentially contains a high density of 
reactive primary, secondary and tertiary amine functional groups. In this regard, 
within the right setting, under optimized conditions, these reactive groups  can 
confirm ionic cross-linking with the functional groups of PVA through ionic 
complexation between the cationic group (NH3
+
C)  of PEI and anionic group 
(CO2)of PVA and/or other hydrogel-blend membrane co-constituents, to form  a 
structurally stable hydrophilic blend membrane, that effectively allows the 
permeation of water molecules and associated analyte/ions contained within the  
surrounding solution. Moreover, the presence of PEI can induce a small degree of 
plasticisation of the polymers within the blend [164], a factor that can prove 
favourable, particularly in terms of  increasing selectivity of fabricated biosensor .  
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On the other hand, if the ratio of PEI is too high, as compared to that of the other 
components, the cross-linking reaction may be intensified by the multifold increase in 
available functional moieties, resulting in excessive reduction in the proximity of the 
polymer chains with respect to each other, thus producing a very rigid membrane, 
which in turn highly restricts movement of reagent-layer constituents, as well as 
impeding diffusion of analyte species.   
 
Interestingly, upon interaction of the biosensor with indinavir, the electrocatalytic 
response was dominated at operating potential in the region of -660 mV, which was 
accompanied by a measurable concentration of H2O2, as determined from the reagent 
layer through quantofix peroxide sticks. The significance of this finding is quite 
pivotal, since as will be shown in subsequent sections (electrocatalysis section), this 
is in fact related to the autooxidation of the enzyme and the formation of uncoupling 
reactions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.6 Voltammetric response of GCnafEl-Co(Sep)3+nCYP3A4PVA-PEI-
Agrs electrode in: (a)argon-degassed PBS (ArPBS); (b) response after 60min 
equilibration in aerobic conditions (OxPBS); and  after ±210 min in OxPBS  (II). 
Note: The outer layer of the biosensor is prepared with a ratio of PEI : PVA-Agrs of 
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0.25 : 1 (v/v). Experimental conditions:  CVs taken in PB, pH 7.4 at 10 mV s
-1
; 
reductively scanned: Ei = - 100 mV, Ef = -950 mV.  
 
 
Figure 5B.7 shows the obtained voltammetric response for a biosensor, based on a 
0.1 : 1 ratio of  PEI:PVA-Agrs. Indeed, the exhibited electrochemical behaviour is 
distinctly different from that observed previously in Figure 5B.6. In this regard, in 
argon-degassed PBS, a cyclic voltammogram consisting of a single set of fairly 
symmetric cathodic and anodic peak currents, with an average Em of 
approximately -617 ( 5) mV is observed. Moreover, the Ip,c and Ip,a increases 
gradually with increasing equilibration time, up to about 50 min, after which a steady 
state CVs were obtained, as observed with subsequent cycling. The electrocatalytic 
response of the biosensor to dissolved molecular oxygen was also investigated, from 
which the results are shown in the inset of Figure 5B.7. As can be seen, the presence 
of oxygen, signified by a dramatic increase in Ip,c. Moreover, this is accompanied by a 
fundamental augmentation of the Ip,c, due to the appearance of a single new peak 
centred at -445 ( 5) mV, while the Ip,a completely disappeared. These results suggest 
the rapid binding and reduction of dioxygen, catalyzed by the reduced immobilized 
nCYP3A4. When compared to the results obtained for bio-electrocatalysis exhibited 
by the biosensor platform in Chapter 4, the overpotential was reduced by at least 135 
mV, whereas in terms of the results shown in aforementioned sections within the 
current chapter, the overpotential for oxygen reduction was reduced by between 180 – 
200 mV. Thus, based on the favourable results shown by the biosensor, this 
fabrication method was taken forward. 
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Figure 5B.7 Voltammetric response of GCnafEl-Co(Sep)3+nCYP3A4PVA-PEI-
Agrs electrode in: (a)argon-degassed PBS (ArPBS); inset: response to dissolved 
molecular oxygen in aerobic conditions; Parameters: Ratio of biosensor outer-layer 
(PEI:PVA-Agrs) = 0.1 : 1 (v/v). Experimental conditions:  CVs taken in PB, pH 7.4 
at 10 mV s
-1
; reductively scanned: Ei = - 100 mV, Ef = -950 mV.  
 
With protocol now in place, the next step was just to optimize on the specific minor 
variables, such as the enzyme loading amount and the potentiodynamic deposition 
time. 
 
 
5B.3.1.3 Optimisation of Enzyme (nCYP3A4) loading 
 
From a general perspective, for optimal analytical performance in 
biosensors and/or bio-electrochemical platforms in general, the enzyme concentration 
needs to be sufficiently high, so as to ensure that neither the rate of the enzymatic 
reaction, nor the electrode kinetics is the limiting step in the overall detection scheme. 
In this regard, too low enzyme loading can concomitantly result in high sensitivity to 
 
 
 
 
 Chapter 5   Results and Discussion: Biosensor Platform 2 
 
244 
 
small variations in activity, which in effect can lead to poor analytical performance. 
On the other hand, too high enzyme loading may induce an effect in which the 
enzyme layer itself becomes a barrier for the diffusional movement of both the 
substrate and the mediating species, while simultaneously affecting rates of mass 
transfer to the electrode. In this context, the cumulative effects of these constricts can 
inadvertently cause delaying in biosensor response time. With all such and other 
aspects in mind, the enzyme loading amount for the indinavir amperometric biosensor 
was investigated, by varying the amount of the enzyme per unit area(i.e. μg 
nCYP3A4 cm
-2
), while keeping all other variables constant. Regarding the practical 
aspects – for this particular variable, the calibration plot for indinavir in the 0.0582.8 
μM concentration range was selected, with the resulting sensitivity obtained as slope 
from overall regression analysis obtained and comparatively assessed. Figure 5B.3 
exhibits the slopes (μA μM-1)as a function of amount of nCYP3A4 loaded (μg cm-2). 
Evaluation of the graph reveals that the slope of the indinavir calibration plot 
increased with enzyme loading up to 5.58 μg nCYP3A4 cm-2, after which the slope 
value levelled off. With regard to relating the aforementioned obtained amount to 
units of enzyme cm
-2
: Considering that, 1 mg of nCYP3A4 contains approximately 
0.828 x 10
-4
  units of enzyme, thus 5.58 μg (i.e. 5.58 x 10-3 mg) nCYP3A4 is 
determined to contain 4.61 x 10
-7
 units cm
-2
. The school of thought regarding the 
determination of the units of nCYP3A4 in 1 mg of enzyme is in relation with the 
established standard unit for expression of enzyme, according to the International 
Union of Biochemistry. In this regard, in terms of a definitive context, one 
international unit (IU) of enzyme activity is defined as “the amount of enzyme 
necessary to produce one μmol of product per minute, under specified standardized 
conditions of substrate concentration, pH and temperature” [99].  Thus, the unit factor 
here, is in specific reference to the amount of active enzyme per unit area.   The plot 
showing the slopes as a function of enzyme units as a function of amount of 
nCYP3A4 loaded in particular is shown in Appendix A1-2(b). 
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The individual calibration graphs and all obtained parameters for each enzyme 
loading amount is exhibited in Appendix B1-2 a-b.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.8 Effect of nCYP3A4 loading amount on the bio-electrocatalytic response 
of the nCYP3A4-based biosensor [GCE||naf|El-Co(Sep)3+|nCYP3A4|Agrs-PEI-
PVA]. Slopes obtained from indinavir calibration plots in the 0.05  25.60 μM 
concentration range. Supporting electrolyte: 0.05 M aerobic PB (pH 7.4). 
 
 
 
5B.3.1.4 Optimisation of potentiostatic electro-deposition time for Co(Sep)3+ 
 
The optimisation on the deposition time of Co(Sep)
3+
 is a subject area that 
required the judicious all-inclusive consideration of a range of different, but equally 
fundamental aspects:   
 Firstly, from a general perspective, physiological reconstitution of microsomal 
P450-mediated monooxygenase activity requires a relationship with its 
NADPH-based electron transfer donor-component, such that a 1:1 complex is 
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formed. In terms of a bioelectrochemical setup on the other hand, although no 
actual complex is formed  as exhibited in Equation 2.1(c), enzyme 
reduction proceeds via a chemically-based interaction between the reduced 
mediator (MR) and the oxidized enzyme (EOx). In this regard, diffusion of the 
mediating species to and from the underlying electrode needs to be 
sufficiently swift in order to ensure fast, continuous regeneration of enzyme 
active site.  Moreover, the percentile of available electroactive mediating 
species needs to be sufficient as to provide optimally favourable interactions 
with all catalytically active immobilized enzyme units per unit electrode area. 
 Due to the inherent susceptibility to denaturisation of microsomal mammalian 
heme thiolate CYP450s, particularly in the case of N-terminally modified 
constructs, as a precautionary measure to maintain the functional integrity of 
the enzyme during immobilization, no exchange of buffer for glycerol-free 
casting solution was made, resulting in casting solutions containing 20% 
glycerol. However, considering glycerol’s hydrophobic nature, coupled with 
its low dielectric constant (as compared to water, i.e. 43) and high viscosity, 
the overall effect of its presence on the electrode would of course confer a 
substantial degree of electronic resistance. Moreover, according to 
documented findings, the buried cofactor of the enzyme, which is normally 
encased in a fairly hydrophobic intervening peptide shell, normally results in 
moderately weak electronic coupling  between the prosthetic group and the 
external reluctant (the GCnafEl-Co(Sep)3+). The cumulative effect of the 
aforementioned constricts, generally translates into lowered electronic 
conductivity, and in this regard, it is essential that the carrier matrix contains a 
sufficient percentile of electroactive species, in order to effectively 
recompense these constricts. 
 In terms of the specific activity of the synthesized recombinant enzymes ( ± 
66 kDa), on average, they have been determined to contain 0.828 x 10
-4
 
(catalytically active) units per mg of protein, which is essentially on the low 
side. Moreover, from a general perspective, in a bio-electrochemical setting, 
 
 
 
 
 Chapter 5   Results and Discussion: Biosensor Platform 2 
 
247 
 
enzyme immobilization always occurs at the expense of denaturalization of a 
small percentage of active enzyme [87]. The cumulative effect of these 
constricts results in the requirement of higher amount of enzyme per unit 
surface area (cm
2
) in order to drive a sufficiently productive catalytic 
turnover. On the other hand, based on documented literature, as stated in 
Chapter 2 Section 2.24, the diffusional movement of the mediator is an 
absolute prerequisite for productive and successful electron transfer in 
amperometric biosensor configurations. Considering the aforementioned 
aspects, including the fact that as shown in Section 5B.3.1.2, the enzyme 
sample used in the current research investigation contains a  small percentile 
of inactive P420 component, it is essential that sufficient mediator species is 
pre-concentrated within the carrier matrix, such as to ensure optimum 
interaction with the active immobilized enzyme units at the shortest distance 
possible. 
In view all the preceding aspects, the primary objective during the investigation of the 
effects of Co(Sep)
3+
 loading time, the focus was on providing the highest fraction of 
electroactive mediating species within the base-nafion matrix to ensure that all 
available exchange sites are filled, while not exceeding an amount that may actively 
block electron transfer, as too high fractions of mediating species has been shown to 
incur blockage effects. With regard to the actual experiments, as a sensitivity criterion 
for the optimisation on this particular variable, the slope for the calibration plot for 
indinavir in the 0.05  25.60 M concentration range was chosen, and as such, 
mediator loading time was varied (from 300 s  2000 s), while keeping all other 
variables constant, of which the results are shown in Figure 5B.8. In particular, the 
graph shows the obtained slopes for the aforementioned indinavir concentration range 
obtained by the Agrs-PEI-PVAnCYP3A4Co(Sep)3+nafGC electrode (nCYP3A4-
based biosensor),  as a function of Co(Sep)
3+
 loading time. As can be seen from the 
graph, 300 s resulted in the poorest performance, while optimum response was 
observed for deposition times between 600 and up to 1200 s, thus exhibiting an 
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upper-limit within this region. Potentiostatic loading times exceeding 1200sec, on the 
other hand,  resulted in drastic reduction in biosensor response to the selected 
concentration range – in fact, the value obtained for a loading time of 2000sec, fell 
completely out of the range of the points shown in Figure 5B.8 and, as such, could 
not be included in the graph. This phenomenon has been encountered before in 
mediated biosensor systems, and as such, can probably be attributed to non-
conductivity,  caused by hindrance of electron transfer in the presence of too high 
fraction of pre-concentrated Co(Sep)
3+
 [138]. Although 600 sec, fell within the 
starting range of the upper slope value limit for this particular variable,  1200 sec was 
selected as the formal Co(Sep)
3+
 loading time, since it enabled the highest mediator 
pre-concentration without exhibiting any visible kinetic limitations to electron 
transfer in terms of blocking interactions. Moreover, this particular deposition time 
resulted in highly stable and reproducible results observed, for the electroactive naf-
Co(Sep)
3+
 carrier matrix in particular. Still on this subject of the carrier matrix, a 
comprehensive morphological, structural and electrochemical investigation on the 
nafion-Co(Sep)
3+
 was conducted, the results of which have been exhibited and 
discussed in Chapter 5A.   
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Figure 5B.9 Effect of Co(Sep)
3+
 electrostatic deposition loading time on bio-
electrocatalytic response of the GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA 
biosensor. Showing slopes of indinavir calibration plots in the 0.05  25.60 μM 
concentration range. Supporting electrolyte: 0.05 M aerobic PB (pH 7.4). 
 
 
The typical calibration curves obtained for each Co(Sep)
3+
 loading time is exhibited 
in Appendix B.1. 
 
 
 
5B.3.2 Voltammetric characterization of the  fabricated biosensor (prepared 
under optimized conditions): General electrochemical behaviour in 
anaerobic conditions 
 
 
Figure 5B.10 exhibits the voltammetric response of the fabricated 
biosensor, both in terms of the biosensor un-mediated biosensor [plot (a)], denoted 
GCE||naf|nCYP3A4|Args-PEI-PVA, as well as the mediated biosensor [i.e. plot (b)], 
denoted GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Args-PEI-PVA. The cyclic 
voltammograms were obtained for a typical experiment conducted in argon-degassed 
phosphate buffer, for a scan done cathodically, at 3 mV s
-1
 in (pH 7.45). In this 
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regard, in the absence of the Co(Sep)
3+
 the obtained CVs were defined by ill-formed 
cathodic and anodic waves, with no observable Ip,c and Ip,a maxima, and as such the 
E’ could not be determined. Similarly, complimentary techniques, with inherently 
higher signal-noise ratio, such as SWV also did not show an observable or Ip,c and Ip,a 
maxima. This phenomenon has been observed before, in particular, attempts to 
observe cytochrome C electroactive signals in nafion films were shown to be 
unsuccessful [101], while, in a separate study conducted with myoglobin, the 
presence of surfactants were required to observe electroactivity signals with 
hemoglobin, since no observable signals could be obtained with unmodified nafion 
films [122]. Similarly, in yet another study,  HRP could not be incorporated into 
unmodified nafion films [160]. Based on these documented findings and the results, 
as shown in Figure 5B.10 of the current study, this phenomenon observed here can 
probably be ascribed to somewhat weak electronic coupling of the immobilized 
enzyme with the underlying nafion-modified GCE, which may be due to a 
combination of factors: Firstly, the enzyme prosthetic group is buried within a  fairly 
hydrophobic intervening peptide shell and as such will not readily exchange electrons 
with the modified electrode [64, 87]. Moreover, in terms of nafion in particular,  it 
has a small micellar pore structure [122, 160], with small water-filled volume, due to 
its limited water imbibing ability (dry nafion films, was shown to absorb up to 28% 
water upon rehydration) [161-162], and as such cannot incorporated large molecular 
weight biological molecules into its porous microstructure. In fact,  according to 
documented literature, nafion is not able to incorporate species with a molecular mass 
higher than 10 000 g mol
-1
  into its microstructure [160]. Therefore in the current 
study, with nCYP3A4 having an average MW of  46 500 g mol-1, such an endeavour 
would also prove difficult. In addition to this, nafion’s phase segregation, which 
confers it a substantial degree of heterogeneity, exhibiting a large percentage of 
hydrophobic regions, can in turn result in the formation highly hydrophobic 
interactions with immobilized biological molecules [101],  as it would probably do in 
the present platform, which in turn would be unfavourable for electron transfer due to 
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enhanced electronic resistance, and as such, exhibiting moderately weak electronic 
coupling between the enzyme and the modified electrode. 
 
In terms of the Co(Sep)
3+
 mediated biosensor, on the other hand, the results were 
significantly different, as shown by the CV in Figure 5B.10 (b). The voltammogram 
exhibits a typical electroactive signal of the fabricated biosensor, and essentially 
consists of a reduction and oxidation wave, typical of a single redox couple. 
Considering that substrate- and oxygen-free electrolyte reaction medium was used, 
the observed anodic and cathodic waves were attributed to the Co(Sep)
3+
/Co(Sep)
2+
 
redox species contained within  the reagent layer. In this regard, the electrochemistry 
under anaerobic conditions are normally dominated by the mediating species [74]. 
The  Ep,c and Ep,a, determined as average values from four different biosensors at scan 
rates between 2- and 10 mV s
-1
, was determined as  -670 ( 5) mV and -565 ( 5) 
mV, respectively. The average E
’
, as determined from cyclic voltammetry was -617 
( 5) mV.  Moreover the Ep was determined as 100 ( 10) mV. As far as the peak 
shapes are concerned, they are roughly symmetric, however, the Ip,c was larger than 
the Ip,a, a phenomenon that was observed at all scan rates studied, by on average, 1.2 
orders of magnitude.  As compared to the results obtained for the peak analysis of the 
nafion-Co(Sep)
3+
 carrier matrix platform and that obtained for the control sensor 
(containing all reagent-layer components, but with BSA instead of nCYP3A4) in 
particular, variations in all parameters was observed. In this regard, Table 5B.1, lists 
comparatively enlists the obtained values for Ep,c, Ep,a, Ep and E’.   
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Figure 5B.10 Cyclic voltammetric response of (a) GCnafnCYP3A4Agrs-PEI-
PVA electrode; (b) GCEnafCo(Sep)3+nCYP3A4Agrs-PEI-PVA biosensor. Scans 
taken in substrate-free argon-degassed PB solution at ν = 3 mV s-1. Scans done 
reductively, thus negative scan represent Ip,c (cathodic). 
 
Table 5B.1 Peak parameters as obtained from GCE||naf|El-Co(Sep)
3+
; 
GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA (control sensor); 
GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA 
 Ep,c(mV) Ep,a(mV) E
0´
 Ep 
GCE||naf|El-Co(Sep)
3+
 -654 -575 -615 79 
GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-
PVA -703 -547 -625 156 
GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-
PEI-PVA 
 -670 -565 -617 100 
 
With regard to the aforementioned results, it is also noteworthy to add that the CV of 
the control sensor, denoted GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA, is shown in 
Appendix C (Figure C-1). 
 
In addition to cyclic voltammetry, other complimentary voltammetric techniques, 
known for their low signal-to-noise ratio and particular exclusion of charging current, 
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was also used explored, the results of which was compared to that obtained for the 
biosensor from CV.  In this regard, the square wave voltammetric response for the  
GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA biosensor in substrate-free argon-
degassed PBS  exhibited as the difference SW, for a scan done cathodically, is 
shown in Figure 5B.11 (a). Moreover, plot (b) shows the cathodic- (red) and anodic 
(black) differential pulse waves as obtained for the biosensor in argon-degassed PBS. 
With respect to the SWV results, the E’, obtained as an average from the evaluation 
of at least four biosensors, was determined as -616 ( 5) mV. Results obtained from 
DPV on the other hand, exhibited cathodic and anodic waves showing good 
symmetry. Close evaluation of the scans, revealed a Ep,c of -600 mV and Ep,a 
corresponding to a value of -610 mV respectively, thus showing an overall Ep of 10 
mV. Moreover, the Ip,a/Ip,c ratio was determined to be 0.97, which is close to the 
theoretical value of 1, for electrochemically reversible system. These results, with 
respect to both SWV, as well as DPV are in fact in good agreement with that obtained 
from cyclic voltammetry. Moreover, the small Ep suggest rapid electron transfer 
between the electroactive species in the reagent layer film and the underlying GCE . 
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Figure 5B.11  (a) Square wave (SW) voltammetry response of the   GCEnafEl-
Co(Sep)
3+nCYP3A4Agrs-PEI-PVA biosensor (plot shows the difference SW current 
obtained for a cathodic scan). (b) Differential pulse waves, showing cathodic (red) 
and anodic scans for the GCEnafCo(Sep)3+nCYP3A4Agrs-PEI-PVA biosensor. 
Experimental conditions: All scans were taken in substrate-free, argon-degassed PBS 
(pH 7.45). SWV: square wave amplitude 25 mV; potential step 4 mV. DPV: pulse 
amplitude 25 mV; sample width of 15 ms; pulse period of 200 ms. 
 
 
On a final note, the background-subtracted CV of the GCEnafEl-
Co(Sep)
3+nCYP3A4Agrs-PEI-PVA biosensor is exhibited in Appendix C (Figure 
C-2). 
 
 
The next factor involved the determination of the type of current involved 
in the redox reaction of electroactive film of the nCYP3A4-based biosensor. In this 
regard, the dependence of peak current on the scan rate was investigated in order to 
identify the type of current, from which it was shown that the current function (Ip/ν
½
) 
has a constant value at the different scan rates studied (i.e. 3 – 10 mV s-1), the results 
of which is depicted in Figure 5B.13.  The electrochemical behaviour, as it presents 
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itself here, is in accordance with the unique structural aspects of nafion membranes, 
since as explained in Chapter 5A (Section 5A.2), according to documented 
literature, in general, electron transfer in nafion membranes has been shown to be 
equivalent to a diffusion process. On the subject of scan rates and electron transfer, it 
is noteworthy to also add that at scan rates up to 10 mV s-1, peak potentials for the 
Co(Sep)
3+
 mediated biosensor were  nearly constant in the film. However, as the scan 
rate increased beyond 10 mVs
-1
, a marked negative shift in peak potentials could be 
observed. This behaviour has been depicted in Figure 5B.14, which exhibits Ep,c as a 
function of log ν. This suggests the onset of limiting kinetic effects in association 
with increase in scan rate. Nevertheless, overall, in a critical comparison of the 
electrochemical behaviour (which includes all determined parameters) of the enzyme-
based biosensor, as compared to that exhibited by the naf-El-Co(Sep)
3+
 film (the 
results of which was presented and comprehensively discussed in Chapter 5A)    
based on the exhibited and afore-discussed results, as well as data shown in Table 
5B.1, the key aspects including Ip,a/Ip,c; E
’
; Ep; Ip/ν
½
; Ep/Log ν all exhibit an 
unambiguous similarity. The cumulative implications of this finding suggest that, 
indeed, in substrate-free argon-degassed electrolyte medium, the observed 
electrochemistry is dictated by the electroactive Co(Sep)
3+
 mediating species, and as 
such, the observed redox waves may be ascribed to the Co
3+
 + 1e− ⇄ Co2+ redox 
system. 
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Figure 5B.12 Influence of scan rate on peak current. Inset: Ip,c and Ip,a as a 
function of ν½ for scan rates of 3 – 10 mV s-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.13 Influence of scan rate on cathodic peak potential for a GC||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode 
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5.B.3.3  Bio-electrocatalytic actvity of  the GCE||naf-El-Co(Sep)
3+
|nCYP3A4|-
PVA-PEI-Agrs biosensor 
 
According to documented literature, with reference to the quest for 
preventing the futile cycling of electrons and for curtailing/attenuating the formation 
of reactive oxygen species, it has been proposed that electrocatalytic investigations 
involving Co(Sep)
3+
 mediated systems with P450 enzymes are best done under 
conditions of low oxygen tension, by gentle blanketing of the reaction mixture with 
an inert gas [120]. However, due to the possible associated constraints with regard to 
diffusional rate limiting of dioxygen within the reagent layer under conditions of low 
oxygen tension  in the current research investigation, catalytic studies were done in 
ambient conditions in the presence of molecular oxygen, while other additional steps 
were taken to help to maintain the catalytic integrity  of the enzyme-based recognition 
component. With regard to the latter constrict, maintaining a 15–20% glycerol 
presence within the reagent layer, proved to be an important factor, the reasons of 
which will become apparent in the discussion involving a more comprehensive 
overview of the reaction steps in the bio-electrocatalytic process (Section 5B.3.3.1.1). 
In addition to this, due to the fairly low small amount of active CYP450 units per mg 
of protein (as determined by standard reconstitution methods) and the known liability 
of these enzyme constructs, all electrochemical investigations with the prepared 
biosensor platforms were done in a salt-free phosphate buffer solution (PBS), as 
supporting electrolyte, rather than the phosphate buffer saline (PBL), which 
according to documented findings may induce possible inhibitory effects due to ionic 
competition [166]. 
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5B.3.3.1 Bio-electrocatalytic response to molecular oxygen and substrate 
(indinavir) 
 
Under optimized biosensor fabrication conditions, voltammetric  
experiments were undertaken to ascertain the effect of heme-co-substrate/substrate 
interactions on the redox properties of the immobilized nCYP3A4, without the 
presence of the electroactive Co(Sep)
3+
 mediator species. This was done in order to 
observe the effect of the absence and/or presence of the mediator on the bio-
electrocatalytic response of the enzyme-based biosensor, with particular reference to 
observing any changes in the obtained overpotential. Figure 5B.14 exhibits the 
voltammetric results obtained from the bio-electrocatalytic studies with the 
mediatorless nCYP3A4-based biosensor, which was fabricated by immobilizing the 
enzyme directly on the unmodified nafion membrane, denoted 
GCE||naf|nCYP3A4|Agrs-PEI-PVA. In this regard, plot I (a) exhibits the cyclic 
voltammetric response of the biosensor in substrate-free, argon-degassed PBS, 
whereas plot I (b) shows the cyclic voltammetric response of the nCYP3A4-based 
biosensor in substrate-free oxygen in air-saturated PBS, and plot I (c) depicts the 
biosensor  response in oxygen-saturated PBS containing 14 M indinavir. The 
voltammetric response of the biosensor in substrate-free argon-degassed PBS was 
already discussed in previous sections and thus need not be further elaborated now. 
Compared to the ill-defined redox waves seen in substrate-free, argon-degassed, the 
presence of dissolved molecular oxygen (O2), however, was signified by a dramatic 
augmentation of the cathodic peak current, which was simultaneously accompanied 
by a marked increase in Ip,c. From a general perspective, in an electrode-based 
electrochemical setting, the observation of additional catalytic current is in effect the 
classic voltammetric signature for electrochemical catalysis [85, 167]. In the current 
situation it reflects the reaction of the reduced nCYP3A4 heme iron, i.e. nCYP3A4-
Fe
II
, with dioxygen followed by the reduction of the  nCYP3A4-Fe
IIO2 complex 
(known as the oxy-ferrous complex), a reaction which within the context of the 
current experimental conditions, occurred at a determined Ep,c of  -650 ( 10) mV.  
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Direct reduction of oxygen on these electrodes (prepared without enzyme) occurs at 
potentials significantly more negative than observed for the enzyme-based electrode. 
Nevertheless, under aerobic conditions, in the presence of 14 M indinavir, as shown 
in plot (c) of Figure 5B.14, a further increase in the cathodic peak current was 
observed, which in effect reflects the increase in turnover of dioxygen induced by the 
presence of the substrate, suggesting the metabolism of the substrate by nCYP3A4, 
which is in turn regenerated for the next catalytic cycle. Indeed, based on documented 
findings regarding the catalytic interactions of  CYP450 enzymes, it has been shown 
that the presence of substrate favourably affects the enzyme-oxygen interaction, by 
significantly increasing the rate of oxygen binding  to the heme redox centre, a factor 
that has been observed in numerous studies involving CYP450 and/or heme-
containing enzymes [74, 77, 85, 135].  A closer evaluation of the exhibited CV 
showed that the bio-electrocatalytic response to indinavir occurred at a potential 
of -687 mV, which, compared to the operating potential determined for oxygen 
reduction, shifted negatively by a value of 36 mV. Normally, in the context of 
electrochemical systems, and with regard to CYP450 enzymes in general, a positive 
shift in Ep in association with substrate interaction signifies the thermodynamic 
favourability of the interactions, which in terms of specifics portrays the expulsion of 
a water molecule (bound as a sixth axial ligand) from the heme centre, in association 
with the change in heme iron from six co-ordinate, low spin to five co-ordinate high 
spin state. On the other hand, as explained in Chapter 2 (Section 2.2.3.2), according 
to the Marcus theory for biological electron transfer [65, 70], the kinetic effects of 
electron transfer is between two redox species is directly dependent on the driving 
force (i.e. the potential difference), as well as the reorganizational energy. Having 
said that, a cathodic (negative) potential shift, in this context, signifies a larger 
reorganization energy in association with a slower rate of electron transfer [134]. In 
this context, on a microscopic level, due to nafion’s small micellar pore size, it cannot 
incorporate the large enzyme into its structure. However,  based on its inherent phase-
related heterogeneity (consisting of the bulk hydrophobic phase and the much lower 
density hydrophilic ionic cluster region), it can form strong interactions with 
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compounds largely dominated by lipophillic forces, which is probably the case 
between the pre-formed nafion and the nCYP3A4 in the current investigation,  the 
results of which would be unfavourable for electron transfer with the underlying 
electrode. Indeed, this phenomenon has been observed with other enzymes 
immobilised on nafion matrices [101]. Moreover, this in itself could also constrict the 
accessibility to the enzyme’s deeply-buried prosthetic group, the overall effect which 
would be an increase in reorganization energy in association with co-substrate and/or 
substrate interaction, thus resulting in a negative shift in Ep. In addition to this, the 
enzyme  stabilizing effect of glycerol, by-and-large operating by slowing down the 
conformational changes of the enzyme required for electron transfer, to minimize 
enzyme denaturation and/or unwanted harmful side reactions, could also contribute to 
the observed negative shifts in potential, as well as the high operating potential. 
Nevertheless, the presence of the Co(Sep)
3+
 mediating species would thus play a 
significant role in enhancing the electron transfer reactions and as such, the overall 
bioelectrocatalytic response of the enzyme-based biosensor.  In addition to cyclic 
voltammetry, the bioelectrocatalytic response was also studied with SW voltammetry, 
the results of which are shown in plot II of Figure 5B.14. The scans were done 
cathodically, and as such, the difference SWs shown here represents the net reduction 
process. Evaluation of these results showed that once again, as in the case of the 
cyclic voltammetric study, the presence of dioxygen (scan b) and substrate (scan c – 
e) results in a marked increase in catalytic peak current. In the case of the plots 
showing the substrate (indinavir) interaction in particular, a concentration dependent 
increase in peak current up to the final concentration (i.e. 14 M) can be seen. 
Moreover, with regard to the peak potentials observed from SW voltammetric studies 
in particular, oxygen reduction occurred at approximately – 678 mV, whereas the 
catalytic response to indinavir occurred at a more negative potential, corresponding to 
a value of -706 mV, thus coinciding with results observed from cyclic voltammetric 
studies. At this stage it must also be emphasized that the high operating potential with 
regard to reduction of dioxygen, as well as substrate detection and monoxygenation, 
as observed from both cyclic voltammetric and square wave voltammetric results, 
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holds the potential consequence of a much higher likelihood of the formation of 
reactive oxygen species and  associated uncoupling reactions, and as such, as earlier 
stated, the presence of the mediator will greatly aid the bio-electrocatalytic response 
to effective substrate turnover. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.14 I: Cyclic voltammograms of the GC||naf|nCYP3A4|Agrs-PEI-PVA 
electrode in 50 mM PBS, showing biosensor response in (a) substrate-free argon-
degassed PBS; (b) air-saturated PBS with 0 M indinavir; (c) air-saturated PBS with 
14 M indinavir. II: square wave voltammograms of the GC||naf|nCYP3A4|Agrs-
PEI-PVA electrode, showing response in (a) substrate-free argon-degassed PBS; (b) 
air-saturated PBS with 0 M indinavir; air-saturated PBS with (c) 1 M, (d) 2 M 
and (e) 14 M indinavir, respectively. Experimental conditions are: CVs scanned 
cathodically at 5 mV s
-1
.  SWVs: square wave amplitude 25 mV; potential step 4 mV 
(showing difference SWs) 
 
The results as observed for the Co(Sep)
3+mediated electrochemically driven 
catalysis of nCYP3A4 in the presence of dissolved molecular dioxygen and indinavir 
was markedly different. In this regard, the voltammetric response of the GC||naf-El-
Co(Sep)
3+
|nCYP3A4|-PVA-PEI-Agrs electrode (biosensor) in the presence of O2, as 
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well indinavir was investigated with cyclic voltammetry and square wave 
voltammetry, for which the results are exhibited in Figure 5B.15 I, (plot b, c) and 
Figure 5B.16 I (plot a, b). With regard to the cyclic voltammetric results in 
particular, Figure 5B.15 I, plot b and c exhibits the response of the GC||naf-El-
Co(Sep)
3+
|nCYP3A4|-Agrs-PEI-PVA electrode in substrate-free air-saturated 
phosphate buffer solution (PBS) and air-saturated PBS containing 5 M indinavir, 
respectively. Plot a on the other hand depicts the cyclic voltammetric behaviour of 
the biosensor in substrate-free argon-degassed PBS. These plots show results for an 
experiment conducted at 5 mV s
-1
 for which scans were done cathodically. Evaluation 
of the exhibited results revealed that the presence of molecular oxygen caused a 
dramatic augmentation of the CV as compared to the cyclic voltammetric response 
observed from the biosensor in substrate-free, argon-degassed PBS [plot a]. In a 
more descriptive context, the presence of oxygen was signified by a distinct increase 
in the cathodic current, which was accompanied by the emergence of a new peak, 
centred at an average potential of -440 ( 10) mV (n = 10), and also accompanied 
by a considerable decline of the anodic current. Moreover, as compared to the CV in 
argon atmosphere, for which the cathodic wave exhibited a single peak centred at   
approximately -670 mV, the response in the cathodic wave of the CV in oxygen on 
the other hand, was dominated by the new peak, centred at -440 mV, while the peak 
in the region of  -670 mV became almost ‘featureless’ and thus its exact parameters 
could not be determined.  When indinavir was added to the air-saturated PBS there 
was a further increase in the cathodic current, in specific association with the peak 
centred in the region of that observed for the response to oxygen. Moreover, the small 
increase in reduction (cathodic) peak current, in association with indinavir addition, 
coupled with the negligible amount of H2O2 formation (as measured by Quantofix 
hydrogen peroxide sticks), suggest the miminal occurrence of “futile” redox cycling 
of the system and associated concomitant production of reactive oxygen species [86, 
89, 168].  Considering the latter, including the fact that oxygen is the co-substrate of 
nCYP3A4, and in view of the exhibited voltammetric responses, as well as the 
absence in catalytic response of the enzyme in substrate-free argon-degassed PBS (of 
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which the observed redox process is dominated by the Co(Sep)
3+
 mediating species), 
these results suggest the bio-electrocatalytic reduction of oxygen by the 
mediatorreduced nCYP3A4, (i.e.nCYP3A4-FeII), in the substrate-free aerated buffer 
and the increase in turnover of dioxygen affected by indinavir in the substrate-
containing aerated buffer (shown in plot b) [77-78, 136, 142]. With regard to the 
square wave voltammetric results, a more well-defined indication of the position and 
magnitude of the peak response for the GC||naf-El-Co(Sep)
3+
|nCYP3A4|-Agrs-PEI-
PVA electtrode in the presence of oxygen, and in the presence of indinavir can be 
observed. In this regard, Figure 5B.16 I plot a and b depicts the response of the 
GC||naf-El-Co(Sep)
3+
|nCYP3A4|-Agrs-PEI-PVA electrode in substrate-free air-
saturated phosphate buffer solution (PBS) and air-saturated PBS containing indinavir, 
respectively. The voltammograms represent the net (difference between forward and 
reverse scans) SWV responses when the modified electrode was scanned 
cathodically. Evaluation of the observed plots revealed that these results coincide 
with that exhibited for cyclic voltammetry and as such, the presence of both O2 and 
indinavir was signified by a distinct response, centred in the potential region where 
the new peak emerged [as compared to the SWV observed in substrate-free, argon-
degassed PBS (see inset in Figure 5B.16, i.e. plot II)] . It must also be emphasized at 
this stage that although the exhibited SWs are characterized by two peaks, no 
discernible  response was observed at the other peak position (i.e.  -637 mV), which 
can be evidenced by the noticeable lack of catalytic-type increase in in Ip in 
association with indinavir/ O2 addition. Moreover, at the same time, an increase in net 
current in association with the response of the biosensor to both O2 and indinavir, as 
compared to that observed for the biosensor in substrate-free argon-degassed PBS 
(plot II) was also observable. With regard to the  exact position of the emerged peak 
in association with the bio-electrocatalytic response to O2, the peak potential was 
determined as -365  ( 5) mV, while the addition of the indinavir resulted in a small 
cathodic shift  of approximately 4 mV, thus yielding a final response potential of -369 
( 10, n=10)  mV . In terms of current  magnitude on the other hand,   the   
         in 
the presence of indinavir was significantly higher than that observed in the presence 
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of dioxygen (containing no indinavir), thus showing an increase in the value of  
  
        ( -369 mV) of approximately 1.6 orders of magnitude. Still on the subject 
of the observed bio-electrocatalytic results, it is noteworthy to emphasize the fact that 
the presence of the Co(Sep)
3+
 mediator has enabled an unequivocal reduction in the 
overpotential for the bio-electrocatalytic reduction of O2, as well as for the bio-
electrocatalytic substrate turnover, as compared to the results observed for the un-
mediated biosensor (i.e., GCE||naf|nCYP3A4|Agrs-PEI-PVA). In particular, the 
overpotential for the reduction of O2 was reduced by at least 210 mV, while the 
overpotential for indinavir detection/metabolism was reduced approximately 240 mV. 
Moreover, with specific reference to the reduction of O2, as compared to the results 
obtained for the biosensor platform1, presented and discussed in Chapter 4, (i.e. 
CGE|naf|CMECo(Sep)
3+
|flCYP3A4|naf), the operating potential was reduced by 
approximately 215 mV. This observation also holds for previous investigations 
involving CYP3A4-based biosensor platforms  in particular, compared to the study 
involving full-length human recombinant CYP3A4 in a PDDA-polyelectrolyte 
platform [135], the overpotential for the bioelectrocatalytic reduction of dioxygen 
was reduced by  250 mV; and as compared to another study also involving full-
length microsomal CYP3A4, in a DDAB liquid crystal vesicular system [136], the 
overpotential was reduced by  270 mV.  It is also noteworthy to again point out the 
effectiveness of the design path used in this biosensor platform, as compared to that 
used for biosensor platform 1, with particular reference of the technique used in the 
fabrication of the electroactive carrier matrix. In this regard, the design path used in 
biosensor platform 2  probably enabled a better coupling efficiency between the 
immobilised enzyme and the transducer material. 
 
 
In the interest of negative control measures, the behaviour of the control sensor, 
fabricated with the exclusion of nCYP3A4, by using the pseudo carrier enzyme, 
bovine serum albumin (BSA), in the presence of oxygen and in the presence of 
indinavir was also investigated with cyclic voltammetry, as well as square wave 
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voltammetry. In this regard, with reference to the CV results in particular, plot b of 
Figure 5B.15 II depicts the cy c l i c  v o l t a m m e t r i c  r e s p o n s e  o f  t h e  c o n t r o l  
s e n s o r  ( i . e .  G C E | | n a f | E l - C o ( S e p )
3 +
| B S A | A g r s - P E I - P V A )  i n  
s u b s t r a t e - f r e e  air-saturated PBS, while plot c exhibits the behaviour of the 
control sensor in air-saturated PBS in the presence of indinavir. In addition to this, 
plot a (in Figure 5B.15 II), which depicts the redox reactivity of the control sensor in 
substrate-free argon-degassed PBS is also showed. In terms of the SWV results on the 
other hand, Figure 5B.16, plot c depicts the reactivity of the GC||naf|El-
Co(Sep)
3+
|BSA|Agrs-PEI-PVA in substrate-free aerated-PBS, whereas plot d shows 
the reactivity of the control sensor in aerated-PBS containing 5 M indinavir. 
Evaluation of the CV results in particular, showed that indeed, the presence of 
molecular dioxygen, as well as indinavir (in air-saturated PBS) were both 
accompanied by a measurable increase in cathodic current, as compared to the CV in 
substrate-free argon-degassed PBS, and although the cathodic wave was not entirely 
featureless/ill-formed, the exact positions of the observed small cathodic peaks 
(minima) could not be determined. Moreover, unlike in the results observed for the 
nCYP3A4-based biosensor, where a clear response at  -440 mV could be observed, 
no clear Ep could be observed in this region with the BSA-based control sensor. In 
terms of the SWVs, in the presence of oxygen, a small, but measurable increase in net 
current could be observed, while the introduction of indinavir resulted in another 
small measurable increase in net SW current. However, the reactivity in the presence 
of both O2 and indinavir was indistinct, with current increase in both cases observed 
to be at two peak potentials, i.e.   -410 mV and -645 mV. This was contrary to the 
clear response as exhibited by the nCYP3A4-based biosensor, for which a distinct 
current increase centred on a single potential was observed, typical of a catalytically 
active enzyme containing a single prosthetic group.  Nevertheless, in terms of the 
observed increase in cathodic current as seen from CV and SW voltammetric studies 
for the BSA-based control electrode  based on documented literature findings 
regarding catalytic electrochemical studies, this type of phenomenon is in fact not 
uncommon. On the other hand, the observed ‘double-peak increase behaviour’ is 
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characteristic of the reduction of two species at different potentials [169], which, in 
the current case, suggest with relative certainty, the effect of reactive oxygen species, 
particularly H2O2, formed in association with two electrochemically driven processes. 
In this regard, the first process most probably involved the direct reduction of 
dioxygen in the film at the GCE, while the other process may be attributed to the 
coupling of the 1e
-
 reduction of the mediating species with a fast follow-up chemical 
process, which involves the interaction of the reduced species with dioxygen [85, 
120, 135, 169]. A comprehensive description of the details of these interactions and 
their concomitant implications are given in Section 5B.3.3.1.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.15 Cyclic voltammograms showing: (a) response of nCYP3A4-based 
biosensor, (GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA) in argon-degassed 
PBS containing 0 M indinavir; (b) response of nCYP3A4-based biosensor in 
air-saturated PBS containing 0 M indinavir; (c) response of nCYP3A4-based 
biosensor in air-saturated PBS containing 5 M indinavir. (d – e): negative 
control, showing BSA-based control sensor (i.e. GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-
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PEI-PVA  in (d) air-saturated PBS containing 0 M indinavir; (e) air-saturated 
PBS containing indinavir 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.16 Square wave voltammograms showing: (a) response of 
nCYP3A4-based biosensor, (GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA) in 
air-saturated PBS containing 0 M indinavir; (b) response of  nCYP3A4-based 
biosensor in air-saturated PBS containing 5 M indinavir; (d) – (e) negative control 
showing: reactivity of BSA-based control sensor (GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-
PEI-PVA) in air-saturated PBS containing 0  M indinavir [i.e. (a)] and reactivity of 
BSA-based control sensor in air-saturated PBS containing  5 M indinavir. 
Experimental conditions are: square wave amplitude 25 mV; potential step 4 mV; 
plots show net currents for forward and reverse SW currents for scans done 
cathodically.  
 
 
To further explore the catalytic response of the nCYP3A4-based, Co(Sep)
3+ 
mediated biosensor with respect to indinavir  the voltammetric response of the 
GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode in the presence of 
increasing indinavir concentrations in the potential region where the afore-discussed 
biosensor response was observed was investigated. In this regard, Figure 5B.17 
 
 
 
 
 Chapter 5   Results and Discussion: Biosensor Platform 2 
 
268 
 
exhibits the dependence of the square wave voltammetric current (response)  as a 
function of concentration, for indinavir. The depicted plots represent the net 
(difference between forward and reverse scans) SWV responses for scans done 
cathodically. Moreover, the voltammograms showed a measurable increase in the  
  
        upon subsequent addition of indinavir to the air-saturated PBS up to the 
final concentration of 73 M. In addition to this, in the interest of corroborating the 
lack of bio-electrocatalytic response of the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-
PEI-PVA electrode in the potential region  where the second peak was shown in the 
afore-discussed results, (i.e.  -637 mV, for plots a and b of Figure 5B.16), the 
reactivity of the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode to 
increasing indinavir concentrations in the region of that potential was also 
investigated with respect to this particular potential region. In this regard, as exhibited 
in Figure 5B.17, other than the normal redox reactive peak seen, no additional 
discernible catalytic response in this region could be observed. 
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Figure 5B.17 Square wave voltammograms showing response of  GC||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode to increasing indinavir concentrations, 
from 0 M up to a final concentration of 73 M. Experimental conditions are: square 
wave amplitude 25 mV; potential step 4 mV. (Plots show the net currents obtained 
from scans done cathodically) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B.18 Square wave voltammograms for the potential region of -490  -950 
mV for the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode, for an 
experiment done with increasing indinavir concentrations (0  73 M). 
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Experimental conditions are: square wave amplitude 25 mV; potential step 4 mV. 
(Plots show the net currents obtained from scans done cathodically) 
 
 
Once again, with the focus on negative-control measures, the reactivity of the BSA-
based control sensor to increasing indinavir concentrations were also investigated, 
with SWV. In this regard, Figure 5B.19 shows exhibits the dependence of the square 
wave voltammetric current as a function of concentration of indinavir. The depicted 
plots represent the net (difference between forward and reverse scans) SWV 
responses for scans done cathodically. Indeed, an increase in current in the presence 
of both O2 and indinavir as compared to the background current observed for the 
substrate-free argon-degassed PBS (see inset, i.e. plot II) could be seen. However 
further evaluation of the voltammograms showed that the results for the GCE||naf|El-
Co(Sep)
3+
|BSA|Agrs-PEI-PVA control electrode was irrefutably different from the 
results showed for the nCYP3A4-based biosensor (GC||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA). In this regard, with particular reference to the 
results showed for indinavir, other than the initial peak current increase with the 
initial indinavir addition, no clearly discernible subsequent increase in peak current 
(Ip) in association with consecutive indinavir additions could be seen, which 
essentially means that for all subsequent indinavir additions, up to the final 16 M, 
the magnitude of Ip stayed the same. Moreover, the observed initial Ip increase 
presented itself as a double-peak increase, thus mirroring and corroborating what was 
seen in the afore-discussed results for control studies exhibited Figure 5B.16 (plot 
c,d).    
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Figure 5B.19 Negative control: square wave voltammograms showing reactivity of 
BSA-based control sensor (GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA) with 
increasing indinavir concentrations from 0  16 M in air-saturated PBS. Inset (i.e. 
II) shows the redox behaviour of the GC||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA 
electrode in substrate-free argon-degassed PBS. Experimental conditions are: square 
wave amplitude 25 mV; potential step 4 mV. (Plots show the net currents obtained 
from scans done cathodically) 
 
Still on the subject of electrocatalysis investigations, it is noteworthy to also show an 
interesting, but not unexpected phenomenon that became apparent during the these 
studies. In this regard, Figure 5B.20 (a  c) exhibits the electrocatalytic reactivity in 
air-saturated PBS, of (a) the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA 
electrode, containing freshly expressed nCYP3A4 (biosensor-n1); (b) GC||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode containing nCYP3A4 which have 
been stored for  six-eight months (biosensor-n2); and (c) the (GCE||naf|El-
Co(Sep)
3+
|BSA|Agrs-PEI-PVA) containing the pseudo-enzyme, BSA (BSA-based 
control).  From an evaluation of the results, it became apparent that the biosensor 
containing the freshly expressed enzyme (biosensr-n1) responded unequivocally 
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different to dioxygen as compared to the biosensor in which the old stored enzyme 
was used as recognition component (biosensor-n2). In this regard, biosensor-n1 
exhibited the classic signature of dioxygen reduction for a enzyme containing a single 
active centre, comprised by a characteristic increase in cathodic peak current, with an 
almost complete attenuation of the anodic peak current [73-74, 82-83, 135], the 
implications of which, essentially suggest the coupling of the Co(Sep)
3+/2+
-mediated 
Fe
3+
/Fe
2+
 reduction event to fast binding of oxygen to the  ferro-heme. Moreover, the 
exhibited results corroborate the afore-shown and discussed results for the    
GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA biosensor. On the other hand, the 
results as exhibited for biosensor-n2 showed a rather vague reactivity to dioxygen, 
which was in fact similar to what was observed in the case of the BSA-based control 
electrode, the difference being just a slightly more pronounced intensity in the 
cathodic peak currents in the case of biosensor-n2 as compared to that seen for the 
BSA-based control. The reason for this seemingly reprehensible behaviour in the case 
of  biosensor-n2, may be attributed to the fact that since it contained very little 
catalytically active nCYP3A4, the results was essentially  a very weak interaction 
between the enzyme and the mediator-containing carrier matrix, resulting in the 
formation of a large percentile of reactive oxygen species, particularly H2O2, due to 
unspecific interaction of Co(Sep)
2+
 with dioxygen, as well as uncoupling reactions in 
association with the small percent of enzyme that  engaged in reductive dioxygen 
activation [77-78, 86]. In fact, the latter is a known possible branching point in 
observed uncoupling reactions involving CYP450 enzymes [23, 67]. Moreover, with 
the BSA-control, as well as biosensor-n2, a measurable amount of H2O2 was formed 
in association with electrocatalytic studies (10  25 mg L-1) as measured by 
quantofix-peroxide sticks, whereas in the case of biosensor-n1 which contained the 
fresh active nCYP3A4 H2O2 formation was more-or-less negligible. In this regard, it 
suggest that the reduction of oxygen competes poorly with the reduction processes 
involving  Co(Sep)
3+/2+
 and  nCYP3A4–Fe3+/2+, and as such, much less H2O2 
peroxide is formed with fresh enzyme samples. Similar results have been seen before 
with  CYP450 3A4 enzymes using reductase as electron transfer mediator [86]. 
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Figure 5B.20 Comparisons of effect of oxygen : Cyclic voltammograms showing: 
(a)  (GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA)  electrode containing 
fresh nCYP3A4, (b) (GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA)  
electrode containing nCYP3A4 which have been stored for    six-eight 
months;  (c) (GC||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA) electrode (BSA-
control)  in substrate-free air-saturated PBS. 
 
On a sub-conclusive note, in the context of the collective implications of the afore-
exhibited and discussed results regarding the catalytic investigations for the 
GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode, a few noteworthy 
sub-conclusions may be drawn at this stage. Firstly, with regard to the response of 
dioxygen in particular, these results are consistent with catalytic reduction involving 
nCYP3A4-Fe
2+O2, and as such, suggest that the electrochemically-based reduction 
of the nCYP3A4 ferric heme, through the Co(Sep)
3+
 mediating species, is followed 
by rapid binding of dioxygen with the subsequent formation of the ferrous-dioxygen 
complex.  Secondly, the results obtained in association with indinavir addition, all in 
turn coincides with previously documented findings, and as such suggests that  the 
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presence of substrate increases the rate of the reduction of dioxygen [74, 77-78, 135-
136, 142]. In addition to this, comparative evaluations between response behaviour of 
the Co(Sep)
3+
 mediated nCYP3A4-based biosensor, and that observed in the case of 
the BSA-based control was fundamentally different, in all electrocatalytic 
investigations done. Thus cumulatively, these results all suggest, that firstly, the 
enzyme may be activated along a similar pathway utilized in its physiological 
reaction cycle the overall response of the GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-
PVA biosensor upon substrate addition to the air-saturated PBS is due to bio-
electrocatalytic substrate turnover,  
 
 
 
Evaluation of the voltammograms exhibited in the presence and absence of 
indinavir all suggest that indinavir increases the rate of oxygenation of nCYP3A4. 
The significance of this observation is the implication that the GC||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PV electrode can be used for varying the indinavir 
concentration in the construction of a calibration curve for indinavir. In this regard, 
Figure5B.21 shows the full calibration curve obtained from experimental studies 
with increasing indinavir concentrations up to a final concentration of 147.5 M.  A 
linear calibration curve was also constructed, as shown in the inset of Figure 5B.21, 
from which it was shown that the biosensor response to indinavir exhibited a linear 
concentration range from 2.183 x 10
-6
 to 3.552 x 10
-6
 M (r = 0.99501). Moreover, the 
accompanied sensitivity value was determined as 0.00349 A M-1. In addition to 
this, the value for the LOD, (calculated as the concentration giving a signal equal to 
three times the standard deviation of the blank signal divided by the sensitivity) was 
determined as 59.72 mg L
-1
. This value is markedly higher than the documented 
maximum plasma drug concentration range (CMax) for indinavir (i.e. 5 – 11 mg L
-1
) 
[2, 170], however, according to the Handbook for HIV Medicine [14], as well as 
other documented literature [4, 7, 170-171], there is a high degree of variability in 
terms of plasma levels among individuals. Moreover, the quoted literature-based 
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value showed above, is based on the in-vitro model for the unboosted indinavir dose 
regiment, and secondly, is recorded in association with standard prediction in-vitro 
models, which are in effect based on animal studies and/or intermediate to extensive 
metabolisers. The effect of ritonavir-boosting on the other hand can lead to up to a 3–
5 fold increase in indinavir CMax value, since it results in a significant increase in the 
most important pharmacokinetic paramters, including CMax, trough levels and half life 
[14]. The implications of these factors, essentially means that in poor metabolisers (as 
are most HIV/AIDS patients), as well as within the context of the multi-drug based 
HAART associated regiments, the CMax value for indinavir and/or any other PI ARV 
may in reality rise to markedly higher values, therefore, within the context of these 
criteria, a higher LOD does not necessarily reflect an out of range detection rating. 
Still on the subject of the obtained LOD, it is also noteworthy to add that the value is 
higher than the value published for indinavir, based on a biosensor platform 
developed during the course of this research investigation, with wild type full length 
microsomal CYP3A4 in a vesicle dispersion of DDAB [136]. In this regard, vesicular 
dispersions/liquid crystal film environments are known to have a distinct effect on the 
heme environment of the immobilized enzyme, mostly through dehydration, which 
very effectually leads to more positive shifts in potential, and as such can 
significantly influence the obtained results. On the other hand, full-length wild-type 
CYP450s are known to be more stable than the N-terminally truncated enzymes 
(which are easily perturbed), while the use of detergents (which are necessary to 
obtain acceptable yields of soluble N-terminally modified constructs during the 
process of genetic engineering) is also known to have a destabilizing effect on the 
prepared CYP450s. The implications of these factors may have also contributed to 
the observed variance in results.          
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Figure 5B.21 Calibration curves for GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-
PVA biosensor response to indinavir: Main plot shows increasing concentration of 
indinavir up to a final concentration of  147.5 M. Inset shows the linear calibration 
plot for indinavir.  
 
 
With regard to the plot shown in Figure 5B.21, at high indinavir concentration a 
current plateau can be observed. In this regard, the curvature from the initial straight 
line represents the characteristics of Michaelis-Menten (MM) kinetics (see Chapter 
3A, Section for a comprehensive overview of the MM theory aspects) . The apparent 
Michaelis-Menten constant,   
   
, which essentially gives an indication of the 
enzyme-substrate kinetics for the biosensor, i.e.  GC||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode can then be calculated from the 
electrochemical version of the Lineweaver-Burk equation: 
 
 
   
 = 
  
   
    
 
 
 
 + 
 
    
        5B-1 
where Iss the steady-state current after the addition of the substrate, IMax the maximum 
current measured under conditions of substrate saturation, and C is the concentration 
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of the substrate. In this regard, the slope (  
   
     ) and intercept (1/    ) from the 
plot of the reciprocal current versus the receprocal indinavir concentration was used 
to calculate   
   
.  With regard to the general implication of determined   
   
    it 
gives an indication of the kinetics of the enzyme-substrate system [74, 77, 172]. A 
low   
   
 shows that the E–S complex is stable, thus indicating that the saturation of 
the enzyme active site is a fast process. Moreover, a smaller    
   
 implies that the 
proposed electrode exhibits a higher affinity for indinavir. Having said that, the   
   
 
value for the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode was 
determined as 17.539 M. 
 
 
5B.3.3.1.1 A deeper insight into the specifics of the electrocatalytic interactions 
with dioxygen and with the substrate, indinavir 
 
This section serves to provide a deeper insight into the specific interactions 
pertaining to the results as observed from the afore-exhibited (bio)electrocatalytic 
studies. On this subject, the common phenomenon that was apparent in all catalytic 
interaction studies was the distinct increase in cathodic current. In this regard, 
through the comprehensive discussions provided in this section, as well as the 
schematic information shown, the common role in reactive dioxygen in the observed 
results will be become apparent and collectively, will help explain the observed 
results, both with regard to the control electrodes, as well as the Co(Sep)
3+–mediated 
nCYP3A4-based biosensor.  
 
With oxygen shown to be the important factor here, to grasp the significance of the 
fundamental role of the biosensor’s interaction with oxygen, one needs to firstly 
understand the effect of oxygen in the context of general electrochemically based 
studies; secondly, its role in the physiological reaction cycle of CYP3A4; and thirdly, 
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the possible implication of oxygen interaction with the mediating species in mediated 
biosensor systems. Let us first divert our attention to oxygen in general electrode-
based interactions in particular. Generally, oxygen is chemically reactive with 
numerous substances and also electrochemically reducible, therefore, unless catalytic 
studies are being conducted, electrochemical work is best done with the exclusion of 
oxygen. Having said that, according to documented literature, at unmodified or 
modified electrodes, the overall electrochemical reduction of dioxygen with electron 
transfer, results in the production of H2O, with the complete process consuming a 
total of 4e
¯
. In a more descriptive context, the reduction usually occurs through two 
well separated steps, the first of which corresponds to the formation of  hydrogen 
peroxide: 
O2 + 2H
+
 + 2e¯  H2O2      5B-2 
While the second step corresponds to the reduction of peroxide:  
 H2O2 + 2H+ + 2e¯  2H2O     5B-3 
 
Moreover, while the latter two equations gives a broad description of the overall 
process, on a microscopic level, the formation of H2O2 and H2O, may generally be 
preceded and/or accompanied by a series of  other intermediate basic reactive 
dioxygen and monooxygen species, including   
– 
, HOO•, HOO¯, •O¯, HO¯, that 
may take up one or two hydronium ions (H3O
+
) from the electrolyte media. 
Generally, the large background current accrued from this stepwise oxygen reduction, 
can interfere with the measurements of many reducible analytes. Moreover, the 
products of the oxygen reduction may affect the electrochemical process under 
investigation.     
 
With regard to the role of oxygen in CYP450 enzymes and CYP3A4 on the other 
hand, the binding and reduction of dioxygen plays a pivotal role in the reaction cycle 
of CYP3A4 and CYP450 enzymes in general. In fact, according to documented 
literature, the oxy-ferrous/ferrous-dioxygen complex (CYP3A4-Fe
IIO2) has been 
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labelled the first and most fundamental intermediate for successful monooxygenation 
of substrate in the catalytic reaction cycle of the enzyme. In this regard, from a 
general perspective, for catalytic reactions involving P450 isoenzymes, the reduction 
of molecular oxygen to reactive oxygen species, such as H2O2, is preferably an 
unwanted occurrence, since it can essentially curtail the electron transfer between the 
reducing equivalents and the isoenzyme under study. In this regard, once formed, the 
oxy-ferrous complex rapidly binds dioxygen, but the catalytic reduction to H2O2 
rapidly follows. Moreover, the introduction of the second electron thus can result in 
H2O2 dissociation, and the overall process is known as autooxidation. Therefore, the 
oxy-complex is believed to be the primary source of such reactive species (radicals), 
i.e. superoxide/peroxide, and the resultant challenge thus is getting the second 
electron to be used in peroxoiron complex formation and not in H2O2 dissociation. 
Considering these factors, it is not surprising that, according to documented literature, 
the oxy-ferrous complex has also been categorized “the first major branching 
intermediate in the catalytic cycle of CYP450 in which the total efficiency of the 
substrate monooxygenation may be curtailed by the uncoupling reaction of 
autooxidation”. On the other hand, as in the case of physiological reducing 
equivalents, in catalytic systems utilizing electroactive pseudo-mediating species, the 
formation of H2O2 due to non-specific inadvertent reactions between the reduced 
mediator and dioxygen can result in catalytic activities of P450s that are uncoupled 
from the natural enzyme-based consumption of dioxygen. Moreover, this reaction 
pathway does not consume electrons, and as such, occurs in association with 
uncoupling of the mediator-based electron transfer to the enzyme. This can 
essentially divert the sequence of CYP3A4’s reaction cycle through what is known as 
the peroxide shunt pathway, which can also contribute to substrate turnover, but may 
come at the cost of enzyme longevity. In this regard, the stability of the biosensor is 
more inclined to the envisaged realization of a disposable platform, as opposed to 
reusable platform.  Considering all of these aspects, the electrocatalytic response of 
the CYP3A4-based biosensor (GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA), to 
dioxygen may be regarded as a key juncture in the overall evaluation of the biosensor 
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dynamics and thus merits due consideration with regard to its own plausible reaction 
pathways, in tandem with substrate-related electrocatalytic discussions.  
 
 
Bearing in mind all of the above aspects, we will now take a closer look at the 
electrocatalytic dynamics of the biosensor platform  in the current study, essentially 
providing a comprehensive overview of all reactions taking place at the modified GC 
working electrode. In this regard, Figure 5B gives a schematic representation of all 
envisaged reactions, occurring during typical voltammetric catalytic experiments, 
with reference to both the nCYP3A4-based biosensor, as well as the BSA-based 
control electrode, as done according to the context of the experimental for the current 
research investigation. With regard to the reactions outlined in Figure 5B, reactions 
A and C refers to reaction pathways which may typically occur in the GC||naf|El-
Co(Sep)
3+
|BSA|Agrs-PEI-PVA electrode, i.e., the BSA-based control sensor, whereas 
reaction B and D exhibits the reaction pathway typically occurring in the context of 
the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode, i.e., the 
Co(Sep
)3+mediated, nCYP3A4-based biosensor. Let us start with the GC||naf|El-
Co(Sep)
3+
|BSA|Agrs-PEI-PVA electrode: In this regard, no nCYP3A4 is present to 
initiate the substrate monooxygenation pathway, and as such the futile redox cycling 
of the system can lead to the reactive oxygen species. Firstly, as shown in reaction A, 
a small amount of dioxygen may be reduced in the film at the underlying GCE, 
forming the reactive dioxygen species, superoxide (  
– 
), which, when formed 
dismutaes to H2O2 through another reduction process. Secondly, according to 
equation 5B-4 
Co(Sep)
3+
 + e

 ⇄ Co(Sep)2+       5B-4 
– Electrochemical 
     
the electroactive mediator, Co(Sep)
3+
 is reduced to Co(Sep)
2+
, and with no nCYP3A4 
present, the reaction of the reduced species with dioxygen is highly probable, a 
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process which also produces superoxide that dismutates to H2O2, according to the 
following equation: 
Co(Sep)
2+
 + O2 O2 

  H2O2 5B-5 
The produced H2O2 can of course be further reduced in the formation of H2O as by-
product, according to equation 5B-3. The general implications of these processes is 
that the accrued current associated with the produced reactive oxygen species adds to 
the catalytic oxygen reduction current, i.e. in the reverse scan in the cyclic 
voltammetric studies, and in the overall difference current in the square wave 
voltammetric studies, in air-saturated electrolyte media (i.e. PBS). Needless to say, 
this then explains the catalytic current, as observed from the results in association 
with the response of the  GC||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA electrode in the 
presence of dioxygen in substrate-free air-saturated PBS (see Figure 5B.15, 5B.16). 
Moreover, the reaction associated with the GCE and with the Co(Sep)
3+
 occurs at 
separate potentials, hence the increase at two separate peak currents, as shown from 
the voltammograms. On the other hand, with reference to the formed H2O2 particular, 
during electrocatalytic substrate interaction studies, it is known induce the formation 
of small amounts of minor metabolites, a reaction path that occurs through a non-
enzymatic reaction of the selected substrate with the formed H2O2. In fact, this 
phenomenon has been documented for numerous studies involving enzyme-based 
electrocatalytic investigations conducted in the presence of oxygen, for which 
negative control-electrode studies with the occlusion of active enzyme was done [85-
86, 135]. However, it must be emphasized that this reaction pathway is completely 
distinct from the catalytic pathway followed by the active enzyme-based 
electrode/biosensor, and as such, no main metabolites can form through this reaction 
path. Moreover, no characteristic increase with each consecutive substrate addition is 
seen, as opposed to the case for the active enzyme-based electrocatalysis, hence the 
distinctly different voltammetric reactivity exhibited by the control-electrode in the 
presence of increasing indinavir concentration, as shown in Figure 5B.19.  
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We can now focus our attention to the electrocatalytic reactions as occurring at the 
GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode (i.e. the Co(Sep)–mediated 
nCYP3A4based biosensor). The reaction pathways in Figure 5B.22 that are of 
significance in the case of the active-enzyme based electrode include reaction B and 
D. It is important to emphasize the fact that while the indinavir is the selected 
substrate, dioxygen is the co-substrate of nCYP3A4, and as such the reaction 
pathways need to be discussed with respect to both aspects. To provide a complete 
comprehensive stepwise overview of all the possible reaction pathways with regard to 
the GC||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA electrode in particular, an 
additional schematic reaction scheme, exhibited in Figure 5B.23, which  illustrates 
possible reaction pathways and also explains both the bioelectrocatalytic oxygen 
reduction current and the bioelectrocatalytic substrate conversion. In addition to this, 
where relevant, representative equations are given to provide more insight into exact 
reactions: Let us start with dioxygen, which, as observed in exhibited catalytic 
studies, showed a distinct increase in reduction peak current (see Figures 5B.15 I and 
5B.16, 5B.20 ), and as such, generally, served as evidence for the electrocatalytic 
activity of cytochrome P450, based on the rapid binding of dioxygen to the reduced 
ferrous nCYP3A4, a process with a usual rate  in the order of   106 M-1 s-1. In this 
case, without substrate (indinavir) present, the resulting ferrous-dioxygen complex is 
known to be highly unstable. In this regard, it can simply accept a second electron, 
but on the contrary, may also release superoxide or alternatively H2O2, while it is 
itself oxidized back to the ferric form. The latter is then reduced again 
electrochemically, which generates the increase in cathodic (reduction) current. With 
regard to the exact sequence of the afore-discussed dioxygen reduction process and 
its associated possible pathways, the following reaction sequence describes the 
process, and as such, provides a in-depth explanation of the results exhibited for the 
catalytic studies of the fabricated biosensor.  
 
All enzyme-based reactions are mediated through the Co(Sep)
3+/2+
 species and as 
such, is preceded by the initial 1e
-
 reduction reaction as shown in equation 5B-3. 
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 The Co(Sep)2+ species then in turn reduces the immobilized active enzyme 
 Co(Sep)
2+
 + nCYP3A4-Fe
III
  Co(Sep)3+ + nCYP3A4-FeII  5B-6 
– Chemical 
 In the presence of oxygen, the reduction of nCYP3A4 –Fe (3+/2+) (equation 5B-6)  is 
followed by  rapid dioxygen binding (equation 5B-7) and introduction of a second 
electron (equation 5B-8), or alternatively, the abstraction of reactive oxygen species 
(equation 5B-9) and regeneration of the ferric state. 
 nCYP3A4-Fe
II 
+ O2  nCYP3A4Fe
IIO2 5B-7 
 nCYP3A4FeIIO2 
     
→     nCYP3A4FeIIIOOH
  
→  nCYP3A4 FeIII + H2O2
   5B-8 
 EFeIIO2 EFe
III O2 

   E FeIII + O2 

   5B-9 
– Autooxidation 
The electrocatalytic reduction of any generated peroxide will also contribute to catalytic 
current (equation 5B-10). 
 EFeIII +H2O2  PFe
IV=O
       
→       EFeIII + EFeIII + H2O  5B-10 
 
 
In the case of  the  nCYP3A4-based bio-electrocatalytic interaction with the substrate on the 
other hand,  the possible reaction pathways are a bit more complex, as exhibited in the 
schematic reaction scheme in Figure 5B.23. In this regard, after the substrate binding 
(reaction 1), the Co(Sep)–mediated 1e– reduction of the ferric iron occurs (reaction 
2). This is followed by binding of dioxygen (reaction 3), thus forming the ferrous-
dioxygen complex. Following this, through another 1e

 transfer interaction, mediated 
by Co(Sep)
3+/2+
 (reaction 4), the highly reactive peroxy intermediate is formed. 
Furthermore, the input of protons to the reactive intermediate can result in the 
cleavage of the OO bond, so producing a high-valence iron-oxygen complex (i.e. 
Fe(IV)═O, also known as Compound I), which at this stage, is then reactive enough 
to insert an oxygen atom into the substrate (indinavir). On this subject, it must be 
emphasised that, although electron abstraction from substrates do occur during the 
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physiological reaction cycle of P450 enzymes, the substrate itself (i.e. indinavir), is 
unable ro reduce the high valencenCYP3A4FeV═O species directly. Finally, 
dissociation of the monooxygenated product, ROH, then restores the nCYP3A4 to the 
starting ferric state (reaction 5). 
 
At this stage, the release of reactive oxygen species needs to also be considered, since 
it is known to be a highly probable envisaged reaction pathway in the P450 reaction 
cycle, particularly in the case of human microsomal P450 isoenzymes, [67, 73, 77, 
87]. In this regard, within the enzyme, the release of superoxide is followed by 
disproportionation and generation of H2O2, which as explained earlier, in the 
vocabulary of P450 enzymology, is referred to as the decoupling/uncoupling reaction. 
Indeed, the uncoupled formation of peroxide has been observed with various 
mammalian P450 isoenzymes [81]. In the context of the current investigation, as 
outlined by the scheme in Figure 5B.23, the main branching points for uncoupling 
for the nCYP3A4 may be envisaged at the level of the dioxygen ferrous complex 
(reaction 6) or the ferric-hydroperoxy complex (reaction 7) [12, 23, 77]. In the 
absence of substrate, this catalytic oxygen reduction may effectually regenerate the 
ferric enzyme, which may again be reduced (reaction 2). The concomitant effect will 
be enhancement of the electrochemical reduction. On the other hand, the peroxide can 
substitute for oxygen and reducing equivalents in what was earlier described as, the 
peroxide shunt pathway, in which the  formed H2O2 directly converts the enzyme to 
its reactive putative ferryl species, i.e. nCYP3A4-Fe(V)═O, which is the reactive 
electrophilic iron oxo intermediate that attacks the substrate for monoxygenative 
product formation [23]. In fact this reaction pathway has played been identified as 
minor and major contributory reaction pathways in numerous electrode-based 
enzyme-substrate electrocatalytic investigations [77, 85, 89, 135]. Still on this 
subject, this reaction, however, does not occur in association with the consumption of 
electrons and will thus not lead to catalytic reduction current.  A noteworthy aspect to 
add is that the general process of catalytic oxygen reduction, as well as the catalytic 
substrate conversion process consume the same number of electrons, and as such, 
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substrate conversion will not result in a higher electron uptake per cycle, therefore 
increase of the reduction current should in effect be a result of a increase in rate 
(hence the further increase in reduction current with indinavir, as shown in Figures 
5B.15 and 5B.16). In this regard, it is not possible to conclusively elucidate the 
reaction pathway from net current alone. 
 
With respect to substrate in particular, substrate binds to the six co-ordinate low spin 
ferric heme (reaction 1). In terms of the natural reaction cycle of P450s, binding of 
the substrate  induces the displacement of the axial H2O molecule from the enzyme 
active site, and as such, generally triggers the catalytic cycle of the enzyme, resulting 
in a penta-coordinated high spin substrate-complexed heme [78, 134]. This 
essentially makes the heme a better electron sink and thus triggers electron transfer 
from the natural NADPH reducing equivalents; this electron transfer event then 
initiates the cycle [22]. In the context of the current research investigation, the 
favourable effect of substrate in tandem with interaction with the reduced Co(Sep) 
mediator, results in the overall initiation of the catalytic cycle. Dioxygen binds, with a 
diffusion limited rate constant of  10-6 M-1 s-1 in the context of P450s in general [22, 
77], and in the context of CYP3A4 in particular, the rate constant is estimated to be 5 
x 10
-5
 M
-1
 s
-1
 [67],  and as such, the process is not rate limited [77]. A noteworthy 
cautionary factor to consider at this stage, though is that according to documented 
research findings, in general, with regard to rate-limiting steps in human CYP3A4 
catalysis, uncoupled autooxidation reactions for this enzyme was shown to be 2–3 
orders of magnitude faster than in the case of the other P450s [67]. Additionally, 
product formation in human P450s was generally shown to be slower than the rates of 
uncoupling reactions, thus, in the absence of substrate the oxy complex in CYP3A4 
would usually tend to autoxidise rapidly and return to the ferric heme state [22, 67]. 
Notwithstanding these factors, it must be said here that catalytic studies in the current 
research investigation was done by maintaining a 15–20% glycerol content within 
enzyme region of the reagent layer. The significance of this aspect lies in the fact that 
according to documented literature, glycerol has been generally shown to confer a 
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unique stabilizing effect on P450 enzymes [24, 173]. In the context of catalysis in 
particular, stabilization is thought to occur mainly through slowing down enzyme 
reaction rates, and reducing non-specific potentially harmful uncoupling interactions, 
while also providing the necessary lubrication for enzyme catalysis through multiple 
hydrogen bond capability, conferred by its water mimicking nature [174-175].    
Furthermore, in this context, the overall stabilizing effect of glycerol may result in a 
longer-lived, iron-peroxy species, thus attenuating its premature dissociation before 
substrate conversion to compound I, which will of course have a favourable effect on 
enzyme-based substrate hydroxylation [73, 82]. In addition to this, with reference to 
human microsomal CYP3A4 in particular, prior research has also shown  that the 
bound presence of substrate significantly stabilizes the oxy-ferrous complex  against 
any uncoupling oxygen reduction reactions, while also modulating  the escape of any 
superoxide or hydroperoxyl species from the heme binding pocket [67]. Considering 
these aspects, and the infinitesimally low detected concentrations of H2O2 during 
enzyme-based catalytic studies, as well as the small relatively small difference 
between catalytic oxidation current in the absence and in the presence of indinavir (as 
shown in Figure 5B.15–5B.17) it appears that in the current investigation, “futile” 
reduction reaction pathways is slower than the substrate conversion, which also 
consumes electrons. On this note, it must also be said at this stage though, that further 
studies will be required to completely understand and elucidate the intricate details of 
the electrocatalytic CYP3A4-reaction. 
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Figure 5B.22 Schematic representation of the reactions occurring at the modified 
glassy carbon working electrode during electroctalaysis experiments. 
 
Figure 5B.23 Suggested general scheme of the electrocatalytic reaction of nCYP3A4 
[mediated by Co(Sep)] in the presence of oxygen. The presence of bound substrate is 
marked by (RH). All reaction pathways are included in a catalytic cycle for better 
indication/illustration of the possible processes.  
 
5B.4 Conclusions 
 
This study demonstrates the successful incorporation of the catalytically 
active N-terminally modified CYP3A4, consisting only of the heme domain and 
surrounding apoprotein, synthesized through genetic engineering by over expression 
in ecoli cells as biorecognition component in a reagentless amperometrically-based 
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biosensor. Moreover, the nafion-modified GCE, containing the potentiostatically 
integrated Co(Sep)
3+
 electroactive mediating species served as pseudo-electron 
transfer donor species for the nCYP3A4 isoenzyme and as such, enabled the electron 
transfer for bio-electrocatalytic activity of the enzyme, while the Co(Sep)
3+
 was in 
turn continuously regenerated at the modified GCE. In addition to this, the detection 
and quantification of the PI ARV, indinavir was realized, while the hydrogen 
peroxide shunt path did not appear to play a role in substrate catalytic interaction. 
Another important observation is that the working potential, with particular reference 
to the reduction/activation of dioxygen is was shown to be considerably reduced, as 
compared to biosensor platform 1 and some other documented studies. 
 
 
 
5B.5 Materials and Methods of Investigation 
 
 
5B.5.1  Preparation of Recombinant N-terminally modified CYP3A4 
(nCYP3A4) 
 
 
5B.5.1.1 Reagents and materials 
 
All categories of materials and reagents (including their specific 
constituents) used in during this process are comprehensively described and outlined 
in table 3B.1, under the section labelled “The reagents and materials for enzyme 
expression and purification of N-terminally modified CYP3A4”, in Chapter 3B. An 
important fact to also emphasize at this stage is that all working solutions used 
throughout the process of expression and purification of the enzyme was either 
autoclaved or filtered through specialized filters, or both. 
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5B.5.1.2 Expression and purification of CYP3A4 construct 
 
 
This process describes the expression and purification of the human 
recombinant, heme-thiolate CYP3A4 isoenzyme, in which genetic engineering was 
used to modify the hydrophobic N-terminal anchor of the CYP450 3A4 isoenzyme, 
by removal of 25 amino acids from this region, and as such, eventually preparing a N-
terminally modified soluble construct tagged with a histidine residue. 
 
 
From a general perspective, the expression/purification process comprised five 
consecutive steps, which included (1) inoculation of the preculture; (2) growing the 
culture and adding specific reactants to induce protein expression in the host cell; (3) 
disrupting the cell membrane to release proteins (lysis); (4) purification of obtained 
protein through making use of affinity-based columns; (5) quantification of the 
obtained product to measure protein concentration. On the other hand, the ‘micro-
steps’ in the actual process was quite an intricate endeavour. Moreover, to ensure 
successful product formation, it was absolutely necessary that each of these steps 
were conscientiously and meticulously carried out. Having said that, an outline of the 
complete protocol is described as follows:  
 
5B.5.1.2.1 Construct expression for CYP3A4/Preculture inoculation 
 
5 mL of the luria broth (LB) medium (see table 3B.1 for constituents of the 
LB medium) was pipetted into a 50 mL, high density glass vial. To this solution,  10 
μL of the glycerol stock (consisting of the single colony E-coli cells containing the 
DNA that encodes the N-terminally truncated P450 3A4 isoenzyme), and 5 L of a 
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(previously prepared) 1 M ampicillin (AMP) was added. The so formed mixture 
(solution A), usually referred to as the pre-culture, was then incubated over night 
(O/N) at 37 °C with shaking at 150 rpm  (strict adherence to the temperature was 
ensured by proper thermostating). With regard to solution A, depending on the 
amount yield required, usually 2 or 3 samples of solution A was prepared during each 
expression/purification experiment. On the same day that the pre-culture was 
prepared, 900 mL terrific broth (TB) medium was also prepared (see table 3B.1), in a 
1 L conical flask, which was followed by autoclaving and overnight cooling. The 
following day, after the 24 hr incubation period, 100 mL (1x) K-phosphate buffer 
solution was added to the (pre-warmed) TB medium, forming solution B. To solution 
B, the following was added: 1 mL of 1 M AMP, 1 mL of 1 M thiamine and 2.5 mL 
trace element solution (see table 3B.1 for specific constituents), thus forming 
solution C. Solution C was then divided into two 500 mL samples. The two samples 
can be referred to as culture C1 and C2. To each of the 500 mL cultures, i.e. C1 and C2, 
a 5 mL of the previously incubated solution A (pre-culture) was added, thus forming 
solution D1 and D2. Solution D1 and D2 was then incubated at 37 °C with shaking 
until the the optical density for each culture was between 0.4 – 0.6. It took 
approximately 3 – 4 h of incubation to   attain the required OD. After the desired 
absorbance readings were attained, δ-aminolevulinic acid (δ‐ALA) was added to 
each of solutions D1 and solution D2 to a final concentration of 0.5 mM. Each of the 
δ‐ALA –containing solutions was subsequently incubated at 30 °C, 150 rpm for 30 
min. After the 30 min has lapsed, CYP3A4 heme expression was induced in each 
solution by addition of IPTG to a final concentration of 1 mM. The induced cultures, 
i.e. solution D1 and D2, were then incubated for a total of 18 h at 30 °C, with shaking 
at 150 rpm. 
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5B.5.1.2.2 Preparation of the crude lysates 
 
Following the 18 h incubation period, the expressed cultures were harvested. For this 
process, each of the two culture samples were further divided into smaller aliquots in 
high density centrifuge tubes, followed by centrifugation of each sample at 5 000 rpm 
for 15 min at 4 °C. During centrifugation, a cell pellet collected at the bottom of each 
centrifugation tube, which was used in the subsequent steps, while the supernatant 
was discarded. In this regard, each of the cell pellets was re-suspended in 250 mL 1 x 
phosphate buffer saline (PBL, pH 7.4). The re-suspension process generally 
comprised of gentle agitation of the pellets until complete dissolution has taken place, 
and all solid pellets were suspended in the PBL. After re-suspension, the 
centrifugation process was repeated at 4 °C, again resulting in cell pelleting. Next, the 
cell formed pellets were re-suspended in 5 mL lysis buffer (see table 3B.1), following 
the same ‘agitation process’ as before. To the re-suspended pellets, lysozyme (to a 
final concentration of 1 mg mL-1), DNase I (500 U), CaCl2 (final concentration = 0.5 
mM), and MgCl2 (final concentration 2.5 mM) were all added. It is noteworthy to 
also add that the lysis suspended cell pellets gave a final volume of approximately 10 
mL, therefore the final concentrations of all the latter constituents were with respect 
to a 10 mL solvent volume. Next, the cell suspensions were incubated on ice for 30 
min with very gentle shaking. Following the ice incubation step, the cell suspensions 
were then subsequently centrifuged at 10 000 xg at 4 °C for 30 min and the resulting 
supernatants, which may be referred to as the crude soluble lysate preparations, were 
either stored in 100 L aliquots at -20 °C for later analysis, or were then used for the 
subsequent protein purification process. 
5B.5.1.2.3 Protein purification 
 
The Ni-TED resin (see table 3B.1) was used for the initiation of the protein 
purification process. The, Ni-TED, with the provided buffers were obtained from the 
manufacturers. To the Ni-TED HisLink wash buffer obtained was added 75 mM 
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imidazole. In addition to this, 250 and 500 mM imidazole was also added to the 
elution buffer which was for use in the sequential elution process involving 2.5 mL of 
the elution buffer for each elution.  The Ni-TED resins were then packed into 
Pharmacodynamics (PD) – 10 columns. The histidine-tagged crude soluble lysate 
preparations were then purified with the Ni-TED resins, by affinity. Meanwhile, 
Centriprep YM – 10 columns were rinsed with 15 mL Milli-Q water by 
centrifugation at 3000 xg. Next, each  resin – purified protein sample was added to a 
cleaned Centriprep column and centrifuged at 3 000 xg at 4 °C until the protein 
samples were concentrated to just below 700 L. The Centriprep concentration 
process took approximately 35 min. Following this, each protein concentrate was 
then added to a Zeba column for buffer exchange into the final P450 storage buffer 
(see table 3B.1 for constituents), according to the instructions provided by the 
manufacturer. The final soluble purified protein samples were eluted from the Zeba 
columns and immediately divided into 5 – 10 L aliquots, which was stored at -20 °C 
until used.      
 
 
 
5B.5.1.3 Total protein quantification 
 
The determination of total protein concentrations in the purified protein 
samples were done with the use of the Bio-Rad protein dye, based on the Bradford 
micro-assay. In this regard bovine serum albumin (BSA) was used for creation of 
standard curves. The exact protocol was done according to the manufacturer’s 
instructions. Briefly, 20 mg/mL BSA were prepared in the P450 storage buffer, thus 
forming solution A. Solution A was then diluted to 100 g mL-1, thus forming 
solution B. Solution B was then used to prepare 5 standard BSA solutions of 
concentrations, 2-, 4-, 6-, 8- and 10 g mL-1. In this regard, three replicates of these 
standard solutions were prepared. Meanwhile, 1 in 20 dilutions of the purified protein 
samples were prepared (also in triplicate). Next, 200 L concentrated Bardfords 
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reagent was thoroughly mixed with 800 L of each standard or purified protein 
sample working solution. Each of the mixtures were aged for 5 min, after which the 
absorbance readings were recorded at A595. The results were then used to obtain a 
calibration curve, from which the purified protein concentrations were estimated. To 
eventually calculate the molarity, the molecular weights used for the   
 
 
5B.5.1.3  Spectral analysis of and activity assays the prepared nCYP3A4 
construct 
 
5B.5.1.3.1 FTIR spectral analysis 
 
Spectra were recorded by placing a drop of the enzyme-containing solution 
directly on the gasket of the cell window, as shown in Figure 5B.24. The background 
spectra of the protein storage solution were also taken and the necessary background 
subtractions were done with the inherent mathematical software of the system. 
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Figure 5B.24 Showing method of FTIR analysis with high-pressure anvil cell for 
wet nCYP3A4 samples.  
 
 
 
5B.5.1.3.2 UV-Vis spectra of resting state nCYP3A4 (nCYP3A4-Fe
3+
) 
construct 
 
UV-Vis spectra of the resting state nCYP3A4 were taken with 3 M 
nCYP3A4, in a potassium-phosphate buffer solution, containing 20% glycerol, 1 mM 
DTT and 0.2 mM EDTA, with a dual-beam spectrometer. The enzyme storage 
solution was used for background. 
 
 
5B.5.1.3.3 Activity assay for the nCYP3A4 construct: Carbon monoxide 
complex 
 
Cytochromes P450 got their name from their atypical spectral properties 
displaying a characteristic absorption maximum of the reduced carbon-bound 
complex at 450 nm. Thus the ability of the reduced P450 to produce an absorption 
peak at 450 nm upon CO binding has been used thru ought the years for estimation of 
the P450 content [21, 23]. In this regard, the method of analysis is still done, 
according to its discoverers,  i.e. according to the method of Omural and Sato [159]: 
 A working solution of the synthesized enzyme construct was prepared by 
dilution of the stock into 50 mM KPBS (pH 7.4), containing glycerol ( 20% 
v/v). The glycerol was necessary to stabilize the enzyme against autooxidation 
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 The solution was argon-degassed and the baselines were recorded with a dual-
beam UV-Vis spectrometer (see details of instrument in Chapter 3B). 
 Reduction of the protein was then initiated by injection of equimolar 
concentration of sodium dithionite (made up in a 0.5 mM solution with the 
buffer). The spectra was them measured at 1.5 – 2 min intervals, until no 
further reduction was observed. i.e. until no further variation in the 420 nm 
peak was observed. 
 At this point, CO was gently bubbled through the solution for 30 sec intervals 
followed by intermittent measurement of the spectra until no further increase 
in the 450 nm peak was observed.  
 The difference spectra were then obtained by subtraction of each reduced 
protein spectrum from the relevant CO – bound reduced spectrum to obtain 
the final difference spectrum.  
 Amount of catalytically active heme – bound protein content was calculated 
using ε450 – 490 = 91 mM cm-1, whereas inactive (denatured) heme  - bound 
nCYP3A4 content was calculated according to ε420 – 490 = 111 mM cm-1. 
 
 
 
 
 
 
5B.5.2 Methods and protocols for biosensor preparation, optimisation studies 
and voltammetric investigations 
 
Table 5B.2  Materials and reagents used  
 
Reagents and materials for optimized Co(Sep)
3+
-mediated nCYP3A4-based 
biosensor 
Reagents for carrier 
matrix preparation 
1% nafion (pH 7.4);  1mM Co(Sep)
3+
 (in 100 mM KPBL) 
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Reagents for outer-film 
preparation 
5% PVA (in 100 mM KPBS), 1% agarose (in milli-Q 
H2O), PEI in (100 mM KPBS)  
nCYP3A4 casting 
solution 
1.5 M nCYP in 100 mM KPBST, pH 7.4 (See table 
3B.1 for exact constituents of buffer) 
Reagents for catalytic 
studies 
Molecular dioxygen (O2) and indinavir 
Reagents and materials for un-mediated nCYP3A4-based biosensor 
Reagents for carrier 
matrix 
1% nafion only (pH 7.4) 
Reagents for outer-film 
preparation 
Exactly the same as described in previous section 
nCYP3A4 casting 
solution 
Exactly the same as described in previous section 
Reagents for catalytic 
studies 
Molecular dioxygen (O2) and indinavir 
Reagents and materials for Control sensor platform 
Reagents or carrier 
matrix preparation 
1% nafion (pH 7.4);  1mM Co(Sep)
3+
 (in 100 mM KPBL) 
Reagents for outer-film 
preparation 
5% PVA (in 100 mM KPBS), 1% agarose (in milli-Q 
H2O), PEI in (100 mM KPBS)  
Pseudo enzyme casting BSA in 100 mM KPBST, pH 7.4 
Note: For exact constituents of reagents and protocols for preparation of working 
solutions etc, the reader may consult the relevant subsections in Chapter 3B 
 
 
 
5B.5.2.1 Preparation of Co(Sep)3+–mediated nCYP3A4-based biosensor 
(under optimised conditions) for voltammetric characterization and 
catalytic investigations 
 
The working electrode used in this study was a clean or modified GCE. 
Before modification, the GCE was activated and pre-treated according to the method 
outlined in Section 3B.3.1.1 of Chapter 3.  5 L 1% nafion (pH 7.4) was 
subsequently drop coated onto the activated GCE surface. The electrode was then 
covered with a tight-fitting cover to allow the stable formation of a smooth nafion 
film. After a dry nafion film has formed the Co(Sep)
3+
 was incorporated into the 
nafion membrane by potentiostatic electrodeposition. For this process, the a argon-
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degassed 100 mM potassium phosphate buffer saline (KPBL, pH 7.4) solution,  
containing 1 mM cobalt(III) sepulchrate (prepared as described in Section 3B.2.2.3.2, 
Chapter 3) was used as electrolyte medium. The electrodeposition was done at a 
constant potential of +450 mV for 1 200 sec, after which the modified electrode was 
rinsed and air dried. The naf-El-Co(Sep)
3+
 modified GCE (GCE||naf|El-Co(Sep)
3+
) 
was then subjected to electrochemical cycling in a 50 mM PBS until a stable 
background current was obtained. At this point the nCYP3A4-based biosensor was 
prepared. In this regard, a total of 6 L  nCYP3A4 (1.5 M) was drop-coated onto the 
GCE||naf|El-Co(Sep)
3+
 in two 3L aliquots by a sterilized, calibrated glass micro-
syringe. In addition to this, each drop-casting step was followed by intermittent 
setting at 2 °C after each casting step for duration of 5 min each. In addition to this,  
the enzyme modified electrode was placed in a gentle flow of argon for 
approximately 5 min, followed by immediate casting of the outer layer solution. In 
this regard, 7 L of the blended ionic polymer-composite solution (prepared as 
described in Section 3B.2.2.3.6, Chapter 3B) was drop-cast onto the GC||naf|El-
Co(Sep)
3+
|nCYP3A4 electrode with a calibrated glass micro-syringe. An important 
requirement for this step was that both the casting solution and the syringe needed to 
be pre-warmed in order to prevent pre-mature solidification of the solution. Finally, 
the prepared biosensor, denoted GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA, 
was set for eight hours at 2 °C. 
 
 
 
5B.5.2.2 Preparation of un-mediated nCYP3A4-based biosensor for 
voltammetric characterization and catalytic investigations 
 
The preparation of this biosensor was exactly the same as described in the 
pre-ceding section, except that in this case, no Co(Sep)
3+
 electrodeposition was done 
and as such, enzyme casting was done directly after the formation of the base nafion-
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film, exactly as described above. This was then followed by casting of the outer-film 
solution, also done exactly as described above. The prepared biosensor may be 
denoted, GCE||naf|nCYP3A4|Agrs-PEI-PVA. 
 
 
 
5B.5.2.3 Preparation of the Co(Sep)3+ based  control sensor platform 
 
The sequential steps for preparation of the control sensor platform was 
exactly the same, as outlined in Section  5B.5.2.1. However, in the case of the control 
platform, instead of the prepared nCYP3A4 construct, bovine serum albumin (BSA) 
was cast as pseudo enzyme substitute. The prepared control sensor may be denoted 
GCE||naf|El-Co(Sep)
3+
|BSA|Agrs-PEI-PVA. 
 
  
 
5B.5.2.4  Preparation of the platforms for optimisation of the variables 
concerning the indinavir amperometric biosensor  
 
5B.5.2.4.1 Preparation of Co(Sep)
3+–mediated nCYP3A4-based biosensor 
platform with Eastman-AQ as base layer and  crosslinked PVA as 
outer film 
5 L of an aqueous 3% EAQ dispersion was drop coated onto a clean, 
activated GCE with a micro-pipette. The modified GCE was covered with a tightly 
fitting lid to allow even formation of the EAQ-film. Once dry, the Co(Sep)
3+
 
mediating species was incorporated into the pre-formed EAQ using a protocol exactly 
as described in Section 5B.5.2.1 above. Since the EAQ-El-Co(Sep)
3+
 film did not 
appear very stable, it was not subjected to subsequent electrochemical cycling in a 50 
mM PBS before biosensor construction, as in the case of the biosensor with nafion as 
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base film. The next step involved drop-coating 6 L of the prepared nCYP3A4 (1.5 
M) with a sterilized calibrated glass microsyringe. Following this, the enzyme-film 
was set for approximately 5 min at 2 °C followed by further setting under gentle 
argon flow for 5 min.  In the next step, 7 L of a 5% aqueous PVA solution (prepared 
as described in Section 3B.2.2.3.5, Chapter 3) was cast onto the nCYP3A4-
derivitized electrode, as outer film component. PVA is usually labile in aqueous 
solution and as such, to ensure stable enzyme encapsulation, the cast PVA was 
subsequently crosslinked. The technique used for crosslinking was customised from 
standard methods [103, 164]. The method basically comprised acid catalyzed 
crosslinking with glutaraldehyde (25% v/v).   The biosensor, denoted GCE||EAQ|El-
Co(Sep)
3+
|nCYP3A4|clPVA was placed in milli-Q water to remove any unreacted 
components and stored  at 2 °C for further setting .  
 
 
 
5B.5.2.4.2 Preparation of Co(Sep)
3+–mediated nCYP3A4-based biosensor 
platform with nafion as base layer and  crosslinked PVA as outer film 
 
The nafion base layer was formed exactly as described in Section 5B.5.2.1. 
In addition to this, incorporation of the Co(Sep)
3+
 mediating species into the pre-
formed nafion membrane was also done exactly according to the method outlined in 
Section 5B.5.2.1. The GCE|naf|El-Co(Sep)
3+
 electrode was then subjected to 
electrochemical cycling in a 50 mM PBS until a stable background current was 
obtained. Following this, the prepared nCYP3A4 was immobilized in exactly the 
same manner as outlined in Section 5B.5.2.4.1. In addition to this, casting and 
crosslinking of the PVA outer layer was also done exactly the same as described in 
Section 5B.5.2.4.1. The prepared biosensor is denoted GCE||naf|El-
Co(Sep)
3+
|nCYP3A4|clPVA. 
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5B.5.2.4.2 Preparation of Co(Sep)
3+–mediated nCYP3A4-based biosensor 
platform with nafion as base layer and  crosslinked PVA as outer film 
 
In this case the nafion film, Co(Sep)
3+
 incorporation and  immobilization 
of nCYP3A4 was done exactly according to the method outlined in Section 5B.5.2.1. 
In addition to this, the casting of the outer layer solution was also done exactly 
according to method outlined in the afore-mentioned section. However, the ratio of 
PEI with respect to the PVA-Agrs was varied by varying the volume of PEI in the 
casting solution.  
 
 
5B.5.2.4.3 Preparation of biosensor platforms for nCYP3A4 loading optimisation 
studies 
 
For investigation of this variable, the amount of nCYP3A4 was varied, 
while all other variables were kept constant. In this regard, the casting volume of 
nCYP3A4 was varied, i.e. 4-, 5-, 6-, 7- and 8 L. In terms of the fabrication of the 
biosensor platforms, in its entirety, each platform was prepared exactly according to 
the sequential protocol outlined in Section 5B.5.2.1. 
5B.5.2.4.4 Preparation of biosensor platforms for Co(Sep)
3+
 potentiostatic 
loading time optimisation studies 
 
With regard to investigation of this particular variable, the potentiostatic 
Co(Sep)
3+
 electrodeposition time was varied, while all other parameters were kept 
absolutely constant. For this purpose, Co(Sep)
3+
 electro-deposit times were varied 
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from 300 up to 2 000 sec. Again, as in the previous case, with regard to fabrication of 
the biosensor platforms, the protocol followed was exactly according to the method 
outline in Section 5B.5.2.1, the only difference, where relevant, being the Co(Sep)
3+
 
electro-deposition times.  
 
 
 
5B.5.2.4 Procedures for voltammetric characterization of the prepared 
platforms 
 
All voltammetric characterization studies were done with a three electrode 
arrangement as described in Section 3B.3.1, Chapter 3B (see also Figure 3A.8). The 
supporting electrolyte used throughout characterization in all cases, were argon-
degassed 50 mM phosphate buffer solution (PBS, pH7.4). For cyclic voltammetric 
investigations, the particular electrode was cathodically scanned from -100 mV to the 
switch potential, -950 mV (vs Ag/AgCl). Cycling was done until a steady state 
background current for the Faradaic redox response was observed, and as such, all 
voltammograms were collected from the 5
th
 cycle onward, when a stable background 
current was observed. Osteryoung square wave voltammetry (SWV) was done by 
applying a linear reductive potential scan (cathodic mode – one direction only) 
between -100 and -950 mV at a step potential of 4 mV, a frequency of 1 Hz, and a 
square wave amplitude of 25 mV. Differential pulse voltammetry (DPV) for the 
reduction wave was performed by applying a potential scan from -100 to -950 mV (vs 
Ag/AgCl), with specific parameters as follows: scan rate = 20 mV s
-1
, pulse 
amplitude = 25 mV, sample width = 2 ms, pulse width = 15 ms, pulse period = 200 
ms and quiet time = 2 s. For the DPV of the oxidative wave, the electrode was 
scanned from -950 to -100 mV, while all other parameters were exactly the same of 
the for the reductive scan.   
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5B.5.2.5 Procedures for catalytic response investigations 
 
All catalytic response investigations were conducted in un-degassed 50 
mM PBS in the presence, or absence of the substrate of interest (i.e. indinavir). 
Response experiments were done with cyclic voltammetry and square wave 
voltammetry. In this regard CV and SWV was run in the presence and absence of 
oxygen and/or indinavir to investigate the Co(Sep)
3+–mediated or un-mediated 
enzyme-oxygen-substrate interaction. For all cyclic voltammetric investigations, in 
the presence of oxygen and/or indinavir, the electrode was cathodically scanned from 
-100 mV to the switch potential, -950 mV (vs Ag/AgCl) at a scan rate of 5 mV s
-1
. 
Square wave voltammetric investigations were done by applying a linear reductive 
potential scan (cathodic mode – one direction only) between -100 and -950 mV at a 
step potential of 4 mV, a frequency of 1 Hz, and square wave amplitude of 25 mV. 
 
 
 
 
5B.5.2.6 Procedures for investigations of optimisation of the variables 
 
As a sensitivity criterion for the optimisation of the relevant working 
variables affecting the behaviour of the indinavir biosensor: Firstly, optimisation was 
done with respect to the working potential for the reduction of oxygen. In this regard, 
the platforms were evaluated with regard to a lower operating potential which could 
significantly reduce the overpotential for oxygen reduction as compared to the results 
obtained for biosensor platform 1, as well as previous investigations involving 
CYP3A4. Secondly, in terms of response to indinavir, evaluations, where relevant 
was done with the slope of calibration curves for indinavir for predetermined 
concentration range as sensitivity criterion. The specific concentration ranges and 
slopes, etc. are discussed in the relevant results sections in the current chapter.  
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CHAPTER 6 
 
Summary and Conclusions 
 
6.1 Introduction 
 
In the current chapter the results obtained in association with the two 
biosensor platforms from the work presented in the dissertation is summarized. In this 
regard, a summary of each individual results chapter, with particular reference to 
recapitulating the main and most significant findings and conclusions for that 
particular chapter is given. In addition to this,     
 
 
6.2 Summary of individual results chapters 
 
6.2.1  Chapter 4 
 
These results are based on design path 1, as shown in the flow diagram 
exhibited in Chapter 3B. 
 
 The detection and quantification of endocrine disruptor compound/priority pollutant, 
2,4-DCP have been successfully realized by using the fabricated 
GCE||naf|CMECo(Sep)
3+
|flCYP3A4|naf biosensor. The design path for this biosensor 
platform, was based on sandwich configuration, in which detergent-monomerized, 
commercially obtained, full-length human recombinant CYP3A4 was entrapped 
between a cobalt(III) sepulchrate derivatised nafion inner-membrane and a thin 
nafion outer film. Entrapment of the Co(Sep)
3+
 in the preformed nafion membrane 
was achieved through simple manual drop-casting and mixing method. In this regard, 
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FTIR confirmed the existence of the Co(Sep)
3+
 counter-ion species in the nafion 
membrane. The variation in the electrochemical characteristics in association with the 
progression from the nafion-modified GCE, to the reagentless mediator containing 
flCYP3A-derivatized biosensor platform confirmed the electron flow from the 
electrode to the flCYP3A4 via the (nafion pre-concentrated) Co(Sep)
3+
 mediator. 
Moreover, comparitive evaluation of the exhibited electrochemically based results for 
the GCE||naf|CMECo(Sep)
3+
|flCYP3A4|naf biosensor with that of the 
GCE||naf|CMECo(Sep)
3+
 carrier matrix, suggested the favourable interaction between 
the monomerized flCYP3A4 through possible coulombic and/or hydrophobic 
interactions of the nafion with the surfactant-type CHAPS detergent.  
 
The voltammetric investigations of the GCE||naf|CMECo(Sep)
3+
|flCYP3A4|naf, 
revealed a Em of   -590 mV. Moreover, the surface coverage, Γ, of the electroactive 
Co(Sep)
3+
 species was determined as 9.8 x 10
-8
 mol cm
-2
. On the other hand, the 
constant value exhibited for the current function Ip/ν
½
 suggests that the charge 
transfer of the biosensor in the absence of oxygen and substrated in the higher scan 
region is a diffusion-kinetically controlled process. Thus, the Dct, calculated by 
Randle Sevick analysis, was determined as 0.5 x 10
-8
 cm
2
 s
-1
. Inter-day 
electrochemical evaluation of the storage stability of the biosensor revealed a gradual 
decline in signal in association with progressive leaching of the mediating species 
from the reagent layer. 
 
With respect to the electrocatalytic investigations, the following findings were made:  
 The catalytic increase in Ip,c in association with the injection of the substrate,  
2,4-DCP, in anaerobic phosphate buffer saline, coupled to the small 
simultaneous anodic Ep shift, suggested the presence of sufficient residual 
dioxygen in the substrate containing solution to induce bioelectrocatalytic 
response from the reduced heme iron, flCYP3A4-Fe
2+
 for the formation of the 
active oxy-ferryl species, for effecting hydroxylation of the 2,4-DCP. 
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 The GCE||naf|CMECo(Sep)3+|flCYP3A4|naf  biosensor showed an average 
reduction potential for dioxygen of -600 ( 10) mV, as determined from CV 
and SWV. With regard to the cyclic voltammetric results in particular, the bio-
electrocatalytic response to molecular dioxygen was signified by a considerable 
increase in Ip,c which was  simultaneously accompanied by a complete 
attenuation of the Ip,a. 
 The results exhibiting  the catalytic response of the biosensor to the 2,4-DCP, 
suggested that the presence of the substrate increased the rate of dioxygen 
binding to the flCYP3A4-Fe
2+
. 
 In the presence of increasing 2.4-DCP concentrations, the biosensor exhibited a 
periodic increase in catalytic peak current in conjunction with each consecutive 
addition, up to the final concentration.  
 The catalytic investigations with the native physiological CYP3A4 substrate, 
erythromycin, exhibited results that was in complete agreement with the 
findings as observed for 2,4-DCP. This re-affirmed and corroborated the 
catalytic response was due to the enzyme-based bio-recognition component, i.e. 
flCYP3A4. 
 Similarly, the inhibition of the bio-electrocatalytic response of the flCYP3A4 in 
association with the observed decrease in catalytic response signal to 2,4-DCP 
in the presence of native, physiological CYP3A4 inhibitor, ketoconazole, 
served as additional re-affirmation of catalytic activity of the bio-recognition 
component.  
 With regard to the calibration curve for 2,4-DCP: The dynamic linear range for 
this substrate had an upper limit of 45 A and a sensitivity of 0.038 A M-1. 
In addition to this, the LOD was determined as 0.043 g L-1. 
 The linear curve for ERM showed a linear range over 4.63  26.4 M, while 
the dynamic linear range showed an upper limit of 26.4 A. The sensitivity was 
determined as 0.323 A M-1 and the LOD calculated as 1.271 x 10-5 M. 
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Overall, the biocatalytic response of the flCYP3A4 to the selected substrates were 
successfully mediated by the immobilized Co(Sep)
3+
 species. The manual 
casting/mixing method thus seemed to be a feasible method of pre-concentrating the 
mediator within the reagent layer.  
 
 
6.2.2 Chapter 5A 
 
These results are based on design path 2, as shown by the flow diagram 
exhibited in Chapter 3B. 
 
Here, the incorporation of the electroactive Co(Sep)
3+
 cationic species  into the 
microstructure of a pre-formed nafion film is successfully achieved through an 
innovative electrochemically based technique, which involved potentiostatic 
deposition  at a potential of +450 mV for a duration of 1 200 sec.   The cyclic 
voltammetric characterization of the nafion-derivatised GCE, suggested that the 
nafion film effectively filled approximately 15 – 20% of the active sites of the 
underlying GCE, but did not substantially impede ET with respect to the underlying 
electrode, which essentially meant that the pre-formed nafion film could serve as 
efficient matrix for subsequent incorporation counter-ion species. Moreover, 
morphological analysis of the nafion film revealed a microstructure with highly 
evenly formed, smooth consistency and compact nature. The thickness of the nafion 
membrane was determined as 3.1 m. With regard to the Co(Sep)3+ modified nafion 
film, the electrochemical characterization studies indicated fast reversible ET for the 
metal-centred electroactive species, with an  average Em determined as -615 mV. 
Moreover, Ep variation for scan rates between 2  10 mV s
-1
 was negligible, while 
the average Ip,a/Ip,c was shown to be  1. In addition to this, the GCE||naf|El-
Co(Sep)
3+
 exhibited a stable background current under continuous and/or  
intermittent cycling, with no indication of variation or reduction in the observed 
redox signal for scans taken at half hour up to four hour intervals. The total surface 
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coverage, Γ, of the Co(Sep)3+ electroactive species, determined under conditions of 
exhaustive electrolysis, was calculated to be 1.537 x 10
-5
 mol cm
-2
.  
 
Above and beyond these findings, cumulatively, the electrochemical characterization 
studies showed the following additional findings:  
 The results suggest a strong affinity of nafion for the cationic Co(Sep)3+ 
species. 
 The results also suggest that the novel electrochemical technique allowed the 
nafion to extract and incorporate the Co(Sep)
3+
 into the lower density ionic 
cluster phase in a manner that is inline with its unique inherent structural 
features. In this regard, uptake of Co(Sep)
3+
 appeared to be dominated by 
hydrophobic interactions, rather than normal electrostatic forces.   
 The obtained Em for the naf-El-Co(Sep)
3+
 was shown to be similar to previously 
documented results which also involved an electrochemically based method of 
incorporation, but distinctly different from the results showed for the manual 
casting/mixing method used for the platform shown in Chapter 4. 
 A linear relationship for the current function, Ip/ν
½
 for both Ip,c and Ip,a 
suggested diffusion controlled electrochemistry. In addition to this, the plot of 
log Ip vs log ν for both Ip,c and Ip,a, showed slopes of close to the theoretical 
value of 0.5 for diffusion controlled process. The Dct for the naf-El-Co(Sep)
3+
 
was determined as 2.64 x 10
-7
 cm s
-1
. 
 The unique method of nafion’s cation uptake, which distinctly different and 
from and more effective than as observed in the case of conventional ion 
exchange resins and/or electrostatic binding polymers, combine with its 
inherent phase segregation enabled a three-dimensional charge transport 
network, providing molecular accessibility and rapid diffusional mass 
transport of electroactive species. 
 The long-term stability evaluation of the  GC||naf|El-Co(Sep)3+, revealed a 
retention of 73% of its original signal following intermittent electrochemical 
cycling at  times and intermittent storage over a five day period. 
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 FTIR structural investigations confirmed the existence of the Co(sep)3+. 
 
 
 
6.2.3 Chapter 5B 
 
The first aspect of importance in this study, was that the human 
recombinant heme thiolate CYP3A4 was successfully prepared through genetic 
engineering, as a catalytically active N-terminally modified histidine-tagged, soluble 
construct, consisting of the heme domain and the surrounding apoprotein. Secondly, 
the detection and quantification of HAART associated protease inhibitor drug, 
indinavir, was successfully realized by means of the prepared GCE||naf|El-
Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA biosensor. The design path for this particular 
biosensor was based on a combination of entrapment  encapsulation. In this regard 
the biological molecule was entrapped behind a modified solid polymer electrolyte 
nafion membrane,  and  further encapsulated by a biocompatible ionically crosslinked 
blended hydrogel outer membrane, consisting of a composite of agarose, poly(vinyl 
alcohol) and polyethylene imine. Entrapment of the Co(Sep)
3+
 mediating species 
within the microstructure of the pre-formed nafion membrane was uniquely done 
through novel potentiostatic electrodeposition method, for which the major findings 
were discussed in Section 6.2.2.  
 
 
For the enzyme that was synthesised, the FTIR spectra exhibited major vibrational 
absorption bands in association with the unique structural characteristics of P450 
enzymes, while  the catalytically active P450 content was confirmed by the 
absorption maximum of the reduced CO-bound complex at 450 nm. As for the 
fabricated GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-PVA biosensor, firstly, 
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different factors and variables in the construction of  biosensor was evaluated, which 
included: 
1)  the effect of carrier matrix assembly, 
 here optimisation was done with respect to constituents, as well as 
method of preparation.  
2) outer layer optimisation, 
 here optimisation was done with respect to film constituents and 
ratio.  
3) the optimal enzyme loading amount, 
4) optimisation of potentiostatic electro-deposition time for cobalt(III) 
sepulchrate. 
 
Overall, with regard the un-mediated biosensor, GCE||naf|nCYP3A4|Agrs-PEI-
PVA, the results suggested weak electronic coupling with the underlying nafion-
modified GCE, characterized by ill-formed voltammograms in substrate-free argon-
degassed PB eletrolyte solution. This translated into high operating potentials, with 
regard to the biocatalytic reduction of dioxygen, and response to the substrate, 
indinavir. In particular, the reduction of dioxygen occurred at an average Ep of -664 
mV, while average Ep response for indinavir was approximately -700 mV. 
Nevertheless, overall, the GCE||naf|nCYP3A4|Agrs-PEI-PVA biosensor exhibited 
the classic additional catalytic current in response to oxygen, as well as indinavir.  
 
With regard to the optimized Co(Sep)
3+
 mediated biosensor on the other hand, the 
results were unequivocally different. The bioelectrocatalytic response in the 
presence of oxygen and indinavir was signified by the emergence of a new peak in 
the reduction wave, which dominated the cathodic wave. On average, oxygen 
reduction occurred at -365 mV, while response to indinavir occurred at -369 mV. 
Moreover, the possible effects of the peroxide shunt pathway appeared to be 
negligible. The behaviour of the control sensor, for which the active enzyme was 
replaced by the pseudo carrier enzyme (BSA), an indistinct current increase with 
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maxima at two peak potentials i.e.  -410 mV and  -645 mV was observed in the 
presence of oxygen and indinavir. The double peak behaviour was suggested to be 
ascribed to the effect of reactive H2O2 formed in association with the reduction of 
oxygen in the film of the GCE, as well as the coupling of the 1e
–
 reduction of the 
mediating species with a fast follow- up chemical reaction with oxygen. 
Experiments involving investigation with varying indinavir concentration with the 
GCE||naf|nCYP3A4|Agrs-PEI-PVA biosensor, showed a concentration dependent 
increase in Ip,c in association with consecutive addition of substrate, at the potential 
of the response of the nCYP3A4-Fe
2+
. The GCE||naf|BSA|Agrs-PEI-PVA control 
sensor on the other hand did not exhibit a discernible response to increasing 
indinavir concentrations. 
 
Above and beyond all these findings, the  GCE||naf|nCYP3A4|Agrs-PEI-PVA 
biosensor exhibited a linear concentration range for the constructed calibration 
curve in the range of between 2.18 x 10-6  3.552 x 10-6 M. The sensitivity was 
determined as 0.035 A M-1, while the LOD was determined as 59.72 mg L-1. This 
value for LOD was shown to be of significance in the CMax of ritonavir–boosted 
indinavir regimen, which is the current proposed method of treatment for 
administration of indinavir, while also being of significance in patients which are 
poor metabolisers. The apparent Michaelis Menten constant was determined as 
17.54 M, which is on the low side, and as such shows affinity of the enzyme for 
the substrate. 
 
 
6.3 Critical overview of the studies in this dissertation 
 
In the following segments, some additional findings are highlighted, while 
comparative evaluations between the design paths are given and a brief overview of 
achieved aims are given. 
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Overall, with regard to the pre-formed nafion films and the Co(Sep)
3+
 modified films, 
as compared by the techniques used in the two different design paths, i.e. design path 
1 and design path 2: The results with reference to the morphological,  structural and 
electrochemical  investigation, firstly suggest that a larger amount of nafion yields a 
better coverage on the underlying GCE. Secondly, still, vacuum conditions, rather 
than argon drying yields a more evenly formed nafion film. Thirdly, the results 
suggest that the electrochemically based technique of Co(sep)
3+
 incorporation into the 
nafion film is much more superior than the manual casting/mixing method, both with 
regard to ideal film formation, as well as enabling the incorporation of the Co(Sep)
3+
 
deep within the micro-structure of the nafion membrane. In addition to this, the 
electrochemically based technique proved to be a more reproducible method of 
preparation. 
 
All the catalytic studies in the presence of the selected substrate(s), as observed for 
both biosensor platforms 1 and 2, in effect corroborated documented findings 
regarding catalytic interactions of CYP3A4 in particular and/or P450 enzymes in 
general, in which it has been shown that the presence of substrate favourably affects 
the enzyme-oxygen interaction, by significantly increasing the rate of dioxygen 
binding to the redox centre. In addition to this, in a critical comparative evaluation, 
the overpotential for the bioelectrocatalytic reduction of dioxygen was shown to be 
considerably reduced in the case of biosensor platform 2, as compared to biosensor 
platform 1.  
 
 
 
6.4 Recommendations for future study 
  
1. Although it appears that the major rout of hydroxylation of substrate was 
formed by the completion of the natural catalytic cycle of the CYP3A4 
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isoenzyme, further studies will be required to conclusively corroborate all the 
proposed reaction pathways in the electrochemically driven enzyme catalysis. 
In particular, the most significant recommended studies would include rotating 
disk electrochemical studies (to determine exact coupling efficiency), bulk 
electrolysis, with subsequent analysis of products to determine the exact 
metabolites formed, and catalysis experiments in the presence of reactive 
oxygen species scavengers. Additional incubations with H2O2 conducted 
without the use of an electromotive force under the same electrolysis 
experimental conditions as would be used above, with subsequent analysis of 
products is also suggested.  These experiments are thus recommended for future 
work. 
2. The application of and characterization of GCE||naf|nCYP3A4|Agrs-PEI-PVA 
with real human plasma was not done, due to time constraints. Thus it is 
recommended that such studies be conducted in future post-doctoral studies. 
3. It is also recommended that additional ex-situ investigations of the complete 
biosensor platforms be done, both before and after catalytic investigations, 
which can then be combined with the observed results to have a more 
comprehensive picture of the changes in the enzyme in association with 
immobilization, as well as catalytic studies. 
4. Probing  of the biosensor platforms with  
 
6.5 Overall significance of the study 
 
The results obtained  in this dissertation firstly contributes significantly in 
the overall stride toward decentralized methods of assaying drug concentrations in 
chronic  conditions such as HIV/AIDS, which could eventually serve useful in the 
quest for alternative  analytically based methods for DTM during such chronic 
conditions. Secondly, with regard to 2,4-DCP,  the study is a step forward in research 
with regard to alternative proposed methods for preparation of small analytical 
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devices for  on-the-spot detection and measurement of environmental samples. 
Moreover, a fundamental aspect regarding the scope of the dissertation in its entirety 
is the fact that the natural electron delivery system which is absolutely necessary for 
the CYP catalytic cycle was replaced by an electromotive force. What is more, is that  
catalysis was effectuated with just the heme domain of the enzyme, which is a huge 
milestone, since the application of this kind of human microsomal isoenzymes are by-
and-large impeded  by the  requirement of physiological  reducing equivalents, either 
immobilized within the reagent layer or usually expressed with the enzyme, as a 
fusion construct. Another milestone is the synthesis and expression of the soluble 
construct of CYP3A4. In this regard, the full-length native isoenzyme is known to 
require the obligatory presence of highly expensive additional surfactant-type 
compounds and/or other monomerisation agents in order to prevent its aggregation.  
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APPENDIX A 
 
Additional results for Section 5B.2.2: Structural aspects of the genetically 
engineered his6-tagged N-terminally modified recombinant CYP3A4 
(nCYP3A4) 
 
 
 
 
 
 
 
 
 
Figure A-1  Electronic absorption spectra for the synthesized, N-terminally 
modified CYP450 3A4 (nCYP3A4). (nCYP3A4-Fe
IIcarbon 
monoxide, prepared by reducing nCYP3A4Fe
III
 with excess sodium 
dithionite and saturating with CO by bubbling for 2 min). Spectra 
exhbited is the difference spectra taken against references of reduced 
nCYP3A4 before addition of CO. Working solution of nCYP3A4 was 
20 mM potassium phosphate buffer, pH 7.40, 20% glycerol. 
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APPENDIX B 
 
 Additional results for Section 5B.3.1.1:  
 Optimisation of the variables concerning the indinavir amperometric biosensor 
assembly  
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APPENDIX B.1 
 
Optimisation of Co(Sep)
3+
 Loading time: 
 
 
Figure B.1-1: Typical calibration plots, showing nCYP-based biosensor [GCnafEl-
Co(Sep)
3+nCYP3A4] response, to indinavir in the 0.05  25.60 μM 
concentration range for biosensors prepared  
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APPENDIX B.2 
 
Calibration plots obtained for nCYP3A4 loading optimisation studies: 
 
Table B.2-1: Specific parameters with regard to the calibration plots 
Figure 
Amount of nCYP3A4 Loaded 
Paramaters obtained from 
Regression analysis 
μg cm-2 Units cm-2 (x 10-7) Slope R2 
a 3.718 3.06 0.029 0.941 
b 4.650 3.85 0.038 0.906 
c 5.579 4.61 0.043 0.958 
d 5.935 4.91 0.043 0.961 
e 7.437 6.15 0.021  
 
 
Figure B.2-1: 
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APPENDIX C 
Additional results for section 5B.3.1.2 
Voltammetric characterization of the fabricated biosensor (prepared under 
optimized conditions): General electrochemical behaviour in anaerobic 
conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-1 CV for control sensor (GCE||naf|El-Co(Sep)
3+
|nCYP3A4|Agrs-PEI-
PVA. Experimental conditions: Scan taken in argon-degassed PBS (pH 7.45) at 
3 mV s
-1
. Scan direction: cathodically. 
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Figure 5B.12 Background-subtracted CV showing GCnafCo(Sep)3+nCYP3A4Agrs-PEI-
PVA electrode, showing biosensor response in argon-degassed PB solution. 
Conditions: ν = 3 mV s-1; scanned cathodically. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
